<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33627603</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Thrombosis and Bleeding in Extracorporeal Membrane Oxygenation (ECMO) Without Anticoagulation: A Systematic Review.</ArticleTitle><Pagination><StartPage>290</StartPage><EndPage>296</EndPage><MedlinePgn>290-296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0000000000001230</ELocationID><Abstract><AbstractText>Extracorporeal membrane oxygenation (ECMO) causes both thrombosis and bleeding. Major society guidelines recommend continuous, systemic anticoagulation to prevent thrombosis of the ECMO circuit, though this may be undesirable in those with active, or high risk of, bleeding. We aimed to systematically review thrombosis and bleeding outcomes in published cases of adults treated with ECMO without continuous systemic anticoagulation. Ovid MEDLINE, Cochrane CENTRAL and CDSR, and hand search via SCOPUS were queried. Eligible studies were independently reviewed by two blinded authors if they reported adults (&#x2265;18 years) treated with either VV- or VA-ECMO without continuous systemic anticoagulation for &#x2265;24 hours. Patient demographics, clinical data, and specifics of ECMO technology and treatment parameters were collected. Primary outcomes of interest included incidence of bleeding, thrombosis of the ECMO circuit requiring equipment exchange, patient venous or arterial thrombosis, ability to wean off of ECMO, and mortality. Of the 443 total publications identified, 34 describing 201 patients met our inclusion criteria. Most patients were treated for either acute respiratory distress syndrome or cardiogenic shock. The median duration of anticoagulant-free ECMO was 4.75 days. ECMO circuity thrombosis and patient thrombosis occurred in 27 (13.4%) and 19 (9.5%) patients, respectively. Any bleeding and major or "severe" bleeding was reported in 66 (32.8%) and 56 (27.9%) patients, respectively. Forty patients (19%) died. While limited by primarily retrospective data and inconsistent reporting of outcomes, our systematic review of anticoagulant-free ECMO reveals an incidence of circuity and patient thrombosis comparable to patients receiving continuous systemic anticoagulation while on ECMO.</AbstractText><CopyrightInformation>Copyright &#xa9; ASAIO 2020.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>Sven R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-2717-4620</Identifier><AffiliationInfo><Affiliation>From the Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphree</LastName><ForeName>Catherine R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>From the Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zonies</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Trauma &amp; Critical Care, Department of Surgery, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0001-8121-2619</Identifier><AffiliationInfo><Affiliation>From the Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Trauma &amp; Critical Care, Department of Surgery, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Critical Care, Department of Pediatrics, University of Texas Health, San Antonio, TX.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mccarty</LastName><ForeName>Owen J T</ForeName><Initials>OJT</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deloughery</LastName><ForeName>Thomas G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>From the Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shatzel</LastName><ForeName>Joseph J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>From the Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Oregon Health &amp; Science University, Portland, OR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL101972</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL144113</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL151367</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><u><i>Conflicts of interest:</i></u> Dr. Shatzel reports receiving consulting fees from Aronora Inc. The remaining authors have no conflicts to disclose</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>25</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33627603</ArticleId><ArticleId IdType="mid">NIHMS1749560</ArticleId><ArticleId IdType="pmc">PMC8623470</ArticleId><ArticleId IdType="doi">10.1097/MAT.0000000000001230</ArticleId><ArticleId IdType="pii">00002480-202103000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. Jama. 2016;315(8):788&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">26903337</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization ELS. ECLS Registry Report International Summary 2019. 2019.</Citation></Reference><Reference><Citation>Gaffey AC, Chen CW, Chung JJ, Goldberg LR, Bermudez CA, Acker MA, et al. Extracorporeal Membrane Oxygenation (ECMO) as a Bridge to Heart Transplantation: Impact on Post Transplantation Outcomes. The Journal of Heart and Lung Transplantation. 2017;36(4):S152&#x2013;S153.</Citation></Reference><Reference><Citation>Krecmerova M, Mosna F, Bicek V, Petrik F, Grandcourtova A, Lekes M, et al. Extracorporeal membrane oxygenation to support repeated whole-lung lavage in a patient with pulmonary alveolar proteinosis in life threatening dyspnoe--a case report. BMC Anesthesiol. 2015;15:173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666039</ArticleId><ArticleId IdType="pubmed">26621369</ArticleId></ArticleIdList></Reference><Reference><Citation>Barac YD, Bryner B, Bonadonna D, Wolfe C, Reynolds J, Haney JC, et al. Bilateral Pneumonectomy with Veno-Arterial Extracoporeal Membrane Oxygention as a Bridge to Lung Transplant. The Journal of Heart and Lung Transplantation.</Citation><ArticleIdList><ArticleId IdType="pubmed">31672221</ArticleId></ArticleIdList></Reference><Reference><Citation>Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. The Lancet Respiratory medicine. 2019;7(2):163&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">30642776</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engstrom AE, Lagrand WK, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive care medicine. 2016;42(12):1922&#x2013;1934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5106498</ArticleId><ArticleId IdType="pubmed">27647331</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaquer S, de Haro C, Peruga P, Oliva JC, Artigas A. Systematic review and meta-analysis of complications and mortality of veno-venous extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome. Annals of intensive care. 2017;7(1):51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5429319</ArticleId><ArticleId IdType="pubmed">28500585</ArticleId></ArticleIdList></Reference><Reference><Citation>Noah MA, Peek GJ, Finney SJ, Griffiths MJ, Harrison DA, Grieve R, et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). Jama. 2011;306(15):1659&#x2013;1668.</Citation><ArticleIdList><ArticleId IdType="pubmed">21976615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham T, Combes A, Roze H, Chevret S, Mercat A, Roch A, et al. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. American journal of respiratory and critical care medicine. 2013;187(3):276&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">23155145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in Nonorthopedic Surgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST. 2012;141(2):e227S&#x2013;e277S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Schunemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood Adv. 2018;2(22):3198&#x2013;3225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6258910</ArticleId><ArticleId IdType="pubmed">30482763</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle AJ, Hunt BJ. Current Understanding of How Extracorporeal Membrane Oxygenators Activate Haemostasis and Other Blood Components. Front Med (Lausanne). 2018;5:352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299009</ArticleId><ArticleId IdType="pubmed">30619862</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization ELS. ELSO Anticoagulation Guideline. 2014.</Citation></Reference><Reference><Citation>Hirsh J, Anand SS, Halperin JL, Fuster V. Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Circulation. 2001;103(24):2994&#x2013;3018.</Citation><ArticleIdList><ArticleId IdType="pubmed">11413093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH. 2015;13(11):2119&#x2013;2126.</Citation><ArticleIdList><ArticleId IdType="pubmed">26764429</ArticleId></ArticleIdList></Reference><Reference><Citation>Factora FN, Bustamante S, Spiotta A, Avitsian R. Intracranial hemorrhage surgery on patients on mechanical circulatory support: a case series. J Neurosurg Anesthesiol. 2011;23(1):30&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">20706140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion. 2015;30(8):675&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">25823366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalbhenn J, Schlagenhauf A, Rosenfelder S, Schmutz A, Zieger B. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018;37(8):985&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">29650295</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J, Kostousov V, Teruya J. Bleeding and Thrombotic Complications in the Use of Extracorporeal Membrane Oxygenation. Semin Thromb Hemost. 2018;44(1):20&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">28898902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ontaneda A, Annich GM. Novel Surfaces in Extracorporeal Membrane Oxygenation Circuits. Front Med (Lausanne). 2018;5:321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6256321</ArticleId><ArticleId IdType="pubmed">30525038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, et al. Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. Eur J Cardiothorac Surg. 2007;31(6):1058&#x2013;1069.</Citation><ArticleIdList><ArticleId IdType="pubmed">17306555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S. A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome. The Annals of Thoracic Surgery. 2009;87(4):1311&#x2013;1319.</Citation><ArticleIdList><ArticleId IdType="pubmed">19324190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn N, Marcoux J, Mycyk T, Krahn J, Meng Q. The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Perfusion. 2009;24(4):231&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">19858237</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer AD, Rishmawi AR, Kamucheka R, Lafleur C, Batchinsky AI, Mackman N, et al. Effect of Blood Flow on Platelets, Leukocytes, and Extracellular Vesicles in Thrombosis of Simulated Neonatal Extracorporeal Circulation. Journal of thrombosis and haemostasis : JTH. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7350929</ArticleId><ArticleId IdType="pubmed">31628728</ArticleId></ArticleIdList></Reference><Reference><Citation>Annich GM, Zaulan O, Neufeld M, Wagner D, Reynolds MM. Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions. Am J Cardiovasc Drugs. 2017;17(6):425&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">28536932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JJ-M, Lam JCM, Mok YH, Lee JH. Anticoagulation in extracorporeal membrane oxygenation. Journal of Emergency and Critical Care Medicine. 2018;2(2).</Citation></Reference><Reference><Citation>Matafonov A, Leung PY, Gailani AE, Grach SL, Puy C, Cheng Q, et al. Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood. 2014;123(11):1739&#x2013;1746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954054</ArticleId><ArticleId IdType="pubmed">24408325</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson M, Rayzman V, Nolte MW, Nickel KF, Bjorkqvist J, Jamsa A, et al. A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med. 2014;6(222):222ra217.</Citation><ArticleIdList><ArticleId IdType="pubmed">24500405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood. 2010;116(19):3981&#x2013;3989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2981546</ArticleId><ArticleId IdType="pubmed">20634381</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLoughery EP, Olson SR, Puy C, McCarty OJT, Shatzel JJ. The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials. Semin Thromb Hemost. 2019;45(5):502&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6657806</ArticleId><ArticleId IdType="pubmed">31216587</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization ELS. ECLS Registry Report International Summary 2017. 2017.</Citation></Reference><Reference><Citation>Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15(3):172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">23944202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sy E, Sklar MC, Lequier L, Fan E, Kanji HD. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. J Crit Care. 2017;39:87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">28237895</ArticleId></ArticleIdList></Reference><Reference><Citation>Makdisi G, Makdisi T, Wang IW. Use of distal perfusion in peripheral extracorporeal membrane oxygenation. Ann Transl Med. 2017;5(5):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5360617</ArticleId><ArticleId IdType="pubmed">28361068</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27520452</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>The value of blood lactate kinetics in critically ill patients: a systematic review.</ArticleTitle><Pagination><StartPage>257</StartPage><MedlinePgn>257</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">257</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-016-1403-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The time course of blood lactate levels could be helpful to assess a patient's response to therapy. Although the focus of published studies has been largely on septic patients, many other studies have reported serial blood lactate levels in different groups of acutely ill patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic search of PubMed, Science Direct, and Embase until the end of February 2016 plus reference lists of relevant publications. We selected all observational and interventional studies that evaluated the capacity of serial blood lactate concentrations to predict outcome. There was no restriction based on language. We excluded studies in pediatric populations, experimental studies, and studies that did not report changes in lactate values or all-cause mortality rates. We separated studies according to the type of patients included. We collected data on the number of patients, timing of lactate measurements, minimum lactate level needed for inclusion if present, and suggested time interval for predictive use.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 96 studies met our criteria: 14 in general ICU populations, five in general surgical ICU populations, five in patients post cardiac surgery, 14 in trauma patients, 39 in patients with sepsis, four in patients with cardiogenic shock, eight in patients after cardiac arrest, three in patients with respiratory failure, and four in other conditions. A decrease in lactate levels over time was consistently associated with lower mortality rates in all subgroups of patients. Most studies reported changes over 6, 12 or 24&#xa0;hrs, fewer used shorter time intervals. Lactate kinetics did not appear very different in patients with sepsis and other types of patients. A few studies suggested that therapy could be guided by these measurements.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The observation of a better outcome associated with decreasing blood lactate concentrations was consistent throughout the clinical studies, and was not limited to septic patients. In all groups, the changes are relatively slow, so that lactate measurements every 1-2 hrs are probably sufficient in most acute conditions. The value of lactate kinetics appears to be valid regardless of the initial value.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium. jlvincent@intensive.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintairos E Silva</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couto</LastName><ForeName>L&#xfa;cio</ForeName><Initials>L</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taccone</LastName><ForeName>Fabio S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27520452</ArticleId><ArticleId IdType="pmc">PMC4983759</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1403-5</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1403-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Broder G, Weil MH. Excess lactate: an index of reversibility of shock in human patients. Science. 1964;143:1457&#x2013;9. doi: 10.1126/science.143.3613.1457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.143.3613.1457</ArticleId><ArticleId IdType="pubmed">14107454</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock) Circulation. 1970;41:989&#x2013;1001. doi: 10.1161/01.CIR.41.6.989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.41.6.989</ArticleId><ArticleId IdType="pubmed">5482913</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretz DI, McGregor M, Dossetor JB. Lactic acidosis: a clinically significant aspect of shock. Can Med Assoc J. 1964;90:673&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1922420</ArticleId><ArticleId IdType="pubmed">14127378</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726&#x2013;34. doi: 10.1056/NEJMra1208943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208943</ArticleId><ArticleId IdType="pubmed">24171518</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12:315&#x2013;21. doi: 10.1097/01.ccx.0000235208.77450.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccx.0000235208.77450.15</ArticleId><ArticleId IdType="pubmed">16810041</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14:R25. doi: 10.1186/cc8888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8888</ArticleId><ArticleId IdType="pmc">PMC2875540</ArticleId><ArticleId IdType="pubmed">20181242</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;10. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309&#x2013;19. doi: 10.1056/NEJMra1309483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1309483</ArticleId><ArticleId IdType="pubmed">25494270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40:1795&#x2013;815. doi: 10.1007/s00134-014-3525-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3525-z</ArticleId><ArticleId IdType="pmc">PMC4239778</ArticleId><ArticleId IdType="pubmed">25392034</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol A, Bailey M, Egi M, Pettila V, French C, Stachowski E, et al. Dynamic lactate indices as predictors of outcome in critically ill patients. Crit Care. 2011;15:R242. doi: 10.1186/cc10497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10497</ArticleId><ArticleId IdType="pmc">PMC3334793</ArticleId><ArticleId IdType="pubmed">22014216</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas SA, Lange T, Saugel B, Petzoldt M, Fuhrmann V, Metschke M, et al. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42:202&#x2013;10. doi: 10.1007/s00134-015-4127-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4127-0</ArticleId><ArticleId IdType="pubmed">26556617</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Dufaye P, Berre J, Leeman M, Degaute JP, Kahn RJ. Serial lactate determinations during circulatory shock. Crit Care Med. 1983;11:449&#x2013;51. doi: 10.1097/00003246-198306000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198306000-00012</ArticleId><ArticleId IdType="pubmed">6406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Orringer CE, Eustace JC, Wunsch CD, Gardner LB. Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med. 1977;297:796&#x2013;9. doi: 10.1056/NEJM197710132971502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197710132971502</ArticleId><ArticleId IdType="pubmed">19702</ArticleId></ArticleIdList></Reference><Reference><Citation>Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052&#x2013;9. doi: 10.1097/00000539-200005000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200005000-00010</ArticleId><ArticleId IdType="pubmed">10781452</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182:752&#x2013;61. doi: 10.1164/rccm.200912-1918OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200912-1918OC</ArticleId><ArticleId IdType="pubmed">20463176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739&#x2013;46. doi: 10.1001/jama.2010.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.158</ArticleId><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock. 2015;43:55&#x2013;61. doi: 10.1097/SHK.0000000000000260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000260</ArticleId><ArticleId IdType="pmc">PMC4269567</ArticleId><ArticleId IdType="pubmed">25186838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Kuan WS, Batech M, Shrikhande P, Mahadevan M, Li CH, et al. Outcome effectiveness of the severe sepsis resuscitation bundle with addition of lactate clearance as a bundle item: a multi-national evaluation. Crit Care. 2011;15:R229. doi: 10.1186/cc10469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10469</ArticleId><ArticleId IdType="pmc">PMC3334775</ArticleId><ArticleId IdType="pubmed">21951322</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL. Serial blood lactate levels reflect both lactate production and clearance. Crit Care Med. 2015;43:e209. doi: 10.1097/CCM.0000000000000906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000906</ArticleId><ArticleId IdType="pubmed">25978172</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL. Lactic acidosis. N Engl J Med. 2015;372:1077&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25760371</ArticleId></ArticleIdList></Reference><Reference><Citation>Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998;157:1021&#x2013;6. doi: 10.1164/ajrccm.157.4.9705037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.157.4.9705037</ArticleId><ArticleId IdType="pubmed">9563714</ArticleId></ArticleIdList></Reference><Reference><Citation>Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC, Berger MM, et al. Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med. 2005;33:2235&#x2013;40. doi: 10.1097/01.CCM.0000181525.99295.8F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000181525.99295.8F</ArticleId><ArticleId IdType="pubmed">16215376</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan BN, Burns HJ, Boyle P, Ledingham IM. The relative prognostic value of lactate and haemodynamic measurements in early shock. Anaesthesia. 1984;39:750&#x2013;5. doi: 10.1111/j.1365-2044.1984.tb06516.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.1984.tb06516.x</ArticleId><ArticleId IdType="pubmed">6476309</ArticleId></ArticleIdList></Reference><Reference><Citation>Suistomaa M, Ruokonen E, Kari A, Takala J. Time-pattern of lactate and lactate to pyruvate ratio in the first 24&#xa0;hrs of intensive care emergency admissions. Shock. 2000;14:8&#x2013;12. doi: 10.1097/00024382-200014010-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00024382-200014010-00002</ArticleId><ArticleId IdType="pubmed">10909886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wu DW, Chen XM, Li C, Ding SF, Zhai Q, et al. Relationship between blood lactic level, lactic clearance, duration of lacticemia and prognosis of critically ill patients in intensive care unit. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21:357&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19570343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Mulder PG, Lima AP, van der Hoven B, Rommes JH, et al. Prognostic value of blood lactate levels: does the clinical diagnosis at admission matter? J Trauma. 2009;66:377&#x2013;85. doi: 10.1097/TA.0b013e3181648e2f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181648e2f</ArticleId><ArticleId IdType="pubmed">19204510</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna U, Joshi SP, Modh M. An evaluation of serial blood lactate measurement as an early predictor of shock and its outcome in patients of trauma or sepsis. Indian J Crit Care Med. 2009;13:66&#x2013;73. doi: 10.4103/0972-5229.56051.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-5229.56051</ArticleId><ArticleId IdType="pmc">PMC2772249</ArticleId><ArticleId IdType="pubmed">19881186</ArticleId></ArticleIdList></Reference><Reference><Citation>Soliman HM, Vincent JL. Prognostic value of admission serum lactate concentrations in intensive care unit patients. Acta Clin Belg. 2010;65:176&#x2013;81. doi: 10.1179/acb.2010.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/acb.2010.037</ArticleId><ArticleId IdType="pubmed">20669785</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beest PA, Brander L, Jansen SP, Rommes JH, Kuiper MA, Spronk PE. Cumulative lactate and hospital mortality in ICU patients. Ann Intensive Care. 2013;3:6. doi: 10.1186/2110-5820-3-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-3-6</ArticleId><ArticleId IdType="pmc">PMC3599274</ArticleId><ArticleId IdType="pubmed">23446002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Chen K, Ni H, Fan H. Predictive value of lactate in unselected critically ill patients: an analysis using fractional polynomials. J Thorac Dis. 2014;6:995&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4120171</ArticleId><ArticleId IdType="pubmed">25093098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Mulder PG, Rommes JH, Schieveld SJ, Bakker J. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care. 2008;12:R160. doi: 10.1186/cc7159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7159</ArticleId><ArticleId IdType="pmc">PMC2646325</ArticleId><ArticleId IdType="pubmed">19091118</ArticleId></ArticleIdList></Reference><Reference><Citation>McNelis J, Marini CP, Jurkiewicz A, Szomstein S, Simms HH, Ritter G, et al. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 2001;182:481&#x2013;5. doi: 10.1016/S0002-9610(01)00755-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(01)00755-3</ArticleId><ArticleId IdType="pubmed">11754855</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003;185:485&#x2013;91. doi: 10.1016/S0002-9610(03)00044-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(03)00044-8</ArticleId><ArticleId IdType="pubmed">12727572</ArticleId></ArticleIdList></Reference><Reference><Citation>Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care. 2004;8:R60&#x2013;5. doi: 10.1186/cc2423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2423</ArticleId><ArticleId IdType="pmc">PMC420024</ArticleId><ArticleId IdType="pubmed">15025779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinal Fernandez PA, Olano E, Acosta C, Bertullo H, Albornoz H, Bagnulo H. Prognostic value of lactate clearance in the first 6&#xa0;hrs of intensive medicine course. Med Intensiva. 2009;33:166&#x2013;70. doi: 10.1016/S0210-5691(09)71212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0210-5691(09)71212-4</ArticleId><ArticleId IdType="pubmed">19558937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim WA, Ahmed AS. Serial estimations of blood lactate predict postoperative outcome in cancer patients undergoing head and neck surgeries. Egyptian J Anaesth. 2013;29:149&#x2013;54. doi: 10.1016/j.egja.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.egja.2012.10.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsay AJ, Xu M, Sessler DI, Blackstone EH, Bashr CA. Lactate clearance time and concentration linked to morbidity and death in cardiac surgical patients. Ann Thorac Surg. 2013;95:486&#x2013;92. doi: 10.1016/j.athoracsur.2012.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.07.020</ArticleId><ArticleId IdType="pubmed">22959571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Almeida JP, Fukushima JT, Rhodes A, Vincent JL, Osawa EA, et al. High lactate levels are predictors of major complications after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146:455&#x2013;60. doi: 10.1016/j.jtcvs.2013.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.02.003</ArticleId><ArticleId IdType="pubmed">23507124</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SJ, Kim SP, Kim JB, Jung SH, Choo SJ, Chung CH, et al. Blood lactate level during extracorporeal life support as a surrogate marker for survival. J Thorac Cardiovasc Surg. 2014;148:714&#x2013;20. doi: 10.1016/j.jtcvs.2014.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.02.078</ArticleId><ArticleId IdType="pubmed">24685378</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Delgado JC, Esteve F, Javierre C, Torrado H, Rodriguez-Castro D, Carrio ML, et al. Evaluation of serial arterial lactate levels as a predictor of hospital and long-term mortality in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29:1441&#x2013;53. doi: 10.1053/j.jvca.2015.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.04.024</ArticleId><ArticleId IdType="pubmed">26321121</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study. J Thorac Cardiovasc Surg. 2015;149:1445&#x2013;50. doi: 10.1016/j.jtcvs.2014.11.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.11.052</ArticleId><ArticleId IdType="pubmed">25534305</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramson D, Scalea TM, Hitchcock R, Trooskin SZ, Henry SM, Greenspan J. Lactate clearance and survival following injury. J Trauma. 1993;35:584&#x2013;8. doi: 10.1097/00005373-199310000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199310000-00014</ArticleId><ArticleId IdType="pubmed">8411283</ArticleId></ArticleIdList></Reference><Reference><Citation>Manikis P, Jankowski S, Zhang H, Kahn RJ, Vincent JL. Correlation of serial blood lactate levels to organ failure and mortality after trauma. Am J Emerg Med. 1995;13:619&#x2013;22. doi: 10.1016/0735-6757(95)90043-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-6757(95)90043-8</ArticleId><ArticleId IdType="pubmed">7575797</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm C, Melcer B, Horbrand F, Worl HH, von Donnersmarck GH, Muhlbauer W. Haemodynamic and oxygen transport responses in survivors and non-survivors following thermal injury. Burns. 2000;26:25&#x2013;33. doi: 10.1016/S0305-4179(99)00095-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0305-4179(99)00095-9</ArticleId><ArticleId IdType="pubmed">10630316</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerovic O, Golubovic V, Spec-Marn A, Kremzar B, Vidmar G. Relationship between injury severity and lactate levels in severely injured patients. Intensive Care Med. 2003;29:1300&#x2013;5. doi: 10.1007/s00134-003-1753-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1753-8</ArticleId><ArticleId IdType="pubmed">12904861</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamolz LP, Andel H, Schramm W, Meissl G, Herndon DN, Frey M. Lactate: early predictor of morbidity and mortality in patients with severe burns. Burns. 2005;31:986&#x2013;90. doi: 10.1016/j.burns.2005.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2005.06.019</ArticleId><ArticleId IdType="pubmed">16274931</ArticleId></ArticleIdList></Reference><Reference><Citation>Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hr lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558&#x2013;66. doi: 10.1007/s00268-008-9896-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-008-9896-y</ArticleId><ArticleId IdType="pubmed">19148699</ArticleId></ArticleIdList></Reference><Reference><Citation>Regnier MA, Raux M, Le MY, Asencio Y, Gaillard J, Devilliers C, et al. Prognostic significance of blood lactate and lactate clearance in trauma patients. Anesthesiology. 2012;117:1276&#x2013;88. doi: 10.1097/ALN.0b013e318273349d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318273349d</ArticleId><ArticleId IdType="pubmed">23168430</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubendorfer C, Billeter AT, Seifert B, Keel M, Turina M. Serial lactate and admission SOFA scores in trauma: an analysis of predictive value in 724 patients with and without traumatic brain injury. Eur J Trauma Emerg Surg. 2013;39:25&#x2013;34. doi: 10.1007/s00068-012-0212-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00068-012-0212-z</ArticleId><ArticleId IdType="pubmed">26814920</ArticleId></ArticleIdList></Reference><Reference><Citation>Odom SR, Howell MD, Silva GS, Nielsen VM, Gupta A, Shapiro NI, et al. Lactate clearance as a predictor of mortality in trauma patients. J Trauma Acute Care Surg. 2013;74:999&#x2013;1004. doi: 10.1097/TA.0b013e3182858a3e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3182858a3e</ArticleId><ArticleId IdType="pubmed">23511137</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinonen E, Hardcastle TC, Barle H, Muckart DJ. Lactate clearance predicts outcome after major trauma. Afr J Emerg Med. 2014;4:61&#x2013;5. doi: 10.1016/j.afjem.2013.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.afjem.2013.11.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas AD, Franzon O. Lactate as predictor of mortality in polytrauma. Arq Bras Cir Dig. 2015;28:163&#x2013;6. doi: 10.1590/S0102-67202015000300004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0102-67202015000300004</ArticleId><ArticleId IdType="pmc">PMC4737353</ArticleId><ArticleId IdType="pubmed">26537138</ArticleId></ArticleIdList></Reference><Reference><Citation>Dezman ZD, Comer AC, Smith GS, Narayan M, Scalea TM, Hirshon JM. Failure to clear elevated lactate predicts 24-hr mortality in trauma patients. J Trauma Acute Care Surg. 2015;79:580&#x2013;5. doi: 10.1097/TA.0000000000000810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0000000000000810</ArticleId><ArticleId IdType="pmc">PMC4586044</ArticleId><ArticleId IdType="pubmed">26402531</ArticleId></ArticleIdList></Reference><Reference><Citation>Roumen RM, Redl H, Schlag G, Sandtner W, Koller W, Goris RJ. Scoring systems and blood lactate concentrations in relation to the development of adult respiratory distress syndrome and multiple organ failure in severely traumatized patients. J Trauma. 1993;35:349&#x2013;55. doi: 10.1097/00005373-199309000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199309000-00004</ArticleId><ArticleId IdType="pubmed">8371291</ArticleId></ArticleIdList></Reference><Reference><Citation>Blow O, Magliore L, Claridge JA, Butler K, Young JS. The golden hr and the silver day: detection and correction of occult hypoperfusion within 24&#xa0;hrs improves outcome from major trauma. J Trauma. 1999;47:964&#x2013;9. doi: 10.1097/00005373-199911000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-199911000-00028</ArticleId><ArticleId IdType="pubmed">10568731</ArticleId></ArticleIdList></Reference><Reference><Citation>Claridge JA, Crabtree TD, Pelletier SJ, Butler K, Sawyer RG, Young JS. Persistent occult hypoperfusion is associated with a significant increase in infection rate and mortality in major trauma patients. J Trauma. 2000;48:8&#x2013;14. doi: 10.1097/00005373-200001000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200001000-00003</ArticleId><ArticleId IdType="pubmed">10647559</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker J, Coffernils M, Leon M, Gris P, Vincent JL. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest. 1991;99:956&#x2013;62. doi: 10.1378/chest.99.4.956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.99.4.956</ArticleId><ArticleId IdType="pubmed">2009802</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman G, Berlot G, Kahn RJ, Vincent JL. Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med. 1995;23:1184&#x2013;93. doi: 10.1097/00003246-199507000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199507000-00006</ArticleId><ArticleId IdType="pubmed">7600825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17&#x2013;25. doi: 10.1007/BF01728326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01728326</ArticleId><ArticleId IdType="pubmed">8857433</ArticleId></ArticleIdList></Reference><Reference><Citation>Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent JL. Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med. 1996;22:404&#x2013;8. doi: 10.1007/BF01712155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01712155</ArticleId><ArticleId IdType="pubmed">8796390</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996;171:221&#x2013;6. doi: 10.1016/S0002-9610(97)89552-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9610(97)89552-9</ArticleId><ArticleId IdType="pubmed">8619454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi S, Gando S, Morimoto Y, Nanzaki S, Kemmotsu O. Serial measurement of arterial lactate concentrations as a prognostic indicator in relation to the incidence of disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. Surg Today. 2001;31:853&#x2013;9. doi: 10.1007/s005950170022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s005950170022</ArticleId><ArticleId IdType="pubmed">11759877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637&#x2013;42. doi: 10.1097/01.CCM.0000132904.35713.A7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000132904.35713.A7</ArticleId><ArticleId IdType="pubmed">15286537</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35:1105&#x2013;12. doi: 10.1097/01.CCM.0000259463.33848.3D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000259463.33848.3D</ArticleId><ArticleId IdType="pubmed">17334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J, Koay ES, Lee KH. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock. 2008;29:328&#x2013;33. doi: 10.1097/SHK.0b013e318150716b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318150716b</ArticleId><ArticleId IdType="pubmed">18277855</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CS, Qiu HB, Huang YZ, Xie JF, Mo M, Liu SQ, et al. Prospective research on the prognosis of septic shock based on the change of lactate concentration in arterial blood. Zhonghua Wai Ke Za Zhi. 2009;47:685&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19615239</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32:35&#x2013;9. doi: 10.1097/SHK.0b013e3181971d47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181971d47</ArticleId><ArticleId IdType="pubmed">19533847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Loomba M, Yang JJ, Jacobsen G, Shah K, Otero RM, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) 2010;7:6. doi: 10.1186/1476-9255-7-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-7-6</ArticleId><ArticleId IdType="pmc">PMC2837000</ArticleId><ArticleId IdType="pubmed">20181046</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Heffner AC, Kline JA, et al. Prognostic value and agreement of achieving lactate clearance or central venous oxygen saturation goals during early sepsis resuscitation. Acad Emerg Med. 2012;19:252&#x2013;8. doi: 10.1111/j.1553-2712.2012.01292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2012.01292.x</ArticleId><ArticleId IdType="pmc">PMC3313083</ArticleId><ArticleId IdType="pubmed">22435856</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanaty OM, Megahed M, Demerdash H, Swelem R. Delta neutrophil index versus lactate clearance: early markers for outcome prediction in septic shock patients. Alex J Med. 2012;48:327&#x2013;33. doi: 10.1016/j.ajme.2012.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajme.2012.05.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, Albers AB, Heffner AC, Kline JA, et al. Whole blood lactate kinetics in patients undergoing quantitative resuscitation for severe sepsis and septic shock. Chest. 2013;143:1548&#x2013;53. doi: 10.1378/chest.12-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-0878</ArticleId><ArticleId IdType="pmc">PMC3673659</ArticleId><ArticleId IdType="pubmed">23740148</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker CA, Griffith DM, Gray AJ, Datta D, Hay AW. Early lactate clearance in septic patients with elevated lactate levels admitted from the emergency department to intensive care: time to aim higher? J Crit Care. 2013;28:832&#x2013;7. doi: 10.1016/j.jcrc.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2013.02.004</ArticleId><ArticleId IdType="pubmed">23602032</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu V, Morehouse JW, Soule J, Whippy A, Escobar GJ. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc. 2013;10:466&#x2013;73. doi: 10.1513/AnnalsATS.201304-099OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201304-099OC</ArticleId><ArticleId IdType="pmc">PMC5475420</ArticleId><ArticleId IdType="pubmed">24004068</ArticleId></ArticleIdList></Reference><Reference><Citation>Marty P, Roquilly A, Vallee F, Luzi A, Ferre F, Fourcade O, et al. Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24&#xa0;hrs in intensive care unit: an observational study. Ann Intensive Care. 2013;3:3. doi: 10.1186/2110-5820-3-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-3-3</ArticleId><ArticleId IdType="pmc">PMC3614435</ArticleId><ArticleId IdType="pubmed">23398782</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Lee J, Park YS, Lee CH, Lee SM, Yim JJ, et al. Prognostic value of central venous oxygen saturation and blood lactate levels measured simultaneously in the same patients with severe systemic inflammatory response syndrome and severe sepsis. Lung. 2014;192:435&#x2013;40. doi: 10.1007/s00408-014-9564-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-014-9564-y</ArticleId><ArticleId IdType="pubmed">24549333</ArticleId></ArticleIdList></Reference><Reference><Citation>Permpikul C, Sringam P, Tongyoo S. Therapeutic goal achievements during severe sepsis and septic shock resuscitation and their association with patients' outcomes. J Med Assoc Thai. 2014;97(Suppl 3):S176&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24772596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L, Zhang M, Yan P, Wu X, Shao J, Zheng R. Retrospective analysis of the value of arterial blood lactate level and its clearance rate on the prognosis of septic shock patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:38&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">25591435</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbois A, Bige N, Pichereau C, Boelle PY, Baudel JL, Bourcier S, et al. Exploration of skin perfusion in cirrhotic patients with septic shock. J Hepatol. 2015;62:549&#x2013;55. doi: 10.1016/j.jhep.2014.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.10.012</ArticleId><ArticleId IdType="pubmed">25457199</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Kim SE, Kim EB, Jeong HJ, Son YK, An WS. Lactate clearance and vasopressor seem to be predictors for mortality in severe sepsis patients with lactic acidosis supplementing sodium bicarbonate: a retrospective analysis. PLoS One. 2015;10:e0145181. doi: 10.1371/journal.pone.0145181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145181</ArticleId><ArticleId IdType="pmc">PMC4686961</ArticleId><ArticleId IdType="pubmed">26692209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokhandwala S, Moskowitz A, Lawniczak R, Giberson T, Cocchi MN, Donnino MW. Disease heterogeneity and risk stratification in sepsis-related occult hypoperfusion: a retrospective cohort study. J Crit Care. 2015;30:531&#x2013;6. doi: 10.1016/j.jcrc.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.01.009</ArticleId><ArticleId IdType="pmc">PMC4414712</ArticleId><ArticleId IdType="pubmed">25708119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li Z, Yin M, Chen XM, Ding SF, Li C, et al. Combination of Acute Physiology and Chronic Health Evaluation II score, early lactate area, and N-terminal prohormone of brain natriuretic peptide levels as a predictor of mortality in geriatric patients with septic shock. J Crit Care. 2015;30:304&#x2013;9. doi: 10.1016/j.jcrc.2014.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2014.11.013</ArticleId><ArticleId IdType="pubmed">25499413</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat SR, Swenson KE, Francis MW, Wira CR. Lactate clearance predicts survival among patients in the emergency department with severe sepsis. West J Emerg Med. 2015;16:1118&#x2013;26. doi: 10.5811/westjem.2015.10.27577.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2015.10.27577</ArticleId><ArticleId IdType="pmc">PMC4703153</ArticleId><ArticleId IdType="pubmed">26759665</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertoff J, Chisum M, Simmons L, King B, Walker M, Lascano J. Prognostic utility of plasma lactate measured between 24 and 48&#xa0;h after initiation of early goal-directed therapy in the management of sepsis, severe sepsis, and septic shock. J Intensive Care. 2016;4:13. doi: 10.1186/s40560-016-0142-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-016-0142-7</ArticleId><ArticleId IdType="pmc">PMC4751685</ArticleId><ArticleId IdType="pubmed">26877875</ArticleId></ArticleIdList></Reference><Reference><Citation>Drumheller BC, Agarwal A, Mikkelsen ME, Sante SC, Weber AL, Goyal M, et al. Risk factors for mortality despite early protocolized resuscitation for severe sepsis and septic shock in the emergency department. J Crit Care. 2016;31:13&#x2013;20. doi: 10.1016/j.jcrc.2015.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.10.015</ArticleId><ArticleId IdType="pubmed">26611382</ArticleId></ArticleIdList></Reference><Reference><Citation>He HW, Liu DW, Long Y, Wang XT. High central venous-to-arterial CO2 difference/arterial-central venous O2 difference ratio is associated with poor lactate clearance in septic patients after resuscitation. J Crit Care. 2016;31:76&#x2013;81. doi: 10.1016/j.jcrc.2015.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.10.017</ArticleId><ArticleId IdType="pubmed">26640138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha TS, Shin TG, Jo IJ, Hwang SY, Chung CR, Suh GY et al. Lactate clearance and mortality in septic patients with hepatic dysfunction. Am J Emerg Med. 2016;34:1011&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">26976769</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolvardi E, Malmir J, Reihani H, Hashemian AM, Bahramian M, Khademhosseini P, et al. The role of lactate clearance as a predictor of organ dysfunction and mortality in patients with severe sepsis. Mater Sociomed. 2016;28:57&#x2013;60. doi: 10.5455/msm.2016.28.57-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/msm.2016.28.57-60</ArticleId><ArticleId IdType="pmc">PMC4789646</ArticleId><ArticleId IdType="pubmed">27047270</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir A, Saulters KJ, Olum S, Pitts K, Parsons A, Churchill C et al. Outcomes of patients with severe sepsis after the first 6 hrs of resuscitation at a regional referral hospital in Uganda. J Crit Care. 2016;33:78&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26994777</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian HH, Han SS, Lv CJ, Wang T, Li Z, Hao D, et al. The effect of early goal lactate clearance rate on the outcome of septic shock patients with severe pneumonia. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012;24:42&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22248751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B, Tian HY, Hu ZJ, Zhao C, Liu LX, Zhang Y, et al. Comparison of the effect of fluid resuscitation as guided either by lactate clearance rate or by central venous oxygen saturation in patients with sepsis. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013;25:578&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">24119693</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu X, Xu Q, Cai G, Yan J, Yan M. Efficacies of fluid resuscitation as guided by lactate clearance rate and central venous oxygen saturation in patients with septic shock. Zhonghua Yi Xue Za Zhi. 2015;95:496&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">25916923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan WS, Ibrahim I, Leong BS, Jain S, Lu Q, Cheung YB, et al. Emergency department management of sepsis patients: a randomized, goal-oriented, noninvasive sepsis trial. Ann Emerg Med. 2016;67:367&#x2013;78. doi: 10.1016/j.annemergmed.2015.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2015.09.010</ArticleId><ArticleId IdType="pubmed">26475246</ArticleId></ArticleIdList></Reference><Reference><Citation>Attana P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Lactate clearance in cardiogenic shock following ST elevation myocardial infarction: a pilot study. Acute Card Care. 2012;14:20&#x2013;6. doi: 10.3109/17482941.2011.655293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482941.2011.655293</ArticleId><ArticleId IdType="pubmed">22356569</ArticleId></ArticleIdList></Reference><Reference><Citation>Attana P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction. Acute Card Care. 2013;15:58&#x2013;62. doi: 10.3109/17482941.2013.776691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482941.2013.776691</ArticleId><ArticleId IdType="pubmed">23806089</ArticleId></ArticleIdList></Reference><Reference><Citation>Park TK, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, et al. Clinical outcomes of patients with acute myocardial infarction complicated by severe refractory cardiogenic shock assisted with percutaneous cardiopulmonary support. Yonsei Med J. 2014;55:920&#x2013;7. doi: 10.3349/ymj.2014.55.4.920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2014.55.4.920</ArticleId><ArticleId IdType="pmc">PMC4075395</ArticleId><ArticleId IdType="pubmed">24954319</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther S, Theiss HD, Fischer M, Sattler S, Peterss S, Born F, et al. Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team. Interact Cardiovasc Thorac Surg. 2014;18:283&#x2013;91. doi: 10.1093/icvts/ivt505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivt505</ArticleId><ArticleId IdType="pmc">PMC3930215</ArticleId><ArticleId IdType="pubmed">24336784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliegel A, Losert H, Sterz F, Holzer M, Zeiner A, Havel C, et al. Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore) 2004;83:274&#x2013;9. doi: 10.1097/01.md.0000141098.46118.4c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000141098.46118.4c</ArticleId><ArticleId IdType="pubmed">15342971</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Miller J, Goyal N, Loomba M, Sankey SS, Dolcourt B, et al. Effective lactate clearance is associated with improved outcome in post-cardiac arrest patients. Resuscitation. 2007;75:229&#x2013;34. doi: 10.1016/j.resuscitation.2007.03.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2007.03.021</ArticleId><ArticleId IdType="pubmed">17583412</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnalich F, Menendez M, Lagos V, Ciria E, Quesada A, Codoceo R, et al. Prognostic value of cell-free plasma DNA in patients with cardiac arrest outside the hospital: an observational cohort study. Crit Care. 2010;14:R47. doi: 10.1186/cc8934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8934</ArticleId><ArticleId IdType="pmc">PMC2887159</ArticleId><ArticleId IdType="pubmed">20350299</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B, et al. Extracorporeal life support following out-of-hospital refractory cardiac arrest. Crit Care. 2011;15:R29. doi: 10.1186/cc9976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9976</ArticleId><ArticleId IdType="pmc">PMC3222065</ArticleId><ArticleId IdType="pubmed">21244674</ArticleId></ArticleIdList></Reference><Reference><Citation>Starodub R, Abella BS, Grossestreuer AV, Shofer FS, Perman SM, Leary M, et al. Association of serum lactate and survival outcomes in patients undergoing therapeutic hypothermia after cardiac arrest. Resuscitation. 2013;84:1078&#x2013;82. doi: 10.1016/j.resuscitation.2013.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2013.02.001</ArticleId><ArticleId IdType="pubmed">23402966</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Andersen LW, Giberson T, Gaieski DF, Abella BS, Peberdy MA, et al. Initial lactate and lactate change in post-cardiac arrest: a multicenter validation study. Crit Care Med. 2014;42:1804&#x2013;11. doi: 10.1097/CCM.0000000000000332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000332</ArticleId><ArticleId IdType="pmc">PMC4154535</ArticleId><ArticleId IdType="pubmed">24776606</ArticleId></ArticleIdList></Reference><Reference><Citation>Riveiro DF, de Oliveira VM, Braunner JS, Vieira SR. Evaluation of serum lactate, central venous saturation, and venous-arterial carbon dioxide difference in the prediction of mortality in postcardiac arrest syndrome. J Intensive Care Med. 2015. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">26112759</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TA, Martin R, Celenza A, Bremner A, Fatovich D, Krause J, et al. Use of serum lactate levels to predict survival for patients with out-of-hospital cardiac arrest: a cohort study. Emerg Med Australas. 2016;28:171&#x2013;8. doi: 10.1111/1742-6723.12560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1742-6723.12560</ArticleId><ArticleId IdType="pubmed">26929190</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YF, Lin Y, Zhu XL. Clinical significance of early lactate clearance rate in patients with respiratory failure. Zhonghua Jie He He Hu Xi Za Zhi. 2010;33:183&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20450636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WH, Niu YY, Zhang CR, Xiao LB, Ye HS, Pan DM, et al. Combined APACH II score and arterial blood lactate clearance rate to predict the prognosis of ARDS patients. Asian Pac J Trop Med. 2012;5:656&#x2013;60. doi: 10.1016/S1995-7645(12)60134-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1995-7645(12)60134-5</ArticleId><ArticleId IdType="pubmed">22840456</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang Z, Xu H, Dong L, Gao F, Yan J. Prognostic significance of early lactate clearance rate for severe acute respiratory failure patients on extracorporeal membrane oxygenation. Zhonghua Jie He He Hu Xi Za Zhi. 2014;37:197&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pubmed">24809711</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu XW, Ma T, Qu B, Ji Y, Liu Z. Prognostic value of initial arterial lactate level and lactate metabolic clearance rate in patients with acute paraquat poisoning. Am J Emerg Med. 2013;31:1230&#x2013;5. doi: 10.1016/j.ajem.2013.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2013.04.019</ArticleId><ArticleId IdType="pubmed">23706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JF, Wu RY, Chen J, Ou-Yang B, Chen MY, Guan XD. Early lactate clearance as a reliable predictor of initial poor graft function after orthotopic liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:587&#x2013;92. doi: 10.1016/S1499-3872(11)60100-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1499-3872(11)60100-8</ArticleId><ArticleId IdType="pubmed">22146621</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, Antonaglia V, Guiotto G, Paladino F, Schiraldi F. Two-hr lactate clearance predicts negative outcome in patients with cardiorespiratory insufficiency. Crit Care Res Pract. 2010;2010:917053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2958677</ArticleId><ArticleId IdType="pubmed">20981271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed KAE, Ahmed DAE. Prognostic value of lactate clearance in severe community-acquired pneumonia. Egypt J Chest Dis Tuberc. 2014;63:1053&#x2013;8. doi: 10.1016/j.ejcdt.2014.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcdt.2014.05.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TR, Kang MJ, Cha WC, Shin TG, Sim MS, Jo IJ, et al. Better lactate clearance associated with good neurologic outcome in survivors who treated with therapeutic hypothermia after out-of-hospital cardiac arrest. Crit Care. 2013;17:R260. doi: 10.1186/cc13090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13090</ArticleId><ArticleId IdType="pmc">PMC4057293</ArticleId><ArticleId IdType="pubmed">24172276</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto H, Nihei S, Endo T, Kanazawa A, Arai H, Nagata K, et al. Examination of relationship between lactate clearance and neurologic outcome in cardiac arrest induced by ventricular fibrillation. J UOEH. 2014;36:11&#x2013;6. doi: 10.7888/juoeh.36.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.7888/juoeh.36.11</ArticleId><ArticleId IdType="pubmed">24633180</ArticleId></ArticleIdList></Reference><Reference><Citation>Qvisth V, Hagstrom-Toft E, Enoksson S, Bolinder J. Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue: role of -adrenoreceptor subtypes. J Clin Endocrinol Metab. 2008;93:240&#x2013;6. doi: 10.1210/jc.2007-1313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2007-1313</ArticleId><ArticleId IdType="pubmed">17986640</ArticleId></ArticleIdList></Reference><Reference><Citation>Contenti J, Occelli C, Corraze H, Lemoel F, Levraut J. Long-term beta-blocker therapy decreases blood lactate concentration in severely septic patients. Crit Care Med. 2015;43:2616&#x2013;22. doi: 10.1097/CCM.0000000000001308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001308</ArticleId><ArticleId IdType="pubmed">26427590</ArticleId></ArticleIdList></Reference><Reference><Citation>Orbegozo Cortes D, Rayo Bonor A, Vincent JL. Isotonic crystalloid solutions: a structured review of the literature. Br J Anaesth. 2014;112:968&#x2013;81. doi: 10.1093/bja/aeu047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeu047</ArticleId><ArticleId IdType="pubmed">24736393</ArticleId></ArticleIdList></Reference><Reference><Citation>Didwania A, Miller J, Kassel D, Jackson EV, Jr, Chernow B. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med. 1997;25:1851&#x2013;4. doi: 10.1097/00003246-199711000-00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199711000-00024</ArticleId><ArticleId IdType="pubmed">9366769</ArticleId></ArticleIdList></Reference><Reference><Citation>Dezman ZD, Comer AC, Narayan M, Scalea TM, Hirshon JM, Smith GS. Alcohol consumption decreases lactate clearance in acutely injured patients. Injury. 2016. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5482221</ArticleId><ArticleId IdType="pubmed">27025567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse JA, Zaidi SA, Carlson RW. Significance of blood lactate levels in critically ill patients with liver disease. Am J Med. 1987;83:77&#x2013;82. doi: 10.1016/0002-9343(87)90500-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(87)90500-6</ArticleId><ArticleId IdType="pubmed">3605185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiolero R, Tappy L, Gillet M, Revelly JP, Roth H, Cayeux C, et al. Effect of major hepatectomy on glucose and lactate metabolism. Ann Surg. 1999;229:505&#x2013;13. doi: 10.1097/00000658-199904000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199904000-00009</ArticleId><ArticleId IdType="pmc">PMC1191736</ArticleId><ArticleId IdType="pubmed">10203083</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia P, Soto D, Bruhn A, Alegria L, Jarufe N, Luengo C, et al. Impairment of exogenous lactate clearance in experimental hyperdynamic septic shock is not related to total liver hypoperfusion. Crit Care. 2015;19:188. doi: 10.1186/s13054-015-0928-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0928-3</ArticleId><ArticleId IdType="pmc">PMC4432956</ArticleId><ArticleId IdType="pubmed">25898244</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med. 2006;34:337&#x2013;43. doi: 10.1097/01.CCM.0000194724.70031.B6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000194724.70031.B6</ArticleId><ArticleId IdType="pubmed">16424712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Luengo C, Bruhn A, Kattan E, Friedman G, Ospina-Tascon GA, et al. When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring. Ann Intensive Care. 2014;4:30. doi: 10.1186/s13613-014-0030-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-014-0030-z</ArticleId><ArticleId IdType="pmc">PMC4273696</ArticleId><ArticleId IdType="pubmed">25593746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27885969</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>Suppl 2</Issue><PubDate><Year>2016</Year><Month>Apr</Month><Day>20</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.</ArticleTitle><Pagination><StartPage>94</StartPage><MedlinePgn>94</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">94</ELocationID><Abstract><AbstractText>P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu. J. Sol&#xe9;-Viol&#xe1;n, M. L&#xf3;pez-Rodr&#xed;guez, E. Herrera-Ramos, J. Ru&#xed;z-Hern&#xe1;ndez, L. Border&#xed;as, J. Horcajada, N. Gonz&#xe1;lez-Quevedo, O. Rajas, M. Briones, F. Rodr&#xed;guez de Castro, C. Rodr&#xed;guez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. Esen, G. Orhun, P. Ergin Ozcan, E. Senturk, C. Ugur Yilmaz, N. Orhan, N. Arican, M. Kaya, M. Kucukerden, M. Giris, U. Akcan, S. Bilgic Gazioglu, E. Tuzun P004 - Adenosine a1 receptor dysfunction is associated with leukopenia: A possible mechanism for sepsis-induced leukopenia R. Riff, O. Naamani, A. Douvdevani P005 - Analysis of neutrophil by hyper spectral imaging - A preliminary report R. Takegawa, H. Yoshida, T. Hirose, N. Yamamoto, H. Hagiya, M. Ojima, Y. Akeda, O. Tasaki, K. Tomono, T. Shimazu P006 - Chemiluminescent intensity assessed by eaa predicts the incidence of postoperative infectious complications following gastrointestinal surgery S. Ono, T. Kubo, S. Suda, T. Ueno, T. Ikeda P007 - Serial change of c1 inhibitor in patients with sepsis &#x2013; A prospective observational study T. Hirose, H. Ogura, H. Takahashi, M. Ojima, J. Kang, Y. Nakamura, T. Kojima, T. Shimazu P008 - Comparison of bacteremia and sepsis on sepsis related biomarkers T. Ikeda, S. Suda, Y. Izutani, T. Ueno, S. Ono P009 - The changes of procalcitonin levels in critical patients with abdominal septic shock during blood purification T. Taniguchi, M. O P010 - Validation of a new sensitive point of care device for rapid measurement of procalcitonin C. Dinter, J. Lotz, B. Eilers, C. Wissmann, R. Lott P011 - Infection biomarkers in primary care patients with acute respiratory tract infections &#x2013; Comparison of procalcitonin and C-reactive protein M. M. Meili, P. S. Schuetz P012 - Do we need a lower procalcitonin cut off? H. Hawa, M. Sharshir, M. Aburageila, N. Salahuddin P013 - The predictive role of C-reactive protein and procalcitonin biomarkers in central nervous system infections with extensively drug resistant bacteria V. Chantziara, S. Georgiou, A. Tsimogianni, P. Alexandropoulos, A. Vassi, F. Lagiou, M. Valta, G. Micha, E. Chinou, G. Michaloudis P014 - Changes in endotoxin activity assay and procalcitonin levels after direct hemoperfusion with polymyxin-b immobilized fiber A. Kodaira, T. Ikeda, S. Ono, T. Ueno, S. Suda, Y. Izutani, H. Imaizumi P015 - Diagnostic usefullness of combination biomarkers on ICU admission M. V. De la Torre-Prados, A. Garcia-De la Torre, A. Enguix-Armada, A. Puerto-Morlan, V. Perez-Valero, A. Garcia-Alcantara P016 - Platelet function analysis utilising the PFA-100 does not predict infection, bacteraemia, sepsis or outcome in critically ill patients N. Bolton, J. Dudziak, S. Bonney, A. Tridente, P. Nee P017 - Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients G. Nicolaes, M. Wiewel, M. Schultz, K. Wildhagen, J. Horn, R. Schrijver, T. Van der Poll, C. Reutelingsperger P018 - Il-8: is this a more reliable biomarker for sepsis severity than CRP, Procalcitonin, E-selectin, IL-6 and TNF-[alpha] S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P019 - Relation between adrenomedullin and short-term outcome in ICU patients: Results from the frog ICU study E. G. Gayat, J. Struck, A. Cariou, N. Deye, B. Guidet, S. Jabert, J. Launay, M. Legrand, M. L&#xe9;one, M. Resche-Rigon, E. Vicaut, A. Vieillard-Baron, A. Mebazaa P020 - Impact of disease severity assessment on performance of heparin-binding protein for the prediction of septic shock R. Arnold, M. Capan, A. Linder, P. Akesson P021 - Kinetics and prognostic value of presepsin (sCD14) in septic patients. A pilot study M. Popescu, D. Tomescu P022 - Comparison of CD64 levels performed by the facs and accellix systems C. L. Sprung, R. Calderon Morales, G. Munteanu, E. Orenbuch-Harroch, P. Levin, H. Kasdan, A. Reiter, T. Volker, Y. Himmel, Y. Cohen, J. Meissonnier P023 - Diagnosing sepsis in 5&#xa0;minutes: Nanofluidic technology study with pancreatic-stone protein (PSP/ reg) L. Girard, F. Rebeaud P024 - How nanotechnology-based approaches could contribute to sepsis prevention, diagnosis and treatment I. Herrmann P025 - Il7r transcriptional expression analysis during septic shock B. Delwarde, E. Peronnet, E. Cerrato, F. Venet, A. Lepape, T. Rimmel&#xe9;, G. Monneret, J. Textoris P026 - Disbalance of microbial metabolites of aromatic acids affects the severity in critically ill patients N. Beloborodova, V. Moroz, A. Osipov, A. Bedova, Y. Sarshor, A. Pautova, A. Sergeev, E. Chernevskaya P027 - Copeptin predicts 10-year all-cause mortality in community patients J. Odermatt, R. Bolliger, L. Hersberger, M. Ottiger, M. Christ-Crain, B. Mueller, P. Schuetz P028 - Identification of differential proteomic response in septic patients secondary to community and hospital acquired pneumonia N. K. Sharma, A. K. Tashima, M. K. Brunialti, F. R. Machado, M. Assuncao, O. Rigato, R. Salomao P029 - Monocyte HLA-DR expression in community-acquired bacteremic sepsis - dynamics associated to aetiology and prediction of secondary sepsis S. C. Cajander, G. Rasmussen, E. Tina, B. S&#xf6;derquist, J. K&#xe4;llman, K. Str&#xe5;lin P030 - Soluble B- and T-lymphocyte attenuator: A possible prognostic marker in sepsis A. L. Lange, J. S. Sund&#xe9;n-Cullberg, A. M. Magnuson, O. H. Hultgren P031 - Fractal dimension: A new biomarker for quantifying clot microstructure in patients across the sepsis spectrum G. Davies, S. Pillai, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P032 - Comparison between the new biomarker for coagulation, clot microstructure (Df) with rotational thromboelastometry (ROTEM) in patients across the sepsis spectrum S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P033 - Changes in fibrinolysis across the sepsis spectrum: The use of rotational thromboelastometry (ROTEM) lysis index (LI60) and D-Dimer concentration S. Pillai, G. Davies, G. Mills, R. Aubrey, K. Morris, P. Williams, P. Evans P034 - The intensive care infection score &#x2013; a promising marker for the prediction of infection and its severity. P. Van der Geest, M. Mohseni, J. Linssen, R. De Jonge, S. Duran, J. Groeneveld P035 - Challenges in the clinical diagnosis of sepsis R. Miller III, B. K. Lopansri, L. C. McHugh, A. Seldon, J. P. Burke P036 - Does zero heat flux thermometry more accurately identify sepsis on intensive care? J. Johnston, R. Reece-Anthony, A. Bond, A. Molokhia P037 - Advancing quality (AQ) sepsis programme: Improving early identification &amp; treatment of sepsis in North West England. C. Mcgrath, E. Nsutebu P038 - Prehospital transport of acute septic patients P. Bank Pedersen, D. Pilsgaard Henriksen, S. Mikkelsen, A. Touborg Lassen P039 - Vasodilatory plant extracts gel as an alternative treatment for fever in critically ill patients R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P040 - Host response and outcome of hypothermic sepsis M. A. Wiewel, M. B. Harmon, L. A. Van Vught, B. P. Scicluna, A. J. Hoogendijk, J. Horn, A. H. Zwinderman, O. L. Cremer, M. J. Bonten, M. J. Schultz, T. Van der Poll, N. P. Juffermans, W. J. Wiersinga P041 - Septic shock alert over SIRS criteria has an impact on outcome but needs to be revised G. Eren, Y Tekdos, M. Dogan, O. Acicbe, E. Kaya, O. Hergunsel P042 - Association between previous prescription of &#x3b2;blockers and mortality rate among septic patients: A retrospective observational study S. Alsolamy, G. Ghamdi, L. Alswaidan, S. Alharbi, F. Alenezi, Y. Arabi P043 - Recognition and treatment of sepsis on labour ward&#x2013; teaching &amp; information resources can improve knowledge J. Heaton, A. Boyce, L. Nolan, J. Johnston, A. Dukoff-Gordon, A. Dean, A. Molokhia P044 - Culture negative sepsis in the ICU &#x2013; what is unique to this patient population? T. Mann Ben Yehudah P045 - Organ dysfunction in severe sepsis patients identified in administrative data in Germany, 2007-2013 C. Fleischmann, D. Thomas-Rueddel, C. Haas, U. Dennler, K. Reinhart P046 - A comparison of residents&#x2019; knowledge regarding; the Surviving Sepsis Campaign 2012 guideline O. Suntornlohanakul, B. Khwannimit P047 - Effectiveness of a septic shock bundle to improve outcomes in the ICU F. Breckenridge, A. Puxty P048 - Dose of norepinephrine in the first 24&#xa0;hours as a parameter evaluating the effectiveness of treatment in patients with severe sepsis and septic shock P. Szturz, P. Folwarzcny, J. Svancara, R. Kula, P. Sevcik P049 - Norepinephrine or vasopressin&#x2009;+&#x2009;norepinephrine in septic shock. A retrospective series of 39 patients L. Caneva, A. Casazza, E. Bellazzi, S. Marra, L. Pagani, M. Vetere, R. Vanzino, D. Ciprandi, R. Preda, R. Boschi, L. Carnevale P050 - Methylene blue effectiveness as contributory treatment in patients with septic shock V. Lopez, M. Aguilar Arzapalo, L. Barradas, A. Escalante, J. Gongora, M. Cetina P051 - Coagulation disorders in patients with severe sepsis and DIC evaluated with thromboelastometry. B Adamik, D Jakubczyk, A K&#xfc;bler P052 - Frequency and outcome of early sepsis-associated coagulopathy A. Radford, T. Lee, J. Singer, J. Boyd, D. Fineberg, M. Williams, J. Russell P053 - Assessment of coagulopathy in cancer patients with severe sepsis or septic shock. A case-control pilot study E. Scarlatescu, D. Tomescu, G. Droc, S. Arama P054 - Thromboelastometry in critically ill patients with disseminated intravascular coagulation M. M&#xfc;ller, M. Straat, S. S. Zeerleder, N. P. Juffermans P055 - Cessation of a preexisting chronic antiplatelet therapy is associated with increased mortality rates in severe sepsis and septic shock C. F. Fuchs, C. S. Scheer, S. W. Wauschkuhn, M. V. Vollmer, K. M. Meissner, S. K. Kuhn, K. H. Hahnenkamp, S. R. Rehberg, M. G. Gr&#xfc;ndling P056 - Neutrophil Extracellular Traps (NETs) production under hypoxic condition N. Yamamoto, M. Ojima, S. Hamaguchi, T. Hirose, Y. Akeda, R. Takegawa, O. Tasaki, T. Shimazu, K. Tomono P057 - Impact of ultraviolet air sterilizer in intensive care unit room, and clinical outcomes of patients E. G&#xf3;mez-S&#xe1;nchez, M. Heredia-Rodr&#xed;guez, E. &#xc1;lvarez-Fuente, M. Lorenzo-L&#xf3;pez, E. G&#xf3;mez-Pesquera, M. Arag&#xf3;n-Camino, P. Liu-Zhu, A. S&#xe1;nchez-L&#xf3;pez, A. Hern&#xe1;ndez-Lozano, M. T. Pel&#xe1;ez-Jare&#xf1;o, E. Tamayo P058 - Focus of infection in severe sepsis - comparison of administrative data and prospective cohorts from Germany D. O. Thomas-R&#xfc;ddel, C. Fleischmann, C. Haas, U. Dennler, K. Reinhart P059 - &#x201c;Zero CLABSI&#x201d; &#x2013; can we get there? Obstacles on the 4&#xa0;year journey and our strategies to overcome them &#x2013; experience from an Indian ICU V. Adora, A. Kar, A. Chakraborty, S. Roy, A. Bandyopadhyay, M. Das P060 - Novel molecular techniques to identify central venous catheter (CVC) associated blood stream infections (BSIs) T. Mann Ben Yehudah, G. Ben Yehudah, M. Salim, N. Kumar, L. Arabi, T. Burger, P. Lephart, E. Toth-martin P061 - Zero clabsi&#x201d; &#x2013; can we get there? Obstacles on the 4&#xa0;year journey and our strategies to overcome them &#x2013; experience from an Indian ICU R. Rao, A. Kar, A. Chakraborty P062 - Prevention of central line-associated bloodstream infections in intensive care units: An international online survey C. Valencia, N. Hammami, S. Blot, J. L. Vincent, M. L. Lambert P063 - 30&#xa0;days antimicrobial efficacy of non-leaching central venous catheters J. Brunke, T. Riemann, I. Roschke P064 - Efficacy of noble metal alloy-coated catheter in prevention of bacteriuria R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P065 - Predicting bacteremic urinary tract infection in community setting: A prospective observational study S. Nimitvilai, K. Jintanapramote, S. Jarupongprapa P066 - Eight-year analysis of acinetobacter spp. monobacteremia in surgical and medical intensive care units at university hospital in Lithuania D. Adukauskiene, D. Valanciene P067 - Group A and group B streptococcal infections in intensive care unit &#x2013; our experience in a tertiary centre G. Bose, V. Lostarakos, B. Carr P068 - Improved detection of spontaneous bacterial peritonitis by uritop&#x2009;+&#x2009;tm strip test and inoculation of blood culture bottles with ascitic fluid S. Khedher, A. Maaoui, A. Ezzamouri, M. Salem P069 - Increased risk of cellulitis in patients with congestive heart failure: a population based cohort study J. Chen P070 - Outcomes of severe cellulitis and necrotizing fasciitis in the critically ill D. R. Cranendonk, L. A. Van Vught, M. A. Wiewel, O. L. Cremer, J. Horn, M. J. Bonten, M. J. Schultz, T. Van der Poll, W. J. Wiersinga P071 - Botulism outbreak associated with people who inject drugs (PWIDs) in Scotland. M. Day, G. Penrice, K. Roy, P. Robertson, G. Godbole, B. Jones, M. Booth, L. Donaldson P072 - Surveillance of ESBL-producing enterobacteriaceae fecal carriers in the ICU Y. Kawano, H. Ishikura P073 - Prevalence of ESBL and carbapenemase producing uropathogens in a newly opened hospital in south India S. Sreevidya, N. Brahmananda Reddy, P. Muraray Govind, R. Pratheema, J. Devachandran Apollo Speciality Hospital - OMR, Chennai, India P074 - Prevalence, risk factors and outcomes of methicillin-resistant staphylococcus aureus nasal colonization in critically ill patients H. Al-Dorzi, M. Almutairi, B. Alhamadi, A. Crizaldo Toledo, R. Khan, B. Al Raiy, Y. Arabi P075 - Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: Is there an association? H. Talaie P076 - Multidrug-resistant organisms in a Dutch ICU J. A. Van Oers, A. Harts, E. Nieuwkoop, P. Vos P077 - Epidemiology and risk factors of ICU acquired infections caused by multidrug-resistant gram negative bacilli Y. Boussarsar, F. Boutouta, S. Kamoun, I. Mezghani, S. Koubaji, A. Ben Souissi, A. Riahi, M. S. Mebazaa P078 - Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins E. Giamarellos-Bourboulis, N. Tziolos, C. Routsi, C. Katsenos, I. Tsangaris, I. Pneumatikos, G. Vlachogiannis, V. Theodorou, A. Prekates, E. Antypa, V. Koulouras, N. Kapravelos, C. Gogos, E. Antoniadou, K. Mandragos, A. Armaganidis P079 - Must change the medical practice in ICU? A. R. Robles Caballero, B. Civantos, J. C. Figueira, J. L&#xf3;pez P080 - Mediterranean spotted fever in an infectious diseases intensive care unit A. Silva-Pinto, F. Ceia, A. Sarmento, L. Santos P081 - Clinical features and outcomes of patients with Middle East respiratory syndrome requiring admission to a saudi intensive care unit: A retrospective analysis of 31 cases G. Almekhlafi, Y. Sakr P082 - The ICU response to a hospital outbreak of Middle East respiratory syndrome coronavirus infection H. Al-Dorzi, R. Khan, S. Baharoon, A. Aldawood, A. Matroud, J. Alchin, S. Al Johani, H. Balkhy, Y. Arabi P083 - Middle East respiratory syndrome: Surveillance data analysis S. Alsolamy, S. Y. Yousif, B. O. Alotabi, A. S. Alsaawi P085 - Use of Taqman array card molecular diagnostics in severe pneumonia: A case series J. Ang, MD Curran, D. Enoch, V. Navapurkar, A. Conway Morris P086 - &#x2018;BUNS&#x2019;: An investigation protocol improves the ICU management of pneumonia R. Sharvill, J. Astin P087 - Pneumonia in patients following secondary peritonitis: epidemiological features and impact on mortality M. Heredia-Rodr&#xed;guez, E. G&#xf3;mez-S&#xe1;nchez, M. T. Pel&#xe1;ez-Jare&#xf1;o, E. G&#xf3;mez-Pesquera, M. Lorenzo-L&#xf3;pez, P. Liu-Zhu, M. Arag&#xf3;n-Camino, A. Hern&#xe1;ndez-Lozano, A. S&#xe1;nchez-L&#xf3;pez, E. &#xc1;lvarez-Fuente, E. Tamayo P088 - The use of the &#x201c;CURB-65 score&#x201d; by emergency room clinicians in a large teaching hospital J. Patel, C. Kruger P089 - Incidence of community acquired pneumonia with viral infection in mechanically ventilated patients in the medical intensive care unit J. O&#x2019;Neal, H. Rhodes, J. Jancik P090 - The SAATELLITE Study: Prevention of S aureus Nosocomial Pneumonia (NP) with MEDI4893, a Human Monoclonal Antibody (mAb) Against S aureus B. Fran&#xe7;ois, P. F. Laterre, P. Eggimann, A. Torres, M. S&#xe1;nchez, P. F. Dequin, G. L. Bassi, J. Chastre, H. S. Jafri P091 - Risk factors and microbiological profile for nosocomial infections in trauma patients M. Ben Romdhane, Z. Douira, S. Kamoun, M. Bousselmi, A. Ben Souissi, Y. Boussarsar, A. Riahi, M.S. Mebazaa P092 - Correlation between percentages of ventilated patients developed vap and use of antimicrobial agents in ICU patients. A. Vakalos, V. Avramidis P093 - A comparison of two ventilator associated pneumonia surveillance techniques T. H. Craven, G. Wojcik, K. Kefala, J. McCoubrey, J. Reilly, R. Paterson, D. Inverarity, I. Laurenson, T. S. Walsh P094 - Lung ultrasound before and after fiberbronchoscopy - modifications may improve ventilator-associated pneumonia diagnosis S. Mongodi, B. Bouhemad, A. Orlando, A. Stella, G. Via, G. Iotti, A. Braschi, F. Mojoli P095 - Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia M. Haliloglu, B. Bilgili, U. Kasapoglu, I. Sayan, M. S&#xfc;zer Aslan, A. Yalc&#x131;n, I. Cinel P096 - Impact of pRBCs transfusion on percentage of ventilated patients developed VAP in ICU patients A. Vakalos, V. Avramidis P097 - The impact of a series of interventions on the rate of ventilator associated pneumonia in a large teaching hospital H. E. Ellis, K. Bauchmuller, D. Miller, A Temple P098 - The EVADE study: Prevention of Nosocomial Pneumonia (NP) caused by P aeruginosa with MEDI3902, a Novel Bispecific Monoclonal Antibody, against P aeruginosa virulence factors J. Chastre, B. Fran&#xe7;ois, A. Torres, C. E. Luyt, M. S&#xe1;nchez, M. Singer, H. S. Jafri P099 - Short-term inhaled colistin adjunctive therapy for ventilator-associated pneumonia Y. Nassar, M. S. Ayad P100 - Effect of aerosolised colistin on weaning from mechanical ventilation A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P101 - Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study B. Bilgili, M. Haliloglu, F. Gul, I. Cinel P102 - Nosocomial pneumonia - emphasis on inhaled tobramycin A. Kuzovlev, A. Shabanov, S. Polovnikov, V. Moroz P103 - In vitro evaluation of amikacin inhale and commercial nebulizers in a mechanical ventilator N. Kadrichu, T. Dang, K. Corkery, P. Challoner P104 - The effects of nebulized amikacin/fosfomycin and systemic meropenem on severe amikacin-resistant meropenem-susceptible P.aeruginosa pneumonia G. Li Bassi, E. Aguilera, C. Chiurazzi, C. Travierso, A. Motos, L. Fernandez, R. Amaro, T. Senussi, F. Idone, J. Bobi, M. Rigol, A. Torres P105 - Optimization of gentamicin peak concentrations in critically ill patients C. J. Hodiamont, N. P. Juffermans, J. M. Janssen, C. S. Bouman, R. A. Math&#xf4;t, M. D. De Jong, R. M. Van Hest P106 - Systematic review of cefepime induced neurotoxicity L. Payne, G. L. Fraser P107 - Unasyn&#xae; causes QT prolongation during treatment of intensive care patients B. Tudor, M. Lahner, G. Roth, C. Krenn P108 - Comparative study between teicoplanin and vancomycin in methicillin-resistant staphylococcus aureus (mrsa) infectious of toxicological intensive care unit (ticu) patients &#x2013; Tehran, Iran H. Talaie P109 - Phage therapy against antimicrobial resistance, design of the first clinical study phagoburn P. Jault, J. Gabard, T. Leclerc, S. Jennes, Y. Que, A. Rousseau, F. Ravat P110 - Antibiotic dosing errors in critically ill patients with severe sepsis or septic shock H. Al-Dorzi, A. Eissa, S. Al-Harbi, T. Aldabbagh, R. Khan, Y. Arabi P111 - Does empiric antifungal therapy improve survival in septic critically ill patients? (immunocompromised excluded) A. Trifi, S. Abdellatif, F. Daly, R. Nasri, S. Ben Lakhal P112 - Neurocysticercosis-Qatar experience F. Paramba, N. Purayil, V. Naushad, O. Mohammad, V. Negi, P. Chandra P113 - Early indicators in acute haemorrhagic shock A. Kleinsasser P114 - Filtering of red blood cells reduces the inflammatory response of pulmonary cells in an in vitro model of mechanical ventilation M. R. Witrz, J. F. Buchner-Doeven, A. M. Tuip-de Boer, J. C. Goslings, N. P. Juffermans P115 - Microparticles from red blood cell transfusion induce a pro-coagulant and pro-inflammatory endothelial cell response M. Van Hezel, M. Straat, A Boing, R Van Bruggen, N Juffermans P116 - The contribution of cytokines on thrombosis development during hospitalization in ICU D. Markopoulou, K. Venetsanou, V. Kaldis, D. Koutete, D. Chroni, I. Alamanos P117 - Prophylactic enoxaparin dosing and adjustment through anti-xa monitoring in an inpatient burn unit L. Koch, J. Jancik, H. Rhodes, E. Walter P118 - Determination of optimal cut-off values of haemoglobin, platelet count and fibrinogen at 24&#xa0;hours after injury associated with mortality in trauma patients K. Maekawa, M. Hayakawa, S. Kushimoto, A. Shiraishi, H. Kato, J. Sasaki, H. Ogura, T. Matauoka, T. Uejima, N. Morimura, H. Ishikura, A. Hagiwara, M. Takeda P119 - Trauma-induced coagulopathy - prothrombin complex concentrate vs fresh frozen plasma O. Tarabrin, S. Shcherbakow, D. Gavrychenko, G. Mazurenko, V. Ivanova, O. Chystikov P120 - First study to prove the superiority of prothrombin complex concentrates on mortality rate over fresh frozen plasma in patients with acute bleeding C. Plourde, J. Lessard, J. Chauny, R. Daoust P121 - Prothrombin complex concentrate vs fresh frozen plasma in obstetric massive bleeding S. Shcherbakow, O. Tarabrin, D. Gavrychenko, G. Mazurenko, O. Chystikov P122 - Impact of FFP transfusion on VAP in ICU patients A. Vakalos, V. Avramidis P123 - Preoperative platelet function test and the thrombin generation assay are predictive for blood loss after cardiac surgery L. Kropman, L. In het Panhuis, J. Konings, D. Huskens, E. Schurgers, M. Roest, B. De Laat, M. Lance P124 - Rotational thromboelastometry versus standard coagulation tests before surgical interventions M. Durila, P. Lukas, M. Astraverkhava, J. Jonas P125 - Correction of impaired clot quality and stability by fibrinogen and activated prothrombin complex concentrate in a model of severe thrombocytopenia I. Budnik, B. Shenkman P126 - Assessment of point-of-care prothrombin time analyzer as a monitor after cardiopulmonary bypass H. Hayami, Y. Koide, T. Goto P127 - Disseminated intravascular coagulation (dic) is underdiagnosed in critically ill patients: do we need d-dimer measurements? R. Iqbal, Y. Alhamdi, N. Venugopal, S. Abrams, C. Downey, C. H. Toh, I. D. Welters P128 - Validity of the age-adjusted d-dimer cutoff in patients with COPD B. Bombay, J. M. Chauny, R. D. Daoust, J. L. Lessard, M. M. Marquis, J. P. Paquet P129 - A scoping review of strategies for prevention and management of bleeding following paediatric cardiopulmonary bypass surgery K. Siemens, D. Sangaran, B. J. Hunt, A. Durward, A. Nyman, I. A. Murdoch, S. M. Tibby P130 - Nadir hemoglobulin during cardiopulmonary bypass: impact on postoperative morbidity and mortality F. Ampatzidou, D. Moisidou, E. Dalampini, M. Nastou, E. Vasilarou, V. Kalaizi, H. Chatzikostenoglou, G. Drossos P131 - Red blood cell transfusion do not influence the prognostic value of RDW in critically ill patients S. Spadaro, A. Fogagnolo, T. Fiore, A. Schiavi, V. Fontana, F. Taccone, C. Volta P132 - Reasons for admission in the paediatric intensive care unit and the need for blood and blood products transfusions E. Chochliourou, E. Volakli, A. Violaki, E. Samkinidou, G. Evlavis, V. Panagiotidou, M. Sdougka P133 - The implementation of a massive haemorrhage protocol (mhp) for the management of major trauma: a ten year, single-centre study R. Mothukuri, C. Battle, K. Guy, G. Mills, P. Evans P134 - An integrated major haemorrhage protocol for pre-hospital and retrieval medical teams J. Wijesuriya, S. Keogh P135 - The impact of transfusion thresholds on mortality and cardiovascular events in patients with cardiovascular disease (non-cardiac surgery): a systematic review and meta-analysis A. Docherty, R. O&#x2019;Donnell, S. Brunskill, M. Trivella, C. Doree, L. Holst, M. Parker, M. Gregersen, J. Almeida, T. Walsh, S. Stanworth P136 - The relationship between poor pre-operative immune status and outcome from cardiac surgery is specific to the peri-operative antigenic threat S. Moravcova, J. Mansell, A. Rogers, R. A. Smith, C. Hamilton-Davies P137 - Impact of simple clinical practice guidelines for reducing post-operative atrial fibrillation after cardiac surgery. A. Omar, M. Allam, O. Bilala, A. Kindawi, H. Ewila P138 - Dexamethasone administration during cardiopulmonary bypass has no beneficial effects on elective postoperative cardiac surgery patients F. Ampatzidou, D. Moisidou, M. Nastou, E. Dalampini, A. Malamas, E. Vasilarou, G. Drossos P139 - Intra-aortic balloon counterpulsation in patients undergoing cardiac surgery (IABCS): preliminary results G. Ferreira, J. Caldas, J. Fukushima, E. A. Osawa, E. Arita, L. Camara, S. Zeferino, J. Jardim, F. Gaioto, L. Dallan, F. B. Jatene, R. Kalil Filho, .F Galas, L. A. Hajjar P140 - Effects of low-dose atrial natriuretic peptide infusion on cardiac surgery-associated acute kidney injury C. Mitaka, T. Ohnuma, T. Murayama, F. Kunimoto, M. Nagashima, T. Takei, M. Tomita P141 - Acute kidney injury influence on high sensitive troponin measurements after cardiac surgery A. Omar, K. Mahmoud, S. Hanoura, S. Sudarsanan, P. Sivadasan, H. Othamn, Y. Shouman, R. Singh, A. Al Khulaifi P142 - Complex evaluation of endothelial dysfunction markers for prognosis of outcomes in patients undergoing cardiac surgery I. Mandel, S. Mikheev, I. Suhodolo, V. Kiselev, Y. Svirko, Y. Podoksenov P143 - New-onset atrial fibrillation in intensive care: incidence, management and outcome S. A. Jenkins, R. Griffin P144 - One single spot measurement of the sublingual microcirculation during acute pulmonary hypertension in a pig model of shock M. S. Tovar Doncel, A. Lima, C. Aldecoa, C. Ince P145 - Assessment of levosimendan as a therapeutic option to recruit the microcirculation in cardiogenic shock &#x2013; initial experience in cardiac ICU A. Taha, A. Shafie, M. Mostafa, N. Syed, H. Hon P146 - Terlipressin vs. norepinephrine in the Potential Multiorgan Donor(PMD) F. Righetti, E. Colombaroli, G. Castellano P147 - Echocardiography in the potential heart donor exposed to substitution hormonotherapy F. Righetti, E. Colombaroli P148 - Machine learning can reduce rate of monitor alarms M. Hravnak, L. C. Chen, A. D. Dubrawski, G. C. Clermont, M. R. Pinsky P149 - Peripherally inserted central catheters placed in the ICU S. Gonzalez, D. Macias, J. Acosta, P. Jimenez, A. Loza, A. Lesmes, F. Lucena, C. Leon P150 - Recordings of abnormal central venous pressure waveform morphology during an episode of pulmonary hypertension in a porcine shock model M. S. Tovar Doncel, C. Ince, C. Aldecoa, A. Lima P151 - Ultrasound guided central venous access technique among French intensivists M. Bastide, J. Richecoeur, E. Frenoy, C. Lemaire, B. Sauneuf, F. Tamion, S. Nseir, D. Du Cheyron, H. Dupont, J. Maizel P152 - Predictive ability of the Pv-aCO2 gap in patients with shock M. Shaban, R. Kolko, N. Salahuddin, M. Sharshir, M. AbuRageila, A. AlHussain P153 - Comparison of echocardiography and pulmonary artery catheter measurements of hemodynamic parameters in critical ill patients P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, M. Slama P154 - The volume clamp method for noninvasive cardiac output measurement in postoperative cardiothoracic surgery patients: a comparison with intermittent pulmonary artery thermodilution J. Wagner, A. K&#xf6;rner, M. Kubik, S. Kluge, D. Reuter, B. Saugel P155 - Hemodynamic monitoring in patients with septic shock (SS) &#x2013; CPCCO (continuous pulse contour cardiac output) vs. TEE (transesophageal echocardiography) E. Colombaroli, F. Righetti, G. Castellano P156 - Cardiac output measurement with transthoracic echocardiography in critically ill patients: a pragmatic clinical study T. Tran, D. De Bels, A. Cudia, M. Strachinaru, P. Ghottignies, J. Devriendt, C. Pierrakos P157 - Left ventricular outflow tract velocity time integral correlates with stroke volume index in mechanically ventilated patients &#xd3;. Mart&#xed;nez Gonz&#xe1;lez, R. Blancas, J. Luj&#xe1;n, D. Ballesteros, C. Mart&#xed;nez D&#xed;az, A. N&#xfa;&#xf1;ez, C. Mart&#xed;n Parra, B. L&#xf3;pez Matamala, M. Alonso Fern&#xe1;ndez, M. Chana P158 - Transpulmonary thermodilution (TPTD) derived from femoral vs. jugular central venous catheter: validation of a previously published correction formula and a proprietary correction formula for global end-diastolic volume index (GEDVI) W. Huber, M. Eckmann, F. Elkmann, A. Gruber, I. Klein, R. M. Schmid, T. Lahmer P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P159 - Venous return driving pressure and resistance in acute blood volume changes P. W. Moller, S. Sondergaard, S. M. Jakob, J. Takala, D. Berger P160 - Dynamic arterial elastance calculated with lidcoplus monitor does not predict changes in arterial pressure after a fluid challenge in postsurgical patients D. Bastoni, H. Aya, L. Toscani, L. Pigozzi, A. Rhodes, M. Cecconi P161 - Analysis of duration of post-operative goal-directed therapy protocol C. Ostrowska, H. Aya, A. Abbas, J. Mellinghoff, C. Ryan, D. Dawson, A. Rhodes, M. Cecconi P162 - Hemodynamic optimization &#x2013; back to square one? M. Cronhjort, O. Wall, E. Nyberg, R. Zeng, C. Svensen, J. M&#xe5;rtensson, E. Joelsson-Alm P163 - Effectiveness of fluid thoracic content measurement by bioimpedance guiding intravascular volume optimization in patients with septic shock M. Aguilar Arzapalo, L. Barradas, V. Lopez, M. Cetina P164 - A systematic review on the role of internal jugular vein ultrasound measurements in assessment of volume status in critical shock patients N. Parenti, C. Palazzi, L. A. Amidei, F. B. Borrelli, S. C. Campanale, F. T. Tagliazucchi, G. S. Sedoni, D. L. Lucchesi, E. C. Carella, A. L Luciani P165 - Importance of recognizing dehydration in medical Intensive Care Unit M. Mackovic, N. Maric, M. Bakula P166 - Effect of volume for a fluid challenge in septic patients H. Aya, A. Rhodes, R. M. Grounds, N. Fletcher, M. Cecconi P167 - Fluid bolus practices in a large Australian intensive care unit B. Avard, P. Zhang P168 - Liberal late fluid management is associated with longer ventilation duration and worst outcome in severe trauma patients: a retrospective cohort of 294 patients M. Mezidi, J. Charbit, M. Ould-Chikh, P. Deras, C. Maury, O. Martinez, X. Capdevila P169 - Association of fluids and outcomes in emergency department patients hospitalized with community-acquired pneumonia P. Hou, W. Z. Linde-Zwirble, I. D. Douglas, N. S. Shapiro P170 - Association of positive fluid balance with poor outcome in medicosurgical ICU patients A. Ben Souissi, I. Mezghani, Y. Ben Aicha, S. Kamoun, B. Laribi, B. Jeribi, A. Riahi, M. S. Mebazaa P171 - Impact of fluid balance to organ dysfunction in critically ill patients C. Pereira, R. Marinho, R. Antunes, A. Marinho P172 - Volume bolus in ICU patients: do we need to balance our crystalloids? M. Crivits, M. Raes, J. Decruyenaere, E. Hoste P173 - The use of 6&#xa0;% HES solution do not reduce total fluid requirement in the therapy of patients with burn shock V. Bagin, V. Rudnov, A. Savitsky, M. Astafyeva, I. Korobko, V. Vein P174 - Electron microscopic assessment of acute kidney injury in septic sheep resuscitated with crystalloids or different colloids T. Kampmeier , P. Arnemann, M. Hessler, A. Wald, K. Bockbreder, A. Morelli, H. Van Aken, S. Rehberg, C. Ertmer P175 - Alterations of conjunctival microcirculation in a sheep model of haemorrhagic shock and resuscitation with 0.9&#xa0;% saline or balanced tetrastarch P. Arnemann, M. Hessler, T. Kampmeier, S. Rehberg, H. Van Aken, C. Ince, C. Ertmer P176 - A single centre nested pilot study investigating the effect of using 0.9&#xa0;% saline or Plasma-Lyte 148 &#xae; as crystalloid fluid therapy on gastrointestinal feeding intolerance in mechanically ventilated patients receiving nasogastric enteral nutrition S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, A. Psirides, P. Young P177 - A single centre nested pilot study investigating the effect on post-operative bleeding of using 0.9&#xa0;% saline or Plasma-Lyte&#xae; 148 as crystalloid fluid therapy in adults in ICU after heart surgery S. Reddy, M. Bailey, R. Beasley, R. Bellomo, D. Mackle, P. Young P178 - Extreme hypernatremia and sepsis in a patient with Huntington&#x2019;s dementia: a conundrum in fluid management H. Venkatesh, S. Ramachandran, A. Basu, H. Nair P179 - Diagnosis and management of severe hypernatraemia in the critical care setting S. Egan, J. Bates P180 - Correlation between arterial blood gas and electrolyte disturbances during hospitalization and outcome in critically ill patients S. Oliveira, N. R. Rangel Neto, F. Q. Reis P181 - Missing the &#x201c;I&#x201d; in MUDPILES &#x2013; a rare cause of high anion gap metabolic acidosis (HAGMA) C. P. Lee, X. L. Lin, C. Choong , K. M. Eu, W. Y. Sim , K. S. Tee, J. Pau , J. Abisheganaden P182 - Plasma NGAL and urinary output: potential parameters for early initiation of renal replacement therapy K. Maas, H. De Geus P183 - Renal replacement therapy for critically ill patients: an intermittent continuity E. Lafuente, R. Marinho, J. Moura, R. Antunes, A. Marinho P184 - A survey of practices related to renal replacement therapy in critically ill patients in the north of England. T. E. Doris, D. Monkhouse, T. Shipley, S. Kardasz, I Gonzalez P185 - High initiation creatinine associated with lower 28-day mortality in critically ill patients necessitating continuous renal replacement therapy S. Stads, A. J. Groeneveld P186 - The impact of Karnofsky performance scale on outcomes in acute kidney injury patients receiving renal replacement therapy on the intensive care unit I. Elsayed, N. Ward, A. Tridente, A. Raithatha P187 - Severe hypophosphatemia during citrate-anticoagulated CRRT A. Steuber, C. Pelletier, S. Schroeder, E. Michael, T. Slowinski, D. Kindgen-Milles P188 - Citrate regional anticoagulation for post dilution continuous renal replacement therapy S. Ghabina P189 - Citrate 18&#xa0;mmol/l improves anticoagulation during RRT with adsorbing filters F. Turani, A. Belli, S. Busatti, G. Barettin, F. Candidi, F. Gargano, R. Barchetta, M. Falco P190 - Calcium gluconate instead of calcium chloride in citrate-anticoagulated CVVHD O. Demirkiran, M. Kosuk, S. Bozbay P191 - Enhanced clearance of interleukin-6 with continuous veno-venous haemodialysis (CVVHD) using Ultraflux EMiC2 vs. Ultraflux AV1000S V. Weber, J. Hartmann, S. Harm, I. Linsberger, T. Eichhorn, G. Valicek, G. Miestinger, C. Hoermann P192 - Removal of bilirubin with a new adsorbent system: in vitro kinetics S. Faenza, D. Ricci, E. Mancini, C. Gemelli, A. Cuoghi, S. Magnani, M. Atti P193 - Case series of patients with severe sepsis and septic shock treated with a new extracorporeal sorbent T. Laddomada, A. Doronzio, B. Balicco P194 - In vitro adsorption of a broad spectrum of inflammatory mediators with CytoSorb&#xae; hemoadsorbent polymer beads M. C. Gruda, P. O&#x2019;Sullivan, V. P. Dan, T. Guliashvili, A. Scheirer, T. D. Golobish, V. J. Capponi, P. P. Chan P195 - Observations in early vs. late use of cytosorb therapy in critically ill patients K. Kogelmann, M. Dr&#xfc;ner, D. Jarczak P196 - Oxiris membrane decreases endotoxin during rrt in septic patients with basal EAA&#x2009;&gt;&#x2009;0,6 F. Turani, A. B. Belli, S. M. Martni, V. C. Cotticelli, F. Mounajergi, R. Barchetta P197 - An observational prospective study on the onset of augmented renal clearance: the first report S. Morimoto, H. Ishikura P198 - An ultrasound- guided algorithm for the management of oliguria in severe sepsis I. Hussain, N. Salahuddin, A. Nadeem, K. Ghorab, K. Maghrabi P199 - Ultrasound in acute kidney injury (aki). First findings of farius, an education-programme in structural ultrasonography S. K. Kloesel, C. Goldfuss, A. Stieglitz, A. S. Stieglitz, L. Krstevska, G. Albuszies P200 - Effectiveness of renal angina index score predicting acute kidney injury on critically ill patients M. Aguilar Arzapalo, L. Barradas, V. Lopez, A. Escalante, G. Jimmy, M. Cetina P201 - Time length below blood pressure thresholds and progression of acute kidney injury in critically ill patients with or without sepsis: a retrospective, exploratory cohort study J. Izawa, T. Iwami, S. Uchino, M. Takinami, T. Kitamura, T. Kawamura P202 - Anaemia does not affect renal recovery in acute kidney injury J. G. Powell-Tuck, S. Crichton, M. Raimundo, L. Camporota, D. Wyncoll, M. Ostermann P203 - Estimated glomerular filtration rate based on serum creatinine: actual practice in Dutch ICU&#x2019;s A. Hana, H. R. De Geus P204 - Comparison of estimated glomerular filtration rate calculated by mdrd, ckd-epi-serum-creatinine and ckd-epi-cystatin-c in adult critically ill patients H. R. De Geus, A. Hana P205 - Early diagnosis of septic acute kidney injury in medical critical care patients with a urine cell cycle arrest marker: insulin like growth factor binding protein-7 (IGFBP-7) M. Aydogdu, N. Boyaci, S. Yuksel, G. Gursel, A. B. Cayci Sivri P206 - Urinary neutrophil gelatinase-associated lipocalin as early biomarker of severe acute kidney injury in intensive care J. Meza-M&#xe1;rquez, J. Nava-L&#xf3;pez, R. Carrillo-Esper P207 - Shrunken pore syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting A. Dardashti, A. Grubb P208 - The biomarker nephrocheck&#x2122; can discriminate the septic shock patients with an akin 1 or 2 acute renal failure who will not progress toward the akin 3 level J. Maizel, M. Wetzstein, D. Titeca, L. Kontar, F. Brazier, B. De Cagny, A. Riviere, T. Soupison, M. Joris, M. Slama P209 - A worldwide multicentre evaluation of acute kidney injury in septic and non-septic critically ill patients: the intensive care over nations (icon) audit E. Peters, H. Njimi, P. Pickkers, J. L. Vincent P210 - Does enhanced recovery after surgery reduce the incidence of acute kidney injury in those undergoing major gynae-oncological surgery? M. Waraich , J. Doyle, T. Samuels, L. Forni P211 - Identification of risk factors for the development of acute kidney injury after lower limb arthroplasty N. Desai, R. Baumber, P. Gunning, A. Sell P212 - Incidences and associations of acute kidney injury after major trauma S. Lin, H. Torrence, M. O&#x2019;Dwyer, C. Kirwan, J. Prowle P213 - Acute kidney injury of major trauma patients T Kim P214 - Trajectory of serum creatinine after major surgery and the diagnosis of acute kidney injury M. E. O&#x2019;Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P215 - Epidemiology of acute kidney injury after cardiac surgery. A single center retrospective study S. Hanoura , A. Omar, H. Othamn, S. Sudarsanan , M. Allam, M. Maksoud, R. Singh, A. Al Khulaifi P216 - Post-operative acute kidney injury after major non-cardiac surgery and its association with death in the following year M. E. O&#x2019;Connor, R. W. Hewson, C. J. Kirwan, R. M. Pearse, J. Prowle P217 - Factors affecting acute renal failure in intensive care unit and effect of these factors on mortality O. Uzundere, D. Memis , M. &#xdd;nal, A. , N. Turan P218 - Results of the live kidney transplantations according to national data of turkish organ and tissue information system M. A. Aydin, H. Basar, I. Sencan, A. Kapuagasi, M. Ozturk, Z. Uzundurukan, D. Gokmen, A. Ozcan, C. Kaymak P219 - Anaesthesia procedure and intensive therapy in patients with neck phlegmon V. A. Artemenko, A. Budnyuk P220 - Nasal high flow oygen for acute respiratory failure: a systematic review R. Pugh , S. Bhandari P221 - Setting optimal flow rate during high flow nasal cannula support: preliminary results T. Mauri, C. Turrini, T. Langer, P. Taccone, C. A. Volta, C. Marenghi, L. Gattinoni, A. Pesenti P222 - Dose to dose consistency across two different gas flow rates using cystic fibrosis and normal adult breathing profiles during nasal high flow oxygen therapy L. Sweeney, A . O&#x2019; Sullivan, P. Kelly, E. Mukeria, R. MacLoughlin P223 - Final results of an evaluation of airway medix closed suction system compared to a standard closed suction system M. Pfeffer, J. T. Thomas, G. B. Bregman, G. K. Karp, E. K. Kishinevsky, D. S. Stavi, N. A. Adi P224 - Different cuff materials and different leak tests - one size does not fit all T. Poropat, R. Knafelj P225 - Observational study on the value of the cuff-leak test and the onset of upper airway obstruction after extubation E. Llopart, M. Batlle, C. De Haro, J. Mesquida, A. Artigas P226 - A device for emergency transtracheal lung ventilation D. Pavlovic, L. Lewerentz, A. Spassov, R. Schneider P227 - Long-term outcome and health-related quality of life in patients discharged from the intensive care unit with a tracheostomy and with or without prolonged mechanical ventilation S. De Smet, S. De Raedt, E. Derom, P Depuydt, S. Oeyen, D. Benoit, J. Decruyenaere P228 - Ultrasound-guided percutaneous dilational tracheostomy versus bronchoscopy-guided percutaneous dilational tracheostomy in critically ill patients (trachus): a randomized clinical trial A. Gobatto, B. Bese, P. Tierno, L. Melro, P. Mendes, F. Cadamuro, M. Park, L. M. Malbouisson P229 - Is it safe to discharge patients with tracheostomy from the ICU to the ward? B. C. Civanto, J. L. Lopez, A. Robles, J. Figueira, S. Yus, A. Garcia P230 - The application of tracheostomy in children in ICU A. Oglinda, G. Ciobanu, C. Oglinda, L. Schirca, T. Sertinean, V. Lupu P231 - The impact of passive humidifiers on aerosol drug delivery during mechanical ventilation P. Kelly, A. O&#x2019;Sullivan, L. Sweeney, R. MacLoughlin P232 - Evaluation of vibrating mesh and jet nebuliser performance at two different attachment setups in line with a humidifier nebuliser system A. O&#x2019;Sullivan, P. Kelly, L. Sweeney, E. Mukeria, M. Wolny , R. MacLoughlin P233 - Psv-niv versus cpap in the treatment of acute cardiogenic pulmonary edema A. Pagano, F. Numis, G. Vison, L. Saldamarco, T. Russo, G. Porta, F. Paladino P234 - Noninvasive ventilation in patients with haematologic malignancy: a retrospective review C. Bell, J. Liu, J. Debacker, C. Lee, E. Tamberg, V. Campbell, S. Mehta P235 - Use of non-invasive ventilation in infectious diseases besides classical indications A. Silva-Pinto, A. Sarmento, L. Santos P236 - The impact of fragility on noninvasive mechanical ventilation application and results in the ICU &#xdd;. Kara, F. Y&#xfd;ld&#xfd;r&#xfd;m, A. Zerman, Z. G&#xfc;ll&#xfc;, N. Boyac&#xfd;, B. Basar&#xfd;k Aydogan, &#xdc;. Gayg&#xfd;s&#xfd;z, K. G&#xf6;nderen, G. Ar&#xfd;k, M. Turkoglu, M. Aydogdu, G. Aygencel, Z. &#xdc;lger, G. Gursel P237 - Effects of metabolic alkalosis on noninvasive ventilation success and ICU outcome in patients with hypercapnic respiratory failure N. Boyac&#xfd;, Z. Is&#xfd;kdogan, &#xd6;. &#xd6;zdedeoglu, Z. G&#xfc;ll&#xfc;, M. Badoglu, U. Gayg&#xfd;s&#xfd;z, M. Aydogdu, G. Gursel P238 - Asynchrony index and breathing patterns of acute exacerbation copd patients assisted with noninvasive pressure support ventilation and neurally adjusted ventilatory assist N. Kongpolprom, C. Sittipunt P239 - High frequency jet ventilation for severe acute hypoxemia A. Eden, Y. Kokhanovsky, S. Bursztein &#x2013; De Myttenaere, R. Pizov P240 - HFOV revisited: a 7&#xa0;year retrospective analysis of patients receiving HFOV who met oscillate trial entry criteria L. Neilans, N. MacIntyre P241 - Implementation of a goal-directed mechanical ventilation order set driven by respiratory therapists can improve compliance with best practices for mechanical ventilation M. Radosevich, B. Wanta, V. Weber, T. Meyer, N. Smischney, D. Brown, D. Diedrich P242 - A reduction in tidal volumes for ventilated patients on ICU calculated from IBW. can it minimise mortality in comparison to traditional strategies? A . Fuller, P. McLindon, K. Sim P243 - Predictive value of lung aeration scoring using lung ultrasound in weaning failure M. Shoaeir, K. Noeam, A. Mahrous, R. Matsa, A. Ali P244 - Conventional versus automated weaning from mechanical ventilation using SmartCare&#x2122; C. Dridi, S. Koubaji, S. Kamoun, F. Haddad, A. Ben Souissi, B. Laribi, A. Riahi, M. S. Mebazaa P245 - Ultrasonographic evaluation protocol for weaning from mechanichal ventilation A. P&#xe9;rez-Calatayud, R. Carrillo-Esper, A. Zepeda-Mendoza, M. Diaz-Carrillo, E. Arch-Tirado P246 - Diaphragm ultrasonography: a method for weaning patients from mechanical ventilation S. Carbognin, L. Pelacani, F. Zannoni, A. Agnoli, G. Gagliardi P247 - Dorsal diaphragmatic excursion tracks transpulmonary pressure in ventilated ARDS patients: a potential non-invasive indicator of lung recruitment? R. Cho, A. Adams , S. Lunos, S. Ambur, R. Shapiro, M. Prekker P248 - Pulse oximetry in the icu patient: is the perfusion index of any value? M. Thijssen, L. Janssen, N. Foudraine P249 - Ventilation is a better assessment of respiratory status than EtCO2 C. J. Voscopoulos, J. Freeman P250 - Evaluation of the relationship between non-invasive minute ventilation and end-tidal CO2 in patients undergoing general vs spinal anesthesia C. J. Voscopoulos, J. Freeman, E. George P251 - Respiratory volume monitoring provides early warning of respiratory depression and can be used to reduce false alarms in non-intubated patients C. J. Voscopoulos, D. Eversole, J. Freeman, E. George P252 - P/i index: a predictive edi-derived weaning index during nava S. Muttini, R. Bigi, G. Villani, N. Patroniti P253 - Adequacy of ventilation in patients receiving opioids in the post anesthesia care unit: minute ventilation versus respiratory rate G. Williams, C. J. Voscopoulos, J. Freeman, E. George P254 - Comparison of regional and global expiratory time constants measured by electrical impedance tomography (EIT) A. Waldmann, S. B&#xf6;hm, W. Windisch, S. Strassmann, C. Karagiannidis P255 - Electrical impedance tomography: robustness of a new pixel wise regional expiratory time constant calculation A. Waldmann, S. B&#xf6;hm, W. Windisch, S. Strassmann, C. Karagiannidis P256 - Validation of regional and global expiratory time constant measurement by electrical impedance tomography in ards and obstructive pulmonary diseases C. K. Karagiannidis, A. W. Waldmann, S. B. B&#xf6;hm, S. Strassmann, W. W. Windisch P257 - Transpulmonary pressure in a model with elastic recoiling lung and expanding chest wall P. Persson, S. Lundin, O. Stenqvist P258 - Lactate in pleural and abdominal effusion G. Porta, F. Numis, C. S. Serra, A. P. Pagano, M. M. Masarone, L. R. Rinaldi, A. A. Amelia, M. F. Fascione, L. A. Adinolfi, E. R. Ruggiero P259 - Outcome of patients admitted to the intensive care with pulmonary fibrosis F. Asota, K. O&#x2019;Rourke, S. Ranjan, P. Morgan P260 - Sedation and analgesia practice in extra-corporeal membrane oxygenation (ECMO)-treated patients with acute respiratory distress syndrome (ARDS): a retrospective study J. W. DeBacker, E. Tamberg, L. O&#x2019;Neill, L. Munshi, L. Burry, E. Fan, S. Mehta P261 - Characteristics and outcomes of patients deemed not eligible when referred for veno-venous extracorporeal membrane oxygenation (vv-ECMO) S. Poo, K. Mahendran, J. Fowles, C. Gerrard, A. Vuylsteke P262 - The SAVE SMR for veno-arterial ECMO R. Loveridge, C. Chaddock, S. Patel, V. Kakar, C. Willars, T. Hurst, C. Park, T. Best, A. Vercueil, G. Auzinger P263 - A simplified score to predict early (48&#xa0;h) mortality in patients being considered for VA-ECMO A. Borgman, A. G. Proudfoot, E. Grins, K. E. Emiley, J. Schuitema, S. J. Fitch, G. Marco, J. Sturgill, M. G. Dickinson, M. Strueber, A. Khaghani, P. Wilton, S. M. Jovinge P264 - Lung function six months post extra corporeal membrane oxygenation (ECMO) for severe acute respiratory failure in adult survivors C. Sampson, S. Harris-Fox P265 - Bicarbonate dialysis removes carbon dioxide in hypoventilated rodents. M. E. Cove, L. H. Vu, A. Sen, W. J. Federspiel, J. A. Kellum P266 - Procalcitonin as predictor of primary graft dysfunction and mortality in post-lung transplantation C. Mazo Torre, J. Riera, S. Ramirez, B. Borgatta, L. Lagunes, J. Rello P267 - New molecular biomarkers of acute respiratory distress syndrome in abdominal sepsis A. K. Kuzovlev, V. Moroz, A. Goloubev, S. Polovnikov, S. Nenchuk P268 - Tight junction&#x2019;s proteins claudin -5 and regulation by tnf in experimental murine lung injury model of ali/ards V. Karavana, C. Glynos, A. Asimakos, K. Pappas, C. Vrettou, M. Magkou, E. Ischaki, G. Stathopoulos, S. Zakynthinos P269 - Cell counts in endobronchial aspirate to assess airway inflammation in ARDS patients: a pilot study S. Spadaro, I. Kozhevnikova, F. Dalla Corte, S. Grasso, P. Casolari, G. Caramori, C. Volta P270 - Epidemiological and clinical profile of patients with acute respiratory distress syndrome in the surgical intensive care unit surgical, hospital JRA, Antananarivo T. Andrianjafiarinoa, T. Randriamandrato, T. Rajaonera P271 - Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS. Is it good for the lung and for the heart? S. El-Dash, ELV Costa, MR Tucci, F Leleu, L Kontar, B. De Cagny, F. Brazier, D. Titeca, G. Bacari-Risal, J. Maizel, M. Amato, M. Slama P272 - Effect of recruitment maneuver on left ventricular systolic strain P. Mercado, J. Maizel, L. Kontar, D. Titeca, F. Brazier, A. Riviere, M. Joris, T. Soupison, B. De Cagny, S. El Dash, M. Slama P273 - Inhaled nitric oxide &#x2013; is switching supplier cost effective? Remmington, A. Fischer, S. Squire, M. Boichat P274 - Epidemiological study of severe acute pancreatitis in Japan, comparison of the etiology and the patient outcomes on 1159 patients. H. Honzawa, H. Yasuda, T. Adati, S. Suzaki, M. Horibe, M. Sasaki, M. Sanui P275 - Extracorporeal liver support therapy. Experience in an intensive care unit R. Marinho, J. Daniel, H. Miranda, A. Marinho P276 - Accuracy of mortality prediction models in acute versus acute-on-chronic liver failure in the intensive care setting K. Milinis, M. Cooper, G. R. Williams, E. McCarron, S. Simants, I. Patanwala, I. Welters P277 - Risk of coronary artery disease in patients with chronic liver disease: a population based cohort study Y. Su P278 - 20&#xa0;years of liver transplantation in Santiago de Compostela (Spain). Experience review J. Fern&#xe1;ndez Villanueva, R. Fern&#xe1;ndez Garda, A. L&#xf3;pez Lago, E. Rodr&#xed;guez Ru&#xed;z, R. Hern&#xe1;ndez Vaquero, S. Tom&#xe9; Mart&#xed;nez de Rituerto, E. Varo P&#xe9;rez P279 - Diarrhea is a risk factor for liver injury and may lead to intestinal failure associated liver disease in critical illness N. Lefel, F. Schaap, D. Bergmans, S. Olde Damink, M. Van de Poll P280 - Bowel care on the intensive care unit: constipation guideline compliance and complications K. Tizard, C. Lister, L. Poole P281 - Malnutrition assessed by phase angle determines outcomes in low risk cardiac surgery patients D. Ringaitiene, D. Gineityte, V. Vicka, I. Norkiene, J. Sipylaite P282 - Preoperative fasting times in an irish hospital A. O&#x2019;Loughlin, V. Maraj, J. Dowling P283 - Costs and final outcome of early x delayed feeding in a private Brazil ICU M. B. Velasco, D. M. Dalcomune, E. B. Dias, S. L. Fernandes P284 - Can ventilator derived energy expenditure measurements replace indirect calorimetry? T. Oshima, S. Graf, C. Heidegger, L. Genton, V. Karsegard, Y. Dupertuis, C. Pichard P285 - Revisiting the refeeding syndrome: results of a systematic review N. Friedli, Z. Stanga, B. Mueller, P. Schuetz P286 - Compliance with the new protocol for parenteral nutrition in our ICU L. Vandersteen, B. Stessel, S. Evers, A. Van Assche, L. Jamaer, J. Dubois P287 - Nutrition may be another treatment in the intensive care unit where less is more? R. Marinho, H. Castro, J. Moura, J. Valente, P. Martins, P. Casteloes, C. Magalhaes, S. Cabral, M. Santos, B. Oliveira, A. Salgueiro, A. Marinho P288 - Should we provide more protein to critically ill patients? R. Marinho, M. Santos, E. Lafuente, H. Castro, S. Cabral, J. Moura, P. Martins, B. Oliveira, A. Salgueiro, S. Duarte, S. Castro, M. Melo, P. Casteloes, A. Marinho P289 Protein provision in an adult intensive care unit S. Gray P290 - Prevalence and clinical outcomes of vitamin d deficiency in the medical critically ill patients in Songklanagarind hospital K. Maipang, R. Bhurayanontachai P291 - Vitamin d deficiency strongly predicts adverse medical outcome across different medical inpatient populations: results from a prospective study L. G. Gr&#xe4;del, P. Sch&#xfc;tz P292 - Omega-3 fatty acids in patients undergoing cardiac surgery: a systematic review and meta-analysis P. Langlois, W. Manzanares P293 - Can 5-hydroxytriptophan prevent post-traumatic stress disorder in critically ill patients? R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P294 - Parenteral selenium in the critically ill: an updated systematic review and meta-analysis W. Manzanares, P. Langlois, M. Lemieux, G. Elke, F. Bloos, K. Reinhart, D. Heyland P295 - Probiotics in the critically ill: an updated systematic review and meta-analysis P. Langlois, M. Lemieux, I. Aramendi, D. Heyland, W. Manzanares P296 - Diabetes with hyperglycemic crisis episodes may be associated with higher risk of pancreatic cancer: a population-based cohort study Y. Su P297 - Incidence of hypoglycemia in an intensive care unit depending on insulin protocol R. Marinho, N. Babo, A. Marinho P298 - Severity of the diseases is two-dimensionally correlated to blood glucose, including blood glucose variability, especially in moderately to severely ill patients with glucose intolerance. M. Hoshino, Y. Haraguchi, S. Kajiwara, T. Mitsuhashi, T. Tsubata, M. Aida P299 - A study of glycemic control by subcutaneous glargine injection transition from continuous regular insulin infusion in critically ill patients T. Rattanapraphat, R. Bhurayanontachai, C. Kongkamol, B. Khwannimit P300 - Glycemic control in Portuguese intensive care unit R. Marinho, M. Santos, H. Castro, E. Lafuente, A. Salgueiro, S. Cabral, P. Martins, J. Moura, B. Oliveira, M. Melo, B. Xavier, J. Valente, C. Magalhaes, P. Casteloes, A. Marinho P301 - Impact of hyperglycemia duration on the day of operation on short-term outcome of cardiac surgery patients D. Moisidou, F. Ampatzidou, C. Koutsogiannidis, M. Moschopoulou, G. Drossos P302 - Lactate levels in diabetic ketoacidosis patients at ICU admissions G. Taskin, M. &#xc7;akir, AK G&#xfc;ler, A. Taskin, N. &#xd6;cal, S. &#xd6;zer, L. Yamanel P303 - Intensive care implications of merging heart attack centre units in London J. M. Wong, C. Fitton, S. Anwar, S. Stacey P304 - Special characteristics of in-hospital cardiac arrests M. Aggou, B. Fyntanidou, S. Patsatzakis, E. Oloktsidou, K. Lolakos, E. Papapostolou, V. Grosomanidis P305 - Clinical evaluation of ICU-admitted patients who were resuscitated in the general medicine ward S. Suda , T. Ikeda, S. Ono, T. Ueno, Y. Izutani P306 - Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystanders S. Gaudry, V. Desailly, P. Pasquier, PB Brun, AT Tesnieres, JD Ricard, D. Dreyfuss, A. Mignon P307 - Public and clinical staff perceptions and knowledge of CPR compared to local and national data J. C White, A. Molokhia, A. Dean, A. Stilwell, G. Friedlaender P308 Dispatcher-assisted telephone cardiopulmonary resuscitation using a French-language compression-ventilation pediatric protocol M. Peters, S. Stipulante, A. Delfosse, AF Donneau, A. Ghuysen P309 Dantrolene versus amiodarone for resuscitation &#x2013; an experimental study C. Feldmann, D. Freitag, W. Dersch, M. Irqsusi, D. Eschbach, T. Steinfeldt, H. Wulf, T. Wiesmann P310 Long term survival and functional neurological outcome in comatose survivors undergoing therapeutic hypothermia N. Kongpolprom, J. Cholkraisuwat P311 Impact of kidney disease on mortality and neurological outcome in out-of-hospital cardiac arrest: a prospective observational study S. Beitland , E. Nakstad, H. St&#xe6;r-Jensen , T. Dr&#xe6;gni , G. Andersen , D. Jacobsen , C. Brunborg, B. Waldum-Grevbo , K. Sunde P312 ICU dependency of patients admitted after primary percutaneous coronary intervention (PPCI) following out of the hospital cardiac arrest K. Hoyland, D. Pandit P313 Prognostic indicators and outcome prediction model for patients with return of spontaneous circulation from cardiopulmonary arrest: comprehensive registry of in-hospital intensive care on OHCA survival (critical) study in Osaka, Japan K. Hayakawa P314 Cerebral oxygen saturation during resuscitation in a porcine model of cardiac arrest E. Oloktsidou, K. Kotzampassi, B. Fyntanidou, S. Patsatzakis, L. Loukipoudi, E. Doumaki, V. Grosomanidis P315 Presumption of cardiopulmonary resuscitation for sustaining cerebral oxidation using regional cerebral saturation of oxygen: observational cohort study (press study) H. Yasuda P316 EEG reactivity in patients after cardiac arrest: a close look at stimuli MM Admiraal, M. Van Assen, MJ Van Putten, M. Tjepkema-Cloostermans, AF Van Rootselaar, J. Horn P317 Prognostic value of neuron-specific enolase after cardiac arrest F. Ragusa, A. Marudi , S. Baroni, A. Gaspari, E. Bertellini P318 Correlation between electroencephalographic findings and serum neuron specific enolase with outcome of post cardiac arrest patients A. Taha, T. Abdullah, S. Abdel Monem P319 Introduction of a targeted temperature management strategy following cardiac arrest in a district general hospital intensive care unit. S. Alcorn, S. McNeill, S. Russell P320 The evolution of cerebral oxygen saturation in post-cardiac arrest patients treated with therapeutic hypothermia W. Eertmans, C. Genbrugge, I. Meex, J. Dens, F. Jans, C. De Deyne P321 Prognostic factors and neurological outcomes of therapeutic hypothermia in comatose survivors from cardiac arrest: 8-year single center experience J. Cholkraisuwat, N. Kongpolprom P322 Adherence to targeted temperature management after out of hospital cardiac arrest B. Avard, R. Burns P323 Implementation of a therapeutic hypothermia protocol for comatose survivors of out-of-hospital cardiac arrest. A. Patarchi, T. Spina P324 Factors associated with ventilator weaning after targeted temperature management for cardiac arrest patients in japan H. Tanaka, N. Otani, S. Ode, S. Ishimatsu P325 Differential activation of c-fos in paraventricular nuclei of the hypothalamus and thalamus of the rat following myocardial infarction J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin, M. H. Won P326 Monitoring of cTroponin I in patients with acute ischemic stroke - predictor of inhospital mortality S. Dakova, Z. Ramsheva, K. Ramshev P327 Hyperthermic preconditioning severely accelerates neuronal damage in the gerbil ischemic hippocampal dentate gyrus via decreasing sods expressions J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P328 Failure in neuroprotection of remote limb ischemic post conditioning in the hippocampus of a gerbil model of transient cerebral ischemia J. Cho, J. B. Moon, C. W. Park, T. G. Ohk, M. C. Shin P329 Brain death and admission diagnosis in neurologic intensive care unit, a correlation? A Marudi, S Baroni, A Gaspari, E Bertellini P330 Brain magnetic resonance imaging findings in patients with septic shock G. Orhun, E. Senturk, P. E. Ozcan, S. Sencer, C. Ulusoy, E. Tuzun, F . Esen P331 Benefits of L-carnitine in valproic acid induced encephalopathy R. Tincu, C. Cobilinschi, D. Tomescu, Z. Ghiorghiu, R. Macovei P332Automatic analysis of EEG reactivity in comatose patients M. Van Assen, M. M. Admiraal, M. J. Van Putten, M. Tjepkema-Cloostermans, A. F. Van Rootselaar, J. Horn P333 Usefulness of common ICU severity scoring systems in predicting outcome after spontaneous intracerebral hemorrhage M. Fallenius, M. B. Skrifvars, M. Reinikainen, S. Bendel, R. Raj P334 Evalution of patients with suspected subarachnoid haemorrhage and negative ct imaging M. Abu-Habsa, C. Hymers, A. Borowska, H. Sivadhas, S. Sahiba, S. Perkins P335 Timing of endovascular and surgical treatment for aneurysmal subarachnoid haemorrhage: early but not so fast. J. Rubio, J. A. Rubio, R. Sierra P336 Red blood cell transfusion in aneurysmal subarachnoid hemorrhage &#x2013; the Sahara cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P337 - Aneurysmal subarachnoid hemorrhage and anemia: a canadian multi-centre retrospective cohort study S. English, M. Chasse, A. Turgeon, F. Lauzier, D. Griesdale, A. Garland, D. Fergusson, R. Zarychanski, A. Tinmouth, C. Van Walraven, K. Montroy, J. Ziegler, R. Dupont Chouinard, R. Carignan, A. Dhaliwal, C. Lum, J. Sinclair, G. Pagliarello, L. McIntyre P338 - Does the neutrophil-to-lymphocyte (NLR) ratio predict symptomatic vasospasm or delayed cerebral ischemia (DCI) after aneurysmal subarachnoid haemorrhage (SAH)? T. Groza, N. Moreau, D. Castanares-Zapatero, P. Hantson P339 - ICU-acquired infections in aneurysmal subarachnoid hemorrhage patients: impact on ICU and hospital length of stay M. Carbonara , F. Ortolano, T. Zoerle, S. Magnoni, S. Pifferi, V. Conte, N. Stocchetti P340 - Cerebral metabolic effects of normobaric hyperoxia during the acute phase of aneurysmal subarachnoid hemorrhage L. Carteron, T. Suys, C. Patet, H. Quintard, M. Oddo P341 - Postoperative care for elective craniotomy: where is best done? J. A. Rubio, J. Rubio, R. Sierra P342 - 5-year follow-up of patients after transplantation of organs from donors from neurocritical care V. Spatenkova, E. Pokorna, P. Suchomel P343 - Evaluation of levetiracetam pharmacokinetics after severe traumatic brain injury in neurocritical care patients at a level one trauma center N. Ebert, J. Jancik, H. Rhodes P344 - Model based time series cluster analysis to determine unique patient states in traumatic brain injury T. Bylinski, C. Hawthorne, M. Shaw, I. Piper, J. Kinsella P345 - Brain compartment monitoring capabilities from ICP to BI (bioimpedance) during HS (hypertonic saline) administration. State of art simulation outcome depending on brain swelling type A. K. Kink , I. R. R&#xe4;tsep P346 - Transfusion of red blood cells in patients with traumatic brain injury admitted to Canadian trauma health centers: a multicenter cohort study A. Boutin, L. Moore, M. Chasse, R. Zarychanski, F. Lauzier, S. English, L. McIntyre, J. Lacroix, D. Griesdale, P. Lessard-Bonaventure, A. F. Turgeon P347 - Hemoglobin thresholds and red blood cell transfusions in adult patients with moderate or severe traumatic brain injury: a retrospective cohort study A. Boutin, L. Moore, R. Green, P. Lessard-Bonaventure, M. Erdogan, M. Butler, F. Lauzier, M. Chasse, S. English, L. McIntyre, R. Zarychanski, J. Lacroix, D. Griesdale, P. Desjardins, D. A. Fergusson, A. F. Turgeon P348 - Characteristics of patients with gunshot wounds to the head - an observational Brazilian study B. Goncalves, B. Vidal, C. Valdez, A. C. Rodrigues, L. Miguez, G. Moralez P349 - Base excess as predictor for ICU admission and the injury severity in blunt trauma patients T. Hong P350 - Enhancement of usual emergency department care with proadrenomedullin to improve outcome prediction - Results from the multi-national, prospective, observational TRIAGE study A. Kutz, P. Hausfater, D. Amin, T. Struja, S. Haubitz, A. Huber, B. Mueller, P. Schuetz P351 - Developing an innovative emergency medicine point-of-care simulation programme T. Brown, J. Collinson, C. Pritchett, T. Slade P352 - The InSim program: an in situ simulation program for junior trainees in intensive care M. Le Guen, S. Hellings, R. Ramsaran P353 - Impact of excessive and inappropriate troponin testing in the emergency setting how good are we A. Alsheikhly P354 - The development of time tracking monitor at emergency department T. Abe P355 - Role of focussed echocardiography in emergency assessment of syncope L. Kanapeckaite, M. Abu-Habsa, R. Bahl P356 - Insertion of an open-ended 14-gauge catheter through the chest wall causes a significant pneumothorax in a self-ventilating swine model M. Q Russell, K. J. Real, M. Abu-Habsa , R. M. Lyon, N. P. Oveland P357 - Ez-io&#xae; intraosseous access teaching in the workplace using a mobile &#x2018;tea trolley&#x2019; training method J. Penketh, M. Mcdonald, F. Kelly P358 - Black widow envenomation in Saudi Arabia: a prospective observational case series M. Alfafi, S. Alsolamy, W. Almutairi, B. Alotaibi P359 - Mechanical ventilation in patients with overdose not yet intubated on icu admission A. E. Van den Berg, Y. Schriel, L. Dawson, I. A. Meynaar P360 - Central nervous system depressants poisoning and ventilator associated pneumonia: an underrated risk factor in toxicological intensive care unit H. Talaie P361 - Acute barium intoxication treated with hemodiafiltration D. Silva, S. Fernandes, J. Gouveia, J. Santos Silva P362 - Major trauma presenting to the emergency department. the spectrum of cycling injuries in Ireland J. Foley, A. Kaskovagheorgescu, D. Evoy, J. Cronin, J. Ryan P363 - Burns from French military operations: a 14-year retrospective observational analysis. M. Huck, C. Hoffmann, J. Renner, P. Laitselart, N. Donat, A. Cirodde, J. V. Schaal, Y. Masson, A. Nau, T. Leclerc P364 - A comparison of mortality scores in burns patients on the intensive care unit. O. Howarth, K. Davenport, P. Jeanrenaud, S. Raftery P365 - Clasification of pain and its treatment and an intensive care rehabiliation clinic P. MacTavish, H. Devine, J. McPeake, M. Daniel, J. Kinsella, T. Quasim P366 - Pain management adequacy in critical care areas ,the process and the barriers perceived by critical care nurses S. Alrabiee, A. Alrashid , S. Alsolamy P367 - Pain assessment in critically ill adult patients: validation of the Turkish version of the critical-care pain observation tool O. Gundogan, C. Bor, E. Ak&#xfd;n Korhan, K. Demirag , M. Uyar P368 - An audit of pain and sedation assessments in the intensive care unit: recommendations for clinical practice F. Frame, C. Ashton, L. Bergstrom Niska P369 - Impact of pharmaceutical care on treatment of pain and agitation in medical intensive care unit P. Dilokpattanamongkol, T. Suansanae, C. Suthisisang, S. Morakul, C. Karnjanarachata, V. Tangsujaritvijit P370 - Agitation in trauma ICU, prevention and outcome S. Mahmood, H. Al Thani, A. Almenyar P371 Correlation between percentages of ventilated patients developed vap and use of sedative agents in icu patients. A. Vakalos , V. Avramidis P372 - Improving recording of sedation events in the Emergency Department: The implementation of the SIVA International Taskforce adverse event reporting tool for procedural sedation R. Sharvill, J. Penketh P373 - Impact of sedative drug use on the length of mechanical ventilation S. E. Morton, Y. S. Chiew, C. Pretty, J. G. Chase, G. M. Shaw P374 - Co-administration of nitric oxide and sevoflurane using anaconda R. Knafelj, P. Kordis P375 - A retrospective study of the use of Dexmedetomidine in an oncological critical care setting S. Patel, V. Grover P376 - Dexmedetomidine and posttraumatic stress disorder incidence in alcohol withdrawal icu patients I. Kuchyn, K. Bielka P377 - Hemodynamic effects of dexmedetomidine in a porcine model of septic shock Z. Aidoni, V. Grosomanidis, K. Kotzampassi, G. Stavrou, B. Fyntanidou, S. Patsatzakis, C. Skourtis P378 - Ketamine for analgosedation in severe hypoxic respiratory failure S. D. Lee, K. Williams, I. D. Weltes P379 - Madness from the moon? lunar cycle and the incidence of delirium on the intensive care unit S. Berhane, C. Arrowsmith, C. Peters, S. Robert P380 - Impaired dynamic cerebral autoregulation after coronary artery bypass grafting and association with postoperative delirium J. Caldas, R. B. Panerai, T. G. Robinson, L. Camara, G. Ferreira, E. Borg-Seng-Shu, M. De Lima Oliveira, N. C. Mian, L. Santos, R. Nogueira, S. P. Zeferino, M. Jacobsen Teixeira, F. Galas, L. A. Hajjar P381 - Risk factors predicting prolonged intensive care unit length of stay after major elective surgery. P. Killeen, M. McPhail, W. Bernal, J. Maggs, J. Wendon, T. Hughes P382 - Systemic inflammatory response syndrome criteria and hospital mortality prediction in a brazilian cohort of critically ill patients L. U. Taniguchi, E. M. Siqueira, J. M. Vieira Jr, L. C. Azevedo P383 - Evaluating the efficacy of a risk predictor panel in identifying patients at elevated risk of morbidity following emergency admission A. N. Ahmad, M. Abu-Habsa, R. Bahl, E. Helme, S. Hadfield, R. Loveridge P384 - A retrospective comparison of outcomes for elective surgical patients admitted post-operatively to the critical care unit or general ward J. Shak, C. Senver, R. Howard-Griffin P385 - Effect of obesity on mortality in surgical critically ill patients. P. Wacharasint, P. Fuengfoo, N. Sukcharoen, R. Rangsin P386 - The national early warning score (news) reliably improves adverse clinical outcome prediction in community-acquired pneumonia - results from a 6&#xa0;year follow-up D. Sbiti-Rohr, P. Schuetz P387 - Clinical usefulness of the charlson&#xa1;&#xaf;s weighted index of comorbidities _as prognostic factor in patients with prolonged acute mechanical ventilation H. Na, S. Song, S. Lee, E. Jeong, K. Lee P388 - Comparison of mortality prediction scoring systems in patients with cirrhosis admitted to general intensive care unit M. Cooper, K. Milinis, G. Williams, E. McCarron, S. Simants, I. Patanwala, I. D. Welters P389 - Impact of admission source and time of admission on outcome of pediatric intensive care patients: retrospective 15&#xa0;years study E. Zoumpelouli, EA Volakli, V. Chrysohoidou, S. Georgiou, K. Charisopoulou, E. Kotzapanagiotou, V. Panagiotidou, K. Manavidou, Z. Stathi, M. Sdougka P390 - Heart rate variability and outcomes prediction in critical illness N. Salahuddin, B. AlGhamdi, Q. Marashly, K. Zaza, M. Sharshir, M. Khurshid, Z. Ali, M. Malgapo, M. Jamil, A. Shafquat, M. Shoukri, M. Hijazi P391 - The incidence and outcome of hyperlactatemia in the post anaesthesia care unit T. Abe, S. Uchino, M. Takinami P392 - Correlation between arterial blood gas disturbances and arterial lactate levels during hospitalization and outcome in critically septic patients N. R. Rangel Neto, S. Oliveira, F. Q. Reis, F. A. Rocha P393 - External validation of saps 3 and mpm iii scores in 48,816 patients from 72 brazilian icus G. Moralez, K. Ebecken, L. S. Rabello, M. F. Lima, R. Hatum, F. V. De Marco, A. Alves, J. E. Pinto, M. Godoy, P. E. Brasil, F. A. Bozza, J. I. Salluh, M. Soares P394 - The frailty penalty: pre-admission functional status confounds mortality prediction models in critically ill patients J. Krinsley, G. Kang P395 - &#x2018;sooner rather than later&#x201d;: how delayed discharge from critical care leads to increased out of hours discharges and subsequent increase in in-hospital mortality. J. Perry, H. Hines P396 - Identifying poor outcome patient groups in a resource-constrained critical care unit K. M. Wilkinson, C. Tordoff, B. Sloan, M. C. Bellamy P397 - Effects of icu weekend admission and discharge on mortality. E. Moreira, F. Verga, M. Barbato, G. Burghi P398 - Organizational factors, outcomes and resource use in 9,946 cancer patients admitted to 70 ICUs M Soares, U. V. Silva, L. C. Azevedo, A. P. Torelly, J. M. Kahn, D. C. Angus, M. F. Knibel, P. E. Brasil, F. A. Bozza, J. I. Salluh P399 - Evaluation of oncological critically ill patients, severity score and outcome compared to not oncological in a particular hospital cti. M. B. Velasco, D. M. Dalcomune P400 - Outcomes of patients admitted to a large uk critical care department with palliative oncological diagnoses R. Marshall, T. Gilpin, A. Tridente, A. Raithatha P401 - Predictors of mortality in febrile neutropenic patients with haematological malignancies admitted to an intensive care unit of a cancer center D. Mota, B. Loureiro, J. Dias, O. Afonso, F. Coelho, A. Martins, F. Faria P402 - Patients with hematologic malignancies requiring invasive mechanical ventilation: characteristics and predictors of mortality H. Al-Dorzi, H. Al Orainni , F. AlEid, H. Tlaygeh, A. Itani, A. Hejazi, Y. Arabi P403 - Patient-important outcomes in randomized controlled trials in critically ill patients: a systematic review S. Gaudry, J. Messika, J. D. Ricard, S. Guillo, B. Pasquet, E. Dubief, D. Dreyfuss, F. Tubach P404 - Alopecia in survivors of critical illness: a qualitative study C . Battle, K. James, P. Temblett P405 - The impact of mental health on icu admission L. Davies, C. Battle, C. Lynch P406 - Cognitive impairment 5&#xa0;years after ICU discharge S. Pereira, S. Cavaco, J. Fernandes, I. Moreira, E. Almeida, F. Seabra Pereira, M. Malheiro, F. Cardoso, I. Arag&#xe3;o, T. Cardoso P407 - Apache ii versus apache iv for octagenerians in medical icu M. Fister, R. Knafelj P408 - Outcomes of octagenarians in an indian icu P. Muraray Govind, N. Brahmananda Reddy, R. Pratheema, E. D. Arul, J. Devachandran P409 - Mortality and outcomes in elderly patients 80&#xa0;years of age or older admitted to the icu M. B. Velasco , D. M. Dalcomune P410 - Octagenerians in medical icu - adding days to life or life to days? R. Knafelj, M. Fister P411 - The very elderly admitted to intensive care unit: outcomes and economic evaluation N. Chin-Yee, G. D&#x2019;Egidio, K. Thavorn, D. Heyland, K. Kyeremanteng P412 - The very elderly in intensive care: relationship between acuity of illness and long-term mortality A. G. Murchison, K. Swalwell, J. Mandeville, D. Stott P413 - Acquired weakness in an oncological intensive care unit I. Guerreiro P414 - Musculoskeletal problems in intensive care unit (ICU) patients post-discharge H. Devine, P. MacTavish, J. McPeake, T. Quasim, J. Kinsella, M. Daniel P415 - Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness C. Goossens M. B. Marques, S. Derde, S. Vander Perre, T. Dufour, S. E. Thiessen, F. G&#xfc;iza, T. Janssens, G. Hermans, I. Vanhorebeek, K. De Bock, G. Van den Berghe, L. Langouche P416 - Physical outcome measures for critical care patients following intensive care unit (icu) discharge H. Devine, P. MacTavish, T. Quasim, J. Kinsella, M. Daniel, J. McPeake P417 - Improving active mobilisation in a general intensive care unit B. Miles , S. Madden, H. Devine P418 - Mobilization in patients on vasoactive drugs use &#x2013; a pilot study. M. Weiler, P. Marques, C. Rodrigues, M. Boeira, K. Brenner, C. Le&#xe3;es, A. Machado, R. Townsend, J. Andrade P419 - Pharmacy intervention at an intensive care rehabilitation clinic P. MacTavish, J. McPeake, H. Devine, J. Kinsella, M. Daniel, R. Kishore, C. Fenlon, T. Quasim P420 - Interactive gaming is feasible and potentially increases icu patients&#x2019; motivation to be engaged in rehabilitation programs T. Fiks, A. Ruijter, M. Te Raa, P. Spronk P421 - Simulation-based design of a robust stopping rule to ensure patient safety Y. S. Chiew, P. Docherty, J. Dickson, E. Moltchanova, C. Scarrot, C. Pretty, G. M. Shaw, J. G. Chase P422 - Are daily blood tests on the intensive care unit necessary? T. Hall, W. C. Ngu, J. M. Jack, P. Morgan P423 - Measuring urine output in ward patients: is it helpful? B. Avard, A. Pavli, X. Gee P424 - The incidence of pressure ulcers in an adult mixed intensive care unit in turkey C . Bor, E. Akin Korhan, K. Demirag, M. Uyar P425 - Intensivist/patient ratios in closed ICUs in Alexandria, Egypt; an overview M. Shirazy, A. Fayed P426 - Eicu (electronic intensive care unit): impact on ALOS (average length of stay) in a developing country like India S. Gupta, A. Kaushal, S. Dewan, A. Varma P427 - Predicting deterioration in general ward using early deterioration indicator E. Ghosh, L. Yang, L. Eshelman, B. Lord, E. Carlson P428 - High impact enhanced critical care outreach - the imobile service: making a difference E. Helme, R. Broderick, S. Hadfield, R. Loveridge P429 - Impact of bed availability and cognitive load on intensive care unit (ICU) bed allocation: a vignette-based trial J. Ramos, D. Forte P430 - Characteristics of critically ill patients admitted through the emergency department F. Yang, P. Hou P431 - Admission to critical care: the quantification of functional reserve J. Dudziak, J. Feeney, K. Wilkinson, K. Bauchmuller, K. Shuker, M. Faulds, A. Raithatha, D. Bryden, L. England, N. Bolton, A. Tridente P432 - Admission to critical care: the importance of frailty K. Bauchmuller, K Shuker, A Tridente, M Faulds, A Matheson, J. Gaynor, D Bryden, S South Yorkshire Hospitals Research Collaboration P433 - Development of an instrument to aid triage decisions for intensive care unit admission J. Ramos, B. Peroni, R. Daglius-Dias, L. Miranda, C. Cohen, C. Carvalho, I . Velasco, D. Forte P434 - Using selective serotonin re-uptake inhibitors and serotonin-norepinephrine re-uptake inhibitors in critical care: a systematic review of the evidence for benefit or harm J. M. Kelly, A. Neill, G. Rubenfeld, N. Masson, A. Min P435 - Measuring adaptive coping of hospitalized patients with a severe medical condition:the sickness insight in coping questionnaire (sicq) E. Boezeman, J. Hofhuis , A. Hovingh, R. De Vries, P. Spronk P436 - Results of a national survey regarding intensive care medicine training G. Cabral-Campello, I. Arag&#xe3;o, T. Cardoso P437 - Work engagement among healthcare professionals in the intensive care unit M. Van Mol, M. Nijkamp, E . Kompanje P438 - Empowering the intensive care practitioners. is it a burnout ameliorating intervention? P. Ostrowski, A. Omar P439 - Icu patients suffer from circadian rhythm desynchronisation K. Kiss , B. K&#xf6;ves, V. Csernus, Z. Moln&#xe1;r P440 - Noise reduction in the ICU: feasible ? Y. Hoydonckx, S. Vanwing, B. Stessel, A. Van Assche, L. Jamaer, J. Dubois P441 - Accidental removal of invasive devices in the critical patient into the bed-washing. does the presence of professional nurse modify his incidence? V. Medo, R. Galvez, J. P. Miranda P442 - Deprivation of liberty safeguards (dols): audit of compliance in a of a 16-bed specialist cancer critical care unit. C. Stone, T. Wigmore P443 - Use of a modified cristal score to predict futility of critical care in the elderly Y. Arunan, A. Wheeler, K. Bauchmuller, D. Bryden P444 - Improvement of Referral Rate to Palliative Care for Patients with Poor Prognosis in Neurosurgical Intensive Care Unit Y. Wong, C. Poi, C. Gu P445 - Factors associated with limitation of life supporting care (lsc) in a medico-surgical intermediate care unit, and outcome of patients with lsc limitation: a monocentric, six-month study. P. Molmy, N. Van Grunderbeeck, O. Nigeon, M. Lemyze, D. Thevenin, J. Mallat P446 - Palliative care consultation and intensive care unit admission request: a cohort study J. Ramos, M. Correa, R. T. Carvalho, D. Forte P447 - Nursing and medicine together in postsurgical intensive care unit: situations of prognostic conflict at the end of life. our critical care nurses suffer with our medical activism? A. Fernandez, C. McBride P448 - End of life who may decide E. Koonthalloor, C. Walsh P449 - Correctly diagnosing death A. Webber, M. Ashe, K. Smith, P. Jeanrenaud P450 - Skin procurement performed by intensive care physicians: yes, we can. A. Marudi , S. Baroni, F. Ragusa, E. Bertellini P451 - Death analysis in pediatric intensive care patients E. A. Volakli , E. Chochliourou, M. Dimitriadou, A. Violaki, P. Mantzafleri, E. Samkinidou, O. Vrani, A. Arbouti, T. Varsami, M. Sdougka P452 - The potential impact of euthanasia on organ donation: analysis of data from belgium J. A. Bollen, T. C. Van Smaalen, W. C. De Jongh, M. M. Ten Hoopen, D. Ysebaert, L. W. Van Heurn, W. N. Van Mook P453 - Communication within an intensive care setting K. Sim, A. Fuller P454 - Development and implementation of a longitudinal communication curriculum for critical care medicine fellows A. Roze des Ordons, P. Couillard, C. Doig P455 - Staff-family conflict in a multi-ethnic intensive care unit R. V. Van Keer, R. D. Deschepper, A. F. Francke, L. H. Huyghens, J. B. Bilsen P456 - Does the source of admission to critical care affect family satisfaction? B. Nyamaizi, C. Dalrymple, A. Molokhia, A. Dobru P457 - A simple alternative to the family satisfaction survey (fs-icu) E. Marrinan, A. Ankuli, A. Molokhia P458 - A study to explore the experiences of patient and family volunteers in a critical care environment: a phenomenological analysis J. McPeake, R. Struthers, R. Crawford , H. Devine , P. Mactavish , T. Quasim P459 - Prevalence and risk factors of anxiety and depression in relatives of burn patients. P. Morelli, M. Degiovanangelo, F. Lemos, V. MArtinez, F. Verga, J. Cabrera, G. Burghi P460 - Guidance of visiting children at an adult intensive care unit (icu) A. Rutten , S. Van Ieperen, S. De Geer, M. Van Vugt, E. Der Kinderen P461 - Visiting policies in Italian pediatric ICUs: an update A. Giannini, G Miccinesi, T Marchesi, E Prandi</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>University of Western Ontario, London, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8884</Identifier><Identifier Source="GRID">grid.39381.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharpe</LastName><ForeName>M. D.</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>University of Western Ontario, London, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8884</Identifier><Identifier Source="GRID">grid.39381.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagger</LastName><ForeName>J. E.</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>University of Western Ontario, London, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8884</Identifier><Identifier Source="GRID">grid.39381.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>C. G.</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Sol&#xe9;-Viol&#xe1;n</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Rodr&#xed;guez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera-Ramos</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ru&#xed;z-Hern&#xe1;ndez</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Border&#xed;as</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital San Jorge, Huesca, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1765 5935</Identifier><Identifier Source="GRID">grid.415076.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horcajada</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitari del Mar, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1767 8811</Identifier><Identifier Source="GRID">grid.411142.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Quevedo</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajas</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Hospital Universitario de la Princesa, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1767 647X</Identifier><Identifier Source="GRID">grid.411251.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briones</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico y Universitario de Valencia, Valencia, Spain </Affiliation><Identifier Source="GRID">grid.411308.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez de Castro</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Dr Negr&#xed;n, Las Palmas de GC, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Gallego</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitari Son Espases, Palma de Mallorca, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1796 5984</Identifier><Identifier Source="GRID">grid.411164.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esen</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Istanbul University, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhun</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Istanbul University, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ergin Ozcan</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Istanbul University, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senturk</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Istanbul University, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugur Yilmaz</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Physiology, Istanbul University, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhan</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Istanbul University, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arican</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Forensic Medicine, Istanbul University, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Faculty of Istanbul, Physiology, Istanbul University, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kucukerden</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Istanbul University, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giris</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Istanbul University, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akcan</LastName><ForeName>U.</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Istanbul University, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilgic Gazioglu</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Immunology, Istanbul University, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuzun</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Istanbul University, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riff</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ben-Gurion University of the Negev, Beer-Sheva, Israel </Affiliation><Identifier Source="ISNI">0000 0004 1937 0511</Identifier><Identifier Source="GRID">grid.7489.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naamani</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ben-Gurion University of the Negev, Beer-Sheva, Israel </Affiliation><Identifier Source="ISNI">0000 0004 1937 0511</Identifier><Identifier Source="GRID">grid.7489.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douvdevani</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Soroka Medical Center, Beer-Sheva, Israel </Affiliation><Identifier Source="ISNI">0000 0004 0470 8989</Identifier><Identifier Source="GRID">grid.412686.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takegawa</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshida</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirose</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiya</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojima</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akeda</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasaki</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan </Affiliation><Identifier Source="ISNI">0000 0000 8902 2273</Identifier><Identifier Source="GRID">grid.174567.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomono</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimazu</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Defense Medical College, Tokorozawa, Saitama Japan </Affiliation><Identifier Source="ISNI">0000 0004 0374 0880</Identifier><Identifier Source="GRID">grid.416614.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirose</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojima</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojima</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimazu</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hachiouji medical center, Tokyo medical university, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hachiouji medical center, Tokyo medical university, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izutani</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hachiouji medical center, Tokyo medical university, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hachiouji medical center, Tokyo medical university, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hachiouji medical center, Tokyo medical university, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kanazawa University, Kanazawa, Japan </Affiliation><Identifier Source="ISNI">0000 0001 2308 3329</Identifier><Identifier Source="GRID">grid.9707.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kanazawa University Hospital, Kanazawa, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0615 9100</Identifier><Identifier Source="GRID">grid.412002.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinter</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ThermoFisher, Hennigsdorf, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lotz</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r Klinische Chemie und Laboratoriumsmedizin, Mainz, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eilers</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>MVZ Labor Limbach Gruppe, Berlin, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wissmann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ThermoFisher, Hennigsdorf, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lott</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r Klinische Chemie und Laboratoriumsmedizin, Mainz, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meili</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuetz</LastName><ForeName>P. S.</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawa</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharshir</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aburageila</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chantziara</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsimogianni</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandropoulos</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagiou</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valta</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micha</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chinou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michaloudis</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Saint Savvas Hospital, Athens, Greece </Affiliation><Identifier Source="GRID">grid.416564.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodaira</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izutani</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411909.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imaizumi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Tokyo Medical University, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De la Torre-Prados</LastName><ForeName>M. V.</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-De la Torre</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enguix-Armada</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puerto-Morlan</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Valero</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Alcantara</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Virgen de la Victoria, M&#xe1;laga, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9788 2492</Identifier><Identifier Source="GRID">grid.411062.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolton</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley NHS Trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudziak</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley NHS Trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonney</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley NHS Trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley NHS Trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nee</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley NHS Trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolaes</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiewel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Experimental and Molecular medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wildhagen</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrijver</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van der Poll</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Center for Experimental and Molecular medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reutelingsperger</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubrey</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayat</LastName><ForeName>E. G.</ForeName><Initials>EG</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Lariboisi&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9725 279X</Identifier><Identifier Source="GRID">grid.411296.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struck</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sphingotec, Berlin, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cariou</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Cochin, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 0274 3893</Identifier><Identifier Source="GRID">grid.411784.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deye</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Lariboisi&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9725 279X</Identifier><Identifier Source="GRID">grid.411296.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guidet</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Saint-Antoine, Paris, France </Affiliation><Identifier Source="ISNI">0000 0004 1937 1100</Identifier><Identifier Source="GRID">grid.412370.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jabert</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHRU de Montpellier, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0000 9961 060X</Identifier><Identifier Source="GRID">grid.157868.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Launay</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Lariboisi&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9725 279X</Identifier><Identifier Source="GRID">grid.411296.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Saint-Louis, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2300 6614</Identifier><Identifier Source="GRID">grid.413328.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe9;one</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AP-HM, Marseille, France </Affiliation><Identifier Source="ISNI">0000 0001 0407 1584</Identifier><Identifier Source="GRID">grid.414336.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resche-Rigon</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Saint-Louis, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2300 6614</Identifier><Identifier Source="GRID">grid.413328.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicaut</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Lariboisi&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9725 279X</Identifier><Identifier Source="GRID">grid.411296.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Ambroise Par&#xe9;, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9982 5352</Identifier><Identifier Source="GRID">grid.413756.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Lariboisi&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 9725 279X</Identifier><Identifier Source="GRID">grid.411296.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Christiana Care Health System, Newark, USA </Affiliation><Identifier Source="ISNI">0000 0004 0444 1241</Identifier><Identifier Source="GRID">grid.414316.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capan</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Christiana Care Health System, Newark, USA </Affiliation><Identifier Source="ISNI">0000 0004 0444 1241</Identifier><Identifier Source="GRID">grid.414316.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linder</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Skane University Hospital, Lund University, Lund, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0930 2361</Identifier><Identifier Source="GRID">grid.4514.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akesson</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Skane University Hospital, Lund University, Lund, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0930 2361</Identifier><Identifier Source="GRID">grid.4514.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popescu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Carol Davila University of Medicine and Pharmacy, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0000 9828 7548</Identifier><Identifier Source="GRID">grid.8194.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Carol Davila University of Medicine and Pharmacy, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0000 9828 7548</Identifier><Identifier Source="GRID">grid.8194.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>C. L.</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Hadassah-Hebrew University Medical Center, Jerusalem, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2221 2926</Identifier><Identifier Source="GRID">grid.17788.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calderon Morales</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hadassah-Hebrew University Medical Center, Jerusalem, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2221 2926</Identifier><Identifier Source="GRID">grid.17788.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munteanu</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hadassah-Hebrew University Medical Center, Jerusalem, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2221 2926</Identifier><Identifier Source="GRID">grid.17788.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orenbuch-Harroch</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hadassah-Hebrew University Medical Center, Jerusalem, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2221 2926</Identifier><Identifier Source="GRID">grid.17788.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hadassah-Hebrew University Medical Center, Jerusalem, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2221 2926</Identifier><Identifier Source="GRID">grid.17788.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasdan</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volker</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Himmel</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meissonnier</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>LeukoDx, Jerusalem, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Abionic SA, Lausanne, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebeaud</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Abionic SA, Lausanne, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Swiss Federal Laboratories (Empa), St. Gallen, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delwarde</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peronnet</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerrato</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venet</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepape</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimmel&#xe9;</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monneret</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Textoris</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pathophysiology of injury induced immunosuppression (PI3) Lab, Lyon 1 University / Hospices Civils de Lyon / bioM&#xe9;rieux, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beloborodova</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moroz</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osipov</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bedova</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarshor</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pautova</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sergeev</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chernevskaya</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Negovsky V.A. Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Odermatt</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolliger</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersberger</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ottiger</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christ-Crain</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Basel, Basel, Switzerland </Affiliation><Identifier Source="GRID">grid.410567.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuetz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>N. K.</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>UNIFESP, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0514 7202</Identifier><Identifier Source="GRID">grid.411249.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tashima</LastName><ForeName>A. K.</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>UNIFESP, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0514 7202</Identifier><Identifier Source="GRID">grid.411249.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunialti</LastName><ForeName>M. K.</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>UNIFESP, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0514 7202</Identifier><Identifier Source="GRID">grid.411249.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>F. R.</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>UNIFESP, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0514 7202</Identifier><Identifier Source="GRID">grid.411249.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assuncao</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Albert Einstein Hospital, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0385 1941</Identifier><Identifier Source="GRID">grid.413562.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigato</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>S&#xed;rio Liban&#xea;s Hospital, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomao</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UNIFESP, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 0514 7202</Identifier><Identifier Source="GRID">grid.411249.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cajander</LastName><ForeName>S. C.</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health &#xd6;rebro University, &#xd6;rebro, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0738 8966</Identifier><Identifier Source="GRID">grid.15895.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health &#xd6;rebro University, &#xd6;rebro, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0738 8966</Identifier><Identifier Source="GRID">grid.15895.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tina</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health &#xd6;rebro University, &#xd6;rebro, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0738 8966</Identifier><Identifier Source="GRID">grid.15895.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;derquist</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health &#xd6;rebro University, &#xd6;rebro, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0738 8966</Identifier><Identifier Source="GRID">grid.15895.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xe4;llman</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health &#xd6;rebro University, &#xd6;rebro, Sweden </Affiliation><Identifier Source="ISNI">0000 0001 0738 8966</Identifier><Identifier Source="GRID">grid.15895.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Str&#xe5;lin</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0000 9241 5705</Identifier><Identifier Source="GRID">grid.24381.3c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>A. L.</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, &#xd6;rebro, Sweden </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sund&#xe9;n-Cullberg</LastName><ForeName>J. S.</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0000 9241 5705</Identifier><Identifier Source="GRID">grid.24381.3c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnuson</LastName><ForeName>A. M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, &#xd6;rebro, Sweden </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultgren</LastName><ForeName>O. H.</ForeName><Initials>OH</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health, &#xd6;rebro, Sweden </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubrey</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubrey</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubrey</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NISCHR Haemostasis Biomarker Research Unit, Swansea, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van der Geest</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Erasmus Medical Center, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohseni</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Erasmus Medical Center, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linssen</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Witten/Herdecke, Witten, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jonge</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Erasmus Medical Center, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duran</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Maasstad Ziekenhuis, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0460 0556</Identifier><Identifier Source="GRID">grid.416213.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeneveld</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Erasmus Medical Center, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>R.</ForeName><Initials>R</Initials><Suffix>III</Suffix><AffiliationInfo><Affiliation>Intermountain Healthcare, Salt Lake City, USA </Affiliation><Identifier Source="ISNI">0000 0004 0460 774X</Identifier><Identifier Source="GRID">grid.420884.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopansri</LastName><ForeName>B. K.</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Intermountain Healthcare, Salt Lake City, USA </Affiliation><Identifier Source="ISNI">0000 0004 0460 774X</Identifier><Identifier Source="GRID">grid.420884.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McHugh</LastName><ForeName>L. C.</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Immunexpress, Seattle, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seldon</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Immunexpress, Seattle, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>J. P.</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Intermountain Healthcare, Salt Lake City, USA </Affiliation><Identifier Source="ISNI">0000 0004 0460 774X</Identifier><Identifier Source="GRID">grid.420884.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reece-Anthony</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bond</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molokhia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mcgrath</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wirral trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsutebu</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>RLBUHT, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bank Pedersen</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Odense University Hospital, Odense C, Denmark </Affiliation><Identifier Source="ISNI">0000 0004 0512 5013</Identifier><Identifier Source="GRID">grid.7143.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilsgaard Henriksen</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Odense University Hospital, Odense C, Denmark </Affiliation><Identifier Source="ISNI">0000 0004 0512 5013</Identifier><Identifier Source="GRID">grid.7143.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikkelsen</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Odense University Hospital, Odense C, Denmark </Affiliation><Identifier Source="ISNI">0000 0004 0512 5013</Identifier><Identifier Source="GRID">grid.7143.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touborg Lassen</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wirral trust, Merseyside, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tincu</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobilinschi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiorghiu</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macovei</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiewel</LastName><ForeName>M. A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmon</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Vught</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scicluna</LastName><ForeName>B. P.</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoogendijk</LastName><ForeName>A. J.</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zwinderman</LastName><ForeName>A. H.</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cremer</LastName><ForeName>O. L.</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>University Medical Center Utrecht, Utrecht, Netherlands </Affiliation><Identifier Source="ISNI">0000000090126352</Identifier><Identifier Source="GRID">grid.7692.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonten</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>University Medical Center Utrecht, Utrecht, Netherlands </Affiliation><Identifier Source="ISNI">0000000090126352</Identifier><Identifier Source="GRID">grid.7692.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van der Poll</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>N. P.</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiersinga</LastName><ForeName>W. J.</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Amsterdam Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eren</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tekdos</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dogan</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acicbe</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hergunsel</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Bakirkoy Dr.Sadi Konuk Training and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0419 1043</Identifier><Identifier Source="GRID">grid.414177.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsolamy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghamdi</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alswaidan</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alenezi</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heaton</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyce</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolan</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dukoff-Gordon</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molokhia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham and Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann Ben Yehudah</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Assaf Harofeh MC, Beer Yaakov, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hopital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas-Rueddel</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Jena University Hopital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hopital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennler</LastName><ForeName>U.</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Jena University Hopital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jena University Hopital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suntornlohanakul</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Hat Yai, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khwannimit</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Hat Yai, Thailand </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breckenridge</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puxty</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szturz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital and Faculty of Medicine Ostrava University, Ostrava, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0692</Identifier><Identifier Source="GRID">grid.412727.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Folwarzcny</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital and Faculty of Medicine Ostrava University, Ostrava, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0692</Identifier><Identifier Source="GRID">grid.412727.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svancara</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Biostatistics and analyses, Masaryk University, Brno, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0001 2194 0956</Identifier><Identifier Source="GRID">grid.10267.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kula</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Hospital and Faculty of Medicine Ostrava University, Ostrava, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0692</Identifier><Identifier Source="GRID">grid.412727.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sevcik</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital and Faculty of Medicine Ostrava University, Ostrava, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0692</Identifier><Identifier Source="GRID">grid.412727.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caneva</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe0; degli studi di Pavia, scuola di specialit&#xe0;: Anestesia e Rianimazione, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casazza</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellazzi</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marra</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe0; degli studi di Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagani</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universit&#xe0; degli studi di Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vetere</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanzino</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciprandi</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preda</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boschi</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnevale</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione Ospedale Civile di Vigevano, AO Pavia, Vigevano, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar Arzapalo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barradas</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escalante</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gongora</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cetina</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamik</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Medical University, Wroclaw, Poland </Affiliation><Identifier Source="ISNI">0000 0001 1090 049X</Identifier><Identifier Source="GRID">grid.4495.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakubczyk</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Medical University, Wroclaw, Poland </Affiliation><Identifier Source="ISNI">0000 0001 1090 049X</Identifier><Identifier Source="GRID">grid.4495.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xfc;bler</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Therapy, Medical University, Wroclaw, Poland </Affiliation><Identifier Source="ISNI">0000 0001 1090 049X</Identifier><Identifier Source="GRID">grid.4495.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radford</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>AKPA, Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>St. Paul&#x2019;s Hospital, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0000 8589 2327</Identifier><Identifier Source="GRID">grid.416553.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Paul&#x2019;s Hospital, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0000 8589 2327</Identifier><Identifier Source="GRID">grid.416553.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyd</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Paul&#x2019;s Hospital, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0000 8589 2327</Identifier><Identifier Source="GRID">grid.416553.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fineberg</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>AKPA, Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AKPA, Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Paul&#x2019;s Hospital, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0000 8589 2327</Identifier><Identifier Source="GRID">grid.416553.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarlatescu</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Droc</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arama</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy &#x201c;Carol Davila&#x201d;, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0000 9828 7548</Identifier><Identifier Source="GRID">grid.8194.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Acedemisch Medisch Centrum, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straat</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Acedemisch Medisch Centrum, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeerleder</LastName><ForeName>S. S.</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Acedemisch Medisch Centrum, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>N. P.</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Acedemisch Medisch Centrum, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>C. F.</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheer</LastName><ForeName>C. S.</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wauschkuhn</LastName><ForeName>S. W.</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vollmer</LastName><ForeName>M. V.</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>K. M.</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>S. K.</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahnenkamp</LastName><ForeName>K. H.</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>S. R.</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xfc;ndling</LastName><ForeName>M. G.</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojima</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamaguchi</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirose</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akeda</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takegawa</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tasaki</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan </Affiliation><Identifier Source="ISNI">0000 0000 8902 2273</Identifier><Identifier Source="GRID">grid.174567.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimazu</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomono</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Suita, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heredia-Rodr&#xed;guez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Fuente</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo-L&#xf3;pez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Pesquera</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n-Camino</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu-Zhu</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-L&#xf3;pez</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Lozano</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pel&#xe1;ez-Jare&#xf1;o</LastName><ForeName>M. T.</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamayo</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas-R&#xfc;ddel</LastName><ForeName>D. O.</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8517 6224</Identifier><Identifier Source="GRID">grid.275559.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8517 6224</Identifier><Identifier Source="GRID">grid.275559.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8517 6224</Identifier><Identifier Source="GRID">grid.275559.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dennler</LastName><ForeName>U.</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8517 6224</Identifier><Identifier Source="GRID">grid.275559.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Jena University Hospital, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8517 6224</Identifier><Identifier Source="GRID">grid.275559.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adora</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bandyopadhyay</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medica Superspecialty Hospital, Kolkata, West Bengal India </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann Ben Yehudah</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Assaf Harofeh MC, Beer Yaakov, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>BenYehudah</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Assaf Harofeh MC, Beer Yaakov, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salim</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DMC, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 0088 6903</Identifier><Identifier Source="GRID">grid.413184.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>DMC, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 0088 6903</Identifier><Identifier Source="GRID">grid.413184.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>DMC, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 0088 6903</Identifier><Identifier Source="GRID">grid.413184.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burger</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>DMC, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 0088 6903</Identifier><Identifier Source="GRID">grid.413184.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lephart</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>DMC, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 0088 6903</Identifier><Identifier Source="GRID">grid.413184.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth-martin</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Wayne State University, Detroit, USA </Affiliation><Identifier Source="ISNI">0000 0001 1456 7807</Identifier><Identifier Source="GRID">grid.254444.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0635 3376</Identifier><Identifier Source="GRID">grid.418170.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammami</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0635 3376</Identifier><Identifier Source="GRID">grid.418170.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blot</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ghent University, Ghent, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2069 7798</Identifier><Identifier Source="GRID">grid.5342.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>J. L.</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Erasme University, Brussels, Belgium </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>M. L.</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0635 3376</Identifier><Identifier Source="GRID">grid.418170.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunke</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>QualityLabs Bt GmbH, Nuremberg, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riemann</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>B.Braun Melsungen AG, Melsungen, Germany </Affiliation><Identifier Source="ISNI">0000 0001 0699 8877</Identifier><Identifier Source="GRID">grid.462046.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roschke</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Dr. Roschke medical marketing GmbH, Cologne, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tincu</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobilinschi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiorghiu</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macovei</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nimitvilai</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nakhonpathom hospital, Nakhonpathom, Thailand </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jintanapramote</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nakhonpathom hospital, Nakhonpathom, Thailand </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarupongprapa</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nakhonpathom hospital, Nakhonpathom, Thailand </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adukauskiene</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Lithuanian University of Health Sciences, Kaunas,, Lithuania </Affiliation><Identifier Source="ISNI">0000 0004 0432 6841</Identifier><Identifier Source="GRID">grid.45083.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valanciene</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Lithuanian University of Health Sciences, Kaunas,, Lithuania </Affiliation><Identifier Source="ISNI">0000 0004 0432 6841</Identifier><Identifier Source="GRID">grid.45083.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bose</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital North Midlands, Stoke-on-Trent, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lostarakos</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University Hospital North Midlands, Stoke-on-Trent, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospital North Midlands, Stoke-on-Trent, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khedher</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>EPS Charles-Nicolle, Bab Saadoun, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maaoui</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>EPS Charles-Nicolle, Bab Saadoun, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezzamouri</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>EPS Charles-Nicolle, Bab Saadoun, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>EPS Charles-Nicolle, Bab Saadoun, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County, Taiwan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cranendonk</LastName><ForeName>D. R.</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000084992262</Identifier><Identifier Source="GRID">grid.7177.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Vught</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiewel</LastName><ForeName>M. A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cremer</LastName><ForeName>O. L.</ForeName><Initials>OL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, Netherlands </Affiliation><Identifier Source="ISNI">0000000090126352</Identifier><Identifier Source="GRID">grid.7692.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonten</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands </Affiliation><Identifier Source="ISNI">0000000090126352</Identifier><Identifier Source="GRID">grid.7692.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van der Poll</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiersinga</LastName><ForeName>W. J.</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Day</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penrice</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Protection Scotland, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2232 4338</Identifier><Identifier Source="GRID">grid.413893.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godbole</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Public Health England, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2196 8713</Identifier><Identifier Source="GRID">grid.9004.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Booth</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donaldson</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawano</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Fukuoka University Hospital, Fukuoka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0594 9821</Identifier><Identifier Source="GRID">grid.411556.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikura</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Fukuoka University Hospital, Fukuoka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0594 9821</Identifier><Identifier Source="GRID">grid.411556.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Dorzi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almutairi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhamadi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crizaldo Toledo</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Raiy</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talaie</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Toxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </Affiliation><Identifier Source="GRID">grid.411600.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Oers</LastName><ForeName>J. A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>St. Elisabeth Hospital, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harts</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St. Elisabeth Hospital, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieuwkoop</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>St. Elisabeth Hospital, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vos</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St. Elisabeth Hospital, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boussarsar</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutouta</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamoun</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezghani</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koubaji</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Souissi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riahi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giamarellos-Bourboulis</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Athens, Medical School, Athens, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2155 0800</Identifier><Identifier Source="GRID">grid.5216.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tziolos</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Athens, Medical School, Athens, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2155 0800</Identifier><Identifier Source="GRID">grid.5216.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Routsi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Athens, Medical School, Athens, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2155 0800</Identifier><Identifier Source="GRID">grid.5216.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsenos</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Korgialeneion Benakeion Hospital, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsangaris</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Athens, Medical School, Athens, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2155 0800</Identifier><Identifier Source="GRID">grid.5216.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pneumatikos</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Thrace, Alexandroupolis, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2170 8022</Identifier><Identifier Source="GRID">grid.12284.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlachogiannis</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aghios Dimitrios Hospital, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theodorou</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Thrace, Alexandroupolis, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2170 8022</Identifier><Identifier Source="GRID">grid.12284.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prekates</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tzaneion Hospital, Piraeus, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antypa</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Gennimatas General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="GRID">grid.414012.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koulouras</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Ioannina, Ioannina, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2108 7481</Identifier><Identifier Source="GRID">grid.9594.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapravelos</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogos</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Patras, Patras, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 5395</Identifier><Identifier Source="GRID">grid.11047.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antoniadou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Gennimatas General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="GRID">grid.414012.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandragos</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Korgialeneion Benakeion Hospital, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armaganidis</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Athens, Medical School, Athens, Greece </Affiliation><Identifier Source="ISNI">0000 0001 2155 0800</Identifier><Identifier Source="GRID">grid.5216.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles Caballero</LastName><ForeName>A. R.</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Civantos</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueira</LastName><ForeName>J. C.</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Pinto</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceia</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmento</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almekhlafi</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>PSMMC, Riyadh, Saudi Arabia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakr</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>UNIKLINIKUM JENA, JENA, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Dorzi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baharoon</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldawood</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matroud</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alchin</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Johani</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balkhy</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsolamy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yousif</LastName><ForeName>S. Y.</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotabi</LastName><ForeName>B. O.</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>King Fahad Medical City, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0593 1832</Identifier><Identifier Source="GRID">grid.415277.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaawi</LastName><ForeName>A. S.</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Addenbrooke&#x2019;s Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0622 5016</Identifier><Identifier Source="GRID">grid.120073.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curran</LastName><ForeName>M. D.</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Addenbrooke&#x2019;s Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0622 5016</Identifier><Identifier Source="GRID">grid.120073.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enoch</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Addenbrooke&#x2019;s Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0622 5016</Identifier><Identifier Source="GRID">grid.120073.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navapurkar</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Addenbrooke&#x2019;s Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0622 5016</Identifier><Identifier Source="GRID">grid.120073.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Cambridge, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000000121885934</Identifier><Identifier Source="GRID">grid.5335.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharvill</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astin</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heredia-Rodr&#xed;guez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-S&#xe1;nchez</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pel&#xe1;ez-Jare&#xf1;o</LastName><ForeName>M. T.</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Pesquera</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo-L&#xf3;pez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu-Zhu</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n-Camino</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Lozano</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-L&#xf3;pez</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc1;lvarez-Fuente</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamayo</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Valladolid, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9274 367X</Identifier><Identifier Source="GRID">grid.411057.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Salford Royal Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 8535 2371</Identifier><Identifier Source="GRID">grid.415721.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Salford Royal Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 8535 2371</Identifier><Identifier Source="GRID">grid.415721.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Neal</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jancik</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fran&#xe7;ois</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Dupuytren, Limoges, France </Affiliation><Identifier Source="ISNI">0000 0001 1481 5225</Identifier><Identifier Source="GRID">grid.412212.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laterre</LastName><ForeName>P. F.</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>St Luc University Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0461 6320</Identifier><Identifier Source="GRID">grid.48769.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggimann</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Clinic of Barcelona, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico San Carlos, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0671 5785</Identifier><Identifier Source="GRID">grid.411068.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dequin</LastName><ForeName>P. F.</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Fran&#xe7;ois Rabelais and CHU Bretonneau, Tours, France </Affiliation><Identifier Source="ISNI">0000 0001 2182 6141</Identifier><Identifier Source="GRID">grid.12366.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassi</LastName><ForeName>G. L.</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Hospital Clinic of Barcelona, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chastre</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2150 9058</Identifier><Identifier Source="GRID">grid.411439.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafri</LastName><ForeName>H. S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>MedImmune, Gaithersburg, USA </Affiliation><Identifier Source="GRID">grid.418152.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Romdhane</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douira</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamoun</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bousselmi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Souissi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boussarsar</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riahi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakalos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avramidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Craven</LastName><ForeName>T. H.</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wojcik</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kefala</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCoubrey</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Protection Scotland, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2232 4338</Identifier><Identifier Source="GRID">grid.413893.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paterson</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Western General Hospital, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0004 0624 9907</Identifier><Identifier Source="GRID">grid.417068.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inverarity</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurenson</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>T. S.</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Royal Infirmary of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongodi</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouhemad</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre Hospitalier Universitaire Dijon, Dijon, France </Affiliation><Identifier Source="GRID">grid.31151.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orlando</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stella</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Via</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iotti</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braschi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mojoli</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1762 5736</Identifier><Identifier Source="GRID">grid.8982.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haliloglu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilgili</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasapoglu</LastName><ForeName>U.</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayan</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xfc;zer Aslan</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yalc&#x131;n</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinel</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakalos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avramidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>H. E.</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauchmuller</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temple</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chastre</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2150 9058</Identifier><Identifier Source="GRID">grid.411439.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fran&#xe7;ois</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Dupuytren, Limoges, France </Affiliation><Identifier Source="ISNI">0000 0001 1481 5225</Identifier><Identifier Source="GRID">grid.412212.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Clinic of Barcelona, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyt</LastName><ForeName>C. E.</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2150 9058</Identifier><Identifier Source="GRID">grid.411439.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico San Carlos, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0671 5785</Identifier><Identifier Source="GRID">grid.411068.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jafri</LastName><ForeName>H. S.</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>MedImmune, Gaithersburg, USA </Affiliation><Identifier Source="GRID">grid.418152.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nassar</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cairo University, Giza, Egypt </Affiliation><Identifier Source="ISNI">0000 0004 0639 9286</Identifier><Identifier Source="GRID">grid.7776.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayad</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Cairo University, Giza, Egypt </Affiliation><Identifier Source="ISNI">0000 0004 0639 9286</Identifier><Identifier Source="GRID">grid.7776.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trifi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University hospital Center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdellatif</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University hospital Center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daly</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University hospital Center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasri</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University hospital Center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Lakhal</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University hospital Center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilgili</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haliloglu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gul</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinel</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Marmara University Pendik Teaching and Research Hospital, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0668 8422</Identifier><Identifier Source="GRID">grid.16477.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuzovlev</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>V.A. Negovsky Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabanov</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>N.V. Sklifosofsky Institute of Emergency Medicine, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polovnikov</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NN Burdenko Main Military Hospital, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moroz</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V.A. Negovsky Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadrichu</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals, San Carlos, USA </Affiliation><Identifier Source="ISNI">0000 0004 0439 2056</Identifier><Identifier Source="GRID">grid.418424.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dang</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals, San Carlos, USA </Affiliation><Identifier Source="ISNI">0000 0004 0439 2056</Identifier><Identifier Source="GRID">grid.418424.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corkery</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Novartis Pharmaceuticals, San Carlos, USA </Affiliation><Identifier Source="ISNI">0000 0004 0439 2056</Identifier><Identifier Source="GRID">grid.418424.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challoner</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nektar Therapeutics, San Francisco, CA USA </Affiliation><Identifier Source="ISNI">0000 0004 0410 3955</Identifier><Identifier Source="GRID">grid.476522.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassi</LastName><ForeName>G. Li</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilera</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiurazzi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travierso</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaro</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senussi</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Idone</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobi</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigol</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0000 9635 9413</Identifier><Identifier Source="GRID">grid.410458.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodiamont</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>N. P.</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouman</LastName><ForeName>C. S.</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Math&#xf4;t</LastName><ForeName>R. A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jong</LastName><ForeName>M. D.</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hest</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payne</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Maine Medical Center, Portland, USA </Affiliation><Identifier Source="GRID">grid.240160.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>G. L.</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Maine Medical Center, Portland, USA </Affiliation><Identifier Source="GRID">grid.240160.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tudor</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Vienna, Austria </Affiliation><Identifier Source="ISNI">0000 0000 9259 8492</Identifier><Identifier Source="GRID">grid.22937.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahner</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Vienna, Austria </Affiliation><Identifier Source="ISNI">0000 0000 9259 8492</Identifier><Identifier Source="GRID">grid.22937.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Vienna, Austria </Affiliation><Identifier Source="ISNI">0000 0000 9259 8492</Identifier><Identifier Source="GRID">grid.22937.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krenn</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical University of Vienna, Vienna, Austria </Affiliation><Identifier Source="ISNI">0000 0000 9259 8492</Identifier><Identifier Source="GRID">grid.22937.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talaie</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Toxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </Affiliation><Identifier Source="GRID">grid.411600.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jault</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>HIA Percy, Clamart, France </Affiliation><Identifier Source="ISNI">0000 0004 1795 3756</Identifier><Identifier Source="GRID">grid.414028.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabard</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pherecydes Pharma, Romainville, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclerc</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>HIA Percy, Clamart, France </Affiliation><Identifier Source="ISNI">0000 0004 1795 3756</Identifier><Identifier Source="GRID">grid.414028.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jennes</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Reine Astrid, Brussels, Belgium </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Que</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousseau</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Liege, Liege, Belgium </Affiliation><Identifier Source="ISNI">0000 0000 8607 6858</Identifier><Identifier Source="GRID">grid.411374.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravat</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CH Saint Jospeh Saint Luc, Lyon, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Dorzi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eissa</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Harbi</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldabbagh</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trifi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University hospital center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdellatif.</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University hospital center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daly</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University hospital center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasri</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University hospital center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Lakhal</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University hospital center of La Rabta, Tunis, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paramba</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Purayil</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naushad</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negi</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kleinsasser</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MUI, Innsbruck, Austria </Affiliation><Identifier Source="ISNI">0000 0000 8853 2677</Identifier><Identifier Source="GRID">grid.5361.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witrz</LastName><ForeName>M. R.</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchner-Doeven</LastName><ForeName>J. F.</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuip-de Boer</LastName><ForeName>A. M.</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goslings</LastName><ForeName>J. C.</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>N. P.</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Academic Medical Centre, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hezel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Center Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straat</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Center Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boing</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Academic Medical Center Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Bruggen</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sanquin, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 2234 6887</Identifier><Identifier Source="GRID">grid.417732.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Academic Medical Center Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Markopoulou</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>KAT Hospital Athens, Kifisia, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0622 8129</Identifier><Identifier Source="GRID">grid.415070.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venetsanou</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>KAT Hospital Athens, Kifisia, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0622 8129</Identifier><Identifier Source="GRID">grid.415070.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaldis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>KAT Hospital Athens, Kifisia, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0622 8129</Identifier><Identifier Source="GRID">grid.415070.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutete</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>KAT Hospital Athens, Kifisia, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0622 8129</Identifier><Identifier Source="GRID">grid.415070.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chroni</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>KAT Hospital Athens, Kifisia, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0622 8129</Identifier><Identifier Source="GRID">grid.415070.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamanos</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ICU-B, KAT Hospital Kifisia, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jancik</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maekawa</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hokkaido University Hospital, Sapporo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0378 6088</Identifier><Identifier Source="GRID">grid.412167.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hokkaido University Hospital, Sapporo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0378 6088</Identifier><Identifier Source="GRID">grid.412167.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushimoto</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tohoku University Graduate School of Medicine, Sendai, Japan </Affiliation><Identifier Source="ISNI">0000 0001 2248 6943</Identifier><Identifier Source="GRID">grid.69566.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.474906.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Hospital Organization Disaster Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0569 9594</Identifier><Identifier Source="GRID">grid.416797.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Keio University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 1936 9959</Identifier><Identifier Source="GRID">grid.26091.3c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Osaka University Graduate School of Medicine, Osaka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matauoka</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rinku General Medical Center, Osaka, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uejima</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kinki University Faculty of Medicine, Osaka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 1936 9967</Identifier><Identifier Source="GRID">grid.258622.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimura</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Yokohama City University Graduate School of Medicine, Yokohama, Japan </Affiliation><Identifier Source="ISNI">0000 0001 1033 6139</Identifier><Identifier Source="GRID">grid.268441.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikura</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Fukuoka University, Fukuoka, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0672 2176</Identifier><Identifier Source="GRID">grid.411497.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center For Global Health and Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0489 0290</Identifier><Identifier Source="GRID">grid.45203.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tokyo Women&#x2019;s Medical University, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0720 6587</Identifier><Identifier Source="GRID">grid.410818.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarabrin</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbakow</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavrychenko</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurenko</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivanova</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chystikov</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plourde</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hopital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessard</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hopital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauny</LastName><ForeName>J.</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Daoust</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hopital Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbakow</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarabrin</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gavrychenko</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazurenko</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chystikov</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Odessa National Medical University, Odessa, Ukraine </Affiliation><Identifier Source="GRID">grid.445907.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakalos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanth, Greece </Affiliation><Identifier Source="GRID">grid.414012.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avramidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanth, Greece </Affiliation><Identifier Source="GRID">grid.414012.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kropman</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>In het Panhuis</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konings</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huskens</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schurgers</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roest</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Laat</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lance</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maastricht UMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durila</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0611 0905</Identifier><Identifier Source="GRID">grid.412826.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukas</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0611 0905</Identifier><Identifier Source="GRID">grid.412826.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astraverkhava</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0611 0905</Identifier><Identifier Source="GRID">grid.412826.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonas</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0611 0905</Identifier><Identifier Source="GRID">grid.412826.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budnik</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sechenov First Moscow Stat Medical University, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shenkman</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Sheba Medical Center, Tel-Hashomer, Israel </Affiliation><Identifier Source="ISNI">0000 0001 2107 2845</Identifier><Identifier Source="GRID">grid.413795.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayami</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yokohama Municipal Citizen&#x2019;s Hospital, Yokohama, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0377 5418</Identifier><Identifier Source="GRID">grid.417366.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koide</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hayama Heart Center, Hayama, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yokohama City University Hospital, Yokohama, Japan </Affiliation><Identifier Source="ISNI">0000 0004 1767 0473</Identifier><Identifier Source="GRID">grid.470126.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Ageing and Chronic Disease, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhamdi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venugopal</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Ageing and Chronic Disease, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abrams</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downey</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Haematology, Royal Liverpool University Hospital (RLUH), Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toh</LastName><ForeName>C. H.</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Institute of Infection and Global Health, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welters</LastName><ForeName>I. D.</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>Institute of Ageing and Chronic Disease, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bombay</LastName><ForeName>V. B.</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauny</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daoust</LastName><ForeName>R. D.</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessard</LastName><ForeName>J. L.</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquis</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquet</LastName><ForeName>J. P.</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>H&#xf4;pital du Sacr&#xe9;-Coeur de Montr&#xe9;al, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2160 7387</Identifier><Identifier Source="GRID">grid.414056.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siemens</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangaran</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunt</LastName><ForeName>B. J.</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>St Thomas Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.425213.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durward</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyman</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murdoch</LastName><ForeName>I. A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tibby</LastName><ForeName>S. M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Evelina London Children&#x2019;s Hospital, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampatzidou</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisidou</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalampini</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nastou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilarou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalaizi</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatzikostenoglou</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drossos</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fogagnolo</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiore</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiavi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taccone</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Bruxelles, Belgium </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volta</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, University of Ferrara, Italy, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chochliourou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volakli</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Violaki</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samkinidou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evlavis</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagiotidou</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sdougka</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hippokration General Hospital Thessaloniki, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mothukuri</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battle</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guy</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wijesuriya</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Central London School of Anaesthesia and Intensive Care Medicine, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keogh</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of the Sunshine Coast, Maroochydore, Australia </Affiliation><Identifier Source="ISNI">0000 0001 1555 3415</Identifier><Identifier Source="GRID">grid.1034.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Docherty</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 7988</Identifier><Identifier Source="GRID">grid.4305.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Donnell</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 7988</Identifier><Identifier Source="GRID">grid.4305.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunskill</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>John Radcliffe Hospital, Oxford, UK </Affiliation><Identifier Source="ISNI">0000 0001 2306 7492</Identifier><Identifier Source="GRID">grid.8348.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivella</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>John Radcliffe Hospital, Oxford, UK </Affiliation><Identifier Source="ISNI">0000 0001 2306 7492</Identifier><Identifier Source="GRID">grid.8348.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doree</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>John Radcliffe Hospital, Oxford, UK </Affiliation><Identifier Source="ISNI">0000 0001 2306 7492</Identifier><Identifier Source="GRID">grid.8348.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holst</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Copenhagen University Hospital, Copenhagen, Denmark </Affiliation><Identifier Source="ISNI">0000 0004 0646 7373</Identifier><Identifier Source="GRID">grid.4973.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Peterborough NHS Trust, Peterborough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gregersen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aarhus University, Aarhus, Denmark </Affiliation><Identifier Source="ISNI">0000 0001 1956 2722</Identifier><Identifier Source="GRID">grid.7048.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital de Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="GRID">grid.413463.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Edinburgh, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 7988</Identifier><Identifier Source="GRID">grid.4305.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanworth</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>John Radcliffe Hospital, Oxford, UK </Affiliation><Identifier Source="ISNI">0000 0001 2306 7492</Identifier><Identifier Source="GRID">grid.8348.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moravcova</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Brompton &amp; Harefield NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0581 2008</Identifier><Identifier Source="GRID">grid.451052.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansell</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Barts Heart Centre, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Barts Heart Centre, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>R. A.</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Barts Heart Centre, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamilton-Davies</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barts Heart Centre, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allam</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilala</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kindawi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewila</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampatzidou</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisidou</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nastou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalampini</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malamas</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilarou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drossos</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>G.Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldas</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukushima</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osawa</LastName><ForeName>E. A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camara</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeferino</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jardim</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaioto</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dallan</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jatene</LastName><ForeName>F. B.</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalil Filho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galas</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Brazi, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitaka</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Juntendo University Hospital, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.411966.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Saitama Medical Center, Jichi Medical University, Saitama, Japan </Affiliation><Identifier Source="ISNI">0000000123090000</Identifier><Identifier Source="GRID">grid.410804.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murayama</LastName><ForeName>T.</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Kunimoto</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Gunma University Hospital, Maebashi, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0595 7039</Identifier><Identifier Source="GRID">grid.411887.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagashima</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Yokohama City Minato Red Cross Hospital, Yokohama, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takei</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yokohama City Minato Red Cross Hospital, Yokohama, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tokyo Medical and Dental University Hospital of Medicine, Tokyo, Japan </Affiliation><Identifier Source="GRID">grid.474906.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmoud</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanoura</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudarsanan</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivadasan</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othamn</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shouman</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Khulaifi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandel</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Research Institution for Cardiology, Tomsk, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikheev</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Institution for Cardiology, Tomsk, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suhodolo</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Siberian State Medical University, Tomsk, Russia </Affiliation><Identifier Source="ISNI">0000 0001 0027 1685</Identifier><Identifier Source="GRID">grid.412593.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiselev</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Research Institution for Cardiology, Tomsk, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svirko</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Institution for Cardiology, Tomsk, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podoksenov</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Research Institution for Cardiology, Tomsk, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>S. A.</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>The Hillingdon Hospitals NHS Foundation Trust, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0476 7073</Identifier><Identifier Source="GRID">grid.440199.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Hillingdon Hospitals NHS Foundation Trust, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0476 7073</Identifier><Identifier Source="GRID">grid.440199.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tovar Doncel</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>University Hospital Rio Hortega, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 1842 3755</Identifier><Identifier Source="GRID">grid.411280.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldecoa</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Rio Hortega, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 1842 3755</Identifier><Identifier Source="GRID">grid.411280.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ince</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates </Affiliation><Identifier Source="ISNI">0000 0004 1773 3278</Identifier><Identifier Source="GRID">grid.415670.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafie</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates </Affiliation><Identifier Source="ISNI">0000 0004 1773 3278</Identifier><Identifier Source="GRID">grid.415670.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates </Affiliation><Identifier Source="ISNI">0000 0004 1773 3278</Identifier><Identifier Source="GRID">grid.415670.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syed</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates </Affiliation><Identifier Source="ISNI">0000 0004 1773 3278</Identifier><Identifier Source="GRID">grid.415670.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hon</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates </Affiliation><Identifier Source="ISNI">0000 0004 1773 3278</Identifier><Identifier Source="GRID">grid.415670.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righetti</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombaroli</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righetti</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombaroli</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hravnak</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9000</Identifier><Identifier Source="GRID">grid.21925.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>L. C.</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Carnegie Mellon University, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0001 2097 0344</Identifier><Identifier Source="GRID">grid.147455.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubrawski</LastName><ForeName>A. D.</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Carnegie Mellon University, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0001 2097 0344</Identifier><Identifier Source="GRID">grid.147455.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clermont</LastName><ForeName>G. C.</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9000</Identifier><Identifier Source="GRID">grid.21925.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinsky</LastName><ForeName>M. R.</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9000</Identifier><Identifier Source="GRID">grid.21925.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macias</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loza</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lesmes</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucena</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Valme University Hospital, Seville, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1768 1690</Identifier><Identifier Source="GRID">grid.412800.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tovar Doncel</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>University Hospital Rio Hortega, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 1842 3755</Identifier><Identifier Source="GRID">grid.411280.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ince</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aldecoa</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Rio Hortega, Valladolid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 1842 3755</Identifier><Identifier Source="GRID">grid.411280.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastide</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richecoeur</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CH Beauvais, Beauvais, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frenoy</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>R&#xe9;animation polyvalente, Le Havre, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemaire</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CH Roubaix, Roubaix, France </Affiliation><Identifier Source="ISNI">0000 0004 0608 7784</Identifier><Identifier Source="GRID">grid.477297.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauneuf</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CH Cotentin, Cherbourg, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamion</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Rouen, Rouen, France </Affiliation><Identifier Source="GRID">grid.41724.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nseir</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHU Lille, Lille, France </Affiliation><Identifier Source="ISNI">0000 0004 0471 8845</Identifier><Identifier Source="GRID">grid.410463.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du Cheyron</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CHU Caen, Caen, France </Affiliation><Identifier Source="ISNI">0000 0004 0472 0160</Identifier><Identifier Source="GRID">grid.411149.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maizel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaban</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolko</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharshir</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AbuRageila</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlHussain</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercado</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maizel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontar</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titeca</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brazier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riviere</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joris</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soupison</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cagny</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slama</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagner</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;rner</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kubik</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuter</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saugel</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Medical Center Hamburg-Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombaroli</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Righetti</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellano</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, St. Boniface Hospital, Verona, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bels</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cudia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strachinaru</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghottignies</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devriendt</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierrakos</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Brugmann Hospital, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0469 8354</Identifier><Identifier Source="GRID">grid.411371.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Gonz&#xe1;lez</LastName><ForeName>&#xd3;.</ForeName><Initials>&#xd3;</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blancas</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luj&#xe1;n</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario Pr&#xed;ncipe de Asturias, Alcal&#xe1; de Henares, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1765 5855</Identifier><Identifier Source="GRID">grid.411338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ballesteros</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez D&#xed;az</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario Pr&#xed;ncipe de Asturias, Alcal&#xe1; de Henares, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1765 5855</Identifier><Identifier Source="GRID">grid.411338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfa;&#xf1;ez</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de San Carlos, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0671 5785</Identifier><Identifier Source="GRID">grid.411068.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;n Parra</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez Matamala</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso Fern&#xe1;ndez</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chana</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario del Tajo, Aranjuez, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckmann</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkmann</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruber</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahmer</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Klinikum rechts der Isar, Technical University of Munich, Munich, Germany </Affiliation><Identifier Source="ISNI">0000000123222966</Identifier><Identifier Source="GRID">grid.6936.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moller</LastName><ForeName>P. W.</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland </Affiliation><Identifier Source="ISNI">0000 0004 0479 0855</Identifier><Identifier Source="GRID">grid.411656.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sondergaard</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Sciences at the Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakob</LastName><ForeName>S. M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland </Affiliation><Identifier Source="ISNI">0000 0004 0479 0855</Identifier><Identifier Source="GRID">grid.411656.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takala</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland </Affiliation><Identifier Source="ISNI">0000 0004 0479 0855</Identifier><Identifier Source="GRID">grid.411656.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland </Affiliation><Identifier Source="ISNI">0000 0004 0479 0855</Identifier><Identifier Source="GRID">grid.411656.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastoni</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aya</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toscani</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pigozzi</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowska</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aya</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mellinghoff</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0004 1937 0626</Identifier><Identifier Source="GRID">grid.4714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wall</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0004 1937 0626</Identifier><Identifier Source="GRID">grid.4714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0004 1937 0626</Identifier><Identifier Source="GRID">grid.4714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Wenzhou Medical University, Wenzhou, Zheijang China </Affiliation><Identifier Source="ISNI">0000 0001 0348 3990</Identifier><Identifier Source="GRID">grid.268099.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Svensen</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0004 1937 0626</Identifier><Identifier Source="GRID">grid.4714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rtensson</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Austin Hospital, Melbourne, VIC Australia </Affiliation><Identifier Source="ISNI">0000 0001 0162 7225</Identifier><Identifier Source="GRID">grid.414094.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joelsson-Alm</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Stockholm, Sweden </Affiliation><Identifier Source="ISNI">0000 0004 1937 0626</Identifier><Identifier Source="GRID">grid.4714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar Arzapalo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barradas</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cetina</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parenti</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palazzi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amidei</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borrelli</LastName><ForeName>F. B.</ForeName><Initials>FB</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campanale</LastName><ForeName>S. C.</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tagliazucchi</LastName><ForeName>F. T.</ForeName><Initials>FT</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedoni</LastName><ForeName>G. S.</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucchesi</LastName><ForeName>D. L.</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carella</LastName><ForeName>E. C.</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luciani</LastName><ForeName>A. L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Policlinico Modena, Bologna, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1769 5275</Identifier><Identifier Source="GRID">grid.413363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackovic</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Hospital Sveti Duh, Zagreb, Croatia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maric</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Hospital Sveti Duh, Zagreb, Croatia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakula</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Hospital Sveti Duh, Zagreb, Croatia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aya</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grounds</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St George&#x2019;s Healthcare NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.451349.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avard</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Canberra Hospital, Hughes, ACT Australia </Affiliation><Identifier Source="ISNI">0000 0000 9984 5644</Identifier><Identifier Source="GRID">grid.413314.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Australian National University Medical School, Canberra, Australia </Affiliation><Identifier Source="ISNI">0000 0001 2180 7477</Identifier><Identifier Source="GRID">grid.1001.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezidi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charbit</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ould-Chikh</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deras</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maury</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capdevila</LastName><ForeName>X.</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Lapeyronie University Hospital, Montpellier, France </Affiliation><Identifier Source="ISNI">0000 0004 0638 8990</Identifier><Identifier Source="GRID">grid.411572.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Brigham and Women&#x2019;s Hospital, Boston, USA </Affiliation><Identifier Source="ISNI">0000 0004 0378 8294</Identifier><Identifier Source="GRID">grid.62560.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linde-Zwirble</LastName><ForeName>W. Z.</ForeName><Initials>WZ</Initials><AffiliationInfo><Affiliation>Trexin Medical, Chicago, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Douglas</LastName><ForeName>I. D.</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>University of Colorado and Denver Health, Denver, USA </Affiliation><Identifier Source="ISNI">0000000107903411</Identifier><Identifier Source="GRID">grid.241116.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>N. S.</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Beth Isreal Deaconess, Boston, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Souissi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mezghani</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Aicha</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamoun</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laribi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeribi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riahi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antunes</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crivits</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital, Ghent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raes</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital, Ghent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decruyenaere</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital, Ghent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoste</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Hospital, Ghent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagin</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudnov</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savitsky</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astafyeva</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korobko</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vein</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>City Clinical Hospital 40, Yekaterinburg, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampmeier</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnemann</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hessler</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wald</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Marienhospital Osnabr&#xfc;ck, Osnabr&#xfc;ck, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bockbreder</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Charit&#xe9;, University of Berlin, Berlin, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome, Italy </Affiliation><Identifier Source="GRID">grid.7841.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Aken</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ertmer</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnemann</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University Hospital of Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hessler</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital of Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kampmeier</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital of Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Greifswald, Greifswald, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9116 8976</Identifier><Identifier Source="GRID">grid.412469.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Aken</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital of Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ince</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Erasmus MC University Hospital Rotterdam, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ertmer</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital of Muenster, Muenster, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0551 4246</Identifier><Identifier Source="GRID">grid.16149.3b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Monash University, Melbourne, Australia </Affiliation><Identifier Source="ISNI">0000 0004 1936 7857</Identifier><Identifier Source="GRID">grid.1002.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beasley</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Austin Hospital, Melbourne, Australia </Affiliation><Identifier Source="ISNI">0000 0001 0162 7225</Identifier><Identifier Source="GRID">grid.414094.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackle</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Psirides</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Wellington Regional Hospital, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0000 8862 6892</Identifier><Identifier Source="GRID">grid.416979.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailey</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Melbourne, Australia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beasley</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Austin Hospital, Melbourne, Australia </Affiliation><Identifier Source="ISNI">0000 0001 0162 7225</Identifier><Identifier Source="GRID">grid.414094.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mackle</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0445 6830</Identifier><Identifier Source="GRID">grid.415117.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Princess of Wales Hospital, Bridgend, UK </Affiliation><Identifier Source="ISNI">0000 0004 0648 9337</Identifier><Identifier Source="GRID">grid.415249.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramachandran</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Imperial College London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2113 8111</Identifier><Identifier Source="GRID">grid.7445.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basu</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Glan Clwyd Hospital, Bodelwyddan, UK </Affiliation><Identifier Source="ISNI">0000 0000 9831 5916</Identifier><Identifier Source="GRID">grid.415564.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glan Clwyd Hospital, Bodelwyddan, UK </Affiliation><Identifier Source="ISNI">0000 0000 9831 5916</Identifier><Identifier Source="GRID">grid.415564.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Galway, Galway, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0617 9371</Identifier><Identifier Source="GRID">grid.412440.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University Hospital Galway, Galway, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0617 9371</Identifier><Identifier Source="GRID">grid.412440.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel Neto</LastName><ForeName>N. R.</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reis</LastName><ForeName>F. Q.</ForeName><Initials>FQ</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>C. P.</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>X. L.</ForeName><Initials>XL</Initials><AffiliationInfo><Affiliation>National Neuroscience Institute, Singapore, Singapore </Affiliation><Identifier Source="ISNI">0000 0004 0636 696X</Identifier><Identifier Source="GRID">grid.276809.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eu</LastName><ForeName>K. M.</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>W. Y.</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tee</LastName><ForeName>K. S.</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pau</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abisheganaden</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tan Tock Seng Hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maas</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Erasmus Medical Centre, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Geus</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Erasmus Medical Centre, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafuente</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Tamega e Sousa, Penafiel, Portugal </Affiliation><Identifier Source="GRID">grid.466592.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade Local de Saude do Alto Minho, Viana do Castelo, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antunes</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doris</LastName><ForeName>T. E.</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>South Tees NHS Trust, Middlesbrough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monkhouse</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>South Tees NHS Trust, Middlesbrough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shipley</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>South Tees NHS Trust, Middlesbrough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kardasz</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>South Tees NHS Trust, Middlesbrough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>South Tees NHS Trust, Middlesbrough, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stads</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ikazia Hospital, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0568 7120</Identifier><Identifier Source="GRID">grid.414565.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeneveld</LastName><ForeName>A. J.</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elsayed</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sheffiled Teaching Hospitals, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Sheffiled Teaching Hospitals, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Whiston Hospital, St Helens &amp; Knowsley, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raithatha</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffiled Teaching Hospitals, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steuber</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Duesseldorf, D&#xfc;sseldorf, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8922 7789</Identifier><Identifier Source="GRID">grid.14778.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelletier</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital Duesseldorf, D&#xfc;sseldorf, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8922 7789</Identifier><Identifier Source="GRID">grid.14778.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital Duesseldorf, D&#xfc;sseldorf, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8922 7789</Identifier><Identifier Source="GRID">grid.14778.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michael</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Hospital Duesseldorf, D&#xfc;sseldorf, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8922 7789</Identifier><Identifier Source="GRID">grid.14778.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slowinski</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Charite University Hospital, Berlin, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2218 4662</Identifier><Identifier Source="GRID">grid.6363.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kindgen-Milles</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Duesseldorf, D&#xfc;sseldorf, Germany </Affiliation><Identifier Source="ISNI">0000 0000 8922 7789</Identifier><Identifier Source="GRID">grid.14778.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghabina</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal London Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0738 5466</Identifier><Identifier Source="GRID">grid.416041.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turani</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belli</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busatti</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barettin</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candidi</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargano</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barchetta</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falco</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aurelia and European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414645.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirkiran</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Istanbul University Cerrahpasa Medical School, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosuk</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Istanbul University Cerrahpasa Medical School, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozbay</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istanbul University Cerrahpasa Medical School, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Danube University Krems, Krems, Austria </Affiliation><Identifier Source="ISNI">0000 0001 2108 5830</Identifier><Identifier Source="GRID">grid.15462.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartmann</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Danube University Krems, Krems, Austria </Affiliation><Identifier Source="ISNI">0000 0001 2108 5830</Identifier><Identifier Source="GRID">grid.15462.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harm</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Danube University Krems, Krems, Austria </Affiliation><Identifier Source="ISNI">0000 0001 2108 5830</Identifier><Identifier Source="GRID">grid.15462.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linsberger</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Danube University Krems, Krems, Austria </Affiliation><Identifier Source="ISNI">0000 0001 2108 5830</Identifier><Identifier Source="GRID">grid.15462.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eichhorn</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Danube University Krems, Krems, Austria </Affiliation><Identifier Source="ISNI">0000 0001 2108 5830</Identifier><Identifier Source="GRID">grid.15462.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valicek</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital St. Poelten, St. Poelten, Austria </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miestinger</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Hospital St. Poelten, St. Poelten, Austria </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoermann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital St. Poelten, St. Poelten, Austria </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faenza</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Teaching Hospital Policlinico S.Orsola-Malpighi, Bologna, Italy </Affiliation><Identifier Source="GRID">grid.412311.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricci</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Dialysis, Hypertension, Bologna, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancini</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Dialysis, Hypertension, Bologna, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gemelli</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Science and Technology Park for Medicine, Mirandola, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuoghi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Science and Technology Park for Medicine, Mirandola, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnani</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aferetica, Bologna, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atti</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aferetica, Bologna, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laddomada</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>San Marco Hospital, Zingonia, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doronzio</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>San Marco Hospital, Zingonia, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balicco</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>San Marco Hospital, Zingonia, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gruda</LastName><ForeName>M. C.</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Sullivan</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dan</LastName><ForeName>V. P.</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guliashvili</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheirer</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golobish</LastName><ForeName>T. D.</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capponi</LastName><ForeName>V. J.</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>P. P.</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>CytoSorbents, Monmouth Junction, USA </Affiliation><Identifier Source="GRID">grid.428484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kogelmann</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Klinikum Emden, Emden, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xfc;ner</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Klinikum Emden, Emden, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarczak</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Eppendorf, Hamburg, Germany </Affiliation><Identifier Source="ISNI">0000 0001 2180 3484</Identifier><Identifier Source="GRID">grid.13648.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turani</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belli</LastName><ForeName>A. B.</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martni</LastName><ForeName>S. M.</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotticelli</LastName><ForeName>V. C.</ForeName><Initials>VC</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounajergi</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barchetta</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aurelia Hospital /European Hospital, Rome, Italy </Affiliation><Identifier Source="GRID">grid.414077.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morimoto</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fukuoka University hospital, Fukuoka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0594 9821</Identifier><Identifier Source="GRID">grid.411556.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishikura</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Fukuoka University hospital, Fukuoka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0594 9821</Identifier><Identifier Source="GRID">grid.411556.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadeem</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghorab</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghrabi</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloesel</LastName><ForeName>S. K.</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldfuss</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stieglitz</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stieglitz</LastName><ForeName>A. S.</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krstevska</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albuszies</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>GPR Klinikum Ruesselsheim, Ruesselsheim, Hessen Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar Arzapalo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barradas</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escalante</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimmy</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cetina</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital O&#x2019;horan, M&#xe9;rida, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izawa</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwami</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kyoto University, Kyoto, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0372 2033</Identifier><Identifier Source="GRID">grid.258799.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchino</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takinami</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitamura</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Osaka University, Osaka, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0373 3971</Identifier><Identifier Source="GRID">grid.136593.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawamura</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kyoto University, Kyoto, Japan </Affiliation><Identifier Source="ISNI">0000 0004 0372 2033</Identifier><Identifier Source="GRID">grid.258799.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Powell-Tuck</LastName><ForeName>J. G.</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Guy&#x2019;s &amp; St Thomas&#x2019; NHS Foundation Trust, London, UK </Affiliation><Identifier Source="GRID">grid.420545.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crichton</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2322 6764</Identifier><Identifier Source="GRID">grid.13097.3c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raimundo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital de Santa Maria, Lisbon, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 2295 9747</Identifier><Identifier Source="GRID">grid.411265.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporota</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Guy&#x2019;s &amp; St Thomas&#x2019; NHS Foundation Trust, London, UK </Affiliation><Identifier Source="GRID">grid.420545.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyncoll</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Guy&#x2019;s &amp; St Thomas&#x2019; NHS Foundation Trust, London, UK </Affiliation><Identifier Source="GRID">grid.420545.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guy&#x2019;s &amp; St Thomas&#x2019; NHS Foundation Trust, London, UK </Affiliation><Identifier Source="GRID">grid.420545.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hana</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ErasmusMC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Geus</LastName><ForeName>H. R.</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>ErasmusMC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Geus</LastName><ForeName>H. R.</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>ErasmusMC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hana</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ErasmusMC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydogdu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gazi University Medical Faculty, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyaci</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Critical Care Fellowship Programme, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuksel</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Biochemistry Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gursel</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gazi University Medical Faculty, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cayci Sivri</LastName><ForeName>A. B.</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Biochemistry Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meza-M&#xe1;rquez</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cl&#xed;nica Medica Sur, Mexico City, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nava-L&#xf3;pez</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cl&#xed;nica Medica Sur, Mexico City, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo-Esper</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cl&#xed;nica Medica Sur, Mexico City, Mexico </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dardashti</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lund University and Skane University Hospital, Lund, Sweden </Affiliation><Identifier Source="GRID">grid.411843.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grubb</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lund University and Skane University Hospital, Lund, Sweden </Affiliation><Identifier Source="GRID">grid.411843.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maizel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetzstein</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titeca</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontar</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brazier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cagny</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riviere</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soupison</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joris</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slama</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Radboudumc, Nijmegen, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0444 9382</Identifier><Identifier Source="GRID">grid.10417.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>E.</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Njimi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2348 0746</Identifier><Identifier Source="GRID">grid.4989.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickkers</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Radboudumc, Nijmegen, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0444 9382</Identifier><Identifier Source="GRID">grid.10417.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>J. L.</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Erasme Hospital, Universit&#xe9; Libre de Bruxelles, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2348 0746</Identifier><Identifier Source="GRID">grid.4989.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waraich</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Royal Surrey County Hospital, Guildford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0648</Identifier><Identifier Source="GRID">grid.416224.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doyle</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Royal Surrey County Hospital, Guildford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0648</Identifier><Identifier Source="GRID">grid.416224.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samuels</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Royal Surrey County Hospital, Guildford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0648</Identifier><Identifier Source="GRID">grid.416224.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forni</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Royal Surrey County Hospital, Guildford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0648</Identifier><Identifier Source="GRID">grid.416224.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Royal National Orthopaedic Hospital, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 7890</Identifier><Identifier Source="GRID">grid.416177.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumber</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal National Orthopaedic Hospital, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 7890</Identifier><Identifier Source="GRID">grid.416177.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunning</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal National Orthopaedic Hospital, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 7890</Identifier><Identifier Source="GRID">grid.416177.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sell</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal National Orthopaedic Hospital, Middlesex, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 7890</Identifier><Identifier Source="GRID">grid.416177.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torrence</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Dwyer</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Asan medical center, Seoul, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0842 2126</Identifier><Identifier Source="GRID">grid.413967.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Connor</LastName><ForeName>M. E.</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewson</LastName><ForeName>R. W.</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanoura</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Othamn</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudarsanan</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allam</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksoud</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Khulaifi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Connor</LastName><ForeName>M. E.</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hewson</LastName><ForeName>R. W.</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirwan</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Barts Health NHS Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 0372 5777</Identifier><Identifier Source="GRID">grid.139534.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prowle</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Queen Mary University of London, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2171 1133</Identifier><Identifier Source="GRID">grid.4868.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uzundere</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Trakya Univ, Edirne, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2342 6459</Identifier><Identifier Source="GRID">grid.411693.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Memis</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Trakya Univ, Edirne, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2342 6459</Identifier><Identifier Source="GRID">grid.411693.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdd;nal</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Trakya Univ, Edirne, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2342 6459</Identifier><Identifier Source="GRID">grid.411693.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gultekin</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Trakya Univ, Edirne, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2342 6459</Identifier><Identifier Source="GRID">grid.411693.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turan</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Trakya Univ, Edirne, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2342 6459</Identifier><Identifier Source="GRID">grid.411693.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydin</LastName><ForeName>M. A.</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>General Directorate of Health Services, Ministry of Health, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.415700.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basar</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>AnkaraNKARA Research and Training Hospital, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sencan</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>General Directorate of Health Services, Ministry of Health, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.415700.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapuagasi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>General Directorate of Health Services, Ministry of Health, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.415700.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozturk</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>General Directorate of Health Services, Ministry of Health, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.415700.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uzundurukan</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>General Directorate of Health Services, Ministry of Health, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.415700.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gokmen</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Faculty of Medicine, Ankara University, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000000109409118</Identifier><Identifier Source="GRID">grid.7256.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozcan</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ankara Research and Training Hospital, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0642 6432</Identifier><Identifier Source="GRID">grid.413783.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaymak</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AnkaraNKARA Research and Training Hospital, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artemenko</LastName><ForeName>V. A.</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>MC Into-Sana, Odessa, Ukraine </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budnyuk</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MC Into-Sana, Odessa, Ukraine </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugh</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Glan Clwyd Hospital, Rhyl, UK </Affiliation><Identifier Source="ISNI">0000 0000 9831 5916</Identifier><Identifier Source="GRID">grid.415564.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhandari</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Glan Clwyd Hospital, Rhyl, UK </Affiliation><Identifier Source="ISNI">0000 0000 9831 5916</Identifier><Identifier Source="GRID">grid.415564.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mauri</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turrini</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Ferrara, Sant&#x2019;Anna Hospital, Ferrara, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langer</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taccone</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volta</LastName><ForeName>C. A.</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>University of Ferrara, Sant&#x2019;Anna Hospital, Ferrara, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marenghi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gattinoni</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda, Maggiore Policlinico Hospital, Milan, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Sullivan</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukeria</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLoughlin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeffer</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>J. T.</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>West Virginia University, Morgantown, West Virginia USA </Affiliation><Identifier Source="ISNI">0000 0001 2156 6140</Identifier><Identifier Source="GRID">grid.268154.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bregman</LastName><ForeName>G. B.</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karp</LastName><ForeName>G. K.</ForeName><Initials>GK</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishinevsky</LastName><ForeName>E. K.</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavi</LastName><ForeName>D. S.</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adi</LastName><ForeName>N. A.</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Kaplan Medical Centre, Rehovot, Israel </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poropat</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knafelj</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llopart</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Corporaci&#xf3; Sanit&#xe0;ria i Universit&#xe0;ria Parc Taul&#xed;, Universitat Aut&#xf2;noma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batlle</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Corporaci&#xf3; Sanit&#xe0;ria i Universit&#xe0;ria Parc Taul&#xed;, Universitat Aut&#xf2;noma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Haro</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Corporaci&#xf3; Sanit&#xe0;ria i Universit&#xe0;ria Parc Taul&#xed;, Universitat Aut&#xf2;noma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesquida</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Corporaci&#xf3; Sanit&#xe0;ria i Universit&#xe0;ria Parc Taul&#xed;, Universitat Aut&#xf2;noma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artigas</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Corporaci&#xf3; Sanit&#xe0;ria i Universit&#xe0;ria Parc Taul&#xed;, Universitat Aut&#xf2;noma de Barcelona, CIBER Enfermedades Respiratorias, Sabadell, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlovic</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Dalhousie University, Halifax, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8200</Identifier><Identifier Source="GRID">grid.55602.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewerentz</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ernst-Moritz-Arndt-Universit&#xe4;t, Greifswald, Germany </Affiliation><Identifier Source="GRID">grid.5603.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spassov</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ernst-Moritz-Arndt-Universit&#xe4;t, Greifswald, Germany </Affiliation><Identifier Source="GRID">grid.5603.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ernst-Moritz-Arndt-Universit&#xe4;t, Greifswald, Germany </Affiliation><Identifier Source="GRID">grid.5603.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Smet</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Raedt</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derom</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Depuydt</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeyen</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decruyenaere</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ghent University Hospital, Gent, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3303</Identifier><Identifier Source="GRID">grid.410566.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gobatto</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besen</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tierno</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melro</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadamuro</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbouisson</LastName><ForeName>L. M.</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Civantos</LastName><ForeName>B. C.</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>J. L.</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figueira</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yus</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital La Paz, Madrid, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8970 9163</Identifier><Identifier Source="GRID">grid.81821.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oglinda</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Mother and Child, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciobanu</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Emergency Medicine, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oglinda</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Mother and Child, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schirca</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Mother and Child, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sertinean</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Mother and Child, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lupu</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>State University of Medicine and Pharmacy, Chisinau mun., Moldova </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Sullivan</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLoughlin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Sullivan</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukeria</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolny</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacLoughlin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aerogen, Galway, Ireland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagano</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Numis</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>San Paolo Hospital, Naples, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visone</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saldamarco</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>San Paolo Hospital, Naples, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paladino</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National University of Ireland, Galway, Galway City, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0488 0789</Identifier><Identifier Source="GRID">grid.6142.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debacker</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamberg</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva-Pinto</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmento</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro Hospitalar S&#xe3;o Jo&#xe3;o, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 9375 4688</Identifier><Identifier Source="GRID">grid.414556.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kara</LastName><ForeName>&#xdd;.</ForeName><Initials>&#xdd;</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#xfd;ld&#xfd;r&#xfd;m</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zerman</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Internal Medicine Critical Care Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ll&#xfc;</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Internal Medicine Critical Care Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyac&#xfd;</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Internal Medicine Critical Care Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basar&#xfd;k Aydogan</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayg&#xfd;s&#xfd;z</LastName><ForeName>&#xdc;.</ForeName><Initials>&#xdc;</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;nderen</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ar&#xfd;k</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Geriatrics Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turkoglu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Internal Medicine Critical Care Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydogdu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aygencel</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Internal Medicine Critical Care Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;lger</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine, Geriatrics Department, Ankara, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gursel</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyac&#xfd;</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Is&#xfd;kdogan</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zdedeoglu</LastName><ForeName>&#xd6;.</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ll&#xfc;</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badoglu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gayg&#xfd;s&#xfd;z</LastName><ForeName>U.</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydogdu</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gursel</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Gazi University School of Medicine Respiratory Medicine and Critical Care Department, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2169 7132</Identifier><Identifier Source="GRID">grid.25769.3f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongpolprom</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sittipunt</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eden</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Carmel, Lady Davis Medical Center, Haifa, Israel </Affiliation><Identifier Source="GRID">grid.471000.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokhanovsky</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Carmel, Lady Davis Medical Center, Haifa, Israel </Affiliation><Identifier Source="GRID">grid.471000.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bursztein &#x2013; De Myttenaere</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Carmel, Lady Davis Medical Center, Haifa, Israel </Affiliation><Identifier Source="GRID">grid.471000.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pizov</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Carmel, Lady Davis Medical Center, Haifa, Israel </Affiliation><Identifier Source="GRID">grid.471000.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neilans</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Duke University, Durham, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 7961</Identifier><Identifier Source="GRID">grid.26009.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacIntyre</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Duke University, Durham, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 7961</Identifier><Identifier Source="GRID">grid.26009.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radosevich</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanta</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smischney</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diedrich</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, USA </Affiliation><Identifier Source="ISNI">0000 0004 0459 167X</Identifier><Identifier Source="GRID">grid.66875.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Helens and Knoowsley, Prescot, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLindon</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Royal Infirmary, Edinburgh, UK </Affiliation><Identifier Source="ISNI">0000 0001 0709 1919</Identifier><Identifier Source="GRID">grid.418716.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St Helens and Knoowsley, Prescot, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaeir</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alexandria Universitry General Hospital, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noeam</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Alexandria Universitry General Hospital, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahrous</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alexandria Universitry General Hospital, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsa</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University Hospital North Middlands, Stoke On Trent, UK </Affiliation><Identifier Source="ISNI">0000 0004 0641 4263</Identifier><Identifier Source="GRID">grid.415598.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alexandria Universitry General Hospital, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dridi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koubaji</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamoun</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben Souissi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laribi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riahi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mebazaa</LastName><ForeName>M. S.</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Mongi Slim University Hospital, La Marsa, Tunisia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Calatayud</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Sur, Mexico City, Mexico </Affiliation><Identifier Source="GRID">grid.414741.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo-Esper</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medica Sur, Mexico City, Mexico </Affiliation><Identifier Source="GRID">grid.414741.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zepeda-Mendoza</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medica Sur, Mexico City, Mexico </Affiliation><Identifier Source="GRID">grid.414741.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Carrillo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medica Sur, Mexico City, Mexico </Affiliation><Identifier Source="GRID">grid.414741.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arch-Tirado</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Rehabilitacion, Mexico City, Mexico </Affiliation><Identifier Source="ISNI">0000 0004 0633 2911</Identifier><Identifier Source="GRID">grid.419223.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbognin</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Padua, Padua, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 3470</Identifier><Identifier Source="GRID">grid.5608.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelacani</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Sant Antony hospital, Padua, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zannoni</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Padua, Padua, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 3470</Identifier><Identifier Source="GRID">grid.5608.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agnoli</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sant Antony hospital, Padua, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gagliardi</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sant Antony hospital, Padua, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>HCMC, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>HCMC, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunos</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Minnesota, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000000419368657</Identifier><Identifier Source="GRID">grid.17635.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambur</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>HCMC, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>HCMC, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prekker</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>HCMC, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thijssen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Viecuri Medical Center, Venlo, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0477 5022</Identifier><Identifier Source="GRID">grid.416856.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssen</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Viecuri Medical Center, Venlo, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0477 5022</Identifier><Identifier Source="GRID">grid.416856.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foudraine</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Viecuri Medical Center, Venlo, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0477 5022</Identifier><Identifier Source="GRID">grid.416856.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voscopoulos</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>University of Hawaii, John A. Burns School of Medicine, Honolulu, USA </Affiliation><Identifier Source="ISNI">0000 0001 2188 0957</Identifier><Identifier Source="GRID">grid.410445.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Motion Inc., Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voscopoulos</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>University of Hawaii, John A. Burns School of Medicine, Honolulu, USA </Affiliation><Identifier Source="ISNI">0000 0001 2188 0957</Identifier><Identifier Source="GRID">grid.410445.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Motion Inc., Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, USA </Affiliation><Identifier Source="ISNI">0000 0004 0386 9924</Identifier><Identifier Source="GRID">grid.32224.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voscopoulos</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>University of Hawaii, John A. Burns School of Medicine, Honolulu, USA </Affiliation><Identifier Source="ISNI">0000 0001 2188 0957</Identifier><Identifier Source="GRID">grid.410445.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eversole</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory Motion Inc., Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Motion Inc., Waltham, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, USA </Affiliation><Identifier Source="ISNI">0000 0004 0386 9924</Identifier><Identifier Source="GRID">grid.32224.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muttini</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AO Desio e Vimercate, Vimercate, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bigi</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>AO Desio e Vimercate, Vimercate, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villani</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AO Crema, Crema, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patroniti</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Milan-Bicocca, Monza, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2174 1754</Identifier><Identifier Source="GRID">grid.7563.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UT Health Science Center at Houston, Houston, TX USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 2401</Identifier><Identifier Source="GRID">grid.267308.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voscopoulos</LastName><ForeName>C. J.</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>University of Hawaii, John A. Burns School of Medicine, Honolulu, HI USA </Affiliation><Identifier Source="ISNI">0000 0001 2188 0957</Identifier><Identifier Source="GRID">grid.410445.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Respiratory Motion Inc., Waltham, MA USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>George</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Boston, MA USA </Affiliation><Identifier Source="ISNI">0000 0004 0386 9924</Identifier><Identifier Source="GRID">grid.32224.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldmann</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Swisstom AG, Landquart, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Swisstom AG, Landquart, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windisch</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten / Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strassmann</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten / Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karagiannidis</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten / Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldmann</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Swisstom AG, Landquart, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Swisstom AG, Landquart, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windisch</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten/ Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strassmann</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten/ Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karagiannidis</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kliniken der Stadt K&#xf6;ln, Pneumology and Critical Care Medicine, Witten/ Herdecke University, Ostmerheimer Str. 200, 51109 Cologne, Germany </Affiliation><Identifier Source="ISNI">0000 0000 9024 6397</Identifier><Identifier Source="GRID">grid.412581.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karagiannidis</LastName><ForeName>C. K.</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>ARDS and ECMO Center K&#xf6;ln-Merheim, Cologne, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldmann</LastName><ForeName>A. W.</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Swisstom, Chur, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>S. B.</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Swisstom, Chur, Switzerland </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strassmann</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ARDS and ECMO Center K&#xf6;ln-Merheim, Cologne, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Windisch</LastName><ForeName>W. W.</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>ARDS and ECMO Center K&#xf6;ln-Merheim, Cologne, Germany </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persson</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Sahlgrenska Univ Hospital, G&#xf6;teborg, Sweden </Affiliation><Identifier Source="ISNI">000000009445082X</Identifier><Identifier Source="GRID">grid.1649.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundin</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sahlgrenska Univ Hospital, G&#xf6;teborg, Sweden </Affiliation><Identifier Source="ISNI">000000009445082X</Identifier><Identifier Source="GRID">grid.1649.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenqvist</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Sahlgrenska Univ Hospital, G&#xf6;teborg, Sweden </Affiliation><Identifier Source="ISNI">000000009445082X</Identifier><Identifier Source="GRID">grid.1649.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porta</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Second University of Naples, Naples, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2200 8888</Identifier><Identifier Source="GRID">grid.9841.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Numis</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>San Paolo Hospital, Naples, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serra</LastName><ForeName>C. S.</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>University of Sassari, Sassari, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2097 9138</Identifier><Identifier Source="GRID">grid.11450.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagano</LastName><ForeName>A. P.</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Cardarelli Hospital, Naples, Italy </Affiliation><Identifier Source="GRID">grid.413172.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masarone</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>University of Saerno, Salerno, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>L. R.</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Second University of Naples, Naples, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2200 8888</Identifier><Identifier Source="GRID">grid.9841.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amelia</LastName><ForeName>A. A.</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Second University of Naples, Naples, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2200 8888</Identifier><Identifier Source="GRID">grid.9841.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fascione</LastName><ForeName>M. F.</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Second University of Naples, Naples, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2200 8888</Identifier><Identifier Source="GRID">grid.9841.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adinolfi</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Second University of Naples, Naples, Italy </Affiliation><Identifier Source="ISNI">0000 0001 2200 8888</Identifier><Identifier Source="GRID">grid.9841.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruggiero</LastName><ForeName>E. R.</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>San Paolo Hospital, Naples, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asota</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>East Surrey Hospital, Surrey and Sussex NHS Trust, Surrey, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Rourke</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>East Surrey Hospital, Surrey and Sussex NHS Trust, Surrey, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranjan</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>East Surrey Hospital, Surrey and Sussex NHS Trust, Surrey, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>East Surrey Hospital, Surrey and Sussex NHS Trust, Surrey, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeBacker</LastName><ForeName>J. W.</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamberg</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Neill</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munshi</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burry</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Health Network-Toronto General Hospital and Univeristy of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0001 0661 1177</Identifier><Identifier Source="GRID">grid.417184.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Mount Sinai Hospital and University of Toronto, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0473 9881</Identifier><Identifier Source="GRID">grid.416166.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poo</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Cambridge, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000000121885934</Identifier><Identifier Source="GRID">grid.5335.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahendran</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Papworth Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0399 2308</Identifier><Identifier Source="GRID">grid.417155.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fowles</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Papworth Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0399 2308</Identifier><Identifier Source="GRID">grid.417155.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerrard</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Papworth Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0399 2308</Identifier><Identifier Source="GRID">grid.417155.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuylsteke</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Papworth Hospital, Cambridge, UK </Affiliation><Identifier Source="ISNI">0000 0004 0399 2308</Identifier><Identifier Source="GRID">grid.417155.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loveridge</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaddock</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakar</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willars</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurst</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Best</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vercueil</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Auzinger</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgman</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proudfoot</LastName><ForeName>A. G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grins</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emiley</LastName><ForeName>K. E.</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuitema</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitch</LastName><ForeName>S. J.</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marco</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturgill</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickinson</LastName><ForeName>M. G.</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strueber</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaghani</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilton</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Meijer Heart &amp; Vascular Institute, Grand Rapids, USA </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovinge</LastName><ForeName>S. M.</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Glenfield Hospital, UHL, Leicester, UK </Affiliation><Identifier Source="ISNI">0000 0004 0648 9396</Identifier><Identifier Source="GRID">grid.416025.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris-Fox</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Glenfield Hospital, UHL, Leicester, UK </Affiliation><Identifier Source="ISNI">0000 0004 0648 9396</Identifier><Identifier Source="GRID">grid.416025.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cove</LastName><ForeName>M. E.</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>National University Hospital, Singapore, Singapore </Affiliation><Identifier Source="ISNI">0000 0004 0621 9599</Identifier><Identifier Source="GRID">grid.412106.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu</LastName><ForeName>L. H.</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>National University Singapore, Singapore, Singapore </Affiliation><Identifier Source="ISNI">0000 0001 2180 6431</Identifier><Identifier Source="GRID">grid.4280.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Phoenix, AZ USA </Affiliation><Identifier Source="ISNI">0000 0000 8875 6339</Identifier><Identifier Source="GRID">grid.417468.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federspiel</LastName><ForeName>W. J.</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, PA USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9000</Identifier><Identifier Source="GRID">grid.21925.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellum</LastName><ForeName>J. A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Pittsburgh, Pittsburgh, PA USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9000</Identifier><Identifier Source="GRID">grid.21925.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazo Torre</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Vall D&#x2019;Hebron University Hospital, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0675 8654</Identifier><Identifier Source="GRID">grid.411083.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riera</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vall D&#x2019;Hebron University Hospital, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0675 8654</Identifier><Identifier Source="GRID">grid.411083.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Vall D&#x2019;Hebron University Hospital, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0675 8654</Identifier><Identifier Source="GRID">grid.411083.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgatta</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Vall D&#x2019;Hebron University Hospital, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0675 8654</Identifier><Identifier Source="GRID">grid.411083.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagunes</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Vall D&#x2019;Hebron University Hospital, Barcelona, Spain </Affiliation><Identifier Source="ISNI">0000 0001 0675 8654</Identifier><Identifier Source="GRID">grid.411083.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rello</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universitat Autonoma de Barcelona, Barcelona, Spain </Affiliation><Identifier Source="GRID">grid.7080.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuzovlev</LastName><ForeName>A. K.</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>V.A. Negovsky Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moroz</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V.A. Negovsky Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goloubev</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>V.A. Negovsky Research Institute of General Reanimatology, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polovnikov</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NN Burdenko Main Military Hospital, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nenchuk</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NN Burdenko Main Military Hospital, Moscow, Russia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karavana</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glynos</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asimakos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappas</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrettou</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magkou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ischaki</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stathopoulos</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Patras, Rio, Achaia Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 5395</Identifier><Identifier Source="GRID">grid.11047.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakynthinos</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>George P. Livanos and Marianthi Simou Laboratories, Athens, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spadaro</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozhevnikova</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Corte</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grasso</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University of Bari, Bari, Italy </Affiliation><Identifier Source="ISNI">0000 0001 0120 3326</Identifier><Identifier Source="GRID">grid.7644.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casolari</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caramori</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volta</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Ferrara, Ferrara, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2064</Identifier><Identifier Source="GRID">grid.8484.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrianjafiarinoa</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU HJRA, Antananarivo, Madagascar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randriamandrato</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU HJRA, Antananarivo, Madagascar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajaonera</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU HJRA, Antananarivo, Madagascar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Dash</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>E. L. V.</ForeName><Initials>ELV</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tucci</LastName><ForeName>M. R.</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leleu</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontar</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cagny</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brazier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titeca</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacari-Risal</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maizel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardio-Pulmonary Department, Pulmonary Division, Heart Institute (Incor), University of S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slama</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>R&#xe9;animation m&#xe9;dicale, Centre Hospitalier Universitaire, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercado</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maizel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontar</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titeca</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brazier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riviere</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joris</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soupison</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cagny</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Dash</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slama</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Amiens, Amiens, France </Affiliation><Identifier Source="ISNI">0000 0004 0593 702X</Identifier><Identifier Source="GRID">grid.134996.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remmington</LastName><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439338.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439338.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squire</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439338.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boichat</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Brompton Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439338.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honzawa</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Musashino Red Cross Hospital, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0000 9887 307X</Identifier><Identifier Source="GRID">grid.416332.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasuda</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Musashino Red Cross Hospital, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0000 9887 307X</Identifier><Identifier Source="GRID">grid.416332.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adati</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Musashino Red Cross Hospital, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0000 9887 307X</Identifier><Identifier Source="GRID">grid.416332.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzaki</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Musashino Red Cross Hospital, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0000 9887 307X</Identifier><Identifier Source="GRID">grid.416332.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horibe</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>JSEPTIC Clinical Trial Group, Tokyo, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>JSEPTIC Clinical Trial Group, Tokyo, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanui</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>JSEPTIC Clinical Trial Group, Tokyo, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Milinis</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>G. R.</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarron</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simants</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patanwala</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welters</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County, Taiwan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Villanueva</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Garda</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez Lago</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Ru&#xed;z</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez Vaquero</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tom&#xe9; Mart&#xed;nez de Rituerto</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varo P&#xe9;rez</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Universitario de Santiago de Compostela, Santiago de Compostela, Spain </Affiliation><Identifier Source="ISNI">0000 0000 8816 6945</Identifier><Identifier Source="GRID">grid.411048.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefel</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MUMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaap</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>MUMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergmans</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MUMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olde Damink</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MUMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van de Poll</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MUMC, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tizard</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lister</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poole</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringaitiene</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania </Affiliation><Identifier Source="ISNI">0000 0004 0567 3159</Identifier><Identifier Source="GRID">grid.426597.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gineityte</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vilnius University, Faculty of Medicine, Vilnius, Lithuania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vicka</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Vilnius University, Faculty of Medicine, Vilnius, Lithuania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norkiene</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania </Affiliation><Identifier Source="ISNI">0000 0004 0567 3159</Identifier><Identifier Source="GRID">grid.426597.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sipylaite</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania </Affiliation><Identifier Source="ISNI">0000 0004 0567 3159</Identifier><Identifier Source="GRID">grid.426597.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O&#x2019;Loughlin</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Mercy University Hospital, Cork, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0575 9497</Identifier><Identifier Source="GRID">grid.411785.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maraj</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Mercy University Hospital, Cork, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0575 9497</Identifier><Identifier Source="GRID">grid.411785.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dowling</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mercy University Hospital, Cork, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0575 9497</Identifier><Identifier Source="GRID">grid.411785.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalcomune</LastName><ForeName>D. M.</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>E. B.</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>S. L.</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oshima</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graf</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidegger</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genton</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karsegard</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupertuis</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pichard</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Geneva Universtiy Hospital, Geneva, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0721 9812</Identifier><Identifier Source="GRID">grid.150338.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedli</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical University Department, Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanga</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital Bern, Bern, Switzerland </Affiliation><Identifier Source="ISNI">0000 0004 0479 0855</Identifier><Identifier Source="GRID">grid.411656.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical University Department, Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuetz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical University Department, Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandersteen</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stessel</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evers</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Assche</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamaer</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade Local de Saude do Alto Minho, Viana do Castelo, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade de Saude Local de Castelo Branco, Castelo Branco, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casteloes</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 8902 4519</Identifier><Identifier Source="GRID">grid.418336.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magalhaes</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Algarve, Faro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Portugues de Oncologia do Porto, Porto, Portugal </Affiliation><Identifier Source="GRID">grid.435544.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutricao e Alimentacao da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutricao e Alimentacao da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgueiro</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutri&#xe7;&#xe3;o e Alimenta&#xe7;&#xe3;o da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafuente</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Tamega e Sousa, Penafiel, Portugal </Affiliation><Identifier Source="GRID">grid.466592.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade Local de Saude do Alto Minho, Viana do Castelo, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutri&#xe7;&#xe3;o e Alimenta&#xe7;&#xe3;o da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgueiro</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidade de Saude Local de Castelo Branco, Castelo Branco, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Algarve, Faro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Baixo Vouga, Aveiro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casteloes</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 8902 4519</Identifier><Identifier Source="GRID">grid.418336.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nottingham University Hospital NHS Trust, Nottingham, UK </Affiliation><Identifier Source="ISNI">0000 0001 0440 1889</Identifier><Identifier Source="GRID">grid.240404.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maipang</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Songkla, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhurayanontachai</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Songkla, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;del</LastName><ForeName>L. G.</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;tz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langlois</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke, Sherbrooke, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9064 6198</Identifier><Identifier Source="GRID">grid.86715.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzanares</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University Hospital, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tincu</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobilinschi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiorghiu</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macovei</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzanares</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University Hospital, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langlois</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke, Sherbrooke, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9064 6198</Identifier><Identifier Source="GRID">grid.86715.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemieux</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Queen&#x2019;s University, Kingston, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8331</Identifier><Identifier Source="GRID">grid.410356.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elke</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University Medical Center Schleswig-Holstein, Kiel, Germany </Affiliation><Identifier Source="ISNI">0000 0004 0646 2097</Identifier><Identifier Source="GRID">grid.412468.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloos</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Jena, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Jena, Jena, Germany </Affiliation><Identifier Source="ISNI">0000 0001 1939 2794</Identifier><Identifier Source="GRID">grid.9613.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyland</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Queen&#x2019;s University, Kingston, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8331</Identifier><Identifier Source="GRID">grid.410356.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langlois</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Sherbrooke, Sherbrooke, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9064 6198</Identifier><Identifier Source="GRID">grid.86715.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemieux</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Queen&#x2019;s University, Kingston, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8331</Identifier><Identifier Source="GRID">grid.410356.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aramendi</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>University Hospital, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyland</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Queen&#x2019;s University, Kingston, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8331</Identifier><Identifier Source="GRID">grid.410356.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzanares</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University Hospital, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi County, Taiwan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babo</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshino</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aida Hospital, Fukushima, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haraguchi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Keiyo Hospital, Tokyo, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajiwara</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aida Hospital, Fukushima, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitsuhashi</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Shisei Hospital, Saitama, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsubata</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Keiyo Hospital, Tokyo, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aida</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aida Hospital, Fukushima, Japan </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattanapraphat</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Hat Yai City, Songkhla Province Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhurayanontachai</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Hat Yai City, Songkhla Province Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongkamol</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Hat Yai City, Songkhla Province Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khwannimit</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Prince of Songkla University, Hat Yai City, Songkhla Province Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0470 1162</Identifier><Identifier Source="GRID">grid.7130.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutri&#xe7;&#xe3;o e Alimenta&#xe7;&#xe3;o da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lafuente</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Tamega e Sousa, Penafiel, Portugal </Affiliation><Identifier Source="GRID">grid.466592.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgueiro</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade Local de Saude do Alto Minho, Viana do Castelo, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculdade de Ciencias da Nutri&#xe7;&#xe3;o e Alimenta&#xe7;&#xe3;o da Universidade do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 1503 7226</Identifier><Identifier Source="GRID">grid.5808.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Baixo Vouga, Aveiro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Baixo Vouga, Aveiro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidade de Saude Local de Castelo Branco, Castelo Branco, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magalhaes</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Algarve, Faro, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casteloes</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal </Affiliation><Identifier Source="ISNI">0000 0000 8902 4519</Identifier><Identifier Source="GRID">grid.418336.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Hospitalar do Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisidou</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ampatzidou</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutsogiannidis</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moschopoulou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drossos</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, George Papanikolaou General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0576 574X</Identifier><Identifier Source="GRID">grid.415248.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taskin</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;akir</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ler</LastName><ForeName>AK</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taskin</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ankara Mevki Military Hospital, Ankara, Turkey </Affiliation><Identifier Source="GRID">grid.461837.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;cal</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;zer</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanel</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>G&#xfc;lhane Military Medical Academy, Ankara, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 0720 6034</Identifier><Identifier Source="GRID">grid.413460.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>St Bartholomew&#x2019;s Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 9244 0345</Identifier><Identifier Source="GRID">grid.416353.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitton</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St Bartholomew&#x2019;s Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 9244 0345</Identifier><Identifier Source="GRID">grid.416353.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anwar</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Bartholomew&#x2019;s Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 9244 0345</Identifier><Identifier Source="GRID">grid.416353.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stacey</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Bartholomew&#x2019;s Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0000 9244 0345</Identifier><Identifier Source="GRID">grid.416353.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fyntanidou</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patsatzakis</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oloktsidou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lolakos</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papapostolou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosomanidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suda</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachiosi Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachiosi Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachiosi Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachiosi Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izutani</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tokyo Medical University Hachiosi Medical Center, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0663 3325</Identifier><Identifier Source="GRID">grid.410793.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudry</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desailly</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquier</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire ILUMENS, Paris, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brun</LastName><ForeName>PB</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Institut de Hauts de Seine, Nanterre, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesnieres</LastName><ForeName>AT</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Laboratoire ILUMENS, Paris, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricard</LastName><ForeName>JD</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreyfuss</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mignon</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire ILUMENS, Paris, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>J. C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molokhia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stilwell</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedlaender</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Minet Green Health Practice, London, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Li&#xe8;ge, Li&#xe8;ge, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0805 7253</Identifier><Identifier Source="GRID">grid.4861.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stipulante</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Li&#xe8;ge, Li&#xe8;ge, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0805 7253</Identifier><Identifier Source="GRID">grid.4861.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delfosse</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium </Affiliation><Identifier Source="ISNI">0000 0000 8607 6858</Identifier><Identifier Source="GRID">grid.411374.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donneau</LastName><ForeName>AF</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Medical Biostatistics, University of Li&#xe8;ge, Li&#xe8;ge, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0805 7253</Identifier><Identifier Source="GRID">grid.4861.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghuysen</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health, University of Li&#xe8;ge, Li&#xe8;ge, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0805 7253</Identifier><Identifier Source="GRID">grid.4861.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldmann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freitag</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dersch</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irqsusi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eschbach</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinfeldt</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wulf</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesmann</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University Hospital, Philipps University Marburg, Marburg, Germany </Affiliation><Identifier Source="ISNI">0000 0004 1936 9756</Identifier><Identifier Source="GRID">grid.10253.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongpolprom</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholkraisuwat</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beitland</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakstad</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xe6;r-Jensen</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dr&#xe6;gni</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunborg</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldum-Grevbo</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunde</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Oslo University Hospital, Oslo, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0389 8485</Identifier><Identifier Source="GRID">grid.55325.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoyland</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>William Harvey Hospital, Ashford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0398 7998</Identifier><Identifier Source="GRID">grid.417122.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandit</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>William Harvey Hospital, Ashford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0398 7998</Identifier><Identifier Source="GRID">grid.417122.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Kansai Medical University Takii Hospital, Moriguchi, Japan </Affiliation><Identifier Source="GRID">grid.410783.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oloktsidou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotzampassi</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fyntanidou</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patsatzakis</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loukipoudi</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doumaki</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosomanidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasuda</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Japanese Red Cross Musashino Hospital, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0004 1762 2623</Identifier><Identifier Source="GRID">grid.410775.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Admiraal</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Assen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Putten</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Medisch Spectrum Twente, Enschede, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0399 8347</Identifier><Identifier Source="GRID">grid.415214.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjepkema-Cloostermans</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medisch Spectrum Twente, Enschede, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0399 8347</Identifier><Identifier Source="GRID">grid.415214.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Rootselaar</LastName><ForeName>A. F.</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragusa</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University Modena, Modena, Italy </Affiliation><Identifier Source="ISNI">0000000121697570</Identifier><Identifier Source="GRID">grid.7548.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marudi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaspari</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Modena, Modena, Italy </Affiliation><Identifier Source="ISNI">0000000121697570</Identifier><Identifier Source="GRID">grid.7548.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertellini</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Alexandria University, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Alexandria University, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdel Monem</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine Alexandria University, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alcorn</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Victoria Hospital, Kirkcaldy, UK </Affiliation><Identifier Source="ISNI">0000 0004 0624 9667</Identifier><Identifier Source="GRID">grid.416854.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeill</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Victoria Hospital, Kirkcaldy, UK </Affiliation><Identifier Source="ISNI">0000 0004 0624 9667</Identifier><Identifier Source="GRID">grid.416854.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Victoria Hospital, Kirkcaldy, UK </Affiliation><Identifier Source="ISNI">0000 0004 0624 9667</Identifier><Identifier Source="GRID">grid.416854.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eertmans</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genbrugge</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meex</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dens</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jans</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Deyne</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ziekenhuis Oost-Limburg, Genk, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0612 7379</Identifier><Identifier Source="GRID">grid.470040.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cholkraisuwat</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kongpolprom</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Chulalongkorn University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0001 0244 7875</Identifier><Identifier Source="GRID">grid.7922.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avard</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Canberra Hospital, Hughes, ACT Australia </Affiliation><Identifier Source="ISNI">0000 0000 9984 5644</Identifier><Identifier Source="GRID">grid.413314.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ANU Medical School, Canberra, Australia </Affiliation><Identifier Source="ISNI">0000 0001 2180 7477</Identifier><Identifier Source="GRID">grid.1001.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patarchi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>&#x201c;Spirito Santo&#x201d; Hospital, Pescara, Italy </Affiliation><Identifier Source="GRID">grid.416240.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spina</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>&#x201c;Spirito Santo&#x201d; Hospital, Pescara, Italy </Affiliation><Identifier Source="GRID">grid.416240.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>St Lukes International Hospital, Akashi-Chou Chuo-Ku, Japan </Affiliation><Identifier Source="GRID">grid.430395.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otani</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>St Lukes International Hospital, Akashi-Chou Chuo-Ku, Japan </Affiliation><Identifier Source="GRID">grid.430395.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ode</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Lukes International Hospital, Akashi-Chou Chuo-Ku, Japan </Affiliation><Identifier Source="GRID">grid.430395.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishimatsu</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Lukes International Hospital, Akashi-Chou Chuo-Ku, Japan </Affiliation><Identifier Source="GRID">grid.430395.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>J. B.</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>C. W.</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohk</LastName><ForeName>T. G.</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>M. C.</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Won</LastName><ForeName>M. H.</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dakova</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Military Medical Academy, Sofia, Bulgaria </Affiliation><Identifier Source="ISNI">0000 0004 0621 0228</Identifier><Identifier Source="GRID">grid.413126.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsheva</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Military Medical Academy, Sofia, Bulgaria </Affiliation><Identifier Source="ISNI">0000 0004 0621 0228</Identifier><Identifier Source="GRID">grid.413126.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramshev</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Military Medical Academy, Sofia, Bulgaria </Affiliation><Identifier Source="ISNI">0000 0004 0621 0228</Identifier><Identifier Source="GRID">grid.413126.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>J. B.</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>C. W.</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohk</LastName><ForeName>T. G.</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>M. C.</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>J. B.</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>C. W.</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohk</LastName><ForeName>T. G.</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>M. C.</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Kangwon National University, Chuncheonsi, South Korea </Affiliation><Identifier Source="ISNI">0000 0001 0707 9039</Identifier><Identifier Source="GRID">grid.412010.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marudi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaspari</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Modena, Modena, Italy </Affiliation><Identifier Source="ISNI">0000000121697570</Identifier><Identifier Source="GRID">grid.7548.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertellini</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orhun</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istanbul University, Medical Faculty of Istanbul, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senturk</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istanbul University, Medical Faculty of Istanbul, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozcan</LastName><ForeName>P. E.</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Istanbul University, Medical Faculty of Istanbul, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sencer</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istanbul University, Medical Faculty of Istanbul, Department of Neuroradiology, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulusoy</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Istanbul University, Institute of Experimental Medicine, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuzun</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Istanbul University, Institute of Experimental Medicine, Neuroscience, Istanbul, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 2166 6619</Identifier><Identifier Source="GRID">grid.9601.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esen</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Istanbul University, Medical Faculty of Istanbul, Anesthesiology and Intensive Care, Istanbul, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tincu</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobilinschi</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Fundeni Clinical Institute, Bucharest, Romania </Affiliation><Identifier Source="ISNI">0000 0004 0540 9980</Identifier><Identifier Source="GRID">grid.415180.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghiorghiu</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macovei</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bucharest Clinical Emergency Hospital, Bucharest, Romania </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Assen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Admiraal</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Putten</LastName><ForeName>M. J.</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Medisch Spectrum Twente, Enschede, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0399 8347</Identifier><Identifier Source="GRID">grid.415214.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tjepkema-Cloostermans</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medisch Spectrum Twente, Enschede, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0399 8347</Identifier><Identifier Source="GRID">grid.415214.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Rootselaar</LastName><ForeName>A. F.</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fallenius</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Helsinki University Hospital, Helsinki, Finland </Affiliation><Identifier Source="ISNI">0000 0000 9950 5666</Identifier><Identifier Source="GRID">grid.15485.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrifvars</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Helsinki University Hospital, Helsinki, Finland </Affiliation><Identifier Source="ISNI">0000 0000 9950 5666</Identifier><Identifier Source="GRID">grid.15485.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinikainen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>North Karelia Central Hospital, Joensuu, Finland </Affiliation><Identifier Source="ISNI">0000 0004 0368 0478</Identifier><Identifier Source="GRID">grid.416446.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendel</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kuopio University Hospital, Kuopio, Finland </Affiliation><Identifier Source="ISNI">0000 0004 0628 207X</Identifier><Identifier Source="GRID">grid.410705.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raj</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Helsinki University Hospital, Helsinki, Finland </Affiliation><Identifier Source="ISNI">0000 0000 9950 5666</Identifier><Identifier Source="GRID">grid.15485.3d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Habsa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hymers</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borowska</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivadhas</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahiba</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perkins</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario Puerta del Mar, Cadiz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 1175</Identifier><Identifier Source="GRID">grid.411342.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>J. A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Hospital Infanta Cristina, Badajoz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 0842</Identifier><Identifier Source="GRID">grid.411319.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario Puerta del Mar, Cadiz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 1175</Identifier><Identifier Source="GRID">grid.411342.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>English</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasse</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgeon</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauzier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griesdale</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UBC, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garland</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UManitoba, Winnipeg, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UBC, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinmouth</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Walraven</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montroy</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UManitoba, Winnipeg, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont Chouinard</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carignan</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaliwal</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UBC, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lum</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliarello</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>OHRI, Ottawa, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>English</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasse</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgeon</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauzier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griesdale</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>UBC, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garland</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UManitoba, Winnipeg, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UManitoba, Winnipeg, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tinmouth</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Walraven</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montroy</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>UManitoba, Winnipeg, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dupont Chouinard</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carignan</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ulaval, Quebec City, Canada </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaliwal</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UBC, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lum</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagliarello</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groza</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cliniques St Luc, Universit&#xe9; catholique de Louvain, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2294 713X</Identifier><Identifier Source="GRID">grid.7942.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreau</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cliniques St Luc, Universit&#xe9; catholique de Louvain, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2294 713X</Identifier><Identifier Source="GRID">grid.7942.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castanares-Zapatero</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cliniques St Luc, Universit&#xe9; catholique de Louvain, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2294 713X</Identifier><Identifier Source="GRID">grid.7942.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hantson</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cliniques St Luc, Universit&#xe9; catholique de Louvain, Brussels, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2294 713X</Identifier><Identifier Source="GRID">grid.7942.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carbonara</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortolano</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoerle</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnoni</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pifferi</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda Ospedale Maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stocchetti</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Milan University, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 2822</Identifier><Identifier Source="GRID">grid.4708.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carteron</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suys</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patet</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintard</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CHU de Nice, Nice, France </Affiliation><Identifier Source="ISNI">0000 0001 2322 4179</Identifier><Identifier Source="GRID">grid.410528.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oddo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHUV, Lausanne, Switzerland </Affiliation><Identifier Source="ISNI">0000 0001 0423 4662</Identifier><Identifier Source="GRID">grid.8515.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>J. A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Hospital Infanta Cristina, Badajoz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 0842</Identifier><Identifier Source="GRID">grid.411319.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario Puerta del Mar, Cadiz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 1175</Identifier><Identifier Source="GRID">grid.411342.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sierra</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario Puerta del Mar, Cadiz, Spain </Affiliation><Identifier Source="ISNI">0000 0004 1771 1175</Identifier><Identifier Source="GRID">grid.411342.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spatenkova</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Regional Hospital, Liberec, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0449</Identifier><Identifier Source="GRID">grid.447961.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pokorna</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Experimental Medicine, Prague, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0404 6946</Identifier><Identifier Source="GRID">grid.424967.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchomel</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Regional Hospital, Liberec, Czech Republic </Affiliation><Identifier Source="ISNI">0000 0004 0609 0449</Identifier><Identifier Source="GRID">grid.447961.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jancik</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhodes</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hennepin County Medical Center, Minneapolis, USA </Affiliation><Identifier Source="ISNI">0000 0000 9206 4546</Identifier><Identifier Source="GRID">grid.414021.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bylinski</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Glasgow, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2193 314X</Identifier><Identifier Source="GRID">grid.8756.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawthorne</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Neurological Sciences, NHSGGC, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Physics and Bioengineering, NHSGGC, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piper</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Physics and Bioengineering, NHSGGC, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Academic Unit of Anaesthesia, Pain and Critical Care Medicine, University of Glasgow, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2193 314X</Identifier><Identifier Source="GRID">grid.8756.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kink</LastName><ForeName>A. K.</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Smartimplant Ltd., Tallinn, Estonia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe4;tsep</LastName><ForeName>I. R.</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>NEMC, Tallinn, Estonia </Affiliation><Identifier Source="ISNI">0000 0004 0631 377X</Identifier><Identifier Source="GRID">grid.454953.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutin</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasse</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Manitoba, Winnipeg, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 9609</Identifier><Identifier Source="GRID">grid.21613.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauzier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>English</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacroix</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universite de Montreal, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2292 3357</Identifier><Identifier Source="GRID">grid.14848.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griesdale</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessard-Bonaventure</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgeon</LastName><ForeName>A. F.</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutin</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dalhousie University, Halifax, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8200</Identifier><Identifier Source="GRID">grid.55602.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lessard-Bonaventure</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdogan</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dalhousie University, Halifax, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8200</Identifier><Identifier Source="GRID">grid.55602.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dalhousie University, Halifax, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8200</Identifier><Identifier Source="GRID">grid.55602.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauzier</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chasse</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>English</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarychanski</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Manitoba, Winnipeg, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 9609</Identifier><Identifier Source="GRID">grid.21613.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacroix</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universite de Montreal, Montreal, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2292 3357</Identifier><Identifier Source="GRID">grid.14848.31</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griesdale</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, Canada </Affiliation><Identifier Source="ISNI">0000 0001 2288 9830</Identifier><Identifier Source="GRID">grid.17091.3e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desjardins</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>D. A.</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Ottawa Hospital Research Institute, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turgeon</LastName><ForeName>A. F.</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Universite Laval, Quebec, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8390</Identifier><Identifier Source="GRID">grid.23856.3a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goncalves</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>A. C.</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miguez</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moralez</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Estadual Getulio Vargas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Yonsei University College of Medicine, Seoul, South Korea </Affiliation><Identifier Source="ISNI">0000 0004 0470 5454</Identifier><Identifier Source="GRID">grid.15444.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutz</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hausfater</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Emergency Department, Groupe Hospitalier Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France </Affiliation><Identifier Source="ISNI">0000 0001 2150 9058</Identifier><Identifier Source="GRID">grid.411439.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amin</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Morton Plant Hospital, Clearwater, USA </Affiliation><Identifier Source="ISNI">0000 0000 8602 0133</Identifier><Identifier Source="GRID">grid.416123.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struja</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haubitz</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuetz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital Trust, Truro, UK </Affiliation><Identifier Source="ISNI">0000 0004 0474 4488</Identifier><Identifier Source="GRID">grid.412944.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collinson</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital Trust, Truro, UK </Affiliation><Identifier Source="ISNI">0000 0004 0474 4488</Identifier><Identifier Source="GRID">grid.412944.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pritchett</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital Trust, Truro, UK </Affiliation><Identifier Source="ISNI">0000 0004 0474 4488</Identifier><Identifier Source="GRID">grid.412944.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slade</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Cornwall Hospital Trust, Truro, UK </Affiliation><Identifier Source="ISNI">0000 0004 0474 4488</Identifier><Identifier Source="GRID">grid.412944.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Guen</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Manchester Royal Infirmary, Manchester, UK </Affiliation><Identifier Source="ISNI">0000 0004 0641 2823</Identifier><Identifier Source="GRID">grid.419319.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellings</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Manchester Royal Infirmary, Manchester, UK </Affiliation><Identifier Source="ISNI">0000 0004 0641 2823</Identifier><Identifier Source="GRID">grid.419319.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramsaran</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Manchester Royal Infirmary, Manchester, UK </Affiliation><Identifier Source="ISNI">0000 0004 0641 2823</Identifier><Identifier Source="GRID">grid.419319.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsheikhly</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad Medical Corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Tsukuba, Tsukuba Medical Center Hospital, Tsukuba, Japan </Affiliation><Identifier Source="ISNI">0000 0004 1764 0856</Identifier><Identifier Source="GRID">grid.417324.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanapeckaite</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Habsa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahl</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>M. Q.</ForeName><Initials>MQ</Initials><AffiliationInfo><Affiliation>Kent, Surrey &amp; Sussex Air Ambulance Trust, Kent, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Real</LastName><ForeName>K. J.</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Prometheus Delta-Tech, Herefordshire, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Habsa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyon</LastName><ForeName>R. M.</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Kent, Surrey &amp; Sussex Air Ambulance Trust, Kent, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oveland</LastName><ForeName>N. P.</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Stavanger University Hospital, Stavanger, Norway </Affiliation><Identifier Source="ISNI">0000 0004 0627 2891</Identifier><Identifier Source="GRID">grid.412835.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penketh</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mcdonald</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfafi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aseer Central Hospital, Abha, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0607 7156</Identifier><Identifier Source="GRID">grid.413974.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsolamy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almutairi</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alotaibi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>King Fahad Medical City, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0593 1832</Identifier><Identifier Source="GRID">grid.415277.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Berg</LastName><ForeName>A. E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>HagaZiekenhuis, Den Haag, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0568 6689</Identifier><Identifier Source="GRID">grid.413591.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schriel</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Reinier de Graaf Gasthuis, Delft, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0624 5690</Identifier><Identifier Source="GRID">grid.415868.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawson</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Reinier de Graaf Gasthuis, Delft, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0624 5690</Identifier><Identifier Source="GRID">grid.415868.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meynaar</LastName><ForeName>I. A.</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>HagaZiekenhuis, Den Haag, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0568 6689</Identifier><Identifier Source="GRID">grid.413591.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talaie</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Toxicological Research Center, Department of Clinical Toxicology, Loghman-Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran </Affiliation><Identifier Source="GRID">grid.411600.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Santa Maria University Hospital, Lisboa, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 2295 9747</Identifier><Identifier Source="GRID">grid.411265.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Santa Maria University Hospital, Lisboa, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 2295 9747</Identifier><Identifier Source="GRID">grid.411265.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouveia</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Santa Maria University Hospital, Lisboa, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 2295 9747</Identifier><Identifier Source="GRID">grid.411265.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Silva</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Santa Maria University Hospital, Lisboa, Portugal </Affiliation><Identifier Source="ISNI">0000 0001 2295 9747</Identifier><Identifier Source="GRID">grid.411265.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foley</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Vincent&#x2019;s University Hospital, Dublin 4, Ireland </Affiliation><Identifier Source="ISNI">0000 0001 0315 8143</Identifier><Identifier Source="GRID">grid.412751.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaskovagheorgescu</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St. Vincent&#x2019;s University Hospital, Dublin 4, Ireland </Affiliation><Identifier Source="ISNI">0000 0001 0315 8143</Identifier><Identifier Source="GRID">grid.412751.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evoy</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>St. Vincent&#x2019;s University Hospital, Dublin 4, Ireland </Affiliation><Identifier Source="ISNI">0000 0001 0315 8143</Identifier><Identifier Source="GRID">grid.412751.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronin</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Vincent&#x2019;s University Hospital, Dublin 4, Ireland </Affiliation><Identifier Source="ISNI">0000 0001 0315 8143</Identifier><Identifier Source="GRID">grid.412751.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St. Vincent&#x2019;s University Hospital, Dublin 4, Ireland </Affiliation><Identifier Source="ISNI">0000 0001 0315 8143</Identifier><Identifier Source="GRID">grid.412751.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huck</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renner</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laitselart</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donat</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirodde</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaal</LastName><ForeName>J. V.</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nau</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leclerc</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Percy Military Teaching Hospital, Clamart, France </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howarth</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Whiston Hospital, Prescot, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davenport</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Whiston Hospital, Prescot, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeanrenaud</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Whiston Hospital, Prescot, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raftery</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Whiston Hospital, Prescot, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacTavish</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPeake</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quasim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrabiee</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Abdulaziz Medical City, National Guard Hospital, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 1790 7311</Identifier><Identifier Source="GRID">grid.415254.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrashid</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Management, College of Business Administration, King Saud University, Saudi Arabia, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 1773 5396</Identifier><Identifier Source="GRID">grid.56302.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsolamy</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences and King Abdullah International Medical Research Center, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundogan</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Ege University Hospital, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0535 6364</Identifier><Identifier Source="GRID">grid.412190.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bor</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ege University Hospital, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0535 6364</Identifier><Identifier Source="GRID">grid.412190.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ak&#xfd;n Korhan</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Katip Celebi University, Health Sciences Faculty, Izmir, Turkey </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirag</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ege University Hospital, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0535 6364</Identifier><Identifier Source="GRID">grid.412190.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyar</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ege University Hospital, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0535 6364</Identifier><Identifier Source="GRID">grid.412190.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frame</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK </Affiliation><Identifier Source="GRID">grid.415667.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK </Affiliation><Identifier Source="GRID">grid.415667.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergstrom Niska</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK </Affiliation><Identifier Source="GRID">grid.415667.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilokpattanamongkol</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suansanae</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suthisisang</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morakul</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnjanarachata</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangsujaritvijit</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Specialist Anesthesia, Doha, Qatar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Thani</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Specialist Anesthesia, Doha, Qatar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almenyar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Specialist Anesthesia, Doha, Qatar </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vakalos</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avramidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Xanthi General Hospital, Xanthi, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharvill</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penketh</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Royal United Hospital, Bath, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0728</Identifier><Identifier Source="GRID">grid.416091.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morton</LastName><ForeName>S. E.</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiew</LastName><ForeName>Y. S.</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretty</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chase</LastName><ForeName>J. G.</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>G. M.</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Christchurch Hospital, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0614 1349</Identifier><Identifier Source="GRID">grid.414299.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knafelj</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kordis</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinical Center Ljubljana, Ljubljana, Slovenia </Affiliation><Identifier Source="ISNI">0000 0004 0571 7705</Identifier><Identifier Source="GRID">grid.29524.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Royal Marsden Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0461</Identifier><Identifier Source="GRID">grid.424926.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grover</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>The Royal Marsden Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0461</Identifier><Identifier Source="GRID">grid.424926.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuchyn</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Bogomolets National Medical University, Kiev, Ukraine </Affiliation><Identifier Source="GRID">grid.412081.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bielka</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bogomolets National Medical University, Kiev, Ukraine </Affiliation><Identifier Source="GRID">grid.412081.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aidoni</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grosomanidis</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotzampassi</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavrou</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fyntanidou</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patsatzakis</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skourtis</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Aristotle Medical School, Thessaloniki, Greece </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>S. D.</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Royal Liverpool Intensive Care Unit, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Royal Liverpool Intensive Care Unit, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weltes</LastName><ForeName>I. D.</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berhane</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Homerton University Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439591.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrowsmith</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Homerton University Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439591.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Homerton University Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439591.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Homerton University Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439591.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caldas</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panerai</LastName><ForeName>R. B.</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>University of Leicester, Leicester, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8411</Identifier><Identifier Source="GRID">grid.9918.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>T. G.</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>University of Leicester, Leicester, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8411</Identifier><Identifier Source="GRID">grid.9918.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camara</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Leicester, Leicester, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8411</Identifier><Identifier Source="GRID">grid.9918.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borg-Seng-Shu</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lima Oliveira</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mian</LastName><ForeName>N. C.</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeferino</LastName><ForeName>S. P.</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobsen Teixeira</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galas</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>L. A.</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>University of Sao Paulo, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 1937 0722</Identifier><Identifier Source="GRID">grid.11899.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Killeen</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPhail</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernal</LastName><ForeName>W.</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggs</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendon</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taniguchi</LastName><ForeName>L. U.</ForeName><Initials>LU</Initials><AffiliationInfo><Affiliation>Research and Education Institute, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>E. M.</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Research and Education Institute, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira Jr</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Research and Education Institute, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azevedo</LastName><ForeName>L. C.</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Research and Education Institute, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>A. N.</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Habsa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahl</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helme</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadfield</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loveridge</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0391 9020</Identifier><Identifier Source="GRID">grid.46699.34</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shak</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ipswich Hospital NHS Trust, England, UK, Ipswich, UK </Affiliation><Identifier Source="ISNI">0000 0004 0413 7370</Identifier><Identifier Source="GRID">grid.412930.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senver</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ipswich Hospital NHS Trust, England, UK, Ipswich, UK </Affiliation><Identifier Source="ISNI">0000 0004 0413 7370</Identifier><Identifier Source="GRID">grid.412930.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard-Griffin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ipswich Hospital NHS Trust, England, UK, Ipswich, UK </Affiliation><Identifier Source="ISNI">0000 0004 0413 7370</Identifier><Identifier Source="GRID">grid.412930.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wacharasint</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Phramongkutklao Hospital, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0576 1212</Identifier><Identifier Source="GRID">grid.414965.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuengfoo</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Phramongkutklao Hospital, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0576 1212</Identifier><Identifier Source="GRID">grid.414965.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sukcharoen</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Phramongkutklao Hospital, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 0576 1212</Identifier><Identifier Source="GRID">grid.414965.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangsin</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Phramongkutklao College of Medicine, Bangkok, Thailand </Affiliation><Identifier Source="ISNI">0000 0004 1937 0490</Identifier><Identifier Source="GRID">grid.10223.32</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbiti-Rohr</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuetz</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Kantonsspital Aarau, Aarau, Switzerland </Affiliation><Identifier Source="ISNI">0000 0000 8704 3732</Identifier><Identifier Source="GRID">grid.413357.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pusan National University Hospital, Busan, South Korea </Affiliation><Identifier Source="ISNI">0000 0000 8611 7824</Identifier><Identifier Source="GRID">grid.412588.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pusan National University Hospital, Busan, South Korea </Affiliation><Identifier Source="ISNI">0000 0000 8611 7824</Identifier><Identifier Source="GRID">grid.412588.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pusan National University Hospital, Busan, South Korea </Affiliation><Identifier Source="ISNI">0000 0000 8611 7824</Identifier><Identifier Source="GRID">grid.412588.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pusan National University Hospital, Busan, South Korea </Affiliation><Identifier Source="ISNI">0000 0000 8611 7824</Identifier><Identifier Source="GRID">grid.412588.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pusan National University Hospital, Busan, South Korea </Affiliation><Identifier Source="ISNI">0000 0000 8611 7824</Identifier><Identifier Source="GRID">grid.412588.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milinis</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarron</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simants</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patanwala</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Royal Liverpool University Hospital, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 2395</Identifier><Identifier Source="GRID">grid.415970.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Welters</LastName><ForeName>I. D.</ForeName><Initials>ID</Initials><AffiliationInfo><Affiliation>University of Liverpool, Liverpool, UK </Affiliation><Identifier Source="ISNI">0000 0004 1936 8470</Identifier><Identifier Source="GRID">grid.10025.36</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoumpelouli</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volakli</LastName><ForeName>E. A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrysohoidou</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Georgiou</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charisopoulou</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotzapanagiotou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagiotidou</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manavidou</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stathi</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sdougka</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salahuddin</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlGhamdi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marashly</LastName><ForeName>Q.</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaza</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharshir</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khurshid</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malgapo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamil</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafquat</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoukri</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazi</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0001 2191 4301</Identifier><Identifier Source="GRID">grid.415310.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchino</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takinami</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Jikei University School of Medicine, Tokyo, Japan </Affiliation><Identifier Source="ISNI">0000 0001 0661 2073</Identifier><Identifier Source="GRID">grid.411898.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangel Neto</LastName><ForeName>N. R.</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reis</LastName><ForeName>F. Q.</ForeName><Initials>FQ</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>F. A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Albert Schweitzer State Hospital, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moralez</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>PPG Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2294 473X</Identifier><Identifier Source="GRID">grid.8536.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebecken</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>PPG Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2294 473X</Identifier><Identifier Source="GRID">grid.8536.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabello</LastName><ForeName>L. S.</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>PPG Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2294 473X</Identifier><Identifier Source="GRID">grid.8536.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lima</LastName><ForeName>M. F.</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Hospital Esperanca Recife, Recife, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hatum</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Total Cor, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marco</LastName><ForeName>F. V.</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Hospital viValle, S&#xe3;o Jos&#xe9; dos Campos, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alves</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Rios DOr, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>J. E.</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Hospital Norte DOr, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Esperanca Olinda, Olinda, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasil</LastName><ForeName>P. E.</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>F. A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salluh</LastName><ForeName>J. I.</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krinsley</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stamford Hospital, Stamford, USA </Affiliation><Identifier Source="ISNI">0000 0004 0377 0318</Identifier><Identifier Source="GRID">grid.416984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Stamford Hospital, Stamford, USA </Affiliation><Identifier Source="ISNI">0000 0004 0377 0318</Identifier><Identifier Source="GRID">grid.416984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Darent Valley Hospital, Dartford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0398 7314</Identifier><Identifier Source="GRID">grid.413475.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hines</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>William Harvey Hospital, Ashford, UK </Affiliation><Identifier Source="ISNI">0000 0004 0398 7998</Identifier><Identifier Source="GRID">grid.417122.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>K. M.</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>St James&#x2019;s University Hospital, Leeds, UK </Affiliation><Identifier Source="GRID">grid.443984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tordoff</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>St James&#x2019;s University Hospital, Leeds, UK </Affiliation><Identifier Source="GRID">grid.443984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sloan</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>St James&#x2019;s University Hospital, Leeds, UK </Affiliation><Identifier Source="GRID">grid.443984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellamy</LastName><ForeName>M. C.</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>St James&#x2019;s University Hospital, Leeds, UK </Affiliation><Identifier Source="GRID">grid.443984.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verga</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbato</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burghi</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soares</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>U. V.</ForeName><Initials>UV</Initials><AffiliationInfo><Affiliation>Hospital de Cancer de Barretos, Barretos, Brazil </Affiliation><Identifier Source="ISNI">0000 0004 0615 7498</Identifier><Identifier Source="GRID">grid.427783.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azevedo</LastName><ForeName>L. C.</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Hospital S&#xed;rio Liban&#xea;s, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0000 9080 8521</Identifier><Identifier Source="GRID">grid.413471.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torelly</LastName><ForeName>A. P.</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Sta. Casa de Porto Alegre, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Medical Center, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0001 0650 7433</Identifier><Identifier Source="GRID">grid.412689.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angus</LastName><ForeName>D. C.</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>University of Pittsburgh Medical Center, Pittsburgh, USA </Affiliation><Identifier Source="ISNI">0000 0001 0650 7433</Identifier><Identifier Source="GRID">grid.412689.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knibel</LastName><ForeName>M. F.</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Hospital Sao Lucas, Rio de Janeiro, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasil</LastName><ForeName>P. E.</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bozza</LastName><ForeName>F. A.</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salluh</LastName><ForeName>J. I.</ForeName><Initials>JI</Initials><AffiliationInfo><Affiliation>DOr Institute for Research and Education - IDOR, Rio de Janeiro, Brazil </Affiliation><Identifier Source="GRID">grid.472984.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalcomune</LastName><ForeName>D. M.</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilpin</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Whiston Hospital, St Helens &amp; Knowsley, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raithatha</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mota</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Hospitalar e Universit&#xe1;rio de Coimbra, Coimbra, Portugal </Affiliation><Identifier Source="ISNI">0000000106861985</Identifier><Identifier Source="GRID">grid.28911.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loureiro</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dias</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afonso</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto Portugu&#xea;s de Oncologia Francisco Gil - Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0631 0608</Identifier><Identifier Source="GRID">grid.418711.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Dorzi</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Orainni</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlEid</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tlaygeh</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itani</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hejazi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia </Affiliation><Identifier Source="ISNI">0000 0004 0608 0662</Identifier><Identifier Source="GRID">grid.412149.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaudry</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messika</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ricard</LastName><ForeName>J. D.</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guillo</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Bichat, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 8588 831X</Identifier><Identifier Source="GRID">grid.411119.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasquet</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Bichat, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 8588 831X</Identifier><Identifier Source="GRID">grid.411119.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubief</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dreyfuss</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Louis Mourier, Colombes, France </Affiliation><Identifier Source="ISNI">0000 0001 0273 556X</Identifier><Identifier Source="GRID">grid.414205.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tubach</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>H&#xf4;pital Bichat, Paris, France </Affiliation><Identifier Source="ISNI">0000 0000 8588 831X</Identifier><Identifier Source="GRID">grid.411119.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battle</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temblett</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Morriston Hospital, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0004 0649 0266</Identifier><Identifier Source="GRID">grid.416122.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Abertawe Bro Morgannwg University Health Board, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0000 8959 0182</Identifier><Identifier Source="GRID">grid.419728.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battle</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Abertawe Bro Morgannwg University Health Board, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0000 8959 0182</Identifier><Identifier Source="GRID">grid.419728.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Abertawe Bro Morgannwg University Health Board, Swansea, UK </Affiliation><Identifier Source="ISNI">0000 0000 8959 0182</Identifier><Identifier Source="GRID">grid.419728.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavaco</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreira</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seabra Pereira</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malheiro</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xe3;o</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centro Hospitalar Porto, Porto, Portugal </Affiliation><Identifier Source="ISNI">0000 0004 0392 7039</Identifier><Identifier Source="GRID">grid.418340.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fister</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knafelj</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muraray Govind</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Apollo Speciality Hospital - OMR, Chennai, India </Affiliation><Identifier Source="ISNI">0000 0004 1802 3550</Identifier><Identifier Source="GRID">grid.413839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brahmananda Reddy</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Apollo Speciality Hospital - OMR, Chennai, India </Affiliation><Identifier Source="ISNI">0000 0004 1802 3550</Identifier><Identifier Source="GRID">grid.413839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratheema</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Apollo Speciality Hospital - OMR, Chennai, India </Affiliation><Identifier Source="ISNI">0000 0004 1802 3550</Identifier><Identifier Source="GRID">grid.413839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arul</LastName><ForeName>E. D.</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Apollo Speciality Hospital - OMR, Chennai, India </Affiliation><Identifier Source="ISNI">0000 0004 1802 3550</Identifier><Identifier Source="GRID">grid.413839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devachandran</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Apollo Speciality Hospital - OMR, Chennai, India </Affiliation><Identifier Source="ISNI">0000 0004 1802 3550</Identifier><Identifier Source="GRID">grid.413839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalcomune</LastName><ForeName>D. M.</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Hospital Meridional S.A., Cariacica, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knafelj</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fister</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rihard Knafelj, Ljubljana, Slovenia </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chin-Yee</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#x2019;Egidio</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavorn</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heyland</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kingston General Hospital, Kingston, Canada </Affiliation><Identifier Source="ISNI">0000 0004 0633 727X</Identifier><Identifier Source="GRID">grid.415354.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kyeremanteng</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Ottawa Hospital, Ottawa, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9606 5108</Identifier><Identifier Source="GRID">grid.412687.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murchison</LastName><ForeName>A. G.</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Milton Keynes Hospital, Milton Keynes, UK </Affiliation><Identifier Source="GRID">grid.415667.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swalwell</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Imperial College, London, UK </Affiliation><Identifier Source="ISNI">0000 0001 2113 8111</Identifier><Identifier Source="GRID">grid.7445.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandeville</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Buckinghamshire Healthcare NHS Trust, Aylesbury, UK </Affiliation><Identifier Source="ISNI">0000 0004 0368 863X</Identifier><Identifier Source="GRID">grid.439664.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stott</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Buckinghamshire Healthcare NHS Trust, Aylesbury, UK </Affiliation><Identifier Source="ISNI">0000 0004 0368 863X</Identifier><Identifier Source="GRID">grid.439664.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerreiro</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>IPO -Porto, Porto, Portugal </Affiliation><Identifier Source="GRID">grid.435544.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacTavish</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPeake</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quasim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goossens</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>M. B.</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Derde</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vander Perre</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dufour</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiessen</LastName><ForeName>S. E.</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;iza</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janssens</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermans</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanhorebeek</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bock</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Berghe</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langouche</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>KU Leuven, Leuven, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 0668 7884</Identifier><Identifier Source="GRID">grid.5596.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacTavish</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quasim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPeake</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miles</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madden</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiler</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeira</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenner</LastName><ForeName>K.</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Le&#xe3;es</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Machado</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Townsend</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ernesto Dornelles Hospital, Porto Alegre, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacTavish</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPeake</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinsella</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishore</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenlon</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quasim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Glasgow Royal Infirmary, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9825 7840</Identifier><Identifier Source="GRID">grid.411714.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiks</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Gelre Ziekenhuizen, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruijter</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gelre Ziekenhuizen, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Raa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gelre Ziekenhuizen, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spronk</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Gelre Ziekenhuizen, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiew</LastName><ForeName>Y. S.</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Docherty</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moltchanova</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarrot</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretty</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Canterbury, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0001 2179 1970</Identifier><Identifier Source="GRID">grid.21006.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>G. M.</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Christchurch Hospital, Christchurch, New Zealand </Affiliation><Identifier Source="ISNI">0000 0004 0614 1349</Identifier><Identifier Source="GRID">grid.414299.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chase</LastName><ForeName>J. G.</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>University of Western Ontario, London, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 8884</Identifier><Identifier Source="GRID">grid.39381.30</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Surrey and Sussex NHS Trust, Redhill, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngu</LastName><ForeName>W. C.</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Surrey and Sussex NHS Trust, Redhill, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jack</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Surrey and Sussex NHS Trust, Redhill, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Surrey and Sussex NHS Trust, Redhill, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avard</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Canberra Hospital, Hughes, ACT Australia </Affiliation><Identifier Source="ISNI">0000 0000 9984 5644</Identifier><Identifier Source="GRID">grid.413314.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavli</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Canberra Hospital, Hughes, ACT Australia </Affiliation><Identifier Source="ISNI">0000 0000 9984 5644</Identifier><Identifier Source="GRID">grid.413314.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gee</LastName><ForeName>X.</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>ANU Medical School, Canberra, Australia </Affiliation><Identifier Source="ISNI">0000 0001 2180 7477</Identifier><Identifier Source="GRID">grid.1001.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bor</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ege University School of Medicine, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 1092 2592</Identifier><Identifier Source="GRID">grid.8302.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akin Korhan</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>katip Celebi University, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0004 0454 9420</Identifier><Identifier Source="GRID">grid.411795.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demirag</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Ege University School of Medicine, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 1092 2592</Identifier><Identifier Source="GRID">grid.8302.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyar</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ege University School of Medicine, Izmir, Turkey </Affiliation><Identifier Source="ISNI">0000 0001 1092 2592</Identifier><Identifier Source="GRID">grid.8302.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shirazy</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Alexandria University Faculty of medicine, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fayed</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alexandria University Faculty of medicine, Alexandria, Egypt </Affiliation><Identifier Source="ISNI">0000 0001 2260 6941</Identifier><Identifier Source="GRID">grid.7155.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fortis Escorts Heart Institute, New Delhi, India </Affiliation><Identifier Source="ISNI">0000 0004 1804 7827</Identifier><Identifier Source="GRID">grid.417966.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushal</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fortis Escorts Heart Institute, New Delhi, India </Affiliation><Identifier Source="ISNI">0000 0004 1804 7827</Identifier><Identifier Source="GRID">grid.417966.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dewan</LastName><ForeName>S.</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>FMRI, Gurgaon, India </Affiliation><Identifier Source="ISNI">0000 0004 4653 2037</Identifier><Identifier Source="GRID">grid.464839.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Philips Research North America, Cambridge, USA </Affiliation><Identifier Source="GRID">grid.417285.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Philips Research North America, Cambridge, USA </Affiliation><Identifier Source="GRID">grid.417285.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eshelman</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Philips Research North America, Cambridge, USA </Affiliation><Identifier Source="GRID">grid.417285.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Philips Research North America, Cambridge, USA </Affiliation><Identifier Source="GRID">grid.417285.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carlson</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Philips Research North America, Cambridge, USA </Affiliation><Identifier Source="GRID">grid.417285.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helme</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broderick</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadfield</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loveridge</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>King&#x2019;s College Hospital NHS Foundation Trust, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0489 4320</Identifier><Identifier Source="GRID">grid.429705.d</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Sao Rafael, Salvador, Brazil </Affiliation><Identifier Source="GRID">grid.413466.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forte</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Brigham and Women&#x2019;s Hospital, Boston, USA </Affiliation><Identifier Source="ISNI">0000 0004 0378 8294</Identifier><Identifier Source="GRID">grid.62560.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Brigham and Women&#x2019;s Hospital, Boston, USA </Affiliation><Identifier Source="ISNI">0000 0004 0378 8294</Identifier><Identifier Source="GRID">grid.62560.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudziak</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feeney</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkinson</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauchmuller</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>STH, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuker</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>STH, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faulds</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>STH, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raithatha</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>STH, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bryden</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>STH, Sheffield, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>England</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolton</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley, Liverpool, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauchmuller</LastName><ForeName>K.</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Shuker</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Tridente</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Whiston Hospital, Prescot, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 1894</Identifier><Identifier Source="GRID">grid.417083.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faulds</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Freeman Hospital, Newcastle upon Tyne, UK </Affiliation><Identifier Source="ISNI">0000 0004 0641 3308</Identifier><Identifier Source="GRID">grid.415050.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheson</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaynor</LastName><ForeName>J.</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Bryden</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><CollectiveName>S South Yorkshire Hospitals Research Collaboration</CollectiveName></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Sao Rafael, Salvador, Brazil </Affiliation><Identifier Source="GRID">grid.413466.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peroni</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daglius-Dias</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Nove de Julho, Sao Paulo, Brazil </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velasco</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forte</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>J. M.</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University Hospital Coventry and Warwickshire, Coventry, UK </Affiliation><Identifier Source="GRID">grid.15628.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neill</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9743 1587</Identifier><Identifier Source="GRID">grid.413104.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubenfeld</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, Toronto, Canada </Affiliation><Identifier Source="ISNI">0000 0000 9743 1587</Identifier><Identifier Source="GRID">grid.413104.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>NHS Scotland, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0000 9506 6213</Identifier><Identifier Source="GRID">grid.422655.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal College of Surgeons of Ireland, Dublin, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0488 7120</Identifier><Identifier Source="GRID">grid.4912.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boezeman</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University Leiden, Leiden, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 2312 1970</Identifier><Identifier Source="GRID">grid.5132.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofhuis</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gelre Hospitals, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hovingh</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gelre Hospitals, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vries</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>VU University Amsterdam, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 1754 9227</Identifier><Identifier Source="GRID">grid.12380.38</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spronk</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Gelre Hospitals, Apeldoorn, Netherlands </Affiliation><Identifier Source="ISNI">0000 0004 0370 4214</Identifier><Identifier Source="GRID">grid.415355.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabral-Campello</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital de Santo Ant&#xf3;nio, Oporto Hospital Center, Porto, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xe3;o</LastName><ForeName>I.</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital de Santo Ant&#xf3;nio, Oporto Hospital Center, Porto, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hospital de Santo Ant&#xf3;nio, Oporto Hospital Center, Porto, Portugal </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Mol</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijkamp</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Psychology and Educational Sciences, Heerlen, Netherlands </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kompanje</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Erasmus MC, Rotterdam, Netherlands </Affiliation><Identifier Source="ISNI">000000040459992X</Identifier><Identifier Source="GRID">grid.5645.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Toronto at Scarborough, Scarborough, ON Canada </Affiliation><Identifier Source="ISNI">0000 0001 2157 2938</Identifier><Identifier Source="GRID">grid.17063.33</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hamad medical corporation, Doha, Qatar </Affiliation><Identifier Source="ISNI">0000 0004 0571 546X</Identifier><Identifier Source="GRID">grid.413548.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Szeged, Szeged, Hungary </Affiliation><Identifier Source="ISNI">0000 0001 1016 9625</Identifier><Identifier Source="GRID">grid.9008.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;ves</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jahn Ferenc Hospital, Budapest, Hungary </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Csernus</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of P&#xe9;cs, P&#xe9;cs, Hungary </Affiliation><Identifier Source="ISNI">0000 0001 0663 9479</Identifier><Identifier Source="GRID">grid.9679.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moln&#xe1;r</LastName><ForeName>Z.</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>University of Szeged, Szeged, Hungary </Affiliation><Identifier Source="ISNI">0000 0001 1016 9625</Identifier><Identifier Source="GRID">grid.9008.1</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoydonckx</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanwing</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stessel</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Assche</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamaer</LastName><ForeName>L.</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jessa Ziekenhuis, Hasselt, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0578 1096</Identifier><Identifier Source="GRID">grid.414977.8</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medo</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Clinico Universidad de Chile, Santiago, Chile </Affiliation><Identifier Source="GRID">grid.412248.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galvez</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Clinico Universidad de Chile, Santiago, Chile </Affiliation><Identifier Source="GRID">grid.412248.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>J. P.</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Hospital Clinico Universidad de Chile, Santiago, Chile </Affiliation><Identifier Source="GRID">grid.412248.9</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Royal Marsden Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0461</Identifier><Identifier Source="GRID">grid.424926.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wigmore</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Marsden Hospital, London, UK </Affiliation><Identifier Source="ISNI">0000 0004 0417 0461</Identifier><Identifier Source="GRID">grid.424926.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arunan</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauchmuller</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bryden</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sheffield Teaching Hospitals, Sheffield, UK </Affiliation><Identifier Source="GRID">grid.419135.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Y.</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tan Tock Seng hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poi</LastName><ForeName>C.</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Tan Tock Seng hospital, Singapore, Singapore </Affiliation><Identifier Source="GRID">grid.240988.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molmy</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Grunderbeeck</LastName><ForeName>N.</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nigeon</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemyze</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thevenin</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mallat</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre Hospitalier de Lens, Lens, France </Affiliation><Identifier Source="ISNI">0000 0004 0642 1236</Identifier><Identifier Source="GRID">grid.470048.f</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Sao Rafael, Salvador, Brazil </Affiliation><Identifier Source="GRID">grid.413466.2</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correa</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>R. T.</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forte</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hospital das Clinicas, Sao Paulo, Brazil </Affiliation><Identifier Source="ISNI">0000 0001 2297 2036</Identifier><Identifier Source="GRID">grid.411074.7</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ntra Sra de Candelaria University Hospital, Santa Cruz de Tenerife, Spain </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McBride</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Texas at Austin, San Antonio, USA </Affiliation><Identifier Source="ISNI">0000 0004 1936 9924</Identifier><Identifier Source="GRID">grid.89336.37</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koonthalloor</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Beaumont Hospital, Dublin, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0617 6058</Identifier><Identifier Source="GRID">grid.414315.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beaumont Hospital, Dublin, Ireland </Affiliation><Identifier Source="ISNI">0000 0004 0617 6058</Identifier><Identifier Source="GRID">grid.414315.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webber</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley teaching hospitals, Liverpool, UK </Affiliation><Identifier Source="GRID">grid.430747.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashe</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley teaching hospitals, Liverpool, UK </Affiliation><Identifier Source="GRID">grid.430747.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley teaching hospitals, Liverpool, UK </Affiliation><Identifier Source="GRID">grid.430747.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeanrenaud</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Helens and Knowsley teaching hospitals, Liverpool, UK </Affiliation><Identifier Source="GRID">grid.430747.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marudi</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baroni</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragusa</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertellini</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Nuovo Ospedale Civile Sant&#x2019;Agostino Estense, Modena, Italy </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volakli</LastName><ForeName>E. A.</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chochliourou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimitriadou</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Violaki</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mantzafleri</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samkinidou</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrani</LastName><ForeName>O.</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arbouti</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varsami</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sdougka</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>PICU, Hippokration General Hospital, Thessaloniki, Greece </Affiliation><Identifier Source="ISNI">0000 0004 0621 2899</Identifier><Identifier Source="GRID">grid.414122.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bollen</LastName><ForeName>J. A.</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Smaalen</LastName><ForeName>T. C.</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Jongh</LastName><ForeName>W. C.</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ten Hoopen</LastName><ForeName>M. M.</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Maastricht University, Maastricht, Netherlands </Affiliation><Identifier Source="ISNI">0000 0001 0481 6099</Identifier><Identifier Source="GRID">grid.5012.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ysebaert</LastName><ForeName>D.</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University Hospital Antwerp, Edegem, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3418</Identifier><Identifier Source="GRID">grid.411414.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Heurn</LastName><ForeName>L. W.</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, Netherlands </Affiliation><Identifier Source="ISNI">0000000404654431</Identifier><Identifier Source="GRID">grid.5650.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Mook</LastName><ForeName>W. N.</ForeName><Initials>WN</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center, Maastricht, Netherlands </Affiliation><Identifier Source="GRID">grid.412966.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>K.</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>St Helens and Knoowsley, Prescot, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Helens and Knoowsley, Prescot, UK </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roze des Ordons</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 7697</Identifier><Identifier Source="GRID">grid.22072.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couillard</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 7697</Identifier><Identifier Source="GRID">grid.22072.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Calgary, Calgary, Canada </Affiliation><Identifier Source="ISNI">0000 0004 1936 7697</Identifier><Identifier Source="GRID">grid.22072.35</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Keer</LastName><ForeName>R. V.</ForeName><Initials>RV</Initials><AffiliationInfo><Affiliation>Vrije Universiteit Brussel, Brussel, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2290 8069</Identifier><Identifier Source="GRID">grid.8767.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deschepper</LastName><ForeName>R. D.</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Vrije Universiteit Brussel, Brussel, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2290 8069</Identifier><Identifier Source="GRID">grid.8767.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francke</LastName><ForeName>A. F.</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>EMGO+/VU University medical center, Utrecht, Netherlands </Affiliation><Identifier Source="ISNI">0000000090126352</Identifier><Identifier Source="GRID">grid.7692.a</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huyghens</LastName><ForeName>L. H.</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Universitair Ziekenhuis Brussel, Brussel, Belgium </Affiliation><Identifier Source="ISNI">0000 0004 0626 3362</Identifier><Identifier Source="GRID">grid.411326.3</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilsen</LastName><ForeName>J. B.</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Vrije Universiteit Brussel, Brussel, Belgium </Affiliation><Identifier Source="ISNI">0000 0001 2290 8069</Identifier><Identifier Source="GRID">grid.8767.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyamaizi</LastName><ForeName>B.</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalrymple</LastName><ForeName>C.</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Queen Elizabeth Hospital, London, UK </Affiliation><Identifier Source="GRID">grid.439484.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molokhia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobru</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Hospital Lewisham, London, UK </Affiliation><Identifier Source="GRID">grid.439787.6</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marrinan</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Lewisham &amp; Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ankuli</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham &amp; Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molokhia</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lewisham &amp; Greenwich NHS Trust, London, UK </Affiliation><Identifier Source="GRID">grid.429537.e</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McPeake</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Glasgow, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2193 314X</Identifier><Identifier Source="GRID">grid.8756.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struthers</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawford</LastName><ForeName>R.</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>H.</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mactavish</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>NHS Greater Glasgow and Clyde, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 0523 9342</Identifier><Identifier Source="GRID">grid.413301.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quasim</LastName><ForeName>T.</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Glasgow, Glasgow, UK </Affiliation><Identifier Source="ISNI">0000 0001 2193 314X</Identifier><Identifier Source="GRID">grid.8756.c</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>P.</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Burn Unit, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Degiovanangelo</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Burn Unit, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemos</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Burn Unit, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MArtinez</LastName><ForeName>V.</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verga</LastName><ForeName>F.</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Burn Unit, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>J.</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Burn Unit, Montevideo, Uruguay </Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burghi</LastName><ForeName>G.</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Maciel, Montevideo, Uruguay </Affiliation><Identifier Source="GRID">grid.414794.b</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutten</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>St Elisabeth Ziekenhuis, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Ieperen</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Elisabeth Ziekenhuis, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Geer</LastName><ForeName>S.</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>St Elisabeth Ziekenhuis, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Vugt</LastName><ForeName>M.</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>St Elisabeth Ziekenhuis, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Der Kinderen</LastName><ForeName>E.</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>St Elisabeth Ziekenhuis, Tilburg, Netherlands </Affiliation><Identifier Source="GRID">grid.416373.4</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannini</LastName><ForeName>A.</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda - Ospedale maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miccinesi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Istituto per lo Studio e la Prevenzione Oncologica, Florence, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1758 0566</Identifier><Identifier Source="GRID">grid.417623.5</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchesi</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda - Ospedale maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prandi</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondazione IRCCS Ca&#x2019; Granda - Ospedale maggiore Policlinico, Milan, Italy </Affiliation><Identifier Source="ISNI">0000 0004 1757 8749</Identifier><Identifier Source="GRID">grid.414818.0</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Crit Care. 2016 Oct 24;20:347. doi: 10.1186/s13054-016-1358-6.</RefSource><PMID Version="1">31268434</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27885969</ArticleId><ArticleId IdType="pmc">PMC5493079</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1208-6</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1208-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40162941</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-3597</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>16</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Early Intra-Aortic Balloon Support for Heart Failure-Related Cardiogenic Shock: A Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1587</StartPage><EndPage>1597</EndPage><MedlinePgn>1587-1597</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacc.2025.03.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-1097(25)05334-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The impact of intra-aortic balloon pump (IABP) on survival and successful bridging to heart replacement therapies (HRT) in patients with heart failure-cardiogenic shock (HF-CS) remains unclear.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to evaluate the effect of early IABP use vs standard care on 60-day survival or successful bridging to HRT.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In the multicenter, prospective Altshock-2 (Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart&#xa0;Failure Complicated by Cardiogenic Shock), patients with Society for Cardiovascular Angiography and Interventions stage B, C, or D HF-CS and suitable for HRT were randomized to receive early IABP plus standard care (IABP group) or standard care (control group). The primary endpoint was survival or successful bridge to HRT at 60&#xa0;days. Secondary endpoints included overall survival, maximum inotropic score, and maximum sequential organ failure assessment score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 53 patients were randomized to IABP and 48 to standard care. Patients were Society for Cardiovascular Angiography and Interventions stage B (28%, n&#xa0;=&#xa0;28), C (57%, n&#xa0;=&#xa0;56), and D (15%, n&#xa0;=&#xa0;16). At the prespecified interim analysis, the trial was stopped because of futility. The primary endpoint was reached in 43 patients (81%) in the IABP group and 36 patients (75%) in the control group (HR: 0.72; 95%&#xa0;CI: 0.31-1.68; P&#xa0;=&#xa0;0.45). A total of 37 patients (37%) underwent HRT within the 60-day follow-up. Four patients were escalated in the study group (7.5%) vs 2 in the control group (4.2%). Additionally, 6 patients (13%) initially assigned to standard care crossed over to IABP. Complications were comparable between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Routine early IABP plus standard care, compared with standard care, did not significantly improve survival or successful bridging to HRT in patients with HF-CS. (Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart&#xa0;Failure Complicated by Cardiogenic Shock [Altshock-2]; NCT04369573).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morici</LastName><ForeName>Nuccia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Don Gnocchi, ONLUS, Santa Maria Nascente, Milan, Italy. Electronic address: nmorici@dongnocchi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frea</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rota</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Units of Biostatistics and Biomathematics and Bioinformatics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanova</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravinese</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dini</LastName><ForeName>Carlotta Sorini</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ettore</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Anesthesia and Intensive Care, AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maj</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Anesthesia and Intensive Care, AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lio</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potena</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit-IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Serafina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatino</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Heart Failure and Transplant Unit-IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garatti</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavecchia</LastName><ForeName>Giovanni Amedeo</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoldi</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapur</LastName><ForeName>Navin K</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Cardiovascular Medicine Section, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical-Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy; Anesthesia and Intensive Care, Fondazione Policlinico San Matteo Hospital IRCCS, Anestesia e Rianimazione I, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ferrari</LastName><ForeName>Gaetano Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, "Citta della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Kore University, Enna and Centro Cuore GB Morgagni, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Altshock-2 Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04369573</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007423" MajorTopicYN="Y">Intra-Aortic Balloon Pumping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">heart failure-cardiogenic shock</Keyword><Keyword MajorTopicYN="N">heart replacement therapies</Keyword><Keyword MajorTopicYN="N">intra-aortic balloon pump</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures The trial was supported by an unrestricted grant provided by Getinge Global US. Representatives of the funders did not take part in the trial design and did not participate in the analysis or interpretation of data or in the writing of the paper. Dr Kapur has been appointed as Global Chief Medical and scientific officer at Johnson and Johnson MedTech, Heart Recovery; has received institutional research grants from Abbott, Abiomed, Boston Scientific, Getinge, LivaNova, and Teleflex; and has received consulting/speaking honoraria from Abbott, Abiomed, Boston Scientific, Getinge, LivaNova, Teleflex, Zoll, and Edwards. Dr Pappalardo is a consultant for Abiomed and Carmat. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>10</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40162941</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2025.03.003</ArticleId><ArticleId IdType="pii">S0735-1097(25)05334-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36940708</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-1902</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Thoracic and cardiovascular surgeon</Title><ISOAbbreviation>Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Extracorporeal Membrane Oxygenation in Intoxication and Overdoses: A Systematic Review.</ArticleTitle><Pagination><StartPage>288</StartPage><EndPage>295</EndPage><MedlinePgn>288-295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0043-1764160</ELocationID><Abstract><AbstractText>Extracorporeal membrane oxygenation (ECMO) has been increasingly applied over recent decades to treat severe cardiogenic shock and acute lung failure and cardiac arrest of various causes. Acute intoxication with therapeutic substances or other chemical substances can cause severe cardiogenic shock or even cardiac arrest. The purpose of this study was to conduct a qualitative systematic review of ECMO use in intoxication and poisoning. We searched the PubMed, Medline, and Web of Science databases from January 1971 to December 2021 and selected appropriate studies according to our inclusion and exclusion criteria to evaluate the role of ECMO in intoxication and poisoning systematically. Survival at hospital discharge was examined to describe the outcome. The search resulted in 365 publications after removing duplicates. In total, 190 full-text articles were assessed for eligibility. A total of 145 articles from 1985 to 2021 were examined in our final qualitative analysis. A total of 539 (100%) patients were included (mean age: 30.9&#x2009;&#xb1;&#x2009;16.6 years), with a distribution of <i>n</i>&#x2009;=&#x2009;64 (11.9%) cases with venovenous (vv) ECMO, <i>n</i>&#x2009;=&#x2009;218 (40.4%) cases with venoarterial (va) ECMO, and <i>n</i>&#x2009;=&#x2009;257 (47.7%) cases with cardiac arrest and extracorporeal cardiopulmonary resuscitation. Survival at hospital discharge was 61.0% for all patients, 68.8% for vaECMO, 75% for vvECMO, and 50.9% for extracorporeal cardiopulmonary resuscitation. When used and reported, ECMO seems to be a valid tool for adult and pediatric patients suffering intoxication from various pharmaceutical and nonpharmaceutical substances due to a high survival rate at hospital discharge.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Sven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4118-948X</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;sner</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saemann</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University Hospital Halle, Halle, Sachsen-Anhalt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sogl</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyersdorf</LastName><ForeName>Friedhelm</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trummer</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czerny</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benk</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Medical Center-University of Freiburg, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Freiburg Faculty of Medicine, Freiburg, Baden-W&#xfc;rttemberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>7903387</NlmUniqueID><ISSNLinking>0171-6425</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062787" MajorTopicYN="Y">Drug Overdose</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011041" MajorTopicYN="N">Poisoning</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>F.B., C.B. and G.T. are shareholders of ResuSciTec GmbH, Freiburg, Germany. C.B. and G.T. are part-time employees of ResuSciTec GmbH, Freiburg, Germany. The other authors report no conflict of interest regarding this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>19</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36940708</ArticleId><ArticleId IdType="doi">10.1055/s-0043-1764160</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39506714</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC pregnancy and childbirth</Title><ISOAbbreviation>BMC Pregnancy Childbirth</ISOAbbreviation></Journal><ArticleTitle>Outcomes of peripartum cardiomyopathy in North Africa: insights from a single-center observational study in Tunisia.</ArticleTitle><Pagination><StartPage>722</StartPage><MedlinePgn>722</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">722</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12884-024-06911-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Peripartum cardiomyopathy (PPCM) is a rare but potentially life-threatening condition. Due to the scarcity of epidemiological data in North Africa, we conducted this study to assess the outcomes of PPCM in our region.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This monocentric retrospective cohort study involving all patients diagnosed with PPCM was conducted between January 2010 and December 2022.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-seven PPCM patients, with a median age of 33 years (Interquartile range (IQR)&#x2009;=&#x2009;9), were included. 52% of patients were diagnosed during the postpartum period. Dyspnea New York Heart Association III/IV(NYHA III/IV) was the most common functional symptom (85%). The median left ventricle ejection fraction (LVEF) was 30% (IQR&#x2009;=&#x2009;11%). Atrial fibrillation occurred in 11.1% of patients, thromboembolic complications occurred in 18.5%, Pulmonary edema occurred in 85% of patients and cardiogenic shock occurred in 14.8% of patients, with two patients requiring Extracorporeal Membrane Oxygenation (ECMO) support. The predominant mode of delivery was a cesarean Sect.&#xa0;(82% of patients), and the indication for a cesarean delivery was obstetrical in 59% of patients. Prematurity occurred in 36% of newborns, and intrauterine fetal death occurred in one pregnancy. The median follow-up was 24 months [6-144 months]. LVEF recovery was noted in 67% of patients. Bromocriptine was administered to six patients (22%), and none of these patients died and out of them, five patients recovered their LVEF (83%). The overall mortality rate during the follow-up period was 15%, comprising three in-hospital cardiac deaths and one occurring two years later due to refractory advanced heart failure. No significant differences were observed between LVEF recovery and LVEF non-recovery groups. Factors significantly associated with mortality were multiparity, poor antenatal care (ANC) attendance, thromboembolic events, cardiogenic shock, and Pulmonary edema. Five patients with LV recovery subsequently became pregnant, none experienced a relapse of PPCM. However, one of the descendants of a patient was diagnosed with dilated cardiomyopathy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study revealed that the diagnosis of PPCM in our hospital is often delayed until symptoms become more advanced, resulting in high morbi-mortality.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hammami</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, Slim Chaker University Hospital, University of Sfax, Sfax, Tunisia. raniahammami@yahoo.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelhedi</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khanfir</LastName><ForeName>Fatma</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahlaq</LastName><ForeName>Raeesah Sohawon Oumm&#xe9;e</ForeName><Initials>RSO</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargouri</LastName><ForeName>Rania</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, Slim Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medecine,, Hedi Chaker Hospital, University of Sfax, sfax, Tunisie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abid</LastName><ForeName>Leila</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medecine,, Hedi Chaker Hospital, University of Sfax, sfax, Tunisie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elleuch</LastName><ForeName>Sahar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oueslati</LastName><ForeName>Mootez Billah</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Tunisian Ministry of Health, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Hassen IbnHadj</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Faculty of Medicine, Taher Sfar Hospital, University of Monastir, Mahdia, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derbel</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dammak</LastName><ForeName>Aymen</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Faculty of Medicine, Habib Bourguiba University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Safi</LastName><ForeName>Faiza</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Paediatric Intensive Care Unit, Hedi Chaker University Hospital, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaabene</LastName><ForeName>Kais</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, Faculty of Medicine, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pregnancy Childbirth</MedlineTA><NlmUniqueID>100967799</NlmUniqueID><ISSNLinking>1471-2393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058725" MajorTopicYN="Y">Peripartum Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014416" MajorTopicYN="N" Type="Geographic">Tunisia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="Y">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002585" MajorTopicYN="N">Cesarean Section</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011654" MajorTopicYN="N">Pulmonary Edema</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011644" MajorTopicYN="N">Puerperal Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pregnancy</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>4</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>12</Day><Hour>4</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>7</Day><Hour>4</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39506714</ArticleId><ArticleId IdType="pmc">PMC11542243</ArticleId><ArticleId IdType="doi">10.1186/s12884-024-06911-3</ArticleId><ArticleId IdType="pii">10.1186/s12884-024-06911-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sliwa K, Bauersachs J, Arany Z, Spracklen TF, Hilfiker-Kleiner D. Peripartum cardiomyopathy: from genetics to management. Eur Heart J. 2021;42(32):3094&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">34322694</ArticleId></ArticleIdList></Reference><Reference><Citation>MEADOWS WR. Idiopathic myocardial failure in the last trimester of pregnancy and the puerperium. Circulation. 1957;15(6):903&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">13437416</ArticleId></ArticleIdList></Reference><Reference><Citation>Demakis JG, Rahimtoola SH, Sutton GC, Meadows WR, Szanto PB, Tobin JR, et al. Natural course of peripartum cardiomyopathy. Circulation. 1971;44(6):1053&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">4256828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolakale-Rufai IK, Knapp SM, Johnson AE, Brewer LP, Mohammed S, Addison D et al. Association between Race, Cardiology Care, and the receipt of Guideline-Directed Medical Therapy in Peripartum Cardiomyopathy. J Racial Ethn Heal Disparities. 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11035491</ArticleId><ArticleId IdType="pubmed">37870730</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejim EC, Karaye KM, Antia S, Isiguzo GC, Njoku PO. Peripartum cardiomyopathy in low- and middle-income countries. Best Practice and Research. Volume 93. Clinical Obstetrics and Gynaecology. Bailliere Tindall Ltd; 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38395024</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliwa K, van der Meer P, Viljoen C, Jackson AM, Petrie MC, Mebazaa A, et al. Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: a study of the ESC EORP PPCM registry. Int J Cardiol. 2024;398:131596.</Citation><ArticleIdList><ArticleId IdType="pubmed">37979788</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Morales-Lara AC, Dugan J, Garzon-Siatoya WT, Yao X, Johnson PW, et al. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): clinical trial rationale and design. Am Heart J. 2023;261:64&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">36966922</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AM, Bauersachs J, Petrie MC, van der Meer P, Laroche C, Farhan HA, et al. Outcomes at one year in women with peripartum cardiomyopathy: findings from the ESC EORP PPCM Registry. Eur J Heart Fail. 2024;26(1):34&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">37823238</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliwa K, Petrie MC, Van Der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM, et al. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):3787&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846090</ArticleId><ArticleId IdType="pubmed">32840318</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AM, Goland S, Farhan HA, Yaseen IF, Prameswari HS, B&#xf6;hm M et al. A novel score to predict left ventricular recovery in peripartum cardiomyopathy derived from the ESC EORP Peripartum Cardiomyopathy Registry. Eur Heart J. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11032708</ArticleId><ArticleId IdType="pubmed">38282532</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp J, Jackson AM, Abdelhamid M, Fouad D, Youssef G, Petrie MC, et al. Thromboembolic events in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. Eur J Heart Fail. 2023;25(8):1464&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">37092321</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakrishnan A, Dokko J, Pastena P, Kalogeropoulos AP. Thromboembolism in peripartum cardiomyopathy: a systematic review. J Thorac Dis. 2024;16(1):645&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10894371</ArticleId><ArticleId IdType="pubmed">38410599</ArticleId></ArticleIdList></Reference><Reference><Citation>Monda E, Limongelli G. Thromboembolic events in peripartum cardiomyopathy: current dilemmas and future perspectives. Eur J Heart Fail. 2023;25(8):1467&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37323088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludhwani D, Chobufo MD, Gonuguntla K, Shaik A, Sattar Y, Foryoung JB, et al. Mortality due to Peripartum Cardiomyopathy in the United States. Current Problems in Cardiology. Volume 48. Elsevier Inc.; 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">37392978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardissino M, Halliday BP, de Marvao A. The global landscape of peripartum cardiomyopathy: morbidity, mortality, recovery and inequity. European Journal of Heart Failure. Volume 26. John Wiley and Sons Ltd; 2024. pp. 43&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">38013247</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Zhao L, Fu H, Xu R, Xie L, Zhang K, et al. Prognostic value of Cardiac MRI Late Gadolinium Enhancement in patients with Peripartum Cardiomyopathy: a retrospective study. Curr Probl Cardiol. 2023;48(4):101587.</Citation><ArticleIdList><ArticleId IdType="pubmed">36634831</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkayam U. Safety of subsequent pregnancy after recovery from Peripartum Cardiomyopathy. J Am Coll Cardiol. 2023;82(1):27&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37380300</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic C, Schaufelberger M. Peripartum cardiomyopathy: the challenge of predicting cardiac function recovery. Eur Heart J. 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">38442138</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangw&#xe9; Temoua N, Bamouni J, Mandi DG, Kabor&#xe9; E, Allawaye L, Langtar MH, et al. Left ventricular recovery in an African cohort of patients with peripartum cardiomyopathy. Pan Afr Med J. 2024;47:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10870155</ArticleId><ArticleId IdType="pubmed">38371651</ArticleId></ArticleIdList></Reference><Reference><Citation>Prameswari HS, Iswandi CP, Hasan M, Martanto E, Putra ICS, Kamarullah W et al. Predicting poor left ventricular function recovery in Peripartum cardiomyopathy. J Matern Neonatal Med. 2023;36(2).</Citation><ArticleIdList><ArticleId IdType="pubmed">37935592</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi M, Almaghraby A, Abdelgawad H, Saleh Y. Socioeconomic disparities in peripartum cardiomyopathy. Eur Heart J. 2023;44(30):2795&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">37313596</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaye KM, Ishaq NA, Sa&#x2019;idu H, Balarabe SA, Talle MA, Isa MS, et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE Registry. ESC Hear Fail. 2020;7(1):235&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083508</ArticleId><ArticleId IdType="pubmed">31990449</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaye KM, Sa&#x2019;idu H, Ishaq NA, Balarabe SA, Ahmed BG, Mohammed IY, Habib AG, Henein MY. Peripartum Cardiomyopathy in Nigeria (PEACE) Registry investigators. Selenium Deficiency as a risk factor for Peripartum Cardiomyopathy. West Afr J Med. 2024;41(2):209&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">38583094</ArticleId></ArticleIdList></Reference><Reference><Citation>Isogai T, Kamiya CA. Worldwide incidence of peripartum cardiomyopathy and overall maternal mortality. Int Heart J. 2019;60(3):503&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">31019181</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany Z, Peripartum Cardiomyopathy. Leopold JA, editors. N Engl J Med. 2024;390(2):154&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">38197818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiya CA, Kitakaze M, Ishibashi-Ueda H, Nakatani S, Murohara T, Tomoike H, et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-. Circ J. 2011;75(8):1975&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21617320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AM, Petrie MC, Frogoudaki A, Laroche C, Gustafsson F, Ibrahim B, et al. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry. Eur J Heart Fail. 2021;23(12):2058&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9311416</ArticleId><ArticleId IdType="pubmed">34114268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bala R, Mehta S, Roy VC, Kaur G, de Marvao A. Peripartum cardiomyopathy: a review. Rev Port Cardiol. 2023;42(11):917&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">37414337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D. Peripartum cardiomyopathy: Basic mechanisms and hope for new therapies. Cardiovasc Res. 2020;116(3):520&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">31605117</ArticleId></ArticleIdList></Reference><Reference><Citation>Badianyama M, Das PK, Gaddameedi SR, Saukhla S, Nagammagari T, Bandari V et al. A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy. Cureus. 2024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8475739</ArticleId><ArticleId IdType="pubmed">34603902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay-Gravel M, Marquis-Gravel G, Avram R, Desplantie O, Ducharme A, Bibas L, et al. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study. ESC Hear Fail. 2019;6(1):27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351886</ArticleId><ArticleId IdType="pubmed">30565890</ArticleId></ArticleIdList></Reference><Reference><Citation>Trongtorsak A, Kittipibul V, Mahabir S, Ibrahim M, Saint Croix GR, Hernandez GA, et al. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis. Heart Fail Rev. 2022;27(2):533&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">34725781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Ravi R, Sivakumar RK, Chidambaram V, Majella MG, Sinha S et al. Prolactin inhibition in Peripartum Cardiomyopathy: systematic review and Meta-analysis. Curr Probl Cardiol. 2023;48(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9805509</ArticleId><ArticleId IdType="pubmed">36261102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauersachs J, K&#xf6;nig T, van der Meer P, Petrie MC, Hilfiker-Kleiner D, Mbakwem A, et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2019;21(7):827&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">31243866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoevelmann J, Muller E, Azibani F, Kraus S, Cirota J, Briton O, et al. Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM). Clin Res Cardiol. 2021;110(8):1259&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318939</ArticleId><ArticleId IdType="pubmed">33555408</ArticleId></ArticleIdList></Reference><Reference><Citation>Safira A, Tjahjadi AK, Adytia GJ, Waitupu A, Sutanto H. Peripartum cardiomyopathy unveiled: etiology, diagnosis, and therapeutic insights. Curr Probl Cardiol. 2024;49(5).</Citation><ArticleIdList><ArticleId IdType="pubmed">38395115</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, et al. Clinical outcomes for Peripartum Cardiomyopathy in North America: results of the IPAC Study (investigations of pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015;66(8):905&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5645077</ArticleId><ArticleId IdType="pubmed">26293760</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulig V, Pfeffer TJ, Ricke-Hoch M, Schlothauer S, Koenig T, Schwab J, et al. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities. Eur J Heart Fail. 2019;21(12):1534&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">31724271</ArticleId></ArticleIdList></Reference><Reference><Citation>Koziol KJ, Aronow WS. Peripartum Cardiomyopathy: current understanding of Pathophysiology, Diagnostic Workup, Management, and outcomes. Curr Probl Cardiol. 2023;48(8).</Citation><ArticleIdList><ArticleId IdType="pubmed">36972860</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaye KM, Ishaq NA, Sai&#x2019;du H, Balarabe SA, Ahmed BG, Adamu UG, et al. Disparities in clinical features and outcomes of peripartum cardiomyopathy in high versus low prevalent regions in Nigeria. ESC Hear Fail. 2021;8(4):3257&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8318483</ArticleId><ArticleId IdType="pubmed">34137499</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner SF, Brodie D, Burrell A, Taccone FS, Broman LM, Shekar K, et al. Extracorporeal membrane oxygenation during pregnancy and peripartal. An international retrospective multicenter study. Perfus (United Kingdom). 2023;38(5):966&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10265280</ArticleId><ArticleId IdType="pubmed">35549557</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham FG, Byrne JJ, Nelson DB. Peripartum Cardiomyopathy. Obstet Gynecol. 2019;133(1):167&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">30575651</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Riyami N, Al Khayari S, Al Zadjali R, Machado L, Al Madhani A, Al Lawati H, Incidence. Risk factors, maternal and neonatal outcomes of Peripartum Cardiomyopathy (PPCM) in Oman. Glob Heart. 2023;18(1).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10162354</ArticleId><ArticleId IdType="pubmed">37153846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee KH. Favourable outcome after peripartum cardiomyopathy: a ten-year study on peripartum cardiomyopathy in a university hospital. Singap Med J. 2013;54(1):28&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">23338913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijayanto MA, Myrtha R, Lukas GA, Rahma AA, Hanifa SN, Zahira HA, et al. Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis. Open Hear. 2024;11(1):e002626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10989162</ArticleId><ArticleId IdType="pubmed">38569669</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37386548</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2731-3786</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of anesthesia, analgesia and critical care</Title><ISOAbbreviation>J Anesth Analg Crit Care</ISOAbbreviation></Journal><ArticleTitle>Cardiac complications in patients with COVID-19: a systematic review.</ArticleTitle><Pagination><StartPage>18</StartPage><MedlinePgn>18</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">18</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s44158-022-00046-7</ELocationID><Abstract><AbstractText>Cardiac complications in patients with COVID-19 have been described in the literature with an important impact on outcome. The primary objective of our systematic review was to describe the kind of cardiac complications observed in COVID-19 patients and to identify potential predictors of cardiovascular events. The secondary aim was to analyze the effect of cardiac complications on outcome.We performed this systematic review according to PRISMA guidelines using several databases for studies evaluating the type of cardiac complications and risk factors in COVID-19 patients. We also calculated the risk ratio (RR) and 95% CI. A random-effects model was applied to analyze the data. The heterogeneity of the retrieved trials was evaluated through the I<sup>2</sup> statistic. Our systematic review included 49 studies. Acute cardiac injury was evaluated in 20 articles. Heart failure and cardiogenic shock were reported in 10 articles. Myocardial infarction was evaluated in seven of the papers retrieved. Takotsubo, myocarditis, and pericardial effusion were reported in six, twelve, and five articles, respectively. Arrhythmic complications were evaluated in thirteen studies. Right ventricular dysfunction was evaluated in six articles. We included 7 studies investigating 2115 patients in the meta-analysis. The RR was 0.20 (95% CI: 0.17 to 0.24; P &lt; 0.00001, I<sup>2</sup> = 0.75). Acute cardiac injury represented the prevalent cardiac complications observed in COVID-19 patients (from 20 to 45% of the patients). Patients with acute cardiac injury seemed to be significantly older, with comorbidities, more likely to develop complications, and with higher mortality rates. Acute cardiac injury was found to be an independent risk factor for severe forms of SARS-CoV-2 infection and an independent predictor of mortality. Due to the scarce evidence, it was not possible to draw any conclusion regarding Takotsubo, myocarditis, pleural effusion, and right ventricular dysfunction in COVID-19 patients. Noteworthy, possible arrhythmic alterations (incidence rate of arrhythmia from 3 to 60%) in COVID-19 patients have to be taken into account for the possible complications and the consequent hemodynamic instabilities. Hypertension seemed to represent the most common comorbidities in COVID-19 patients (from 30 to 59.8%). The prevalence of cardiovascular disease (CVD) was high in this group of patients (up to 57%), with coronary artery disease in around 10% of the cases. In the majority of the studies retrieved, patients with CVD had a higher prevalence of severe form, ICU admission, and higher mortality rates.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brogi</LastName><ForeName>E</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9010-7941</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Via Paradisa 2, 56124, Pisa, Italy. etruscabrogi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marino</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency-Covid Intensive Care, Azienda Ospedaliera Universitaria di Bologna - Policlinico "S. Orsola Malpighi", Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertini</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Azienda Ospedaliero Universitaria Pisana, Via Roma n&#xb0; 67, 56126, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical-Surgical, Diagnostic and pediatric Sciences, University of Pavia, Via Alessandro Brambilla, 74, 27100, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Fondazione Policlinico San Matteo IRCCS, Viale Camillo Golgi, 19, 27100, Pavia, PV, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Ente Ospedaliero Ospedali Galliera, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forfori</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Anesth Analg Crit Care</MedlineTA><NlmUniqueID>9918591885906676</NlmUniqueID><ISSNLinking>2731-3786</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute cardiac injury</Keyword><Keyword MajorTopicYN="N">Acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">Acute myocardial injury</Keyword><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Cardiac complications</Keyword><Keyword MajorTopicYN="N">Coronavirus</Keyword><Keyword MajorTopicYN="N">Coronavirus infection</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37386548</ArticleId><ArticleId IdType="pmc">PMC9043888</ArticleId><ArticleId IdType="doi">10.1186/s44158-022-00046-7</ArticleId><ArticleId IdType="pii">10.1186/s44158-022-00046-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo E, Brogi E, Gamberini E, Agnoletti V. COVID-19: a clinical and organizational crisis. Intern Emerg Med. 2020;15:897&#x2013;899. doi: 10.1007/s11739-020-02410-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02410-3</ArticleId><ArticleId IdType="pmc">PMC7309684</ArticleId><ArticleId IdType="pubmed">32577909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolondi G, Russo E, Gamberini E, Circelli A, Meca MCC, Brogi E, Viola L, Bissoni L, Poletti V, Agnoletti V. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study. World J Emerg Surg. 2020;15(1):41. doi: 10.1186/s13017-020-00323-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13017-020-00323-2</ArticleId><ArticleId IdType="pmc">PMC7324776</ArticleId><ArticleId IdType="pubmed">32605582</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiacchini G, Tric&#xf2; D, Ribechini A, Forfori F, Brogi E, Lucchi M, Berrettini S, Bertini P, Guarracino F, Bruschini L. Evaluation of the incidence and potential mechanisms of tracheal complications in patients with COVID-19. JAMA Otolaryngol Head Neck Surg. 2021;147(1):70&#x2013;76. doi: 10.1001/jamaoto.2020.4148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.4148</ArticleId><ArticleId IdType="pmc">PMC7677875</ArticleId><ArticleId IdType="pubmed">33211087</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertini P, Forfori F, Bruschini L, Corradi F, Ribechini A, Brogi E, Guarracino F. Percutaneous tracheostomy in COVID-19 critically ill patients: experience from 30 consecutive procedures. Int Arch Otorhinolaryngol. 2021;25(1):e135&#x2013;e140. doi: 10.1055/s-0040-1718528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1718528</ArticleId><ArticleId IdType="pmc">PMC7851370</ArticleId><ArticleId IdType="pubmed">33552294</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, Sultan M, Easton A, Breen G, Zandi M, Coles JP, Manji H, al-Shahi Salman R, Menon DK, Nicholson TR, Benjamin LA, Carson A, Smith C, Turner MR, Solomon T, Kneen R, Pett SL, Galea I, Thomas RH, Michael BD, Allen C, Archibald N, Arkell J, Arthur-Farraj P, Baker M, Ball H, Bradley-Barker V, Brown Z, Bruno S, Carey L, Carswell C, Chakrabarti A, Choulerton J, Daher M, Davies R, di Marco Barros R, Dima S, Dunley R, Dutta D, Ellis R, Everitt A, Fady J, Fearon P, Fisniku L, Gbinigie I, Gemski A, Gillies E, Gkrania-Klotsas E, Grigg J, Hamdalla H, Hubbett J, Hunter N, Huys AC, Ihmoda I, Ispoglou S, Jha A, Joussi R, Kalladka D, Khalifeh H, Kooij S, Kumar G, Kyaw S, Li L, Littleton E, Macleod M, Macleod MJ, Madigan B, Mahadasa V, Manoharan M, Marigold R, Marks I, Matthews P, Mccormick M, Mcinnes C, Metastasio A, Milburn-McNulty P, Mitchell C, Mitchell D, Morgans C, Morris H, Morrow J, Mubarak Mohamed A, Mulvenna P, Murphy L, Namushi R, Newman E, Phillips W, Pinto A, Price DA, Proschel H, Quinn T, Ramsey D, Roffe C, Ross Russell A, Samarasekera N, Sawcer S, Sayed W, Sekaran L, Serra-Mestres J, Snowdon V, Strike G, Sun J, Tang C, Vrana M, Wade R, Wharton C, Wiblin L, Boubriak I, Herman K, Plant G. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatr. 2020;7(10):875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Avila J, Long B, Holladay D, Gottlieb M. Thrombotic complications of COVID-19. Am J Emerg Med. 2021;39:213&#x2013;218. doi: 10.1016/j.ajem.2020.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.09.065</ArticleId><ArticleId IdType="pmc">PMC7528743</ArticleId><ArticleId IdType="pubmed">33036855</ArticleId></ArticleIdList></Reference><Reference><Citation>Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci. 2020;253:117723. doi: 10.1016/j.lfs.2020.117723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117723</ArticleId><ArticleId IdType="pmc">PMC7194533</ArticleId><ArticleId IdType="pubmed">32360126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, G&#xf8;tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi: 10.1371/journal.pmed.1000100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1000100</ArticleId><ArticleId IdType="pmc">PMC2707010</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaratunga EA, Corwin DS, Moran L, Snyder R (2020) Bradycardia in patients with COVID-19: a calm before the storm? Cureus 12(6):e8599. 10.7759/cureus.8599</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294893</ArticleId><ArticleId IdType="pubmed">32550090</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama. 2020;323(16):1612&#x2013;1614. doi: 10.1001/jama.2020.4326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4326</ArticleId><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, Ibrahim H, Friedman GH, Thompson C, Alviar CL, et al. ST-segment elevation in patients with Covid-19 - a case series. N Engl J Med. 2020;482:2478&#x2013;2480. doi: 10.1056/NEJMc2009020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009020</ArticleId><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol. 2020;153(6):725&#x2013;733. doi: 10.1093/ajcp/aqaa062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/aqaa062</ArticleId><ArticleId IdType="pmc">PMC7184436</ArticleId><ArticleId IdType="pubmed">32275742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Hu X, Cheng W, Yu L, Tu WJ, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intens Care Med. 2020;46:851&#x2013;853. doi: 10.1007/s00134-020-05987-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05987-7</ArticleId><ArticleId IdType="pmc">PMC7079866</ArticleId><ArticleId IdType="pubmed">32123993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Xu L, Dai Y, Ling Y, Mao J, Qian J, Zhu W, Di W, Ge J. Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol. 2020;43(7):796&#x2013;802. doi: 10.1002/clc.23384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23384</ArticleId><ArticleId IdType="pmc">PMC7323347</ArticleId><ArticleId IdType="pubmed">32562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, Ma K, Xu D, Yu H, Wang H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj. 2020;368:m1091. doi: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabbagh MF, Aurora L, D'Souza P, Weinmann AJ, Bhargava P, Basir MB. Cardiac tamponade secondary to COVID-19. JACC Case Rep. 2020;2:1326&#x2013;1330. doi: 10.1016/j.jaccas.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7177077</ArticleId><ArticleId IdType="pubmed">32328588</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, Cheng Y, Yan J, Ping H, Zhou Q. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116&#x2013;121. doi: 10.1016/j.ijcard.2020.03.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.03.087</ArticleId><ArticleId IdType="pmc">PMC7141178</ArticleId><ArticleId IdType="pubmed">32291207</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Erquicia P, Dobarro D, Raposeiras-Roub&#xed;n S, Bastos-Fernandez G, I&#xf1;iguez-Romo A. Multivessel coronary thrombosis in a patient with COVID-19 pneumonia. Eur Heart J. 2020;41(22):2132. doi: 10.1093/eurheartj/ehaa393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa393</ArticleId><ArticleId IdType="pmc">PMC7239221</ArticleId><ArticleId IdType="pubmed">32374373</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395(10235):1516. doi: 10.1016/S0140-6736(20)30912-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30912-0</ArticleId><ArticleId IdType="pmc">PMC7180035</ArticleId><ArticleId IdType="pubmed">32334650</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, Wang X, Hu C, Ping R, Hu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372&#x2013;1379. doi: 10.1164/rccm.202003-0543OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0543OC</ArticleId><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Du RH, Liu LM, Yin W, Wang W, Guan LL, Yuan ML, Li YL, Hu Y, Li XY, Sun B, et al. Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann Am Thorac Soc. 2020;17(7):839&#x2013;846. doi: 10.1513/AnnalsATS.202003-225OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202003-225OC</ArticleId><ArticleId IdType="pmc">PMC7328178</ArticleId><ArticleId IdType="pubmed">32255382</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, White A, Salvo GD, Sade LE, Pearce K. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imag. 2020;21(9):949&#x2013;958. doi: 10.1093/ehjci/jeaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):811&#x2013;818. doi: 10.1001/jamacardio.2020.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020;42(2):206. doi: 10.1093/eurheartj/ehaa190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa190</ArticleId><ArticleId IdType="pmc">PMC7184348</ArticleId><ArticleId IdType="pubmed">32176300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain H, Fadel A, Alwaeli H, Guardiola V. Coronavirus (COVID-19) fulminant myopericarditis and acute respiratory distress syndrome (ARDS) in a middle-aged male patient. Cureus. 2020;12(6):e8808. doi: 10.7759/cureus.8808.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8808</ArticleId><ArticleId IdType="pmc">PMC7320646</ArticleId><ArticleId IdType="pubmed">32607304</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(7):819&#x2013;824. doi: 10.1001/jamacardio.2020.1096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HN, Lee JH, Park HS, Yang DH, Jang SY, Bae MH, Cho Y, Chae SC, Lee YH. A case of COVID-19 with acute myocardial infarction and cardiogenic shock. J Korean Med Sci. 2020;35:e258. doi: 10.3346/jkms.2020.35.e258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e258</ArticleId><ArticleId IdType="pmc">PMC7358062</ArticleId><ArticleId IdType="pubmed">32657091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim IC, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41(19):1859. doi: 10.1093/eurheartj/ehaa288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa288</ArticleId><ArticleId IdType="pmc">PMC7184491</ArticleId><ArticleId IdType="pubmed">32282027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunal S, Sharma SM, Sharma SK, Gautam D, Bhatia H, Mahla H, Sharma S, Bhandari S. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart J. 2020;72(6):593&#x2013;598. doi: 10.1016/j.ihj.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7609238</ArticleId><ArticleId IdType="pubmed">33357651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuno T, Takahashi M, Obata R, Maeda T. Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City. Am Heart J. 2020;226:24&#x2013;25. doi: 10.1016/j.ahj.2020.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2020.05.005</ArticleId><ArticleId IdType="pmc">PMC7227573</ArticleId><ArticleId IdType="pubmed">32425197</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer P, Degrauwe S, Van Delden C, Ghadri JR, Templin C. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J. 2020;41(19):1860. doi: 10.1093/eurheartj/ehaa306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa306</ArticleId><ArticleId IdType="pmc">PMC7184501</ArticleId><ArticleId IdType="pubmed">32285915</ArticleId></ArticleIdList></Reference><Reference><Citation>Monmeneu JV, Mafe ED, Soler JA, Perez BV, Caravaca JS, Torres RB, Garc&#xed;a-Gonzalez P, Ortega LH, Lopez-Lereu MP, Maceira AM. Subacute perimyocarditis in a young patient with COVID-19 infection. Eur Heart J Case Rep. 2020;4(FI1):1&#x2013;3. doi: 10.1093/ehjcr/ytaa157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaa157</ArticleId><ArticleId IdType="pmc">PMC7314082</ArticleId><ArticleId IdType="pubmed">33089043</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascariello G, Cimino G, Calvi E, Bernardi N, Grigolato M, Garyfallidis P, Fabbricatore D, Pezzola E, Lombardi CM, Metra M. Cardiogenic shock due to COVID-19-related myocarditis in a 19-year-old autistic patient. J Med Cases. 2020;11(7):207&#x2013;210. doi: 10.14740/jmc3517.</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jmc3517</ArticleId><ArticleId IdType="pmc">PMC8040434</ArticleId><ArticleId IdType="pubmed">33984092</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul JF, Charles P, Richaud C, Caussin C, Diakov C. Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging. 2020;21(7):776. doi: 10.1093/ehjci/jeaa107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa107</ArticleId><ArticleId IdType="pmc">PMC7197601</ArticleId><ArticleId IdType="pubmed">32338706</ArticleId></ArticleIdList></Reference><Reference><Citation>Peigh G, Leya MV, Baman JR, Cantey EP, Knight BP, Flaherty JD. Novel coronavirus 19 (COVID-19) associated sinus node dysfunction: a case series. Eur Heart J Case Rep. 2020;4(FI1):1&#x2013;6. doi: 10.1093/ehjcr/ytaa132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaa132</ArticleId><ArticleId IdType="pmc">PMC7239209</ArticleId><ArticleId IdType="pubmed">33089039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intens Care Med. 2020;46(5):846&#x2013;848. doi: 10.1007/s00134-020-05991-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, De Cobelli F, Tresoldi M, Cappelletti AM, Basso C, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861&#x2013;1862. doi: 10.1093/eurheartj/ehaa286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa286</ArticleId><ArticleId IdType="pmc">PMC7184339</ArticleId><ArticleId IdType="pubmed">32267502</ArticleId></ArticleIdList></Reference><Reference><Citation>Seecheran R, Narayansingh R, Giddings S, Rampaul M, Furlonge K, Abdool K, Bhagwandass N, Seecheran NA. Atrial arrhythmias in a patient presenting with coronavirus disease-2019 (COVID-19) infection. J Investig Med High Impact Case Rep. 2020;8:2324709620925571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218462</ArticleId><ArticleId IdType="pubmed">32370558</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao L, Li X, Zhou Y, Yu Y, Liu Y, Liu M, Zhang R, Zhang H, Wang X, Zhou F. Novel insights into illness progression and risk profiles for mortality in non-survivors of COVID-19. Front Med (Lausanne) 2020;7:246. doi: 10.3389/fmed.2020.00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00246</ArticleId><ArticleId IdType="pmc">PMC7256183</ArticleId><ArticleId IdType="pubmed">32574334</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Cai Y, Liu T, Shen B, Yang F, Cao S, Liu X, Xiang Y, Zhao Q, Huang H, Yang B, Huang C. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41(22):2070&#x2013;2079. doi: 10.1093/eurheartj/ehaa408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa408</ArticleId><ArticleId IdType="pmc">PMC7239100</ArticleId><ArticleId IdType="pubmed">32391877</ArticleId></ArticleIdList></Reference><Reference><Citation>Solano-L&#xf3;pez J, S&#xe1;nchez-Recalde A, Zamorano JL. SARS-CoV-2, a novel virus with an unusual cardiac feature: inverted takotsubo syndrome. Eur Heart J. 2020;41(32):3106. doi: 10.1093/eurheartj/ehaa390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa390</ArticleId><ArticleId IdType="pmc">PMC7239192</ArticleId><ArticleId IdType="pubmed">32391885</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, Metra M, Curello S, Maffeo D, Pero G, Cacucci M, Assanelli E, Bellini B, Russo F, Ielasi A, Tespili M, Danzi GB, Vandoni P, Bollati M, Barbieri L, Oreglia J, Lettieri C, Cremonesi A, Carugo S, Reimers B, Condorelli G, Chieffo A. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. 2020;141(25):2113&#x2013;2116. doi: 10.1161/CIRCULATIONAHA.120.047525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047525</ArticleId><ArticleId IdType="pmc">PMC7302062</ArticleId><ArticleId IdType="pubmed">32352306</ArticleId></ArticleIdList></Reference><Reference><Citation>Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, Gal Oz A, Rothschild E, Baruch G, Peri Y, Arbel Y, Topilsky Y. Spectrum of cardiac manifestations in COVID-19: a systematic echocardiographic study. Circulation. 2020;142(4):342&#x2013;353. doi: 10.1161/CIRCULATIONAHA.120.047971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047971</ArticleId><ArticleId IdType="pmc">PMC7382541</ArticleId><ArticleId IdType="pubmed">32469253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, Sepe PA, Resasco T, Camporotondo R, Bruno R. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911&#x2013;915. doi: 10.1002/ejhf.1828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva DH, Lusby HP, Islam SP, Gupte AA, Beatty NL. Heart failure exacerbation as only presenting sign of COVID-19. IDCases. 2020;21:e00870. doi: 10.1016/j.idcr.2020.e00870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idcr.2020.e00870</ArticleId><ArticleId IdType="pmc">PMC7294254</ArticleId><ArticleId IdType="pubmed">32607310</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, Lang C, Huang D, Sun Q, Xiong Y, Huang X, Lv J, Luo Y, Shen L, Yang H, Huang G, Yang R. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797&#x2013;806. doi: 10.1002/jmv.25783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25783</ArticleId><ArticleId IdType="pmc">PMC7228368</ArticleId><ArticleId IdType="pubmed">32198776</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, You Q, Wu C, Cao S, Qu G, Yan X, Han X, Wang C, Zhang H. Impact of cardiovascular disease on clinical characteristics and outcomes of coronavirus disease 2019 (COVID-19) Circ J. 2020;84(8):1277&#x2013;1283. doi: 10.1253/circj.CJ-20-0348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-20-0348</ArticleId><ArticleId IdType="pubmed">32536672</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong S, Liu L, Lin F, Shi J, Han L, Liu H, He L, Jiang Q, Wang Z, Fu W, Li Z, Lu Q, Chen Z, Ding S. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study. BMC Infect Dis. 2020;20(1):787. doi: 10.1186/s12879-020-05452-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05452-2</ArticleId><ArticleId IdType="pmc">PMC7578439</ArticleId><ArticleId IdType="pubmed">33092539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475&#x2013;481. doi: 10.1016/S2213-2600(20)30079-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Xu D, Fu S, Zhang J, Yang X, Xu L, Xu J, Wu Y, Huang C, Ouyang Y, Yang L, Fang M, Xiao H, Ma J, Zhu W, Hu S, Hu Q, Ding D, Hu M, Zhu G, Xu W, Guo J, Xu J, Yuan H, Zhang B, Yu Z, Chen D, Yuan S, Shang Y. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care. 2020;24(1):219. doi: 10.1186/s13054-020-02939-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02939-x</ArticleId><ArticleId IdType="pmc">PMC7223395</ArticleId><ArticleId IdType="pubmed">32410714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J-H, Liu Y-X, Yuan J, Wang F-X, Wu W-B, Li J-X, Wang L-F, Gao H, Wang Y, Dong C-F. First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020;48(5):1. doi: 10.1007/s15010-020-01424-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01424-5</ArticleId><ArticleId IdType="pmc">PMC7146072</ArticleId><ArticleId IdType="pubmed">32277408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol. 2020;127:104364. doi: 10.1016/j.jcv.2020.104364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104364</ArticleId><ArticleId IdType="pmc">PMC7194884</ArticleId><ArticleId IdType="pubmed">32311650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao XY, Xu XX, Yin HS, Hu QM, Xiong T, Tang YY, Yang AY, Yu BP, Huang ZP. Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study. BMC Infect Dis. 2020;20(1):311. doi: 10.1186/s12879-020-05010-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05010-w</ArticleId><ArticleId IdType="pmc">PMC7188494</ArticleId><ArticleId IdType="pubmed">32345226</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Green S: Cochrane handbook for systematic reviews of interventions, vol. 5: Wiley Online Library; 2008.</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5(1):13. doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed) 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;be S, Richter S, Seige M, Stehr S, Laufs U, Hagendorff A. Echocardiographic characteristics of patients with SARS-CoV-2 infection. Clin Res Cardiol. 2020;109(12):1549&#x2013;1566. doi: 10.1007/s00392-020-01727-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01727-5</ArticleId><ArticleId IdType="pmc">PMC7428201</ArticleId><ArticleId IdType="pubmed">32803387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Chen B, Liao H, Wang Z, Lyu M, Man S, Pu Q, Liu L. The comparable efficacy of lung donation after circulatory death and brain death: a systematic review and meta-analysis. Transplantation. 2019;103(12):2624&#x2013;2633. doi: 10.1097/TP.0000000000002888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000002888</ArticleId><ArticleId IdType="pubmed">31369516</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39:119&#x2013;177. doi: 10.1093/eurheartj/ehx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx393</ArticleId><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kociol RD, Cooper LT, Fang JC, Moslehi JJ, Pang PS, Sabe MA, Shah RV, Sims DB, Thiene G, Vardeny O. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020;141(6):e69&#x2013;e92. doi: 10.1161/CIR.0000000000000745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000745</ArticleId><ArticleId IdType="pubmed">31902242</ArticleId></ArticleIdList></Reference><Reference><Citation>Gali&#xe8; N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J. 2016;37(1):67&#x2013;119. doi: 10.1093/eurheartj/ehv317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv317</ArticleId><ArticleId IdType="pubmed">26320113</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685&#x2013;713. doi: 10.1016/j.echo.2010.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.05.010</ArticleId><ArticleId IdType="pubmed">20620859</ArticleId></ArticleIdList></Reference><Reference><Citation>Padmanabhan P, Desikan R, Dixit NM. Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. PLoS Comput Biol. 2020;16(12):e1008461. doi: 10.1371/journal.pcbi.1008461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008461</ArticleId><ArticleId IdType="pmc">PMC7748278</ArticleId><ArticleId IdType="pubmed">33290397</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383(23):2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Kox M, Waalders NJB, Kooistra EJ, Gerretsen J, Pickkers P. Cytokine levels in critically ill patients with COVID-19 and other conditions. Jama. 2020;324(15):1565&#x2013;1567. doi: 10.1001/jama.2020.17052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17052</ArticleId><ArticleId IdType="pmc">PMC7489366</ArticleId><ArticleId IdType="pubmed">32880615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P, Matthay MA, Calfee CS. Is a &#x201c;cytokine storm&#x201d; relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152&#x2013;1154. doi: 10.1001/jamainternmed.2020.3313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3313</ArticleId><ArticleId IdType="pubmed">32602883</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Fourth universal definition of myocardial infarction (2018) J Am Coll Cardiol. 2018;72(18):2231&#x2013;2264. doi: 10.1016/j.jacc.2018.08.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.1038</ArticleId><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>Delano MJ, Ward PA. The immune system&#x2019;s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330&#x2013;353. doi: 10.1111/imr.12499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12499</ArticleId><ArticleId IdType="pmc">PMC5111634</ArticleId><ArticleId IdType="pubmed">27782333</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffer U, Wade RG, Gourlay T. Cytokines in the systemic inflammatory response syndrome: a review. HSR Proc Intensive Care Cardiovasc Anesth. 2010;2:161&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484588</ArticleId><ArticleId IdType="pubmed">23441054</ArticleId></ArticleIdList></Reference><Reference><Citation>Stengl M, Bartak F, Sykora R, Chvojka J, Benes J, Krouzecky A, Novak I, Sviglerova J, Kuncova J, Matejovic M. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Crit Care Med. 2010;38(2):579&#x2013;587. doi: 10.1097/CCM.0b013e3181cb0f61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181cb0f61</ArticleId><ArticleId IdType="pubmed">20029342</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe H, Semba H, Takeda N. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb. 2017;24(9):884&#x2013;894. doi: 10.5551/jat.RV17009.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.RV17009</ArticleId><ArticleId IdType="pmc">PMC5587513</ArticleId><ArticleId IdType="pubmed">28757538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaki A, Singh H, Cohen G, Schreiber T. A case report of a large intracardiac thrombus in a COVID-19 patient managed with percutaneous thrombectomy and right ventricular mechanical circulatory support. Eur Heart J Case Rep. 2020;4(6):1&#x2013;5. doi: 10.1093/ehjcr/ytaa308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaa308</ArticleId><ArticleId IdType="pmc">PMC7665472</ArticleId><ArticleId IdType="pubmed">33437917</ArticleId></ArticleIdList></Reference><Reference><Citation>Urso C, Brucculeri S, Caimi G. Acid&#x2013;base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev. 2015;20:493&#x2013;503. doi: 10.1007/s10741-015-9482-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-015-9482-y</ArticleId><ArticleId IdType="pmc">PMC4464645</ArticleId><ArticleId IdType="pubmed">25820346</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho H, Richard MC, Chouihed T, Goffinet N, Le Bastard Q, Freund Y, Kratz A, Dubroux M, Masson D, Figueres L, et al. Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: a case&#x2013;control study. Intern Emerg Med. 2021;16:1&#x2013;6. doi: 10.1007/s11739-021-02632-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02632-z</ArticleId><ArticleId IdType="pmc">PMC7823192</ArticleId><ArticleId IdType="pubmed">33484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Tissot Dupont H, Honor&#xe9; S, Colson P, Chabri&#xe8;re E, la Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105949</ArticleId><ArticleId IdType="pmc">PMC7102549</ArticleId><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Awortwe C, Cascorbi I. Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions. Pharmacol Res. 2020;161:105250. doi: 10.1016/j.phrs.2020.105250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.105250</ArticleId><ArticleId IdType="pmc">PMC7550259</ArticleId><ArticleId IdType="pubmed">33059010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tsch&#xf6;pe C, Cooper LT, Jr, Camici PG. Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail. 2020;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.007405</ArticleId><ArticleId IdType="pmc">PMC7673642</ArticleId><ArticleId IdType="pubmed">33176455</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35796755</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1465-3664</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of tropical pediatrics</Title><ISOAbbreviation>J Trop Pediatr</ISOAbbreviation></Journal><ArticleTitle>Etiology, Pathophysiology and Mortality of Shock in Children in Low (Middle) Income Countries: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">fmac053</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/tropej/fmac053</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Shock is a life-threatening condition in children in low- and middle-income countries (LMIC), with several controversies. This systematic review summarizes the etiology, pathophysiology and mortality of shock in children in LMIC.</AbstractText><AbstractText Label="METHODS">We searched for studies reporting on children with shock in LMIC in PubMed, Embase and through snowballing (up to 1 October 2019). Studies conducted in LMIC that reported on shock in children (1 month-18&#x2009;years) were included. We excluded studies only containing data on neonates, cardiac surgery patients or iatrogenic causes. We presented prevalence data, pooled mortality estimates and conducted subgroup analyses per definition, region and disease. Etiology and pathophysiology data were systematically collected.</AbstractText><AbstractText Label="RESULTS">We identified 959 studies and included 59 studies of which six primarily studied shock. Definitions used for shock were classified into five groups. Prevalence of shock ranged from 1.5% in a pediatric hospital population to 44.3% in critically ill children. Pooled mortality estimates ranged between 3.9-33.3% for the five definition groups. Important etiologies included gastroenteritis, sepsis, malaria and severe anemia, which often coincided. The pathophysiology was poorly studied but suggests that in addition to hypovolemia, dissociative and cardiogenic shock are common in LMIC.</AbstractText><AbstractText Label="CONCLUSIONS">Shock is associated with high mortality in hospitalized children in LMIC. Despite the importance few studies investigated shock and as a consequence limited data on etiology and pathophysiology of shock is available. A uniform bedside definition may help boost future studies unravelling shock etiology and pathophysiology in LMIC.</AbstractText><CopyrightInformation>&#xa9; The Author(s) [2022]. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assies</LastName><ForeName>Roxanne</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3563-3460</Identifier><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, PICU, Emma Children's Hospital, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Centre for Global Child Health, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Kamuzu University of Health Sciences KUHeS Malawi, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snik</LastName><ForeName>Ilse</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, PICU, Emma Children's Hospital, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumwenda</LastName><ForeName>Mercy</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Kamuzu University of Health Sciences KUHeS Malawi, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chimalizeni</LastName><ForeName>Yamikani</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Kamuzu University of Health Sciences KUHeS Malawi, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langton</LastName><ForeName>Josephine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Kamuzu University of Health Sciences KUHeS Malawi, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Woensel</LastName><ForeName>Job B M</ForeName><Initials>JBM</Initials><Identifier Source="ORCID">0000-0002-2241-7806</Identifier><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, PICU, Emma Children's Hospital, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Centre for Global Child Health, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doctor</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Maryland School of Medicine, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calis</LastName><ForeName>Job C J</ForeName><Initials>JCJ</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, PICU, Emma Children's Hospital, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Centre for Global Child Health, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics and Child Health, Kamuzu University of Health Sciences KUHeS Malawi, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Trop Pediatr</MedlineTA><NlmUniqueID>8010948</NlmUniqueID><ISSNLinking>0142-6338</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003906" MajorTopicYN="Y">Developing Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">circulatory insufficiency</Keyword><Keyword MajorTopicYN="N">low- and middle-income countries</Keyword><Keyword MajorTopicYN="N">pediatric</Keyword><Keyword MajorTopicYN="N">review</Keyword><Keyword MajorTopicYN="N">shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>7</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35796755</ArticleId><ArticleId IdType="pmc">PMC9586536</ArticleId><ArticleId IdType="doi">10.1093/tropej/fmac053</ArticleId><ArticleId IdType="pii">6633340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Updated Guideline: Paediatric Emergency Triage, Assessment and Treatment. Geneva: World Health Organization, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27010047</ArticleId></ArticleIdList></Reference><Reference><Citation>de Caen AR, Maconochie IK, Aickin R, et al.Part 6: pediatric Basic Life Support and Pediatric Advanced Life Support: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations (Reprint). Pediatrics 2015;136:S88&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">26471382</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss SL, Peters MJ, Alhazzani W, et al.Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med 2020;21:e52&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pubmed">32032273</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, De Backer D.. Circulatory shock. N Engl J Med 2013;369:1726&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">24171518</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, George EC, Evans JA, et al.; for the FEAST trial group. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med 2013;11:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599745</ArticleId><ArticleId IdType="pubmed">23496872</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke T. What the African fluid-bolus trial means. Lancet 2011;378:1685&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21683436</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelbart B. Fluid bolus therapy in pediatric sepsis: current knowledge and future direction. Front Pediatr 2018;6:308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6209667</ArticleId><ArticleId IdType="pubmed">30410875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford N, Hargreaves S, Shanks L.. Mortality after fluid bolus in children with shock due to sepsis or severe infection: a systematic review and meta-analysis. PLoS One 2012;7:e43953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3431361</ArticleId><ArticleId IdType="pubmed">22952819</ArticleId></ArticleIdList></Reference><Reference><Citation>Long E, Duke T.. Fluid resuscitation therapy for paediatric sepsis. J Paediatr Child Health 2016;52:141&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27062617</ArticleId></ArticleIdList></Reference><Reference><Citation>Opiyo N, Molyneux E, Sinclair D, et al.Immediate fluid management of children with severe febrile illness and signs of impaired circulation in low-income settings: a contextualised systematic review. BMJ Open 2014;4:e004934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010848</ArticleId><ArticleId IdType="pubmed">24785400</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassford NJ, Gelbart B, Bellomo R.. Coming full circle: thirty years of paediatric fluid resuscitation. Anaesth Intensive Care 2017;45:308&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">28486889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nteziyaremye J, Paasi G, Burgoine K, et al.Perspectives on aetiology, pathophysiology and management of shock in African children. Afr J Emerg Med 2017;7:S20&#x2013;S26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6246868</ArticleId><ArticleId IdType="pubmed">30505670</ArticleId></ArticleIdList></Reference><Reference><Citation>
The World Bank. World Bank Country and Lending Groups. 2019. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (1 October 2019, date last accessed).</Citation></Reference><Reference><Citation>Munn Z, Moola S, Riitano D, et al.The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag 2014;3:123&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154549</ArticleId><ArticleId IdType="pubmed">25197676</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Munn Z, Tufanaru C, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z (eds). JBI Manual for Evidence Synthesis. JBI, 2020. Available from https://synthesismanual.jbi.global.</Citation></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, et al.Meta-analysis of prevalence. J Epidemiol Community Health 2013;67:974&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufanaru C, Munn Z, Stephenson M, et al.Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc 2015;13:196&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">26355603</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer G, Chemaitelly H, Abu-Raddad LJ, et al.Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods 2019;10:476&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6767151</ArticleId><ArticleId IdType="pubmed">30945438</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Chopra A, Pooni PA, et al.A clinical profile of shock in children in Punjab, India. Indian Pediatr 2006;43:619&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">16891682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Ellis JC, Kamwendo H, et al.Impact of HIV infection and exposure on survival in critically ill children who attend a paediatric emergency department in a resource-constrained setting. Emerg Med J 2010;27:746&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20515902</ArticleId></ArticleIdList></Reference><Reference><Citation>Akech SO, Karisa J, Nakamya P, et al.Phase II trial of isotonic fluid resuscitation in Kenyan children with severe malnutrition and hypovolaemia. BMC Pediatr 2010;10:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2973932</ArticleId><ArticleId IdType="pubmed">20923577</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Kiguli S, Opoka RO, et al.; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Eng J Med 2011;364:2483&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S, Shrestha S, Ghimire A, et al.Development of a PICU in Nepal: the experience of the first year. Pediatr Crit Care Med 2014;15:e314&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">25080149</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbevi G, Ayieko P, Irimu G, et al.; Clinical Information Network authors. Prevalence, aetiology, treatment and outcomes of shock in children admitted to Kenyan hospitals. BMC Med 2016;14:184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111353</ArticleId><ArticleId IdType="pubmed">27846837</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava VK, Suri S, Bhasin A, et al.An epidemic of dengue haemorrhagic fever and dengue shock syndrome in Delhi: a clinical study. Ann Trop Paediatr 1990;10:329&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">1708958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bethell DB, Flobbe K, Cao XT, et al.Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 1998;177:778&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">9498463</ArticleId></ArticleIdList></Reference><Reference><Citation>Dung NM, Day NP, Tam DT, et al.Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 1999;29:787&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589889</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo NT, Cao XT, Kneen R, et al.Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills BA, Oragui EE, Stephens AC, et al.Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002;35:277&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12115093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabilan L, Balasubramanian S, Keshava SM, et al.The 2001 dengue epidemic in Chennai. Indian J Pediatr 2005;72:919&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">16391444</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjit S, Kissoon N, Jayakumar I.. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med 2005;6:412&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15982427</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills BA, Nguyen MD, Ha TL, et al.Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">16135832</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TB, Nguyen TH, Vu TQ, et al.Predictive factors of dengue shock syndrome at the children Hospital No. 1, Ho-chi-Minh City, Vietnam. Bull Soc Pathol Exot 2007;100:43&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17402695</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath SR, Ranjit S.. Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. Indian J Pediatr 2006;73:889&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7101810</ArticleId><ArticleId IdType="pubmed">17090900</ArticleId></ArticleIdList></Reference><Reference><Citation>Djamiatun K, van der Ven AJ, de Groot PG, et al.Severe dengue is associated with consumption of von Willebrand factor and its cleaving enzyme ADAMTS-13. PLoS Negl Trop Dis 2012;6:e1628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341341</ArticleId><ArticleId IdType="pubmed">22563509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngwe Tun MM, Thant KZ, Inoue S, et al.Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar. J Med Virol 2013;85:1258&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">23595687</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothapregada S, Kamalakannan B, Thulasingam M.. Role of platelet transfusion in children with bleeding in dengue fever. J Vector Borne Dis 2015;52:304&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26714510</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay M, Singhi S, Murlidharan J, et al.Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr 2005;42:223&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817970</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranwal AK, Singhi SC, Jayashree M.. A 5-year PICU experience of disseminated staphylococcal disease, part 1: clinical and microbial profile. J Trop Pediatr 2007;53:245&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478541</ArticleId></ArticleIdList></Reference><Reference><Citation>Menif K, Khaldi A, Bouziri A, et al.[Mortality rates in pediatric septic shock secondary to community-acquired infection: about 70 cases]. Med Mal Infect 2009;39:896&#x2013;900.</Citation><ArticleIdList><ArticleId IdType="pubmed">19110390</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhanam I, Sangareddi S, Venkataraman S, et al.A prospective randomized controlled study of two fluid regimens in the initial management of septic shock in the emergency department. Pediatr Emerg Care 2008;24:647&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">19242131</ArticleId></ArticleIdList></Reference><Reference><Citation>Valoor HT, Singhi S, Jayashree M.. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting. Pediatr Crit Care Med 2009;10:121&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19057445</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra A, Kumar V, Dutta A.. Hypertonic versus normal saline as initial fluid bolus in pediatric septic shock. Indian J Pediatr 2011;78:833&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21290201</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MR, Maheshwari PK, Masood K, et al.Epidemiology and outcome of sepsis in a tertiary care PICU of Pakistan. Indian J Pediatr 2012;79:1454&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22392263</ArticleId></ArticleIdList></Reference><Reference><Citation>Couto TB, Farhat SC, Reid T, et al.Mortality in a pediatric secondary-care hospital in post-conflict Liberia in 2009. Einstein (Sao Paulo) 2013;11:413&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880375</ArticleId><ArticleId IdType="pubmed">24488377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjit S, Kissoon N.. Bedside echocardiography is useful in assessing children with fluid and inotrope resistant septic shock. Indian J Crit Care Med 2013;17:224&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3796901</ArticleId><ArticleId IdType="pubmed">24133330</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjit S, Aram G, Kissoon N, et al.Multimodal monitoring for hemodynamic categorization and management of pediatric septic shock: a pilot observational study. Pediatr Crit Care Med 2014;15:e17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">24196006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahiem SK, Galal YS, Youssef MR, et al.Prognostic markers among Egyptian children with sepsis in the Intensive Care Units, Cairo University Hospitals. Allergol Immunopathol (Madr) 2016;44:46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26657169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy KN, Singhi S, Jayashree M, et al.Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock. Pediatr Crit Care Med 2016;17:e502&#x2013;e512.</Citation><ArticleIdList><ArticleId IdType="pubmed">27673385</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortz TB, Axelrod DM, Chisti MJ, et al.Clinical outcomes and mortality before and after implementation of a pediatric sepsis protocol in a limited resource setting: a retrospective cohort study in Bangladesh. PLoS One 2017;12:e0181160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533322</ArticleId><ArticleId IdType="pubmed">28753618</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Nawawy AA, Abdelmohsen AM, Hassouna HM.. Role of echocardiography in reducing shock reversal time in pediatric septic shock: a randomized controlled trial. J Pediatr (Rio J) 2018;94:31&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28873333</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Levin M, English M, et al.Severe P. falciparum malaria in Kenyan children: evidence for hypovolaemia. QJM 2003;96:427&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">12788961</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Pamba A, English M, et al.Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion. Br J Haematol 2005;128:393&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">15667544</ArticleId></ArticleIdList></Reference><Reference><Citation>Akech S, Gwer S, Idro R, et al.Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials 2006;1:e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569382</ArticleId><ArticleId IdType="pubmed">16998584</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondorp AM, Fanello CI, Hendriksen IC, et al.Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (London, England) 2010;376:1647&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3033534</ArticleId><ArticleId IdType="pubmed">21062666</ArticleId></ArticleIdList></Reference><Reference><Citation>Akech SO, Jemutai J, Timbwa M, et al.Phase II trial on the use of Dextran 70 or starch for supportive therapy in Kenyan children with severe malaria. Crit Care Med 2010;38:1630&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20526196</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav D, Chandra J, Aneja S, et al.Changing profile of severe malaria in north Indian children. Indian J Pediatr 2012;79:483&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22090254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinga A, Mayige M, Kagaruki G, et al.Clinical manifestations and outcomes of severe malaria among children admitted at Rungwe and Kyela district hospitals in south-western Tanzania. Tanzan J Health Res 2012;14:3&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26591740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehlawat VK, Arya V, Kaushik JS, et al.Clinical spectrum and treatment outcome of severe malaria caused by Plasmodium vivax in 18 children from northern India. Pathog Glob Health 2013;107:210&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001474</ArticleId><ArticleId IdType="pubmed">23816514</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce R, Reyes R, Keeler C, et al.Anemia was an uncommon complication of severe malaria in a high-transmission rural area of Western Uganda. Am J Trop Med Hyg 2018;98:683&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5930899</ArticleId><ArticleId IdType="pubmed">29280423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarmin M, Ahmed T, Bardhan PK, et al.Specialist hospital study shows that septic shock and drowsiness predict mortality in children under five with diarrhoea. Acta Paediatr 2014;103:e306-311.</Citation><ArticleIdList><ArticleId IdType="pubmed">24661049</ArticleId></ArticleIdList></Reference><Reference><Citation>Breurec S, Vanel N, Bata P, et al.Etiology and epidemiology of diarrhea in hospitalized children from low income country: a matched case-control study in Central African Republic. PLoS Negl Trop Dis 2016;10:e0004283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4701495</ArticleId><ArticleId IdType="pubmed">26731629</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisti MJ, Shahunja KM, Afroze FSharifuzzaman , et al.Hypoxaemia and septic shock were independent risk factors for mechanical ventilation in Bangladeshi children hospitalised for diarrhoea. Acta Paediatr 2017;106:1159&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">28316105</ArticleId></ArticleIdList></Reference><Reference><Citation>Akech S, Ayieko P, Gathara D, et al.Risk factors for mortality and effect of correct fluid prescription in children with diarrhoea and dehydration without severe acute malnutrition admitted to Kenyan hospitals: an observational, association study. Lancet Child Adolesc Health 2018;2:516&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6004535</ArticleId><ArticleId IdType="pubmed">29971245</ArticleId></ArticleIdList></Reference><Reference><Citation>Obonyo N, Brent B, Olupot-Olupot P, et al.Myocardial and haemodynamic responses to two fluid regimens in African children with severe malnutrition and hypovolaemic shock (AFRIM study). Crit Care 2017;21:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5415747</ArticleId><ArticleId IdType="pubmed">28468633</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbert A, Thuo N, Karisa J, et al.Diarrhoea complicating severe acute malnutrition in Kenyan children: a prospective descriptive study of risk factors and outcome. PloS One 2012;7:e38321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3366921</ArticleId><ArticleId IdType="pubmed">22675542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M, Krishnamurthy S, Delhikumar CG, et al.Scrub typhus in children at a tertiary hospital in southern India: clinical profile and complications. J Infect Public Health 2012;5:82&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22341847</ArticleId></ArticleIdList></Reference><Reference><Citation>Palanivel S, Nedunchelian K, Poovazhagi V, et al.Clinical profile of scrub typhus in children. Indian J Pediatr 2012;79:1459&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">22374234</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanasamy DK, Arunagirinathan AK, Kumar RK, et al.Clinico - laboratory profile of scrub typhus - an emerging rickettsiosis in India. Indian J Pediatr 2016;83:1392&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27352842</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NL, Gun RT, Sparnon AL, et al.The importance of initial management: a case series of childhood burns in Vietnam. Burns 2002;28:167&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">11900941</ArticleId></ArticleIdList></Reference><Reference><Citation>Osifo OD, Iribhogbe PE, Ugiagbe EE.. Epidemiology and pattern of paediatric and adolescent trauma deaths in a level 1 trauma centre in Benin city, Nigeria. Injury 2012;43:1861&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">21820655</ArticleId></ArticleIdList></Reference><Reference><Citation>Patregnani JT, Borgman MA, Maegele M, et al.Coagulopathy and shock on admission is associated with mortality for children with traumatic injuries at combat support hospitals. Pediatr Crit Care Med 2012;13:273&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21926654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedro R, Akech S, Fegan G, et al.Changing trends in blood transfusion in children and neonates admitted in Kilifi District Hospital, Kenya. Malar J 2010;9:307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2991344</ArticleId><ArticleId IdType="pubmed">21034494</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Kiguli S, Olupot-Olupot P, et al.; TRACT Group. Immediate transfusion in African children with uncomplicated severe anemia. N Engl J Med 2019;381:407&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611152</ArticleId><ArticleId IdType="pubmed">31365799</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K, Olupot-Olupot P, Kiguli S, et al.Transfusion volume for children with severe anemia in Africa. N Engl J Med 2019;381:420&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610610</ArticleId><ArticleId IdType="pubmed">31365800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma PK, Kumar M, Aggarwal GK, et al.Severe manifestations of chikungunya fever in children, India, 2016. Emerg Infect Dis 2018;24:1737&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6106424</ArticleId><ArticleId IdType="pubmed">30124414</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb C, Ngama M, Ngatia A, et al.Treatment failure among Kenyan children with severe pneumonia&#x2013;a cohort study. Pediatr Infect Dis J 2012;31:e152&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3691501</ArticleId><ArticleId IdType="pubmed">22692700</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburlini G, Di Mario S, Maggi RS, et al.Evaluation of guidelines for emergency triage assessment and treatment in developing countries. Arch Dis Child 1999;81:478&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1718144</ArticleId><ArticleId IdType="pubmed">10569961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming S, Gill P, Jones C, et al.The diagnostic value of capillary refill time for detecting serious illness in children: a systematic review and meta-analysis. PLoS One 2015;10:e0138155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4573516</ArticleId><ArticleId IdType="pubmed">26375953</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Status Report on Road Safety 2015. World Health Organization, Geneva, 2015.</Citation></Reference><Reference><Citation>Facts about Injuries: Burns. World Health Organization, Geneva, 2006.</Citation></Reference><Reference><Citation>Droz N, Hsia Y, Ellis S, et al.Bacterial pathogens and resistance causing community acquired paediatric bloodstream infections in low- and middle-income countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2019;8:207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6937962</ArticleId><ArticleId IdType="pubmed">31893041</ArticleId></ArticleIdList></Reference><Reference><Citation>Church J, Maitland K.. Invasive bacterial co-infection in African children with Plasmodium falciparum malaria: a systematic review. BMC Med 2014;12:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928319</ArticleId><ArticleId IdType="pubmed">24548672</ArticleId></ArticleIdList></Reference><Reference><Citation>Iro MA, Sell T, Brown N, et al.Rapid intravenous rehydration of children with acute gastroenteritis and dehydration: a systematic review and meta-analysis. BMC Pediatr 2018;18:44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807758</ArticleId><ArticleId IdType="pubmed">29426307</ArticleId></ArticleIdList></Reference><Reference><Citation>Houston KA, Gibb J, Olupot-Olupot P, et al.Gastroenteritis aggressive versus slow treatment for rehydration (GASTRO): a phase II rehydration trial for severe dehydration: WHO plan C versus slow rehydration. BMC Med 2019;17:122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600884</ArticleId><ArticleId IdType="pubmed">31256761</ArticleId></ArticleIdList></Reference><Reference><Citation>Calis JC, Phiri KS, Faragher EB, et al.Severe anemia in Malawian children. N Engl J Med 2008;358:888&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305266</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Strategy for Dengue Prevention and Control 2012-2020. World Health Organization, Geneva, 2012.</Citation></Reference><Reference><Citation>Yacoub S, Lang HJ, Shebbe M, et al.Cardiac function and hemodynamics in Kenyan children with severe malaria. Crit Care Med 2010;38:940&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20068463</ArticleId></ArticleIdList></Reference><Reference><Citation>George EC, Kiguli S, Olupot PO, et al.Mortality risk over time after early fluid resuscitation in African children. Crit Care 2019;23:377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6882199</ArticleId><ArticleId IdType="pubmed">31775837</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin M, Cunnington AJ, Wilson C, et al.Effects of saline or albumin fluid bolus in resuscitation: evidence from re-analysis of the FEAST trial. Lancet Respir Med 2019;7:581&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6593355</ArticleId><ArticleId IdType="pubmed">31196803</ArticleId></ArticleIdList></Reference><Reference><Citation>Long E, Babl FE, Oakley E, et al.; on behalf of the Paediatric Research in Emergency Departments International Collaborative (PREDICT). Does fluid bolus therapy increase blood pressure in children with sepsis? Emerg Med Australas 2020;32:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31237412</ArticleId></ArticleIdList></Reference><Reference><Citation>Brent B, Obonyo N, Akech S, et al.Assessment of myocardial function in Kenyan children With severe, acute malnutrition: the Cardiac Physiology in Malnutrition (CAPMAL) Study. JAMA Netw Open 2019;2:e191054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6583281</ArticleId><ArticleId IdType="pubmed">30901050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28716039</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>55</StartPage><MedlinePgn>55</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">55</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13019-017-0618-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postcardiotomy cardiogenic shock (PCCS) refractory to inotropic support and intra-aortic balloon pump (IABP) occurs rarely but is almost universally fatal without mechanical circulatory support. In this systematic review and meta-analysis we looked at the evidence behind the use of veno-arterial extra-corporeal membrane oxygenation (VA ECMO) in refractory PCCS from a patient survival rate and determinants of outcome viewpoint.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was performed in January 2017 using PubMed (with no defined time period) using the keywords "postcardiotomy", "cardiogenic shock", "extracorporeal membrane oxygenation" and "cardiac surgery". We excluded papers pertaining to ECMO following paediatric cardiac surgery, medical causes of cardiogenic shock, as well as case reports, review articles, expert opinions, and letters to the editor. Once the studies were collated, a meta-analysis was performed on the proportion of survivors in those papers that met the inclusion criteria. Meta-regression was performed for the most commonly reported adverse prognostic indicators (API).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 24 studies and a cumulative pool of 1926 patients from 1992 to 2016. We tabulated the demographic data, including the strengths and weaknesses for each of the studies, outcomes of VA ECMO for refractory PCCS, complications, and APIs. All the studies were retrospective cohort studies. Meta-analysis of the moderately heterogeneous data (95% CI 0.29 to 0.34, p&#xa0;&lt;&#xa0;0.01, I <sup>2</sup> &#xa0;=&#xa0;60%) revealed overall survival rate to hospital discharge of 30.8%. Some of the commonly reported APIs were advanced age (&gt;70&#xa0;years, 95% CI -0.057 to 0.001, P&#xa0;=&#xa0;0.058), and long ECMO support (95% CI -0.068 to 0.166, P&#xa0;=&#xa0;0.412). Postoperative renal failure, high EuroSCORE (&gt;20%), diabetes mellitus, obesity, rising lactate whilst on ECMO, gastrointestinal complications had also been reported.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Haemodynamic support with VA ECMO provides a survival benefit with reasonable intermediate and long-term outcomes. Many studies had reported advanced age, renal failure and prolonged VA ECMO support as the most likely APIs for VA ECMO in PCCS. EuroSCORE can be utilized to anticipate the need for prophylactic perioperative VA ECMO in the high-risk category. APIs can be used to aid decision-making regarding both the institution and weaning of ECMO for refractory PCCS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khorsandi</LastName><ForeName>Maziar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery and Transplantation, Golden Jubilee National Hospital, Glasgow, UK. maziarkhorsandi@doctors.org.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dougherty</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ninewells hospital, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouamra</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Medical Statistics, Trauma, Audit &amp; Research Network, University of Manchester, Salford Royal NHS foundation trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pai</LastName><ForeName>Vasudev</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular and Thoracic Surgery, Kasturba Medical College, Manipal University, Manipal, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curry</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery and Transplantation, Golden Jubilee National Hospital, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsui</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery and Transplantation, Papworth hospital, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac surgery and Transplantation, Freeman hospital, Newcastle, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westaby</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Oxford Heart Center, John Radcliffe Hospital, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Attar</LastName><ForeName>Nawwar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery and Transplantation, Golden Jubilee National Hospital, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamvar</LastName><ForeName>Vipin</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extra-corporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Postcardiotomy</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable as this is a meta-analysis. CONSENT FOR PUBLICATION: Not applicable as this is a meta-analysis. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28716039</ArticleId><ArticleId IdType="pmc">PMC5512816</ArticleId><ArticleId IdType="doi">10.1186/s13019-017-0618-0</ArticleId><ArticleId IdType="pii">10.1186/s13019-017-0618-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hernandez AF, Grab JD, Gammie JS, O&#x2019;Brien SM, Hammill BG, Rogers JG, et al. A decade of short-term outcomes in post&#x2013;cardiac surgery ventricular assist device implantation. Circulation. 2007;116:606&#x2013;612. doi: 10.1161/CIRCULATIONAHA.106.666289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.666289</ArticleId><ArticleId IdType="pubmed">17646586</ArticleId></ArticleIdList></Reference><Reference><Citation>DeRose JJ, Umana JP, Argenziano M, Catanese KA, Levin HR, Sun BC, et al. Improved results for Postcardiotomy Cardiogenic shock with the use of implantable left ventricular assist devices. Ann Thorac Surg. 1997;64:1757&#x2013;1763. doi: 10.1016/S0003-4975(97)01107-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(97)01107-7</ArticleId><ArticleId IdType="pubmed">9436568</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehrcke DD, McCarthy PM, Stewart RW, Foster RC, Ogella DA, Borsh JA, et al. Extracorporeal membrane oxygenation for Postcardiotomy Cardiogenic shock. Ann Thorac Surg. 1996;61:684&#x2013;691. doi: 10.1016/0003-4975(95)01042-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(95)01042-4</ArticleId><ArticleId IdType="pubmed">8572788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohite PN, Sabashnikov A, Patil NP, S&#xe1;ez DG, Zych B, Popov AF, et al. Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival. J Artif Organs. 17(3):228&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">24880478</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302&#x2013;311. doi: 10.1016/j.jtcvs.2009.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.10.043</ArticleId><ArticleId IdType="pubmed">20106393</ArticleId></ArticleIdList></Reference><Reference><Citation>Fou AA, John H. Gibbon. The first 20 years of the heart-lung machine. Tex Heart Inst J. 1997;24(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC325389</ArticleId><ArticleId IdType="pubmed">9068131</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart GC, Giverts MM. Mechanical circulatory support for advanced heart failure: patients and technology in evolution. Circulation. 2012;125:1304&#x2013;1315. doi: 10.1161/CIRCULATIONAHA.111.060830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.060830</ArticleId><ArticleId IdType="pubmed">22412091</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll N, Fabricius A, Borger MA, Bucerius J, Doll S, Kr&#xe4;mer K, et al. Temporary extracorporeal membrane oxygenation in patients with refractory postoperative cardiogenic shock--a single center experience. J Card Surg. 2003;18(6):512&#x2013;518. doi: 10.1046/j.0886-0440.2003.02061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0886-0440.2003.02061.x</ArticleId><ArticleId IdType="pubmed">14992102</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoy FB, Mueller DK, Geiss DM, Munns JR, Bond LM, Linett CE, et al. Bridge to recovery for postcardiotomy failure: is there still a role for centrifugal pumps? Ann Thorac Surg. 2000;70(4):1259&#x2013;1263. doi: 10.1016/S0003-4975(00)01715-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(00)01715-X</ArticleId><ArticleId IdType="pubmed">11081882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousse N, Juthier F, Pin&#xe7;on C, Hysi I, Ban C, Robin E, et al. ECMO as a bridge to decision: recovery, VAD, or heart transplantation? Int J Cardiol. 2015;187:620&#x2013;627. doi: 10.1016/j.ijcard.2015.03.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.03.283</ArticleId><ArticleId IdType="pubmed">25863737</ArticleId></ArticleIdList></Reference><Reference><Citation>Roussel A, Al-Attar N, Alkhoder S, Radu C, Raffoul R, Alshammari M, et al. Outcomes of percutaneous femoral cannulation for venoarterial extracorporeal membrane oxygenation support. Eur Heart J Acute Cardiovasc Care. 2012;1(2):111&#x2013;114. doi: 10.1177/2048872612449417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872612449417</ArticleId><ArticleId IdType="pmc">PMC3760531</ArticleId><ArticleId IdType="pubmed">24062897</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Doll N, Kiaii B, Borger M, Bucerius J, Kramer K, Schmitt D, et al. Five year results of 219 consecutive patients treated with extracorporeal membrane oxygenation after refractory postoperative cardiogenic shock. Ann Thorac Surg. 2004;77:151&#x2013;157. doi: 10.1016/S0003-4975(03)01329-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(03)01329-8</ArticleId><ArticleId IdType="pubmed">14726052</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarpino G, Ruggieri VG, Mariscalco G, Bounader K, Beghi C, Fischlein T, et al. Outcome in patients having salvage coronary artery bypass grafting. Am J Cardiol. 2015;116(8):1193&#x2013;1198. doi: 10.1016/j.amjcard.2015.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.07.034</ArticleId><ArticleId IdType="pubmed">26303635</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CL, Wang H, Jia M, Ma N, Meng X, Hou XT. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: a retrospective observational study. J Thorac Cardiovasc Surg. 2015;149(5):1445&#x2013;1450. doi: 10.1016/j.jtcvs.2014.11.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2014.11.052</ArticleId><ArticleId IdType="pubmed">25534305</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsharkawy HA, Li L, Esa WA, Sessler DI, Bashour CA. Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery. J Cardiothorac Vasc Anesth. 2010;24(6):946&#x2013;951. doi: 10.1053/j.jvca.2010.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2010.03.020</ArticleId><ArticleId IdType="pubmed">20599396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MY, Lin PJ, Lee MY, Tsai FC, Chu JJ, Chang YS, et al. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival. Resuscitation. 2010;81(9):1111&#x2013;1116. doi: 10.1016/j.resuscitation.2010.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2010.04.031</ArticleId><ArticleId IdType="pubmed">20627521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhtiary F, Keller H, Dogan S, Dzemali O, Oezaslan F, Meininger D, et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg. 2008;135(2):382&#x2013;388. doi: 10.1016/j.jtcvs.2007.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2007.08.007</ArticleId><ArticleId IdType="pubmed">18242273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS, et al. Extracorporeal membrane oxygenation support for adult Postcardiotomy Cardiogenic shock. Ann Thorac Surg. 2002;73:538&#x2013;545. doi: 10.1016/S0003-4975(01)03330-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(01)03330-6</ArticleId><ArticleId IdType="pubmed">11845871</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorsandi M, Dougherty S, Sinclair A, Buchan K, MacLennan F, Bouamra O, et al. A 20-year multicentre outcome analysis of salvage mechanical circulatory support for refractory cardiogenic shock after cardiac surgery. J Cardiothorac Surg. 2016;8(11):151. doi: 10.1186/s13019-016-0545-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-016-0545-5</ArticleId><ArticleId IdType="pmc">PMC5100311</ArticleId><ArticleId IdType="pubmed">27821152</ArticleId></ArticleIdList></Reference><Reference><Citation>Slottosch I, Liakopoulos O, Kuhn E, Deppe AC, Scherner M, Madershahian N, et al. Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. J Surg Res. 2013;181(2):47&#x2013;55. doi: 10.1016/j.jss.2012.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2012.07.030</ArticleId><ArticleId IdType="pubmed">22878151</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikus E, Tripodi A, Calvi S, Giglio D, Cavallucci A, Lamarra M, et al. CentriMag Venoarterial extracorporeal membrane oxygenation support as treatment for patients with refractory Postcardiotomy Cardiogenic shock. ASAIO J. 2013;59(1):18&#x2013;23. doi: 10.1097/MAT.0b013e3182768b68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0b013e3182768b68</ArticleId><ArticleId IdType="pubmed">23271391</ArticleId></ArticleIdList></Reference><Reference><Citation>Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg. 2001;122:92&#x2013;102. doi: 10.1067/mtc.2001.114351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2001.114351</ArticleId><ArticleId IdType="pubmed">11436041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CY, Chen YC, Tsai FC, Tian YC, Jenq CC, Fang JT, et al. RIFLE classification is predictive of short-term prognosis in critically ill patients with acute renal failure supported by extracorporeal membrane oxygenation. Nephrol Dial Transplant. 2006;21:2867&#x2013;2873. doi: 10.1093/ndt/gfl326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl326</ArticleId><ArticleId IdType="pubmed">16799171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kielstein JT, Heiden AM, Beutel G, Gottlieb J, Wiesner O, Hafer C, et al. Renal function and survival in 200 patients undergoing ECMO therapy. Nephrol Dial Transplant. 2013;28:86&#x2013;90. doi: 10.1093/ndt/gfs398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfs398</ArticleId><ArticleId IdType="pubmed">23136216</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappalardo F, Montisci A. Veno-arterial extracorporeal membrane oxygenation (VA ECMO) in postcardiotomy cardiogenic shock: how much pump flow is enough? J Thorac Dis. 2016;8(10):1444&#x2013;1448. doi: 10.21037/jtd.2016.10.01.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.10.01</ArticleId><ArticleId IdType="pmc">PMC5107499</ArticleId><ArticleId IdType="pubmed">27867655</ArticleId></ArticleIdList></Reference><Reference><Citation>Unosawa S, Sezai A, Hata M, Nakata K, Yoshitake I, Wakui S, et al. Long-term outcomes of patients undergoing extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. Surg Today. 2013;43(3):264&#x2013;270. doi: 10.1007/s00595-012-0322-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-012-0322-6</ArticleId><ArticleId IdType="pubmed">22945889</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheampong B, Johnson JN, Stulak JM, Dearani JA, Kushwaha SS, Daly RC, et al. Postcardiotomy ECMO support after high-risk operations in adult congenital heart disease. Congenit Heart Dis. 2016;11(6):751&#x2013;755. doi: 10.1111/chd.12396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12396</ArticleId><ArticleId IdType="pubmed">27436116</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorsandi M, Shaikhrezai K, Prasad S, Pessotto R, Walker W, Berg G, et al. Advanced mechanical circulatory support for post-cardiotomy cardiogenic shock: a 20-year outcome analysis in a non-transplant unit. J Cardiothorac Surg. 2016;11(29). doi:10.1186/s13019-016-0430-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758144</ArticleId><ArticleId IdType="pubmed">26892226</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunning J. Post-cardiotomy mechanical support update. SCTS annual meeting Belfast: Society for Cardiothoracic Surgery in Great Britain &amp; Ireland. 2017.</Citation></Reference><Reference><Citation>Fl&#xe9;cher E. AA, Corbineau H, Langanay T, Verhoye JP, F&#xe9;lix C, et al. current aspects of extracorporeal membrane oxygenation in a tertiary referral centre: determinants of survival at follow-up. Eur J Cardio-Thoracic Surg. 2014;46(4):665&#x2013;671. doi: 10.1093/ejcts/ezu029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu029</ArticleId><ArticleId IdType="pubmed">24574452</ArticleId></ArticleIdList></Reference><Reference><Citation>Annich GM, Lynch WR, MacLaren G, Wilson JM, Bartlett RH. Extracorporeal Cardiopulmonay support in critical care. 4. ELSO: Michigan; 2012.</Citation></Reference><Reference><Citation>Emin A, Rogers CA, Parameshwar J, MacGowan G, Taylor R, Yonan N, et al. Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail. 2013;15:1185&#x2013;1193. doi: 10.1093/eurjhf/hft127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hft127</ArticleId><ArticleId IdType="pubmed">23901056</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsui S. Outcome of temporary MCS support for post- cardiotomy cardiogenic shock: is it worth the effort? In: meeting SA, editor. Society for Cardiothoracic Surgery in Great Britain &amp; Ireland: Belfast; 2017.</Citation></Reference><Reference><Citation>Westaby S, Taggart D. Inappropriate restrictions on life saving technology. Heart. 2012;98(15):1117&#x2013;1119. doi: 10.1136/heartjnl-2011-301365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2011-301365</ArticleId><ArticleId IdType="pmc">PMC3392688</ArticleId><ArticleId IdType="pubmed">22634172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani A, Manganas C. Extracorporeal membrane oxygenation (ECMO) in post-cardiotomy cardiogenic shock (PCCS) in adults: a systematic review. Heart Lung Circ. 2015;24(1):e56. doi: 10.1016/j.hlc.2014.12.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2014.12.119</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Seco M, Forrest P, Jackson SA, Martinez G, Andvik S, Bannon PG, et al. Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation. Heart Lung Circ. 2014;23(10):957&#x2013;962. doi: 10.1016/j.hlc.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2014.05.006</ArticleId><ArticleId IdType="pubmed">24954708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PS, Chen JL, Hong GJ, Tsai YT, Lin CY, Lee CY, et al. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg. 2010;37:328&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">19748279</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed D, Maxhera B, Westenfeld R, Lichtenberg A, Albert A, et al. An alternative approach for Perioperative extracorporeal life support implantation. Artif Organs. 2015;39(8):719&#x2013;723. doi: 10.1111/aor.12490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.12490</ArticleId><ArticleId IdType="pubmed">25912873</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajjad M, Osman A, Mohsen S, Alanazi M, Ugurlucan M, Canver C, et al. Extracorporeal membrane oxygenation in adults: experience from the Middle East. Asian Cardiovasc Thorac Ann. 2012;2(5):521&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">24570552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokersnik JA, Buda T, Bashour CA, Gonzalez-Stawinski GV. Have changes in ECMO technology impacted outcomes in adult patients developing postcardiotomy cardiogenic shock? J Card Surg. 2012;27(2):246&#x2013;252. doi: 10.1111/j.1540-8191.2011.01409.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8191.2011.01409.x</ArticleId><ArticleId IdType="pubmed">22372761</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno I, Soria A, L&#xf3;pez G&#xf3;mez A, Vicente R, Porta J, Vicente JL, et al. Extracorporeal membrane oxygenation after cardiac surgery in 12 patients with cardiogenic shock. Rev Esp Anestesiol Reanim. 2011;58(3):156&#x2013;160. doi: 10.1016/S0034-9356(11)70023-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0034-9356(11)70023-8</ArticleId><ArticleId IdType="pubmed">21534290</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SS, Chen YS, Ko WJ, Chu SH. Extracorporeal membrane oxygenation support for postcardiotomy cardiogenic shock. Artif Organs. 1996;20(12):1287&#x2013;1291. doi: 10.1111/j.1525-1594.1996.tb00676.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1594.1996.tb00676.x</ArticleId><ArticleId IdType="pubmed">8947449</ArticleId></ArticleIdList></Reference><Reference><Citation>Magovern GJ, Jr, Magovern JA, Benckart DH, Lazzara RR, Sakert T, Maher TD, Jr, et al. Extracorporeal membrane oxygenation: preliminary results in patients with postcardiotomy cardiogenic shock. Ann Thorac Surg. 1994;57(6):1469&#x2013;1471. doi: 10.1016/0003-4975(94)90101-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(94)90101-5</ArticleId><ArticleId IdType="pubmed">8010788</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena P, Neal J, Joyce LD, Greason KL, Schaff HV, Guru P, et al. Extracorporeal membrane oxygenation support in Postcardiotomy elderly patients: the Mayo Clinic experience. Ann Thorac Surg. 2015;99(6):2053&#x2013;2060. doi: 10.1016/j.athoracsur.2014.11.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.11.075</ArticleId><ArticleId IdType="pubmed">25865760</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Jia S, Meng X, Dong P, Jia M, Wan J, et al. Acute kidney injury in adult postcardiotomy patients with extracorporeal membrane oxygenation: evaluation of the RIFLE classification and the acute kidney injury network criteria. European J Cardio-Thoracic Surg. 2010;37(2):334&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">19692267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40436616</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0844</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>European journal of heart failure</Title><ISOAbbreviation>Eur J Heart Fail</ISOAbbreviation></Journal><ArticleTitle>Kidney injury in patients with heart failure-related cardiogenic shock: Results from an international, multicentre cohort study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ejhf.3701</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Heart failure-related cardiogenic shock (HF-CS) accounts for about half of CS cases, with a paucity of data regarding the role of kidney injury in this subset. This study aims to evaluate patient characteristics and outcome associated with renal function in patients with HF-CS.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">In this multicentre, international, retrospective study, patients with HF-CS from 16 tertiary care centres in five countries were enrolled between 2010 and 2021. To investigate differences in clinical presentation, complications, and 30-day mortality, based on renal function, adjusted logistic and Cox regression models were fitted. Among 1010 HF-CS patients, the median age was 64 (interquartile range [IQR] 52-75) years, with 71.7% being male. Median baseline creatinine was 1.7 (IQR 1.2-2.5) mg/dl, corresponding to an estimated glomerular filtration rate (eGFR) of 41.0 (IQR 25.2-62.2) ml/min/1.73&#x2009;m<sup>2</sup>. In patients with acute kidney injury (AKI), 30-day mortality increased with AKI stages (no AKI 41.7%, AKI stage 1 43.3%, AKI stage 2 50.0%, AKI stage 3 63.7%; adjusted hazard ratio [HR] for AKI stage 3 1.97, 95% confidence interval [CI] 1.56-2.48, p&#x2009;&lt;&#x2009;0.001). Similarly, severe renal dysfunction (eGFR &#x2264; median) was associated with a 21% higher 30-day mortality risk (61.0% vs. 40.1%; adjusted HR 1.48, 95% CI 1.20-1.84, p&#x2009;&lt;&#x2009;0.001). Sepsis and bleeding were associated with both AKI and renal dysfunction, even after adjustment.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In HF-CS, kidney injury is associated with higher 30-day mortality, potentially mediated by bleeding and sepsis. These findings support the consideration of kidney function as a prognostic marker and call for the development and evaluation of kidney-restoring adjunct interventions in HF-CS.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). European Journal of Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sundermeyer</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0076-2211</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellner</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Population Health Innovation (POINT), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beer</LastName><ForeName>Benedikt N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besch</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dettling</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoldi</LastName><ForeName>Letizia Fausta</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Cardio Center, Humanitas Clinical and Research Center - IRCCS, Rozzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankenberg</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Population Health Innovation (POINT), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dauw</LastName><ForeName>Jeroen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckner</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Paracelsus Medical University N&#xfc;rnberg, N&#xfc;rnberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eitel</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Heart Center L&#xfc;beck, University Hospital Schleswig-Holstein, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graf</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Heart Center L&#xfc;beck, University Hospital Schleswig-Holstein, L&#xfc;beck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, University Duesseldorf, Duesseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jozwiak-Nozdrzykowska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchhof</LastName><ForeName>Paulus</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Population Health Innovation (POINT), University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linke</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department for Internal Medicine and Cardiology, Heart Center Dresden, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landmesser</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit&#xe9; (DHZC), Campus Benjamin Franklin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;sebrink</LastName><ForeName>Enzo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majunke</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangner</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department for Internal Medicine and Cardiology, Heart Center Dresden, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Sven M&#xf6;bius</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordbeck</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Anesthesia and Intensive Care, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pauschinger</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Paracelsus Medical University N&#xfc;rnberg, N&#xfc;rnberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pazdernik</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, IKEM, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proudfoot</LastName><ForeName>Alastair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelham</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, St. Bartholomew's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassaf</LastName><ForeName>Tienush</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reichenspurner</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>P Christian</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine I, University Hospital Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwinger</LastName><ForeName>Robert H G</ForeName><Initials>RHG</Initials><AffiliationInfo><Affiliation>Medizinische Klinik II, Kliniken Nordoberpfalz AG, Weiden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skurk</LastName><ForeName>Carsten</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit&#xe9; (DHZC), Campus Benjamin Franklin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sramko</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, IKEM, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical-Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Fondazione Policlinico San Matteo Hospital IRCCS, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiele</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiology, Heart Center Leipzig at University of Leipzig and Leipzig Heart Science, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanova</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit&#xe0; di Cure Intensive Cardiologiche and De Gasperis Cardio-Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morici</LastName><ForeName>Nuccia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Don Gnocchi, ONLUS, Santa Maria Nascente, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winzer</LastName><ForeName>Ephraim B</ForeName><Initials>EB</Initials><AffiliationInfo><Affiliation>Department for Internal Medicine and Cardiology, Heart Center Dresden, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westermann</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schrage</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK), Partner site Hamburg/Kiel/L&#xfc;beck, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Heart Fail</MedlineTA><NlmUniqueID>100887595</NlmUniqueID><ISSNLinking>1388-9842</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Kidney function</Keyword><Keyword MajorTopicYN="N">Kidney injury</Keyword><Keyword MajorTopicYN="N">Non&#x2010;AMI CS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40436616</ArticleId><ArticleId IdType="doi">10.1002/ejhf.3701</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599&#x2013;3726. https://doi.org/10.1093/eurheartj/ehab368</Citation></Reference><Reference><Citation>Naidu SS Baran DA Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: A review and incorporation of validation studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December&#x2009;2021. J Am Coll Cardiol 2022 79 933 946 https://doi.org/10.1016/j.jacc.2022.01.018</Citation></Reference><Reference><Citation>Van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association. Circulation 2017;136:e232&#x2013;e268. https://doi.org/10.1161/CIR.0000000000000525</Citation></Reference><Reference><Citation>Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, et al. Fifteen&#x2010;year trends in incidence of cardiogenic shock hospitalization and in&#x2010;hospital mortality in the United States. J Am Heart Assoc 2021;10:e021061. https://doi.org/10.1161/JAHA.121.021061</Citation></Reference><Reference><Citation>Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, S&#xf8;rensen A, et al. Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: A Danish cohort study. Eur J Heart Fail 2019;21:1370&#x2013;1378. https://doi.org/10.1002/ejhf.1566</Citation></Reference><Reference><Citation>Schrage B, Becher PM, Go&#xdf;ling A, Savarese G, Dabboura S, Yan I, et al. Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock. ESC Heart Fail 2021;8:1295&#x2013;1303. https://doi.org/10.1002/ehf2.13202</Citation></Reference><Reference><Citation>Berg DD, Bohula EA, van Diepen S, Katz JN, Alviar CL, Baird&#x2010;Zars VM, et al. Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 2019;12(3):e005618. https://doi.org/10.1161/CIRCOUTCOMES.119.005618</Citation></Reference><Reference><Citation>Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non&#x2010;infarction related cardiogenic shock in the United States. Clin Res Cardiol 2017;107:287&#x2013;303. https://doi.org/10.1007/S00392&#x2010;017&#x2010;1182&#x2010;2</Citation></Reference><Reference><Citation>Thiele H, Ohman EM, De Waha&#x2010;Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: An update 2019. Eur Heart J 2019;40:2671&#x2013;2683. https://doi.org/10.1093/eurheartj/ehz363</Citation></Reference><Reference><Citation>Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez&#x2010;Montfort J, Mahr C, et al. Invasive hemodynamic assessment and classification of in&#x2010;hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail 2020;13:e007099. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007099</Citation></Reference><Reference><Citation>Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, S&#xf6;rensen NA, et al. Application of the SCAI classification in a cohort of patients with cardiogenic shock. Catheter Cardiovasc Interv 2020;96:E213&#x2013;E219. https://doi.org/10.1002/ccd.28707</Citation></Reference><Reference><Citation>Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, et al. Clinical presentation, shock severity and mortality in patients with de novo versus acute&#x2010;on&#x2010;chronic heart failure&#x2010;related cardiogenic shock. Eur J Heart Fail 2024;26:432&#x2013;444. https://doi.org/10.1002/ejhf.3082</Citation></Reference><Reference><Citation>Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, et al. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 2019;74(17):2117 2128. https://doi.org/10.1016/j.jacc.2019.07.077</Citation></Reference><Reference><Citation>Schrage B, Sundermeyer J, Beer BN, Bertoldi L, Bernhardt A, Blankenberg S, et al. Use of mechanical circulatory support in patients with non&#x2010;ischaemic cardiogenic shock. Eur J Heart Fail 2023;25:562&#x2013;572. https://doi.org/10.1002/ejhf.2796</Citation></Reference><Reference><Citation>Ghionzoli N, Sciaccaluga C, Mandoli G, Vergaro G, Gentile F, D'Ascenzi F, et al. Cardiogenic shock and acute kidney injury: The rule rather than the exception. Heart Fail Rev 2021;26:487&#x2013;496. https://doi.org/10.1007/s10741&#x2010;020&#x2010;10034&#x2010;0</Citation></Reference><Reference><Citation>Rewa O, Bagshaw SM. Acute kidney injury&#xa0;&#x2013;&#xa0;epidemiology, outcomes and economics. Nat Rev Nephrol 2014;10:193&#x2013;207. https://doi.org/10.1038/nrneph.2013.282</Citation></Reference><Reference><Citation>Zhang J, Bottiglieri T, McCullough PA. The central role of endothelial dysfunction in cardiorenal syndrome. Cardiorenal Med 2017;7:104&#x2013;117. https://doi.org/10.1159/000452283</Citation></Reference><Reference><Citation>Damman K, Testani JM. The kidney in heart failure: An update. Eur Heart J 2015;36:1437&#x2013;1444. https://doi.org/10.1093/eurheartj/ehv010</Citation></Reference><Reference><Citation>Tarvasm&#xe4;ki T, Haapio M, Mebazaa A, Sionis A, Silva&#x2010;Cardoso J, Tolppanen H, et al.; CardShock Study Investigators. Acute kidney injury in cardiogenic shock: Definitions, incidence, haemodynamic alterations, and mortality. Eur J Heart Fail 2018;20:572&#x2013;581. https://doi.org/10.1002/ejhf.958</Citation></Reference><Reference><Citation>Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, et al. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 2002;112:115&#x2013;119. https://doi.org/10.1016/S0002&#x2010;9343(01)01070&#x2010;1</Citation></Reference><Reference><Citation>Pickering JW, Blunt IRH, Than MP. Acute kidney injury and mortality prognosis in acute coronary syndrome patients: A meta&#x2010;analysis. Nephrol Ther 2018;23:237&#x2013;246. https://doi.org/10.1111/NEP.12984</Citation></Reference><Reference><Citation>Uzendu A, Kennedy K, Chertow G, Amin AP, Giri JS, Rymer JA, et al. Contemporary methods for predicting acute kidney injury after coronary intervention. JACC Cardiovasc Interv 2023;16:2294&#x2013;2305. https://doi.org/10.1016/j.jcin.2023.07.041</Citation></Reference><Reference><Citation>Dalia T, Pothuru S, Chan WC, Mehta H, Goyal A, Farhoud H, et al. Trends and outcomes of cardiogenic shock in patients with end&#x2010;stage renal disease: Insights from USRDS database. Circ Heart Fail 2023;16:e010462. https://doi.org/10.1161/CIRCHEARTFAILURE.122.010462</Citation></Reference><Reference><Citation>Sheikh O, Nguyen T, Bansal S, Prasad A. Acute kidney injury in cardiogenic shock: A comprehensive review. Catheter Cardiovasc Interv 2021;98:E91&#x2013;E105. https://doi.org/10.1002/ccd.29141</Citation></Reference><Reference><Citation>Sundermeyer J, Kellner C, Beer BN, Besch L, Dettling A, Bertoldi LF, et al. Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non&#x2010;ischaemic cardiogenic shock. Clin Res Cardiol 2024;113:570&#x2013;580. https://doi.org/10.1007/s00392&#x2010;023&#x2010;02332&#x2010;y</Citation></Reference><Reference><Citation>Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv, 2019; 94(1): 29&#x2013;37. https://doi.org/10.1002/ccd.28329</Citation></Reference><Reference><Citation>Kramer HJ, Jaar BG, Choi MJ, Palevsky PM, Vassalotti JA, Rocco MV. An endorsement of the removal of race from GFR estimation equations: A position statement from the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Kidney Dis 2022;80:691&#x2013;696. https://doi.org/10.1053/j.ajkd.2022.08.004</Citation></Reference><Reference><Citation>Inker LA Eneanya ND Coresh J Tighiouart H Wang D Sang Y, et al.; Chronic Kidney Disease Epidemiology Collaboration. New creatinine&#x2010; and cystatin C&#x2010;based equations to estimate GFR without race N Engl J Med 2021 385 1737 1749 https://doi.org/10.1056/NEJMoa2102953</Citation></Reference><Reference><Citation>Zweck E, Thayer KL, Helgestad OKL, Kanwar M, Ayouty M, Garan AR, et al. Phenotyping cardiogenic shock. J Am Heart Assoc 2021;10:e020085. https://doi.org/10.1161/JAHA.120.020085</Citation></Reference><Reference><Citation>Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez&#x2010;Montfort J, et al. Criteria for defining stages of cardiogenic shock severity. J Am Coll Cardiol 2022;80:185&#x2013;198. https://doi.org/10.1016/j.jacc.2022.04.049</Citation></Reference><Reference><Citation>Beer BN, Jentzer JC, Weimann J, Dabboura S, Yan I, Sundermeyer J, et al. Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause&#xa0;&#x2013;&#xa0;the Cardiogenic Shock Score. Eur J Heart Fail 2022;24:657&#x2013;667. https://doi.org/10.1002/ejhf.2449</Citation></Reference><Reference><Citation>Kanwar MK, Billia F, Randhawa V, Cowger JA, Barnett CM, Chih S, et al. Heart failure related cardiogenic shock: An ISHLT consensus conference content summary. J Heart Lung Transplant 2024;43:189&#x2013;203. https://doi.org/10.1016/j.healun.2023.09.014</Citation></Reference><Reference><Citation>Padkins M, Breen T, Van Diepen S, Barsness G, Kashani K, Jentzer JC. Incidence and outcomes of acute kidney injury stratified by cardiogenic shock severity. Catheter Cardiovasc Interv 2021;98:330&#x2013;340. https://doi.org/10.1002/ccd.29692</Citation></Reference><Reference><Citation>Fuernau G, Poenisch C, Eitel I, Denks D, de Waha S, P&#xf6;ss J, et al. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP&#x2010;SHOCK II&#x2010;trial. Int J Cardiol 2015;191:159&#x2013;166. https://doi.org/10.1016/j.ijcard.2015.04.242</Citation></Reference><Reference><Citation>Marenzi G, Assanelli E, Campodonico J, de Metrio M, Lauri G, Marana I, et al. Acute kidney injury in ST&#x2010;segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 2010;38:438&#x2013;444. https://doi.org/10.1097/CCM.0B013E3181B9EB3B</Citation></Reference><Reference><Citation>Harjola VP, Lassus J, Sionis A, K&#xf8;ber L, Tarvasm&#xe4;ki T, Spinar J, et al.; CardShock Study Investigators; GREAT network. Clinical picture and risk prediction of short&#x2010;term mortality in cardiogenic shock. Eur J Heart Fail 2015;17:501&#x2013;509. https://doi.org/10.1002/ejhf.260</Citation></Reference><Reference><Citation>Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the American Heart Association. Circulation 2019;139:E840&#x2013;E878. https://doi.org/10.1161/CIR.0000000000000664</Citation></Reference><Reference><Citation>Jentzer JC, Bihorac A, Brusca SB, del Rio&#x2010;Pertuz G, Kashani K, Kazory A, et al.; Critical Care Cardiology Working Group of the Heart Failure and Transplant Section Leadership Council. Contemporary management of severe acute kidney injury and refractory cardiorenal syndrome: JACC Council perspectives. J Am Coll Cardiol 2020;76:1084&#x2013;1101. https://doi.org/10.1016/j.jacc.2020.06.070</Citation></Reference><Reference><Citation>Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, et al. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. Eur J Heart Fail 2008;10:188&#x2013;195. https://doi.org/10.1016/j.ejheart.2008.01.011</Citation></Reference><Reference><Citation>Patsalis N, Kreutz J, Chatzis G, Syntila S, Griewing S, Pirlet&#x2010;Grant C, et al. Renal protection and hemodynamic improvement by Impella&#xae; microaxial pump in patients with cardiogenic shock. J Clin Med 2022;11:6817. https://doi.org/10.3390/jcm11226817</Citation></Reference><Reference><Citation>Lauridsen MD, Gammelager H, Schmidt M, Rasmussen TB, Shaw RE, B&#xf8;tker HE, et al. Acute kidney injury treated with renal replacement therapy and 5&#x2010;year mortality after myocardial infarction&#x2010;related cardiogenic shock: A nationwide population&#x2010;based cohort study. Crit Care 2015;19:452. https://doi.org/10.1186/s13054&#x2010;015&#x2010;1170&#x2010;8</Citation></Reference><Reference><Citation>Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence&#x2010;based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol 2007;3:138&#x2013;153. https://doi.org/10.1038/ncpneph0421</Citation></Reference><Reference><Citation>Prowle JR, Liu YL, Licari E, Bagshaw SM, Egi M, Haase M, et al. Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 2011;15:R172. https://doi.org/10.1186/cc10318</Citation></Reference><Reference><Citation>Hanberg JS, Sury K, Perry Wilson F, Wilson FP, Brisco MA, Ahmad T, et al. Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure. J Am Coll Cardiol 2016;67:2199&#x2013;2208. https://doi.org/10.1016/j.jacc.2016.02.058</Citation></Reference><Reference><Citation>Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589&#x2013;596. https://doi.org/10.1016/j.jacc.2008.05.068</Citation></Reference><Reference><Citation>Roman&#x2010;Pognuz E, Elmer J, Rittenberger JC, Guyette FX, Berlot G, De Rosa S, et al. Markers of cardiogenic shock predict persistent acute kidney injury after out of hospital cardiac arrest. Heart Lung 2019;48:126&#x2013;130. https://doi.org/10.1016/j.hrtlng.2018.10.025</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37774926</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>395</Volume><PubDate><Year>2024</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>131401</StartPage><MedlinePgn>131401</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2023.131401</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(23)01394-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Previous literature suggests that both SARS-CoV-2 infection and COVID-19 mRNA vaccine are associated with myocarditis, in which the incidence is higher in the infection group. COVID-19 mRNA vaccine-related myocarditis is noted to have a more benign course. Despite these findings, there is a need for a larger population systematic review that compares the outcomes to pre-pandemic acute myocarditis to better understand the extent of the current post-COVID state.</AbstractText><AbstractText Label="METHODS">We performed a literature search with PubMed and EMBASE and identified studies investigating COVID-19 and its vaccinated population, and the population prior to the pandemic (control group) who had myocarditis. We performed a one-group meta-analysis of the incidence, baseline demographics, and outcomes of myocarditis for each group.</AbstractText><AbstractText Label="RESULTS">The incidence in the SARS-CoV-2 infection group was 2.76 per thousand (95% CI, 0.85-8.92), 19.7 per million (95% CI, 12.3-31.6) in the vaccine group, and 0.861 per million (95% CI, 0.04-16.7) in the control group. The majority of patients were male, with the highest proportion in the vaccine group. The mean age was the youngest in the vaccine group (24.8, 95% CI, 19.1-30.6). The vaccine group had the lowest mortality (2.0%, 95% CI, 1.3-2.7) followed by the control and the SARS-CoV-2 infection group. The vaccine group had the lowest proportion of immunoglobulin and glucocorticoid use, mechanical circulatory support, and cardiogenic shock.</AbstractText><AbstractText Label="CONCLUSION">Our study showed favorable outcomes of myocarditis in patients with COVID-19 mRNA vaccination, despite a higher incidence than pre-COVID controls. Further studies with standardized myocarditis diagnostic criteria assessing long-term outcomes are necessary.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishisaka</LastName><ForeName>Yoshiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Atsuyuki</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aikawa</LastName><ForeName>Tadao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hokkaido Cardiovascular Hospital, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanaoka</LastName><ForeName>Koshiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medical and Health Information Management, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Hisato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiley</LastName><ForeName>Jose</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Medicine, Tulane University School of Medicine, LA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasuhara</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Royal Children's Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuno</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, NY, New York, USA; Division of Cardiology, Jacobi Medical Center, Albert Einstein College of Medicine, NY, New York, USA. Electronic address: tkuno@montefiore.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000087503">mRNA Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087503" MajorTopicYN="N">mRNA Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">mRNA vaccine</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774926</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2023.131401</ArticleId><ArticleId IdType="pii">S0167-5273(23)01394-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35940444</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6795</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography</Title><ISOAbbreviation>J Am Soc Echocardiogr</ISOAbbreviation></Journal><ArticleTitle>Comparison of Pre- and Postnatally Diagnosed Coronary Artery Fistulae: Echocardiographic Features and Clinical Outcomes.</ArticleTitle><Pagination><StartPage>1322</StartPage><EndPage>1335</EndPage><MedlinePgn>1322-1335</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.echo.2022.07.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0894-7317(22)00390-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Coronary artery fistulae (CAFs) are abnormal connections of a coronary artery to a cardiac chamber or vessel. There is a paucity of data regarding clinical outcomes, especially when detected prenatally.</AbstractText><AbstractText Label="METHODS">This was a multicenter retrospective cohort study of all CAF cases from 2002 to 2016. Clinical characteristics and outcomes were compared between the prenatal and postnatal cohorts. A scoping literature review of prenatal CAFs was completed.</AbstractText><AbstractText Label="RESULTS">CAFs were diagnosed prenatally in 12 (median, 23&#xa0;weeks' gestation; interquartile range, 17-36&#xa0;weeks' gestation) and postnatally in 94 (median, 2.8&#xa0;years; interquartile range, 0-15&#xa0;years) cases. Structural heart defects were present in five (42%) prenatal and 19 (20%) postnatal cases (P&#xa0;=&#xa0;.011) and genetic conditions in five (42%) and 14 (15%), respectively (P&#xa0;=&#xa0;.001). CAFs were considered large in 12 (100%) prenatal versus 14 (15%) postnatal cases (P&#xa0;&lt;&#xa0;.001). The CAF distribution was similar between cohorts: 39 (67%) from the left and 19 (33%) from the right coronary artery, with the most common exit sites being the main pulmonary artery 54 (51%), right ventricle 30 (28%), and right atrium 12 (11%). Of prenatal cases, all large at presentation, none progressed, six (50%) resolved by birth, and one (8%) underwent elective neonatal ligation. Of postnatal cases, one presented in cardiogenic shock, and no other case had ventricular dysfunction, arrhythmias, or ischemic changes. Nine (10%) with large shunts underwent intervention (seven percutaneous, two surgical), of whom three were symptomatic. Two (17%) prenatal and two (2%) postnatal cases had coronary abnormalities, two with normal results on stress perfusion imaging. Postnatal death occurred in two (17%) prenatal and four (4%) postnatal cases (P&#xa0;=&#xa0;.05). Of the total 36 prenatal cases reported in the literature, including the 12 cases in the present series, 10 (28%) had clinical symptoms at birth, including three (8%) with cardiogenic shock, and 19 (53%) underwent intervention.</AbstractText><AbstractText Label="CONCLUSIONS">Prenatally and postnatally encountered CAFs are associated with a good prognosis for most, with many not requiring intervention. Although half of the prenatal CAFs resolved prenatally, given the risk for cardiogenic shock at birth and heart failure in early infancy, appropriate perinatal planning and postnatal surveillance is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pisesky</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Labatt Family Heart Center, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nield</LastName><ForeName>Lynne E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Labatt Family Heart Center, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada. Electronic address: lynne.nield@sickkids.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Fetal and Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Stollery Children's Hospital, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaeggi</LastName><ForeName>Edgar T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Labatt Family Heart Center, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hornberger</LastName><ForeName>Lisa K</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Fetal and Neonatal Cardiology Program, Division of Cardiology, Department of Pediatrics, Stollery Children's Hospital, Edmonton, Alberta, Canada; Department of Obstetrics &amp; Gynecology, University of Alberta, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Echocardiogr</MedlineTA><NlmUniqueID>8801388</NlmUniqueID><ISSNLinking>0894-7317</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005402" MajorTopicYN="Y">Fistula</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016216" MajorTopicYN="N">Ultrasonography, Prenatal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aneuploidy</Keyword><Keyword MajorTopicYN="N">Coronary artery fistula</Keyword><Keyword MajorTopicYN="N">Fetal echocardiography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>8</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35940444</ArticleId><ArticleId IdType="doi">10.1016/j.echo.2022.07.015</ArticleId><ArticleId IdType="pii">S0894-7317(22)00390-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40448257</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Ivabradine use in critical care: a systematic review and metanalysis of cardiogenic and septic shock patients.</ArticleTitle><Pagination><StartPage>276</StartPage><MedlinePgn>276</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">276</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-025-03121-y</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In patients with acute illness, compensatory tachycardia initially serves to maintain adequate cardiac output, oxygen delivery and tissue oxygenation but may persist despite appropriate fluid and vasopressor resuscitation or may be secondary to inotropic therapy. Sustained tachycardia is a predictor of adverse outcomes in critical illness. Ivabradine, a highly selective inhibitor of the sinoatrial node's pacemaker current (I<sub>f</sub> or "funny" current), mitigates tachycardia by modulating diastolic depolarization slope without affecting contractility.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To report the existing evidence on the use of ivabradine in critically ill patients and assess its effect on rate control.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature search was performed up to May 2024 in the MEDLINE/PubMed&#xae;, Cochrane Controlled Clinical Trial register, EMBASE&#xae; and Scopus&#xae; databases. The search included: P- only original studies conducted in humans admitted to the Intensive Care Unit (ICU); I - when ivabradine administration was tested; C - in presence or absence of a control group; O - for any outcome; S - including case reports, randomized and observational trials, published in English in peer-reviewed journals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">After the first screening, 39 studies were assessed for eligibility on a total of 682 records identified. Among those, 29 were excluded; 10 studies (4 randomized controlled trial, 5 case report/series, 1 prospective observational), including a total of 243 patients, were included in the qualitative analysis, 6 studies were included in the quantitative analysis. The use of ivabradine resulted in a pooled mean heart rate reduction of 18.70 [12.70-24.80] bpm (p&#x2009;&lt;&#x2009;0.01) without a significant decrease in cardiac index (p&#x2009;=&#x2009;0.59). A significant reduction of noradrenaline dose was reported in one study (-0.134 mcg/kg/min; 95% CI -0.172 to -0.012; p&#x2009;=&#x2009;0.027). In addition, the combination of dobutamine with ivabradine has been reported to optimize dobutamine inotropic action, while mitigating its positive chronotropic effects, resulting in a more efficient cardiac cycle and improved hemodynamics.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Ivabradine may be a useful alternative to beta-blocker in the management of inappropriate sinus tachycardia. Yet, evidence is limited and inconsistent. Larger randomized trials are needed to investigate the potential benefits or hazards of ivabradine use on hemodynamics and long-term outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Lorenzo Antonino</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, H&#xf4;pital Erasme, Route de Lennik 808, Brussels, BE, 1070, Belgium. l.calabro@hubruxelles.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasetto</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit B, Integrated University Hospital of Verona, Verona, 37134, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Intensive Care Unit, Hospital and University Trust of Verona, P. le A.Stefani, Verona, 37124, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scolletta</LastName><ForeName>Sabino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anestesia E Rianimazione - Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annoni</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, H&#xf4;pital Erasme, Route de Lennik 808, Brussels, BE, 1070, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demailly</LastName><ForeName>Zoe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>CHU Rouen: Centre Hospitalier Universitaire de Rouen, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halenarova</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, H&#xf4;pital Erasme, Route de Lennik 808, Brussels, BE, 1070, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadello</LastName><ForeName>Katia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit B, Integrated University Hospital of Verona, Verona, 37134, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Dentistry, Ginaecology and Paediatrics, University of Verona, Verona, 337129, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taccone</LastName><ForeName>Fabio Silvio</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, H&#xf4;pital Erasme, Route de Lennik 808, Brussels, BE, 1070, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3H48L0LPZQ</RegistryNumber><NameOfSubstance UI="D000077550">Ivabradine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002317">Cardiovascular Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077550" MajorTopicYN="Y">Ivabradine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002317" MajorTopicYN="Y">Cardiovascular Agents</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical studies</Keyword><Keyword MajorTopicYN="N">Critically illness</Keyword><Keyword MajorTopicYN="N">Ivabradine</Keyword><Keyword MajorTopicYN="N">Shock</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>22</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40448257</ArticleId><ArticleId IdType="pmc">PMC12125779</ArticleId><ArticleId IdType="doi">10.1186/s12871-025-03121-y</ArticleId><ArticleId IdType="pii">10.1186/s12871-025-03121-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013;369:1726&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">24171518</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Trabold F, Sharshar T, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. Am J Respir Crit Care Med. 1999;160:458&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430714</ArticleId></ArticleIdList></Reference><Reference><Citation>Domizi R, Calcinaro S, Harris S, et al. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: a multicentre evaluation. J Crit Care. 2020;57:185&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">32171905</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse T, Hossain A, Perkins GD, et al. Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA. 2023;330:1641&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10600724</ArticleId><ArticleId IdType="pubmed">37877587</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumann J, Henrich EC, Strobl H, et al. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2018;1:CD009669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491099</ArticleId><ArticleId IdType="pubmed">29376560</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit. J Cardiovasc Pharmacol Ther. 2015;20:249&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">25432872</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">35363499</ArticleId></ArticleIdList></Reference><Reference><Citation>Koruth JS, Lala A, Pinney S, Reddy VY, Dukkipati SR. The clinical use of Ivabradine. J Am Coll Cardiol. 2017;70:1777&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">28958335</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner SM, Kemp PA, March JE, Bennett T. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Br J Pharmacol. 1995;115:579&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1908496</ArticleId><ArticleId IdType="pubmed">7582475</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale D, De Santis V, Guarracino F, Fontana A, Pellegrini F, Tritapepe L. Use of ivabradine in catecholamine-induced tachycardia after high-risk cardiac surgery. Clin Res Cardiol. 2010;99:853&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20821020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Barilla F, Pannarale G, Torromeo C, et al. Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study. Clin Drug Investig. 2016;36:849&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">27312076</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo CNJ, Dammassa V, Klersy C, et al. Heart rate control and haemodynamic improvement with ivabradine in cardiogenic shock patient on mechanical circulatory support. Eur Heart J Acute Cardiovasc Care. 2022;11:916&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">36222185</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta PK, Rewari V, Ramachandran R, et al. Effectiveness of enteral ivabradine for heart rate control in septic shock: a randomised controlled trial. Anaesth Intensive Care. 2021;49:366&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">34407620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallet R, Ternacle J, Damy T, et al. Hemodynamic effects of Ivabradine in addition to dobutamine in patients with severe systolic dysfunction. Int J Cardiol. 2014;176:450&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">25129291</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen LS, Squara P, Amour J, et al. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Crit Care. 2018;22:193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6097391</ArticleId><ArticleId IdType="pubmed">30115103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuding S, Schroder J, Presek P, et al. Reducing elevated heart rates in patients with multiple organ dysfunction syndrome with the If (Funny Channel Current) inhibitor Ivabradine. Shock. 2018;49:402&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">28930912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwicker C, Becker M, Lepper W, Koch KC, Westenfeld R. Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine. Cardiology. 2010;116:174&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20628253</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke J, Schmahl D, Lehrke S, et al. Adjuvant use of ivabradine in acute heart failure due to myocarditis. Case Rep Med. 2011;2011:203690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3180827</ArticleId><ArticleId IdType="pubmed">21966292</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis V, Frati G, Greco E, Tritapepe L. Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clin Res Cardiol. 2014;103:831&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159564</ArticleId><ArticleId IdType="pubmed">24805930</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">19703817</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42:1387&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">26873833</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A, Landoni G, Lomivorotov VV, Oriani A, Ajello S. Adrenergic downregulation in critical care: molecular mechanisms and therapeutic evidence. J Cardiothorac Vasc Anesth. 2020;34:1023&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">31839459</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Arias Ortiz J, Levy B. The medical treatment of cardiogenic shock: cardiovascular drugs. Curr Opin Crit Care. 2021;27:426&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">33797431</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedberg K, Komajda M, Bohm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">20801500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin Sumarni MN, Chiew AL, Isbister GK, Wylie CJ, Isoardi KZ. Ivabradine poisoning: a retrospective observational case series. Toxicol Commun. 2025;9:2464274.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34301817</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-3624</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Open heart</Title><ISOAbbreviation>Open Heart</ISOAbbreviation></Journal><ArticleTitle>Mechanical circulatory support in CS: device or patient?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e001733</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/openhrt-2021-001733</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morici</LastName><ForeName>Nuccia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>SS UTIC/ SC Cardiologia 1-Emodinamica, ASST Grande Ospedale Metropolitano Niguarda, Milano, Lombardia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fondazione IRCCS Policlinico S. Matteo, Department of Anesthesia and Intensive Care Unit, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>Guido</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-9560-5138</Identifier><AffiliationInfo><Affiliation>Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy guido.tavazzi@unipv.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Heart</MedlineTA><NlmUniqueID>101631219</NlmUniqueID><ISSNLinking>2053-3624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Open Heart. 2021 Jun;8(1):e001662. doi: 10.1136/openhrt-2021-001662.</RefSource><PMID Version="1">34127531</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiomyopathies</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>5</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34301817</ArticleId><ArticleId IdType="pmc">PMC8728356</ArticleId><ArticleId IdType="doi">10.1136/openhrt-2021-001733</ArticleId><ArticleId IdType="pii">openhrt-2021-001733</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lawler PR, Mehra MR. Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock. J Heart Lung Transplant 2018;37:1285&#x2013;8. 10.1016/j.healun.2018.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2018.07.009</ArticleId><ArticleId IdType="pubmed">30197209</ArticleId></ArticleIdList></Reference><Reference><Citation>Basir MB, Kapur NK, Patel K, et al. . Improved outcomes associated with the use of shock protocols: updates from the National cardiogenic shock initiative. Catheter Cardiovasc Interv 2019;93:1173&#x2013;83. 10.1002/ccd.28307</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.28307</ArticleId><ArticleId IdType="pubmed">31025538</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrage B, Ibrahim K, Loehn T, et al. . Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019;139:1249&#x2013;58. 10.1161/CIRCULATIONAHA.118.036614</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.036614</ArticleId><ArticleId IdType="pubmed">30586755</ArticleId></ArticleIdList></Reference><Reference><Citation>Alushi B, Douedari A, Froehlig G, et al. . Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart 2019;6:e000987. 10.1136/openhrt-2018-000987</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2018-000987</ArticleId><ArticleId IdType="pmc">PMC6546200</ArticleId><ArticleId IdType="pubmed">31218000</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo JJ, Aleksova N, Pitcher I, et al. . Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol 2019;73:654&#x2013;62. 10.1016/j.jacc.2018.10.085</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.10.085</ArticleId><ArticleId IdType="pubmed">30765031</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrage B, Becher PM, Bernhardt A, et al. . Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with Venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study. Circulation 2020;142:2095&#x2013;106. 10.1161/CIRCULATIONAHA.120.048792</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.048792</ArticleId><ArticleId IdType="pmc">PMC7688081</ArticleId><ArticleId IdType="pubmed">33032450</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah W, Zghouzi M, Mukhtar M, et al. . Comparative safety of percutaneous ventricular assist device and intra-aortic balloon pump in acute myocardial infarction-induced cardiogenic shock. Open Heart 2021;8:e001662. 10.1136/openhrt-2021-001662</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2021-001662</ArticleId><ArticleId IdType="pmc">PMC8204163</ArticleId><ArticleId IdType="pubmed">34127531</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani BN, Truesdell AG, Psotka MA, et al. . A standardized and comprehensive approach to the management of cardiogenic shock. JACC Heart Fail 2020;8:879&#x2013;91. 10.1016/j.jchf.2020.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2020.09.005</ArticleId><ArticleId IdType="pmc">PMC8167900</ArticleId><ArticleId IdType="pubmed">33121700</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg DD, Bohula EA, van Diepen S, et al. . Epidemiology of shock in contemporary cardiac intensive care units. Circ Cardiovasc Qual Outcomes 2019;12:e005618. 10.1161/CIRCOUTCOMES.119.005618</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.119.005618</ArticleId><ArticleId IdType="pmc">PMC11032172</ArticleId><ArticleId IdType="pubmed">30879324</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Patnaik S, Patel B, et al. . Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 2018;107:287&#x2013;303. 10.1007/s00392-017-1182-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-017-1182-2</ArticleId><ArticleId IdType="pubmed">29134345</ArticleId></ArticleIdList></Reference><Reference><Citation>van Diepen S, Katz JN, Albert NM, et al. . Contemporary management of cardiogenic shock: a scientific statement from the American heart association. Circulation 2017;136:e232&#x2013;68. 10.1161/CIR.0000000000000525</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000525</ArticleId><ArticleId IdType="pubmed">28923988</ArticleId></ArticleIdList></Reference><Reference><Citation>Garan AR, Kanwar M, Thayer KL, et al. . Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC Heart Fail 2020;8:903&#x2013;13. 10.1016/j.jchf.2020.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2020.08.012</ArticleId><ArticleId IdType="pubmed">33121702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38332962</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1551-6776</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG</Title><ISOAbbreviation>J Pediatr Pharmacol Ther</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of Alprostadil for Ductal Patency.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>44</EndPage><MedlinePgn>37-44</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5863/1551-6776-29.1.37</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aims to describe the effectiveness of low initial alprostadil dosages to maintain a patent ductus arteriosus (PDA) in infants with ductal-dependent congenital heart disease (DDCHD). Secondary objectives were to describe any adverse drug events, describe prescribing trends, describe ductus arteriosus diameter changes, and compare the safety and efficacy of very low and low initial alprostadil dosage regimens.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective observational cohort study at the British Columbia's Women's and Children's Hospital neonatal intensive care unit and pediatric intensive care unit examined neonates admitted with DDCHD who received alprostadil to maintain ductal patency. Very low-dose alprostadil (less than 0.01 mcg/kg/min) versus low-dose alprostadil (equal to or greater than 0.01 mcg/kg/min) was examined. Effectiveness was defined as survival and infants not requiring a resuscitation event (cardiac arrest, cardiogenic shock, code blue, extracorporeal life support, requirement for emergent cardiac surgery, and respiratory acidosis). Adverse drug events with a Naranjo score of 3 or more were included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Alprostadil was effective for 88% of patients, with no difference between the very low-dose and low-dose groups. Of the 75 patients included, 25 received very low-dose alprostadil. Adverse drug events were common (51%) with neonates in the low-dose group experiencing more apnea and pyrexia than neonates in the very low-dose group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Alprostadil therapy was effective in maintaining the PDA in neonates with DDCHD with low-dosage regimens. Adverse drug events were common with both dosage regimens; however, the very low dosage appeared to have less apnea and pyrexia.</AbstractText><CopyrightInformation>Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: membership@pediatricpharmacy.org.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Caitlin M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Lower Mainland Pharmacy Services (CMG), Vancouver General Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Jason T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Pharmacy Department (JTT, RRC), BC Women's and Children's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Roxane R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Pharmacy Department (JTT, RRC), BC Women's and Children's Hospital, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pediatr Pharmacol Ther</MedlineTA><NlmUniqueID>101089851</NlmUniqueID><ISSNLinking>1551-6776</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alprostadil</Keyword><Keyword MajorTopicYN="N">congenital heart disease</Keyword><Keyword MajorTopicYN="N">ductus arteriosus</Keyword><Keyword MajorTopicYN="N">infant</Keyword><Keyword MajorTopicYN="N">intensive care units</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement><b>Disclosure.</b> The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. The authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38332962</ArticleId><ArticleId IdType="pmc">PMC10849693</ArticleId><ArticleId IdType="doi">10.5863/1551-6776-29.1.37</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. Elsevier Health Sciences; 2014.</Citation></Reference><Reference><Citation>Lopes SA, Guimar&#xe3;es IC, Costa SF et al. Mortality for critical congenital heart diseases and associated risk factors in newborns: a cohort study. Arq Bras Cardiol. 2018;111(5):666&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6248247</ArticleId><ArticleId IdType="pubmed">30281694</ArticleId></ArticleIdList></Reference><Reference><Citation>Oster ME, Lee KA, Honein MA et al. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502&#x2013;e1508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4471949</ArticleId><ArticleId IdType="pubmed">23610203</ArticleId></ArticleIdList></Reference><Reference><Citation>Samanek M, Slavik Z, Zborilova B et al. Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91,823 live-born children. Pediatr Cardiol. 1989;10(4):205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">2687820</ArticleId></ArticleIdList></Reference><Reference><Citation>Prostin VR Sterile Solution [package insert] Quebec, Canada: Pfizer Canada; 2020.</Citation></Reference><Reference><Citation>Heymann MA, Rudolph AM. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia. Pediatrics. 1977;59(3):325&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pubmed">840551</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham TP, Jr, Atwood GF, Boucek RJ., Jr Pharmacologic dilatation of the ductus arteriosus with prostaglandin E1 in infants with congenital heart disease. South Med J. 1978;71(10):1238&#x2013;1241.</Citation><ArticleIdList><ArticleId IdType="pubmed">81528</ArticleId></ArticleIdList></Reference><Reference><Citation>Heymann MA, Berman WI, Jr, Rudolph AM, Whitman VI. Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities. Circulation. 1979;59(1):169&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">758109</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodlie M, Chaudhari M, Hasan A. Prostaglandin therapy for ductal patency: how long is too long? Acta Paediatr. 2008;97(9):1303&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">18492129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucerea M, Simon M, Moldovan E et al. Congenital heart disease requiring maintenance of ductus arteriosus in critically ill newborns admitted at a tertiary neonatal intensive care unit. Crit Care Med. 2016;2(4):185&#x2013;191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953253</ArticleId><ArticleId IdType="pubmed">29967858</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivananda S, Kirsh J, Whyte HE et al. Accuracy of clinical diagnosis and decision to commence intravenous prostaglandin E1 in neonates presenting with hypoxemia in a transport setting. J Crit Care. 2010;25(1):174-e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">19577418</ArticleId></ArticleIdList></Reference><Reference><Citation>Silove ED, Roberts DG, De Giovanni JV. Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease. Arch Dis Child. 1985;60(11):1025&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1777650</ArticleId><ArticleId IdType="pubmed">3865636</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh GK, Fong LV, Salmon AP, Keeton BR. Chrome congestive heart failure: study of low dosage prostaglandin&#x2013;usages and complications. Eur Heart J. 1994;15(3):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">8013512</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidin AZ, Khalid F, MSaid R. Evaluation of infusion protaglandin (PGE2) versus infusion prostaglandin e1 (PGE1) in management of duct-dependent pulmonary circulation congenital heart disease. Pediatr Crit Care Med. 2014;15(4 suppl):131.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer HH, Sommer M, Rammos S, Krogmann O. Evaluation of low dose prostaglandin E 1 treatment for ductus dependent congenital heart disease. Eur J Pediatr. 1995;154(9):700&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">8582419</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmo KA, Barr P, West M et al. Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F117&#x2013;F119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2675450</ArticleId><ArticleId IdType="pubmed">16905574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yucel IK, Cevik A, Bulut MO et al. Efficacy of very low-dose prostaglandin E1 in duct-dependent congenital heart disease. Cardiol Young. 2015;25(1):56.</Citation><ArticleIdList><ArticleId IdType="pubmed">24168719</ArticleId></ArticleIdList></Reference><Reference><Citation>Buck M, Lim S, Attridge J. Effectiveness of alprostadil dose titration in neonates with congenital heart disease. Pharmacotherapy. 2012;32(10):e227.</Citation></Reference><Reference><Citation>Huang FK, Lin CC, Huang TC et al. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol. 2013;54(2):102&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">23590954</ArticleId></ArticleIdList></Reference><Reference><Citation>Badheka A, Prakash PB, Allareddy V. Prostaglandin E1-induced periostitis and reversibility with discontinuation. J Pediatr. 2017;189:237.</Citation><ArticleIdList><ArticleId IdType="pubmed">28709628</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis AB, Freed MD, Heymann MA et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation. 1981;64(5):893&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">7285304</ArticleId></ArticleIdList></Reference><Reference><Citation>Alprostadil  In: Esau R.
BC Children&#x2019;s Hospital Pediatric Drug Dosage Guidelines
7th ed
Vancouver, Canada: 
Children&#x2019;s and Women&#x2019;s Health Centre Department of Pharmacy; 
201914
http://www.pedmed.org/DrugApp/index.html</Citation></Reference><Reference><Citation>Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. J Clin Pharm Ther. 1981;30(2):239&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">7249508</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R et al. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Epitools Sample size to estimate a proportion or apparent prevalence with specified precision. 2020.  Accessed September 4, 2020.  https://epitools.ausvet.com.au/oneproportion.</Citation></Reference><Reference><Citation>Lewis AB, Takahashi M, Lurie PR. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects. J Pediatr. 1978;93(3):481&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">690772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39957274</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0844</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>European journal of heart failure</Title><ISOAbbreviation>Eur J Heart Fail</ISOAbbreviation></Journal><ArticleTitle>Organ perfusion pressure predicts outcomes in cardiogenic shock patients.</ArticleTitle><Pagination><StartPage>659</StartPage><EndPage>668</EndPage><MedlinePgn>659-668</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ejhf.3627</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The diagnosis of cardiogenic shock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion. The combination of hypoperfusion and systemic congestion identifies patients at particularly high risk. This study evaluated organ perfusion pressure (OPP), calculated as mean arterial pressure minus invasive central venous pressure, as a predictor of outcomes in CS.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">All consecutive patients with acute myocardial infarction-related CS (AMI-CS) or acutely decompensated heart failure-related CS (ADHF-CS) enrolled in the multicentre Altshock-2 registry between January 2020 and November 2023 were included. The primary outcome was in-hospital all-cause mortality. Overall, 316 patients were included (mean age: 64&#x2009;&#xb1;&#x2009;13&#x2009;years, 62 [20%] female, median left ventricular ejection fraction: 22% [interquartile range, IQR 15-30%], 261 [85.9%] SCAI stage C or worse, median OPP at presentation: 57.0&#x2009;mmHg [IQR 47.0-69.8&#x2009;mmHg]). A total of 117 (37%) patients died during the hospitalization. Low OPP (i.e. &lt;57.0&#x2009;mmHg) was associated with significantly higher in-hospital all-cause mortality (hazard ratio [HR] 1.757, 95% confidence interval [CI] 1.208-2.556, p&#x2009;=&#x2009;0.003), whereas low mean arterial pressure alone was not (HR 1.323, 95% CI 0.901-1.941, p&#x2009;=&#x2009;0.153). After multivariable adjustment for significant clinical data available at first bedside assessment (age and Sequential Organ Failure Assessment score), low OPP still predicted significantly higher in-hospital all-cause mortality (HR per mmHg decrease: 1.016, 95% CI 1.004-1.029, p&#x2009;=&#x2009;0.010). Low OPP appeared particularly powerful in predicting higher in-hospital all-cause mortality among ADHF-CS patients (HR 3.172, p&#x2009;=&#x2009;0.002).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this multicentre, observational, prospective study on patients hospitalized for CS, lower OPP on admission was associated with significantly higher in-hospital all-cause mortality.</AbstractText><CopyrightInformation>&#xa9; 2025 European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bocchino</LastName><ForeName>Pier Paolo</ForeName><Initials>PP</Initials><Identifier Source="ORCID">0000-0001-7868-1852</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, 'Citt&#xe0; della Salute e della Scienza' Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frea</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, 'Citt&#xe0; della Salute e della Scienza' Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sacco</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertaina</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, San Giovanni Bosco Hospital, ASL Citt&#xe0; di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Kore University, Enna and Policlinico Centro Cuore G.B. Morgani, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavazzi</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical-Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia and Intensive Care, Fondazione IRCCS Policlinico San Matteo Hospital, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morici</LastName><ForeName>Nuccia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IRCCS Fondazione Don Gnocchi, ONLUS, Santa Maria Nascente, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angelini</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, 'Citt&#xe0; della Salute e della Scienza' Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garatti</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briani</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorini Dini</LastName><ForeName>Carlotta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villanova</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallone</LastName><ForeName>Guglielmo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, 'Citt&#xe0; della Salute e della Scienza' Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravera</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Cardiology Department, S. Giovanni Di Dio e Ruggi d'Aragona Hospital, Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertoldi</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Humanitas Research Hospital, IRCCS Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corsini</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic and Vascular Department, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maj</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Anesthesia and Intensive Care, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Potena</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic and Vascular Department, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporotondo</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Intensive Cardiac Care Unit, Fondazione IRCCS Policlinico San Matteo Hospital, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Costanza Natalia Julia</ForeName><Initials>CNJ</Initials><AffiliationInfo><Affiliation>Intensive Cardiac Care Unit, Fondazione IRCCS Policlinico San Matteo Hospital, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montisci</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiothoracic Intensive Care, ASST Spedali Civili, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiac Intensive Care Unit, De Gasperis Cardio Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannaccone</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, San Giovanni Bosco Hospital, ASL Citt&#xe0; di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Ettore</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic and Vascular Anesthesia and Intensive Care, AO SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Serafina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical Biotechnologies, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagnesi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Cardiothoracic Department, Civil Hospitals, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metra</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Cardiothoracic Department, Civil Hospitals, Brescia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology and ICCU, Department of Cardiovascular Sciences, Ospedali Riuniti, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Ferrari</LastName><ForeName>Gaetano Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular and Thoracic Department, 'Citt&#xe0; della Salute e della Scienza' Hospital, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Heart Fail</MedlineTA><NlmUniqueID>100887595</NlmUniqueID><ISSNLinking>1388-9842</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute heart failure</Keyword><Keyword MajorTopicYN="N">Blood pressure</Keyword><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Central venous pressure</Keyword><Keyword MajorTopicYN="N">Organ perfusion pressure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>17</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>17</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39957274</ArticleId><ArticleId IdType="doi">10.1002/ejhf.3627</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc 2019;8:e011991. https://doi.org/10.1161/JAHA.119.011991</Citation></Reference><Reference><Citation>Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock&#x2014;A position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315&#x2013;1341. https://doi.org/10.1002/ejhf.1922</Citation></Reference><Reference><Citation>Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009;53:589&#x2013;596. https://doi.org/10.1016/j.jacc.2008.05.068</Citation></Reference><Reference><Citation>Shinagawa H, Inomata T, Koitabashi T, Nakano H, Takeuchi I, Osaka T, et al. Increased serum bilirubin levels coincident with heart failure decompensation indicate the need for intravenous inotropic agents. Int Heart J 2007;48:195&#x2013;204. https://doi.org/10.1536/ihj.48.195</Citation></Reference><Reference><Citation>Bocchino PP, Cingolani M, Frea S, Angelini F, Gallone G, Garatti L, et al. Organ perfusion pressure at admission and clinical outcomes in patients hospitalized for acute heart failure. Eur Heart J Acute Cardiovasc Care 2024;13:215&#x2013;224. https://doi.org/10.1093/ehjacc/zuad133</Citation></Reference><Reference><Citation>Wong BT, Chan MJ, Glassford NJ, M&#xe5;rtensson J, Bion V, Chai SY, et al. Mean arterial pressure and mean perfusion pressure deficit in septic acute kidney injury. J Crit Care 2015;30:975&#x2013;981. https://doi.org/10.1016/j.jcrc.2015.05.003</Citation></Reference><Reference><Citation>Bertaina M, Morici N, Frea S, Garatti L, Briani M, Sorini C, et al. Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction. ESC Heart Fail 2023;10:3472&#x2013;3482. https://doi.org/10.1002/ehf2.14510</Citation></Reference><Reference><Citation>Sacco A, Montisci A, Tavecchia G, Frea S, Bernasconi D, Colombo CNJ, et al.; AltShock&#x2010;2 Investigators. Ventilation strategies in cardiogenic shock: Insights from the AltShock&#x2010;2 registry. Eur J Heart Fail 2024;26:2412&#x2013;2420. https://doi.org/10.1002/ejhf.3409</Citation></Reference><Reference><Citation>Kapur NK, Kanwar M, Sinha SS, Thayer KL, Garan AR, Hernandez&#x2010;Montfort J, et al. Criteria for defining stages of cardiogenic shock severity. J Am Coll Cardiol 2022;80:185&#x2013;198. https://doi.org/10.1016/j.jacc.2022.04.049</Citation></Reference><Reference><Citation>Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457&#x2013;481. https://doi.org/10.2307/2281868</Citation></Reference><Reference><Citation>Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685&#x2013;713. https://doi.org/10.1016/j.echo.2010.05.010</Citation></Reference><Reference><Citation>Sarma D, Jentzer JC. Cardiogenic shock: Pathogenesis, classification, and management. Crit Care Clin 2024;40:37&#x2013;56. https://doi.org/10.1016/j.ccc.2023.05.001</Citation></Reference><Reference><Citation>Monge Garc&#xed;a MI, Santos Oviedo A. Why should we continue measuring central venous pressure? Med Intensiva 2017;41:483&#x2013;486. https://doi.org/10.1016/j.medin.2016.12.006</Citation></Reference><Reference><Citation>Hrymak C, Strumpher J, Jacobsohn E. Acute right ventricle failure in the intensive care unit: Assessment and management. Can J Cardiol 2017;33:61&#x2013;71. https://doi.org/10.1016/j.cjca.2016.10.030</Citation></Reference><Reference><Citation>Ostermann M, Hall A, Crichton S. Low mean perfusion pressure is a risk factor for progression of acute kidney injury in critically ill patients&#xa0;&#x2013;&#xa0;a retrospective analysis. BMC Nephrol 2017;18:151. https://doi.org/10.1186/s12882&#x2010;017&#x2010;0568&#x2010;8</Citation></Reference><Reference><Citation>Hu R, Kalam Y, Broad J, Ho T, Parker F, Lee M, et al. Decreased mean perfusion pressure as an independent predictor of acute kidney injury after cardiac surgery. Heart Vessels 2020;35:1154&#x2013;1163. https://doi.org/10.1007/s00380&#x2010;020&#x2010;01578&#x2010;0</Citation></Reference><Reference><Citation>Harjola VP, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short&#x2010;term mortality in cardiogenic shock. Eur J Heart Fail 2015;17:501&#x2013;509. https://doi.org/10.1002/ejhf.260</Citation></Reference><Reference><Citation>Malick W, Fried JA, Masoumi A, Nair A, Zuver A, Huang A, et al. Comparison of the hemodynamic response to intra&#x2010;aortic balloon counterpulsation in patients with cardiogenic shock resulting from acute myocardial infarction versus acute decompensated heart failure. Am J Cardiol 2019;124:1947&#x2013;1953. https://doi.org/10.1016/j.amjcard.2019.09.016</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34318736</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>Veno-arterial extracorporeal membrane oxygenation with concomitant Impella versus concomitant intra-aortic-balloon-pump for cardiogenic shock.</ArticleTitle><Pagination><StartPage>51</StartPage><EndPage>57</EndPage><MedlinePgn>51-57</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/02676591211033947</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The intra-aortic balloon pump (IABP) and Impella are left ventricular unloading devices with peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO) in place and later serve as bridging therapy when VA-ECMO is terminated. We aimed to determine the potential differences in clinical outcomes and rate of complications between the two combinations of mechanical circulatory support.</AbstractText><AbstractText Label="METHODS">This was a retrospective, single institutional cohort study conducted in the intensive care unit (ICU) of Queen Elizabeth Hospital, Hong Kong. Inclusion criteria included all patients aged &#x2a7e;18&#x2009;years, who had VA-ECMO support, and who had left ventricular unloading by either IABP or Impella between January 1, 2018 and October 31, 2020. Patients &lt;18&#x2009;years old, with central VA-ECMO, who did not require left ventricular unloading, or who underwent surgical venting procedures were excluded. The primary outcome was ECMO duration. Secondary outcomes included length of stay (LOS) in the ICU, hospital LOS, mortality, and complication rate.</AbstractText><AbstractText Label="RESULTS">Fifty-two patients with ECMO&#x2009;+&#x2009;IABP and 14 patients with ECMO&#x2009;+&#x2009;Impella were recruited. No statistically significant difference was observed in terms of ECMO duration (2.5 vs 4.6&#x2009;days, p&#x2009;=&#x2009;0.147), ICU LOS (7.7 vs 10.8&#x2009;days, p&#x2009;=&#x2009;0.367), and hospital LOS (14.8 vs 16.5&#x2009;days, p&#x2009;=&#x2009;0.556) between the two groups. No statistically significant difference was observed in the ECMO, ICU, and hospital mortalities between the two groups. Specific complications related to the ECMO and Impella combination were also noted.</AbstractText><AbstractText Label="CONCLUSIONS">Impella was not shown to offer a statistically significant clinical benefit compared with IABP in conjunction with ECMO. Clinicians should be aware of the specific complications of using Impella.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Au</LastName><ForeName>Shek-Yin</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0001-8331-2250</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fong</LastName><ForeName>Ka-Man</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Chun-Fung Sunny</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Cardiology Services, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Ka-Chun Alan</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Cardiology Services, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Chi Yuen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Cardiology Services, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Wing-Yiu George</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kang Yin Michael</ForeName><Initials>KYM</Initials><AffiliationInfo><Affiliation>Cardiology Services, Department of Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007423" MajorTopicYN="N">Intra-Aortic Balloon Pumping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IABP</Keyword><Keyword MajorTopicYN="N">Impella</Keyword><Keyword MajorTopicYN="N">VA-ECMO</Keyword><Keyword MajorTopicYN="N">adult</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">left ventricular venting</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34318736</ArticleId><ArticleId IdType="doi">10.1177/02676591211033947</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25010916</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: a systematic literature review and meta-analysis of observational studies.</ArticleTitle><Pagination><StartPage>487</StartPage><EndPage>497</EndPage><MedlinePgn>487-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0000000000000117</ELocationID><Abstract><AbstractText>The aim of the study was to systematically evaluate effect of CentriMag heart pump (Thoratec Corporation) as temporary ventricular assist device (VAD) and part of extracorporeal membrane oxygenation (ECMO) system on outcomes in patients with cardiac or cardiac-respiratory failure. A systematic search was conducted in five databases for the period 2003 to 2012. Fifty-three publications with data for 999 patients, supported with CentriMag, were included. In 72% studies, CentriMag was used as a VAD and in 25% as part of ECMO circuit. Mean duration of VAD support was 25.0 days in precardiotomy group, 10.9 days in postcardiac surgery cardiogenic shock group, 8.8 days in post-transplant graft failure and rejection group, and 16.0 days in post-LVAD placement right ventricular failure group. Survival on support was 82% (95% CI 70-92) for VAD support in precardiotomy cardiogenic shock indication, 63% (95% CI 46-78) in VAD support in postcardiac surgery cardiogenic shock indication, 62% (95% CI 46-76) in VAD support in post-transplant graft rejection or failure indication, and 83% (95% CI 73-92) in VAD support in post-LVAD placement right ventricular failure indication. CentriMag is an effective technology for temporary support of patients with cardiac and cardiorespiratory failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borisenko</LastName><ForeName>Oleg</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>From the *Synergus AB, Danderyd, Sweden; &#x2020;Scottish Extracorporeal Life Support Service, Royal Hospital for Sick Children, Glasgow, United Kingdom; &#x2021;Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Clydebank, United Kingdom; &#xa7;Medical Management Centre, Department of Learning Informatics, Management and Ethics, Karolinska Institutet, Stockholm, Sweden; &#xb6;Paediatric and Neonatal ECMO Service, Freeman Hospital, Newcastle upon Tyne, United Kingdom; &#x2016;Department of Cardiothoracic Transplant, Wythenshawe Hospital, Manchester, United Kingdom; and #Emeritus Cardiothoracic Surgeon, Glenfield General Hospital, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wylie</LastName><ForeName>Gillian</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Payne</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Bjessmo</LastName><ForeName>Staffan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jon</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yonan</LastName><ForeName>Nizar</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Firmin</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure: O.B. and S.B. are employees of Synergus AB, which was commissioned by Thoratec Corp. to perform the study. G.W. has no conflict of interest to disclose. J.P. has received two travel grants from Thoratec Corp. J.S. is an expert witness in litigation and has received two travel grants from Chalice Medical. N.Y. received honorarium from Synergus AB for support related to design and collection of cost information for cost analysis of VAD and ECMO in the United Kingdom. R.F. is providing consulting support to Thoratec Corp. The study was funded by Thoratec Corporation (Pleasanton, CA).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25010916</ArticleId><ArticleId IdType="pmc">PMC4154791</ArticleId><ArticleId IdType="doi">10.1097/MAT.0000000000000117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Clinical Excellence. Short-Term Circulatory Support with Left Ventricular Assist Devices as a Bridge to Cardiac Transplantation or Recovery. IPG177. London: National Institute for Health and Care Excellence; 2006.</Citation></Reference><Reference><Citation>ECMO. Extracorporeal Cardiopulmonary Support in Critical Care. 4th ed. 2005. p. pp. 625.</Citation></Reference><Reference><Citation>NHS England. Service Specification. Ventricular Assist Devices (VADs) for adults as a bridge to heart transplantation or myocardial recovery. 2011.</Citation></Reference><Reference><Citation>NHS England. Service Specification. Ventricular Assist Devices (VADs) for children as a bridge to heart transplantation. 2011.</Citation></Reference><Reference><Citation>Chuang-Stein C, Beltangady M. Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies. Pharm Stat. 2011;10:3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20073040</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Green S Cochrane Handbook for Systematic Reviews of Interventions. 2011. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration.</Citation></Reference><Reference><Citation>Extracorporeal Membrane Oxygenation: An Evaluation of Current Treatment Approaches in the United Kingdom (Service Evaluation) 2013. p. pp. 43.</Citation></Reference><Reference><Citation>Thomas HL, Dronavalli VB, Parameshwar J, Bonser RS, Banner NR Audit obotSGotUCT. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: A United Kingdom national study. Eur J Cardiothorac Surg. 2011;40:1348&#x2013;1354.</Citation><ArticleIdList><ArticleId IdType="pubmed">21493083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmane S, Venkateswaran R, Salaie J, Williams S, Yonan N. Joint Annual Meeting of ACTA-SCTC. Manchester: United Kingdom; 2012. Outcome of extracorporeal membrane oxygenation as short term mechanical support following heart transplantation: a single centre experience. p. pp. 139.</Citation></Reference><Reference><Citation>De Robertis F, Birks EJ, Rogers P, Dreyfus G, Pepper JR, Khaghani A. Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant. 2006;25:181&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">16446218</ArticleId></ArticleIdList></Reference><Reference><Citation>De Robertis F, Rogers P, Amrani M, et al. Bridge to decision using the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant. 2008;27:474&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">18442711</ArticleId></ArticleIdList></Reference><Reference><Citation>Akay MH, Gregoric ID, Radovancevic R, Cohn WE, Frazier OH. Timely use of a CentriMag heart assist device improves survival in postcardiotomy cardiogenic shock. J Card Surg. 2011;26:548&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">21951040</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz TA, Singh G, Popjes E, et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant. 2010;29:66&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">19837609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">19716053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindoff C, Dean R, Bashford A, et al. Mobilization and physiotherapy of patients with Levitronix CentriMag short-term mechanical circulatory support device. J Heart Lung Transplant. 2009;28:S281.</Citation></Reference><Reference><Citation>Bruschi G, Cannata A, Russo CF, et al. Single center experience with the Levitronix CentriMag circulation support system as short term cardiac assist in different clinical scenarios. J Heart Lung Transplant. 2008;27:S154&#x2013;S155.</Citation></Reference><Reference><Citation>Byrnes J, McKamie W, Swearingen C, et al. Hemolysis during cardiac extracorporeal membrane oxygenation: A case-control comparison of roller pumps and centrifugal pumps in a pediatric population. ASAIO J. 2011;57:456&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pubmed">21822124</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy J, Haynes S, Kirk R, et al. Changing patterns of bridging to heart transplantation in children. J Heart Lung Transplant. 2009;28:249&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">19285616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JM, Richmond ME, Charette K, et al. A decade of pediatric mechanical circulatory support before and after cardiac transplantation. J Thorac Cardiovasc Surg. 2012;143:344&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">22143101</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung DA, Kizner L, Al-Deiri M, et al. Clinical utility of the Levitronix CentriMag in extracorporeal membrane oxygenation for severe cardiogenic shock. J Heart Lung Transplant. 2007;26:S87.</Citation></Reference><Reference><Citation>Clough RE, Vallely MP, Henein MY, Pepper JR. Levitronix ventricular assist device as a bridge-to-recovery for post-cardiotomy cardiogenic shock. Int J Cardiol. 2009;134:408&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">18378019</ArticleId></ArticleIdList></Reference><Reference><Citation>den Uil CA, Maat AP, Lagrand WK, et al. Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J Heart Lung Transplant. 2009;28:906&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">19716043</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Bella I, Ramoni E, Da Col U, et al. Is lower limb venous drainage during peripheral extracorporeal membrane oxygenation necessary? ASAIO J. 2010;56:35&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">20051830</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaloro RR, Bertolotti A, Diez M, et al. Adequate systemic perfusion maintained by a CentriMag during acute heart failure. Tex Heart Inst J. 2008;35:334&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2565526</ArticleId><ArticleId IdType="pubmed">18941648</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia JP, Kon ZN, Evans C, Wu Z, IA M, cCormick B, Griffith BP. Ambulatory veno-venous extracorporeal membrane oxygenation: Innovation and pitfalls. J Thorac Cardiovasc Surg. 2011;142:755&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">21924145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ga&#x161;parovi&#x107; H, Petri&#x10d;evi&#x107; M, Ivan&#x10d;an V, Mili&#x10d;i&#x107; C, Bio&#x10d;ina B. Initial clinical results with the Levitronix CentriMag Mechanical Assist Device at the University Hospital Rebro Zagreb. Rad Med Fak Zagrebu. 2011;36:47&#x2013;53.</Citation></Reference><Reference><Citation>Haj-Yahia S, Birks EJ, Amrani M, et al. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg. 2009;138:227&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">19577084</ArticleId></ArticleIdList></Reference><Reference><Citation>Horv&#xe1;th V, N&#x11b;mec P, Ondr&#xe1;&#x161;ek J, et al. Short-term mechanical support with the Levitronix CentriMag centrifugal pump. Cor Vasa. 2011;53:144&#x2013;147.</Citation></Reference><Reference><Citation>John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007;134:351&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">17662772</ArticleId></ArticleIdList></Reference><Reference><Citation>John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">20605026</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan N, Al-alouo M, Shad DL. Early experience with the Levitronix CentriMag device for extra corporeal membrane oxygenation following lung transplantation. Eur J Cardiothorac Surg. 2008;34:1262&#x2013;1264.</Citation><ArticleIdList><ArticleId IdType="pubmed">18951034</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouretas PC, Kaza AK, Burch PT, et al. Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery. Artif Organs. 2009;33:1002&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">19874281</ArticleId></ArticleIdList></Reference><Reference><Citation>Loforte A, Montalto A, Ranocchi F, et al. Temporary mechanical circulatory support for acute cardiogenic shock. Eur J Heart Fail. 2010;9:S193&#x2013;S194.</Citation></Reference><Reference><Citation>Loforte A, Potapov E, Krabatsch T, et al. Levitronix CentriMag to Berlin Heart Excor: A &#x201c;bridge to bridge&#x201d; solution in refractory cardiogenic shock. ASAIO J. 2009;55:465&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pubmed">19672191</ArticleId></ArticleIdList></Reference><Reference><Citation>Loforte A, Montalto A, Ranocchi F, et al. Levitronix CentriMag third-generation magnetically levitated continuous flow pump as bridge to solution. ASAIO J. 2011;57:247&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pubmed">21701270</ArticleId></ArticleIdList></Reference><Reference><Citation>Loforte A, Montalto A, Lilla Della Monica P, Musumeci F. Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure. Interact Cardiovasc Thorac Surg. 2010;10:847&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">20231307</ArticleId></ArticleIdList></Reference><Reference><Citation>Maat AP, van Thiel RJ, Dalinghaus M, Bogers AJ. Connecting the Centrimag Levitronix pump to Berlin Heart Excor cannulae; a new approach to bridge to bridge. J Heart Lung Transplant. 2008;27:112&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">18187096</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquez TT, D&#x2019;Cunha J, John R, Liao K, Joyce L. Mechanical support for acute right ventricular failure: Evolving surgical paradigms. J Thorac Cardiovasc Surg. 2009;137:e39&#x2013;e40.</Citation><ArticleIdList><ArticleId IdType="pubmed">19154879</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick AJ, Reid BB, Budge D, et al. Versatility and patient outcomes with the levitronix centrimag temporary ventricular assist device. J Heart Lung Transplant. 2010;29:S100.</Citation></Reference><Reference><Citation>Meyer AL, Strueber M, Tomaszek S, et al. Temporary cardiac support with a mini-circuit system consisting of a centrifugal pump and a membrane ventilator. Interact Cardiovasc Thorac Surg. 2009;9:780&#x2013;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">19671580</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan JA, Naseem TM, Cheema FH, et al. Improvement in survival with implantation of levitronix centrimag biventricular circulatory support in patients with acute st-elevation myocardial infarction (STEMI) and refractory cardiogenic shock. J Heart Lung Transplant. 2009;28:S143.</Citation></Reference><Reference><Citation>Nelson KM, Marks JD, Eidson M, et al. Initial pilot study of the Levitronix CentriMag VAS for RVAD support following LVAD implementation. ASAIO J. 2006;52:36A.</Citation></Reference><Reference><Citation>Netuka I, Mal&#xfd; J, Szarszoi O, et al. [Technique of implantation and experience with temporary mechanical cardiac support in right ventricular failure]. Rozhl Chir. 2011;90:88&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">21638844</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlak S, Sliwka J, Przybylski R, et al. Peirwsze doswiadczenia w kiniczynm zastosowaniu system wsopmagania serca pompa rotacynja Levitronix. (Early experience in clinical use of mechanical ventricular assist Levitronix device). Kardiochirugia I Torakochirugia i Polska. 2009;6:171&#x2013;175.</Citation></Reference><Reference><Citation>Reckers J, Asfour B, Fink C. Goodbye Hemolysis! Experience with Levitronix CentriMag in 33 Newborns, Infants and Children. 54th Annual Conference of ASAIO. San Francisco, United States; 2008.</Citation></Reference><Reference><Citation>Russo CF, Cannata A, Lanfranconi M, et al. Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2010;140:1416&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pubmed">20933244</ArticleId></ArticleIdList></Reference><Reference><Citation>Santise G, Petrou M, Pepper JR, Dreyfus G, Khaghani A, Birks EJ. Levitronix as a short-term salvage treatment for primary graft failure after heart transplantation. J Heart Lung Transplant. 2006;25:495&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">16678025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuhaiber JH, Jenkins D, Berman M, et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 2008;27:158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">18267221</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh RK, Addonizio LJ, Richmond M, Vincent J, Torres A, Williams M. A novel approach to management of acute rejection with percutaneous ventricular assist device insertion in two adolescent heart transplant patients. J Card Fail. 2009;15:S55.</Citation></Reference><Reference><Citation>Soleimani B, Brehm C, Wallace S, et al. Application of new generation rotary pumps and oxygenators for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for refractory cardiogenic shock (RCS). J Heart Lung Transplant. 2011;30:S211.</Citation></Reference><Reference><Citation>Stepanenko A, Pappalardo F, Scandroglio AM, Potapov EV, Krabatsch T, Hetzer R. Anticoagulation management during CentriMag right ventricular assist device support after heartmate II implantation. Heart Surg Forum. 2010;13:S113.</Citation></Reference><Reference><Citation>Takayama H, Chen JM, Jorde UP, Naka Y. Implantation technique of the CentriMag biventricular assist device allowing ambulatory rehabilitation. Interact Cardiovasc Thorac Surg. 2011;12:110&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">21047827</ArticleId></ArticleIdList></Reference><Reference><Citation>Takayama H, Naka Y, Kodali SK, et al. A novel approach to percutaneous right-ventricular mechanical support. Eur J Cardiothorac Surg. 2012;41:423&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">21737292</ArticleId></ArticleIdList></Reference><Reference><Citation>Westaby S, Balacumaraswami L, Evans BJ, et al. Elective transfer from cardiopulmonary bypass to centrifugal blood pump support in very high-risk cardiac surgery. J Thorac Cardiovasc Surg. 2007;133:577&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pubmed">17258609</ArticleId></ArticleIdList></Reference><Reference><Citation>Worku B, Naka Y PS, Cheema FH, et al. Predictors of mortality after short-term ventricular assist device placement. Ann Thorac Surg. 2011;92:1608&#x2013;1612.</Citation><ArticleIdList><ArticleId IdType="pubmed">22051257</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JA, Takayama H, Kim H, Cohen SA, Naka Y. Feasibility of BiVAD support with membrane oxygenation. J Heart Lung Transplant. 2010;29:S181&#x2013;S182.</Citation></Reference><Reference><Citation>Zych B, Popov AF, Barsan A, et al. Treatment of refractory right heart failure after implantation of a left ventricular assist device. Is the levitronix centrimag right heart support a solution? Heart. 2011;97:A49.</Citation></Reference><Reference><Citation>Velik-Salchner C, Hoermann C, Hoefer D, Margreiter J, Mair P. Thromboembolic complications during weaning from right ventricular assist device support. Anesth Analg. 2009;109:354&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims DB, Takayama H, Uriel N, Gillam LD, Naka Y, Jorde UP. Ventricular assist device-associated thrombus. Circulation. 2011;124:e197&#x2013;e198.</Citation><ArticleIdList><ArticleId IdType="pubmed">21844083</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: A population-based perspective. Circulation. 2009;119:1211&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730832</ArticleId><ArticleId IdType="pubmed">19237658</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnendran L, Abboud R, Sleeper LA, et al. Trends in cardiogenic shock: report from the SHOCK Study. The SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? Eur Heart J. 2001;22:472&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy J, Dominguez T, Haynes S, et al. A longer waiting game: bridging children to heart transplant with the Berlin Heart EXCOR device&#x2014;The United Kingdom experience. J Heart Lung Transplant. 2013;32:1101&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24060499</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohite PN, Zych B, Popov AF, et al. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: Use beyond 30 days. Eur J Cardiothorac Surg. 2013;44:e310&#x2013;e315.</Citation><ArticleIdList><ArticleId IdType="pubmed">23990618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33803411</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0375</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>Membranes</Title><ISOAbbreviation>Membranes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Conversion from Venovenous to Venoarterial Extracorporeal Membrane Oxygenation in Adults.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">188</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/membranes11030188</ELocationID><Abstract><AbstractText>No major study has been performed on the conversion from venovenous (VV) to venoarterial (VA) extracorporeal membrane oxygenation (ECMO) in adults. This single-center retrospective cohort study aimed to investigate the incidence, indication, and outcome in patients who converted from VV to VA ECMO. All adult patients (&#x2265;18 years) who commenced VV ECMO at our center between 2005 and 2018 were screened. Of 219 VV ECMO patients, 21% (<i>n</i> = 46) were converted to VA ECMO. The indications for conversion were right ventricular failure (RVF) (65%), cardiogenic shock (26%), and other (9%). In the converted patients, there was a significant increase in Sequential Organ Failure Assessment (SOFA) scores between admission 12 (9-13) and conversion 15 (13-17, <i>p</i> &lt; 0.001). Compared to non-converted patients, converted patients also had a higher mortality rate (62% vs. 16%, <i>p</i> &lt; 0.001) and a lower admission Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score (<i>p</i> &lt; 0.001). Outcomes were especially unfavorable in those converted due to RVF. These results indicate that VA ECMO, as opposed to VV ECMO, should be considered as the first mode of choice in patients with respiratory failure and signs of circulatory impairment, especially in those with impaired RV function. For the remaining patients, Pre-admission RESP score, daily echocardiography, and SOFA score trajectories may help in the early identification of those where conversion from VV to VA ECMO is warranted. Multi-centric studies are warranted to validate these findings.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falk</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1845-7418</Identifier><AffiliationInfo><Affiliation>ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher-Sandersj&#xf6;&#xf6;</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3558-3045</Identifier><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Karolinska University Hospital, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hultman</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broman</LastName><ForeName>Lars Mikael</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-4124-4581</Identifier><AffiliationInfo><Affiliation>ECMO Centre Karolinska, Department of Pediatric Perioperative Medicine and Intensive Care, Karolinska University Hospital, 17176 Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology and Pharmacology, Karolinska Institutet, 171 76 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Membranes (Basel)</MedlineTA><NlmUniqueID>101577807</NlmUniqueID><ISSNLinking>2077-0375</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECMO</Keyword><Keyword MajorTopicYN="N">VA</Keyword><Keyword MajorTopicYN="N">VV</Keyword><Keyword MajorTopicYN="N">conversion</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">venoarterial</Keyword><Keyword MajorTopicYN="N">venovenous</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33803411</ArticleId><ArticleId IdType="pmc">PMC7999389</ArticleId><ArticleId IdType="doi">10.3390/membranes11030188</ArticleId><ArticleId IdType="pii">membranes11030188</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Paden M.L., Conrad S.A., Rycus P.T., Thiagarajan R.R. Extracorporeal Life Support Organization Registry Report 2012. J. Am. Soc. Artif. Intern. Organs. 2013;59:202&#x2013;210. doi: 10.1097/MAT.0b013e3182904a52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0b013e3182904a52</ArticleId><ArticleId IdType="pubmed">23644605</ArticleId></ArticleIdList></Reference><Reference><Citation>Extracorporeal, Life, Support, Organization  International ECLS Registry Report.  [(accessed on 1 November 2020)];2019  Available online:  www.elso.org/Portals/0/Files/Reports/2019/International%20Summary%20July%202019.pdf.</Citation></Reference><Reference><Citation>Gerke A.K., Tang F., Cavanaugh J.E., Doerschug K.C., Polgreen P.M. Increased trend in extracorporeal membrane oxygenation use by adults in the United States since 2007. BMC Res. Notes. 2015;8:686. doi: 10.1186/s13104-015-1678-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-015-1678-7</ArticleId><ArticleId IdType="pmc">PMC4650500</ArticleId><ArticleId IdType="pubmed">26581610</ArticleId></ArticleIdList></Reference><Reference><Citation>Peek G.J., Mugford M., Tiruvoipati R., Wilson A., Allen E., Thalanany M.M., Hibbert C.L., Truesdale A., Clemens F., Cooper N., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet. 2009;374:1351&#x2013;1363. doi: 10.1016/S0140-6736(09)61069-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61069-2</ArticleId><ArticleId IdType="pubmed">19762075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer C.M., Yuh D.D., Bonde P. Extracorporeal membrane oxygenation use has increased by 433% in adults in the United States from 2006 to 2011. J. Am. Soc. Artif. Intern. Organs. 2015;61:31&#x2013;36. doi: 10.1097/MAT.0000000000000160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000000160</ArticleId><ArticleId IdType="pubmed">25303799</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogan T.V., Lequier L., Lorusso R., MacLaren G., Peek G. Extracorporeal Life Support: The ELSO Red Book. 5th ed. Extracorporeal Life Support Organization; Ann Arbor, MI, USA: 2017.</Citation></Reference><Reference><Citation>Conrad S.A., Broman L.M., Taccone F.S., Lorusso R., Malfertheiner M.V., Pappalardo F., Di Nardo M., Belliato M., Grazioli L., Barbaro R.P., et al. The Extracorporeal Life Support Organization Maastricht Treaty for Nomenclature in Extracorporeal Life Support. A Position Paper of the Extracorporeal Life Support Organization. Am. J. Respir. Crit. Care Med. 2018 doi: 10.1164/rccm.201710-2130CP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201710-2130CP</ArticleId><ArticleId IdType="pmc">PMC6118026</ArticleId><ArticleId IdType="pubmed">29614239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunge J.J.H., Caliskan K., Gommers D., Reis Miranda D. Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation. J. Thorac. Dis. 2018;10:S674&#x2013;S682. doi: 10.21037/jtd.2017.10.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2017.10.75</ArticleId><ArticleId IdType="pmc">PMC5911554</ArticleId><ArticleId IdType="pubmed">29732186</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzgraefe B., Broome M., Kalzen H., Konrad D., Palmer K., Frenckner B. Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure. Minerva Anestesiol. 2010;76:1043&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pubmed">21178913</ArticleId></ArticleIdList></Reference><Reference><Citation>Patroniti N., Bonatti G., Senussi T., Robba C. Mechanical ventilation and respiratory monitoring during extracorporeal membrane oxygenation for respiratory support. Ann. Transl. Med. 2018;6:386. doi: 10.21037/atm.2018.10.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2018.10.11</ArticleId><ArticleId IdType="pmc">PMC6212363</ArticleId><ArticleId IdType="pubmed">30460260</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein M.D., Andrews A.F., Wesley J.R., Toomasian J., Nixon C., Roloff D., Bartlett R.H. Venovenous perfusion in ECMO for newborn respiratory insufficiency. A clinical comparison with venoarterial perfusion. Ann. Surg. 1985;201:520&#x2013;526. doi: 10.1097/00000658-198504000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198504000-00019</ArticleId><ArticleId IdType="pmc">PMC1250743</ArticleId><ArticleId IdType="pubmed">3977454</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanley C.J., Hirschl R.B., Schumacher R.E., Overbeck M.C., Delosh T.N., Chapman R.A., Coran A.G., Bartlett R.H. Extracorporeal life support for neonatal respiratory failure. A 20-year experience. Ann. Surg. 1994;220:269&#x2013;280. doi: 10.1097/00000658-199409000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-199409000-00004</ArticleId><ArticleId IdType="pmc">PMC1234378</ArticleId><ArticleId IdType="pubmed">8092896</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimmitt R.A., Moss R.L., Rhine W.D., Benitz W.E., Henry M.C., Vanmeurs K.P. Venoarterial versus venovenous extracorporeal membrane oxygenation in congenital diaphragmatic hernia: The Extracorporeal Life Support Organization Registry, 1990&#x2013;1999. J. Pediatric Surg. 2001;36:1199&#x2013;1204. doi: 10.1053/jpsu.2001.25762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpsu.2001.25762</ArticleId><ArticleId IdType="pubmed">11479856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovler M.L., Garcia A.V., Beckman R.M., Salazar J.H., Vacek J., Many B.T., Rizeq Y., Abdullah F., Goldstein S.D. Conversion From Venovenous to Venoarterial Extracorporeal Membrane Oxygenation Is Associated With Increased Mortality in Children. J. Surg. Res. 2019;244:389&#x2013;394. doi: 10.1016/j.jss.2019.06.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2019.06.058</ArticleId><ArticleId IdType="pubmed">31325660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kon Z.N., Bittle G.J., Pasrija C., Pham S.M., Mazzeffi M.A., Herr D.L., Sanchez P.G., Griffith B.P. Venovenous Versus Venoarterial Extracorporeal Membrane Oxygenation for Adult Patients With Acute Respiratory Distress Syndrome Requiring Precannulation Hemodynamic Support: A Review of the ELSO Registry. Ann. Thorac. Surg. 2017;104:645&#x2013;649. doi: 10.1016/j.athoracsur.2016.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.11.006</ArticleId><ArticleId IdType="pubmed">28190548</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk L., Hultman J., Broman L.M. Extracorporeal Membrane Oxygenation for Septic Shock. Crit. Care Med. 2019;47:1097&#x2013;1105. doi: 10.1097/CCM.0000000000003819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003819</ArticleId><ArticleId IdType="pubmed">31162206</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bahr V., Hultman J., Eksborg S., Frenckner B., Kalzen H. Long-Term Survival in Adults Treated With Extracorporeal Membrane Oxygenation for Respiratory Failure and Sepsis. Crit. Care Med. 2017;45:164&#x2013;170. doi: 10.1097/CCM.0000000000002078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002078</ArticleId><ArticleId IdType="pubmed">28098624</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman L.M., Holzgraefe B., Palmer K., Frenckner B. The Stockholm experience: Interhospital transports on extracorporeal membrane oxygenation. Crit. Care. 2015;19:278. doi: 10.1186/s13054-015-0994-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0994-6</ArticleId><ArticleId IdType="pmc">PMC4498561</ArticleId><ArticleId IdType="pubmed">26160033</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher-Sandersjoo A., Frenckner B., Broman M. A Single-Center Experience of 900 Interhospital Transports on Extracorporeal Membrane Oxygenation. Ann. Thorac. Surg. 2018 doi: 10.1016/j.athoracsur.2018.07.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.07.040</ArticleId><ArticleId IdType="pubmed">30240763</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner M.V., Broman L.M., Belliato M., Venti A., Bader A., Taccone F.S., Di Nardo M., Maj G., Pappalardo F. Management strategies in venovenous extracorporeal membrane oxygenation: A retrospective comparison from five European centres. Crit. Care Resusc. J. Australas. Acad. Crit. Care Med. 2017;19:76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">29084505</ArticleId></ArticleIdList></Reference><Reference><Citation>Metnitz P.G., Moreno R.P., Almeida E., Jordan B., Bauer P., Campos R.A., Iapichino G., Edbrooke D., Capuzzo M., Le Gall J.R. SAPS 3&#x2014;From evaluation of the patient to evaluation of the intensive care unit. Part 1: Objectives, methods and cohort description. Intensive Care Med. 2005;31:1336&#x2013;1344. doi: 10.1007/s00134-005-2762-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2762-6</ArticleId><ArticleId IdType="pmc">PMC1315314</ArticleId><ArticleId IdType="pubmed">16132893</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno R.P., Metnitz P.G., Almeida E., Jordan B., Bauer P., Campos R.A., Iapichino G., Edbrooke D., Capuzzo M., Le Gall J.R. SAPS 3&#x2014;From evaluation of the patient to evaluation of the intensive care unit. Part 2: Development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31:1345&#x2013;1355. doi: 10.1007/s00134-005-2763-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-005-2763-5</ArticleId><ArticleId IdType="pmc">PMC1315315</ArticleId><ArticleId IdType="pubmed">16132892</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M., Bailey M., Sheldrake J., Hodgson C., Aubron C., Rycus P.T., Scheinkestel C., Cooper D.J., Brodie D., Pellegrino V., et al. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am. J. Respir. Crit. Care Med. 2014;189:1374&#x2013;1382. doi: 10.1164/rccm.201311-2023OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201311-2023OC</ArticleId><ArticleId IdType="pubmed">24693864</ArticleId></ArticleIdList></Reference><Reference><Citation>Belletti A., Lerose C.C., Zangrillo A., Landoni G. Vasoactive-Inotropic Score: Evolution, Clinical Utility, and Pitfalls. J. Cardiothorac. Vasc. Anesth. 2020 doi: 10.1053/j.jvca.2020.09.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2020.09.117</ArticleId><ArticleId IdType="pubmed">33069558</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H., Reinhart C.K., Suter P.M., Thijs L.G. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M., Burrell A., Roberts L., Bailey M., Sheldrake J., Rycus P.T., Hodgson C., Scheinkestel C., Cooper D.J., Thiagarajan R.R., et al. Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno-arterial-ECMO (SAVE)-score. Eur. Heart J. 2015;36:2246&#x2013;2256. doi: 10.1093/eurheartj/ehv194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv194</ArticleId><ArticleId IdType="pubmed">26033984</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghetti M. Echocardiographic Evaluation of Pulmonary Pressures and Right Ventricular Function after Pediatric Cardiac Surgery: A Simple Approach for the Intensivist. Front. Pediatrics. 2017;5:184. doi: 10.3389/fped.2017.00184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00184</ArticleId><ArticleId IdType="pmc">PMC5581805</ArticleId><ArticleId IdType="pubmed">28900614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., Solomon S.D., Louie E.K., Schiller N.B. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. Off. Publ. Am. Soc. Echocardiogr. 2010;23:685&#x2013;713. doi: 10.1016/j.echo.2010.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.05.010</ArticleId><ArticleId IdType="pubmed">20620859</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid E., Hilberath J.N., Blumenstock G., Shekar P.S., Kling S., Shernan S.K., Rosenberger P., Nowak-Machen M. Tricuspid annular plane systolic excursion (TAPSE) predicts poor outcome in patients undergoing acute pulmonary embolectomy. Heartlung Vessel. 2015;7:151&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4476769</ArticleId><ArticleId IdType="pubmed">26157741</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzgraefe B., Andersson C., Kalz&#xe9;n H., von Bahr V., Mosskin M., Larsson E.M., Palm&#xe9;r K., Frenckner B., Larsson A. Does permissive hypoxaemia during extracorporeal membrane oxygenation cause long-term neurological impairment?: A study in patients with H1N1-induced severe respiratory failure. Eur. J. Anaesthesiol. 2017;34:98&#x2013;103. doi: 10.1097/EJA.0000000000000544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000544</ArticleId><ArticleId IdType="pubmed">28030441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzeri C., Cianchi G., Bonizzoli M., Batacchi S., Terenzi P., Bernardo P., Valente S., Gensini G.F., Peris A. Right ventricle dilation as a prognostic factor in refractory acute respiratory distress syndrome requiring veno-venous extracorporeal membrane oxygenation. Minerva Anestesiol. 2016;82:1043&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">26957118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindfors M., Frenckner B., Sartipy U., Bjallmark A., Broome M. Venous Cannula Positioning in Arterial Deoxygenation During Veno-Arterial Extracorporeal Membrane Oxygenation-A Simulation Study and Case Report. Artif. Organs. 2017;41:75&#x2013;81. doi: 10.1111/aor.12700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.12700</ArticleId><ArticleId IdType="pmc">PMC5297996</ArticleId><ArticleId IdType="pubmed">27086941</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y., Lobo S.M., Moreno R.P., Gerlach H., Ranieri V.M., Michalopoulos A., Vincent J.L. Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit. Care. 2012;16:R222. doi: 10.1186/cc11868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11868</ArticleId><ArticleId IdType="pmc">PMC3672601</ArticleId><ArticleId IdType="pubmed">23158219</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk L., Sallisalmi M., Lindholm J.A., Lindfors M., Frenckner B., Broome M., Broman L.M. Differential hypoxemia during venoarterial extracorporeal membrane oxygenation. Perfusion. 2019;34:22&#x2013;29. doi: 10.1177/0267659119830513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659119830513</ArticleId><ArticleId IdType="pubmed">30966908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X., Yang X., Du Z., Xing J., Li H., Jiang C., Wang J., Xing Z., Li S., Li X., et al. Superior vena cava drainage improves upper body oxygenation during veno-arterial extracorporeal membrane oxygenation in sheep. Crit. Care. 2015;19:68. doi: 10.1186/s13054-015-0791-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0791-2</ArticleId><ArticleId IdType="pmc">PMC4352275</ArticleId><ArticleId IdType="pubmed">25887895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs G., Berg N., Broman L.M., Prahl Wittberg L. Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit. Sci. Rep. 2018;8:13985. doi: 10.1038/s41598-018-32247-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32247-y</ArticleId><ArticleId IdType="pmc">PMC6143512</ArticleId><ArticleId IdType="pubmed">30228350</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29784591</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1008-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Chinese journal of traumatology = Zhonghua chuang shang za zhi</Title><ISOAbbreviation>Chin J Traumatol</ISOAbbreviation></Journal><ArticleTitle>Accuracy and outcome of rapid ultrasound in shock and hypotension (RUSH) in&#xa0;Egyptian polytrauma patients.</ArticleTitle><Pagination><StartPage>156</StartPage><EndPage>162</EndPage><MedlinePgn>156-162</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cjtee.2017.06.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1008-1275(17)30103-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">"Polytrauma" patients are of a higher risk of complications and death than the summation of expected mortality and morbidity of their individual injuries. The ideal goal in trauma resuscitation care is to identify and treat all injuries. With clinical and technological advanced imaging available for diagnosis and treatment of traumatic patients, point of care-rapid ultrasound in shock and hypotension (RUSH) significantly affects modern trauma services and patient outcomes. This study aims to evaluate the accuracy of RUSH and patient outcomes by early detection of the causes of unstable polytrauma.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This cross-sectional, prospective study included 100 unstable polytrauma patients admitted in Suez Canal University Hospital. Clinical exam, RUSH and pan-computed tomography (pan-CT) were conducted. The result of CT was taken as the standard. Patients were managed according to the advanced trauma life support (ATLS) guidelines and treated of life threatening conditions if present. Patients were followed up for 28 days for a short outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The most diagnostic causes of unstability in polytrauma patients by RUSH are hypovolemic shock (64%), followed by obstructive shock (14%), distributive shock (12%) and cardiogenic shock (10%) respectively. RUSH had 94.2% sensitivity in the diagnosis of unstable polytrauma patients; the accuracy of RUSH in shock patients was 95.2%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">RUSH is accurate in the diagnosis of unstable polytrauma patients; and 4% of patients were diagnosed during follow-up after admission by RUSH and pan-CT.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elbaih</LastName><ForeName>Adel Hamed</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Faculty of Medicine, Suez Canal University, Egypt. Electronic address: elbaihzico@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Housseini</LastName><ForeName>Ahmed Mohamed</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Radiology, Faculty of Medicine, Suez Canal University, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalifa</LastName><ForeName>Mohamed E M</ForeName><Initials>MEM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Faculty of Medicine, Suez Canal University, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin J Traumatol</MedlineTA><NlmUniqueID>100886162</NlmUniqueID><ISSNLinking>1008-1275</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009104" MajorTopicYN="N">Multiple Trauma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012769" MajorTopicYN="N">Shock</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Polytrauma</Keyword><Keyword MajorTopicYN="N">Rapid ultrasound in shock and hypotension</Keyword><Keyword MajorTopicYN="N">Shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29784591</ArticleId><ArticleId IdType="pmc">PMC6033727</ArticleId><ArticleId IdType="doi">10.1016/j.cjtee.2017.06.009</ArticleId><ArticleId IdType="pii">S1008-1275(17)30103-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amin N.H., Jakoi A., Katsman A. Incidence of orthopedic surgery intervention in a level I urban trauma center with motorcycle trauma. J&#xa0;Trauma. 2011;71:948&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">21768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldemir M., Ta&#xe7;yildiz I., Girgin S. Predicting factors for mortality in the penetrating abdominal trauma. Acta Chir Belg. 2004;104:429&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">15469156</ArticleId></ArticleIdList></Reference><Reference><Citation>Butcher N., Balogh Z.J. The definition of polytrauma: the need for international consensus. Injury. 2009;40:S12&#x2013;S22.</Citation><ArticleIdList><ArticleId IdType="pubmed">19895948</ArticleId></ArticleIdList></Reference><Reference><Citation>Betz M., Li G. Injury prevention and control. Emerg Med Clin North Am. 2007;25:901&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">17826223</ArticleId></ArticleIdList></Reference><Reference><Citation>King R.W., Plewa M.C., Buderer N.M. Shock index as a marker for significant injury in trauma patients. Acad Emerg Med. 1996;3:1041&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pubmed">8922013</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;reide K. Epidemiology of major trauma. Br J Surg. 2009;96:697&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pubmed">19526611</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateer J., Plummer D., Heller M. Model curriculum for physician training in emergency ultrasonography. Ann Emerg Med. 1994;23:95&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8273966</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum S., Brateman L., Hevezi J. American College of Radiology white paper on radiation dose in medicine. J&#xa0;Am Coll Radiol. 2007;4:272&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">17467608</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson B., Trapp R.G. 4th ed. Lange Basic Science; USA: 2004. Basic &amp; clinical biostatistics.</Citation></Reference><Reference><Citation>Seif D., Perera P., Mailhot T. Bedside ultrasound in resuscitation and the rapid ultrasound in shock protocol. Crit Care Res Pract. 2012;2012:503254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485910</ArticleId><ArticleId IdType="pubmed">23133747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalya P.L., Mchembe M., Gilyoma J.M. Missed injuries in multiple trauma patients: a tertiary care experience in Tanzania. East Central African J Surg. 2010;15:39&#x2013;46.</Citation></Reference><Reference><Citation>Tham K.Y., Seow E., Lau G. Pattern of injuries in helmeted motorcyclists in Singapore. Emerg Med J. 2004;21:478&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1726370</ArticleId><ArticleId IdType="pubmed">15208235</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha M., Elbaih A. Pathophysiology and management of different types of shock. Narayana Med J. 2017;6:14&#x2013;39.</Citation></Reference><Reference><Citation>Elbaih A., Ali M., Attia Y. Accuracy of predictive factors and focused assessment with sonography for trauma (FAST) in management of adult blunt abdominal trauma and its outcome. Int J Surg Med. 2016;2:58&#x2013;63.</Citation></Reference><Reference><Citation>Stawicki S.P., Braslow B.M., Panebianco N.L. Intensivist use of hand-carried ultrasonography to measure IVC collapsibility in estimating intravascular volume status: correlations with CVP. J&#xa0;Am Coll Surg. 2009;209:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19651063</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson P.R., McAuley D.J., Kendall R.J. Abdominal and cardiac evaluation with sonography in shock (ACES): an approach by emergency physicians for the use of ultrasound in patients with undifferentiated hypotension. Emerg Med J. 2009;26:87&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">19164614</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaih A.H., Abu-Elela S.T. Patterns and outcome of missed injuries in Egyptians polytrauma patients. Int J Surg Med. 2018;4:13&#x2013;21.</Citation></Reference><Reference><Citation>Kauvar D.D., Lefering R., Wade C.E. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations and therapeutic considerations. J&#xa0;Trauma. 2006;60:S3&#x2013;S11.</Citation><ArticleIdList><ArticleId IdType="pubmed">16763478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35262574</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>Impact of Preoperative Functional Capacity on Postoperative Outcomes in Congenital Heart Surgery: An Observational and Prospective Study.</ArticleTitle><Pagination><StartPage>411</StartPage><EndPage>419</EndPage><MedlinePgn>411-419</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20201137</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2022000200411</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite advances in surgical technique and postoperative care in congenital heart disease, cardiovascular morbidity is still high.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the association between preoperative cardiovascular fitness of children and adolescents, measured by the 6-minute walk test (6MWT) and Heart Rate Variability (HRV), and the occurrence of cardiogenic, septic shock and death in the postoperative period.</AbstractText><AbstractText Label="METHODS">Prospective, observational clinic study including 81 patients aged from 8 to 18 years. In the preoperative period, the 6MWT (distance walked and SpO2) and HRV were performed. The adjusted risk score for surgeries for congenital heart disease (RACHS-1) was applied to predict the surgical risk factor for mortality. The occurrence of at least one of the listed complications was considered as a combined event. P values &lt; 0.05 were considered as significant.</AbstractText><AbstractText Label="RESULTS">Of the patients, 59% were male, with mean age of 12 years; 33% were cyanotic; and 72% had undergone previous cardiac surgery. Cardiogenic shock was the most common complication, and 31% had a combined event. Prior to surgery, type of current heart disease, RACHS-1, SpO2at rest, during the 6MWT and recovery were selected for the multivariate analysis. The SpO2at recovery by the 6MWT remained as an independent risk factor (OR 0.93, 95%CI [0.88 - 0.99], p=0.02) for the increasing occurrence of combined events.</AbstractText><AbstractText Label="CONCLUSION">SpO2after the application of the 6MWT in the preoperative period was an independent predictor of prognosis in children and adolescents undergoing surgical correction; the walked distance and the HRV did not present this association.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Angela Sachiko</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-1251-8723</Identifier><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Ant&#xf4;nio Augusto Barbosa</ForeName><Initials>AAB</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Ana Cristina Sayuri</ForeName><Initials>ACS</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feltrim</LastName><ForeName>Maria Ign&#xea;z Zanetti</ForeName><Initials>MIZ</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galas</LastName><ForeName>Filomena R B G</ForeName><Initials>FRBG</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Juliano Pinheiro</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajjar</LastName><ForeName>Ludhmila Abrah&#xe3;o</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nozawa</LastName><ForeName>Emilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo Hospital das Cl&#xed;nicas,S&#xe3;o Paulo, SP - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Impacto da Capacidade Funcional Pr&#xe9;-operat&#xf3;ria nos Resultados P&#xf3;s-Operat&#xf3;rios de Cirurgia de Cardiopatia Cong&#xea;nita: Estudo Observacional e Prospectivo.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Arq Bras Cardiol. 2022 Feb;118(2):420-421. doi: 10.36660/abc.20220020.</RefSource><PMID Version="1">35262575</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="Y">Exercise Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070857" MajorTopicYN="N">Walk Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016138" MajorTopicYN="Y">Walking</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="FUNDAMENTO">Apesar de avan&#xe7;os em t&#xe9;cnicas cir&#xfa;rgicas e cuidados p&#xf3;s-operat&#xf3;rios em cardiopatia cong&#xea;nita, a morbidade cardiovascular permanece elevada.</AbstractText><AbstractText Label="OBJETIVO">Avaliar a associa&#xe7;&#xe3;o do condicionamento pr&#xe9;-operat&#xf3;rio de crian&#xe7;as e adolescentes com cardiopatias, mensurado por teste de caminhada de 6-minutos (TC6M) e variabilidade da frequ&#xea;ncia card&#xed;aca (VFC), com a ocorr&#xea;ncia de choque cardiog&#xea;nico, s&#xe9;ptico e morte no per&#xed;odo p&#xf3;s-operat&#xf3;rio.</AbstractText><AbstractText Label="M&#xc9;TODOS">Estudo cl&#xed;nico prospectivo e observacional de 81 pacientes de 8 a 18 anos. No per&#xed;odo pr&#xe9;-operat&#xf3;rio foram realizados o TC6M (dist&#xe2;ncia caminhada e SpO2) e a VFC. O escore de risco ajustado para cirurgia de cardiopatia cong&#xea;nita ( RACHS-1 ) foi aplicado para predizer o fator de risco cir&#xfa;rgico para mortalidade. A ocorr&#xea;ncia de pelo menos uma das complica&#xe7;&#xf5;es citadas foi considerada como evento combinado. Valores de p&lt;0,05 foram considerados significantes.</AbstractText><AbstractText Label="RESULTADOS">Dos 81 pacientes, 59% eram do sexo masculino, com idade m&#xe9;dia de 12 anos; 33% eram cian&#xf3;ticos; e 72% j&#xe1; tinham realizado cirurgias pr&#xe9;vias. O choque cardiog&#xea;nico foi a complica&#xe7;&#xe3;o mais comum, e 31% apresentaram evento combinado. Cirurgia pr&#xe9;via, tipo de cardiopatia atual, RACHS-1 , SpO2 em repouso, durante e ap&#xf3;s recupera&#xe7;&#xe3;o do TC6M foram selecionados para o estudo multivariado. A SpO2 ap&#xf3;s o TC6M permaneceu como fator de risco independente para aumentar a ocorr&#xea;ncia de evento combinado no p&#xf3;s-operat&#xf3;rio (OR: 0,93, IC95% [0,88 &#x2013; 0,99], p=0,02).</AbstractText><AbstractText Label="CONCLUS&#xc3;O">O SpO2 ap&#xf3;s o TC6M no per&#xed;odo pr&#xe9;-operat&#xf3;rio foi o fator independente preditor de progn&#xf3;stico no p&#xf3;s-operat&#xf3;rio em crian&#xe7;as e adolescentes submetidos &#xe0; corre&#xe7;&#xe3;o cir&#xfa;rgica; a dist&#xe2;ncia caminhada e as vari&#xe1;veis da VFC n&#xe3;o tiveram a mesma associa&#xe7;&#xe3;o.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="BACKGROUND">Despite advances in surgical technique and postoperative care in congenital heart disease, cardiovascular morbidity is still high.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the association between preoperative cardiovascular fitness of children and adolescents, measured by the 6-minute walk test (6MWT) and Heart Rate Variability (HRV), and the occurrence of cardiogenic, septic shock and death in the postoperative period.</AbstractText><AbstractText Label="METHODS">Prospective, observational clinic study including 81 patients aged from 8 to 18 years. In the preoperative period, the 6MWT (distance walked and SpO<sub>2</sub>) and HRV were performed. The adjusted risk score for surgeries for congenital heart disease (RACHS-1) was applied to predict the surgical risk factor for mortality. The occurrence of at least one of the listed complications was considered as a combined event. P values &lt; 0.05 were considered as significant.</AbstractText><AbstractText Label="RESULTS">Of the patients, 59% were male, with mean age of 12 years; 33% were cyanotic; and 72% had undergone previous cardiac surgery. Cardiogenic shock was the most common complication, and 31% had a combined event. Prior to surgery, type of current heart disease, RACHS-1, SpO<sub>2</sub>at rest, during the 6MWT and recovery were selected for the multivariate analysis. The SpO<sub>2</sub>at recovery by the 6MWT remained as an independent risk factor (OR 0.93, 95%CI [0.88 - 0.99], p=0.02) for the increasing occurrence of combined events.</AbstractText><AbstractText Label="CONCLUSION">SpO<sub>2</sub>after the application of the 6MWT in the preoperative period was an independent predictor of prognosis in children and adolescents undergoing surgical correction; the walked distance and the HRV did not present this association.</AbstractText></OtherAbstract><CoiStatement>Potencial conflito de interesse. N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35262574</ArticleId><ArticleId IdType="pmc">PMC8856681</ArticleId><ArticleId IdType="doi">10.36660/abc.20201137</ArticleId><ArticleId IdType="pii">S0066-782X2022000200411</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nixon PA, Joswiak ML, Fricker FJ. A Six-Minute Walk Test for Assessing Exercise Tolerance in Severely ill Children. J Pediatr. 1996;129(3):362-6. doi: 10.1016/s0022-3476(96)70067-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8804324</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrindle BW, Williams RV, Mitchell PD, Hsu DT, Paridon SM, Atz AM, et al. Relationship of Patient and Medical Characteristics to Health Status in Children and Adolescents after the Fontan Procedure. Circulation. 2006;113(8):1123-9. doi: 10.1161/CIRCULATIONAHA.</Citation><ArticleIdList><ArticleId IdType="pubmed">16490823</ArticleId></ArticleIdList></Reference><Reference><Citation>Norozi K, Gravenhorst V, Hobbiebrunken E, Wessel A. Normality of Cardiopulmonary Capacity in Children Operated on to Correct Congenital Heart Defects. Arch Pediatr Adolesc Med. 2005;159(11):1063-8. doi: 10.1001/archpedi.159.11.1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">16275798</ArticleId></ArticleIdList></Reference><Reference><Citation>Golpe R, P&#xe9;rez-de-Llano LA, M&#xe9;ndez-Marote L, Veres-Racamonde A. Prognostic Value of Walk Distance, Work, Oxygen Saturation, and Dyspnea during 6-Minute Walk Test in COPD Patients. Respir Care. 2013;58(8):1329-34. doi: 10.4187/respcare.02290.</Citation><ArticleIdList><ArticleId IdType="pubmed">23322886</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubim VS, Drumond Neto C, Romeo JL, Montera MW. Prognostic value of the Six-Minute Walk Test in heart failure. Arq Bras Cardiol. 2006;86(2):120-5. doi: 10.1590/s0066-782x2006000200007.</Citation><ArticleIdList><ArticleId IdType="pubmed">16501803</ArticleId></ArticleIdList></Reference><Reference><Citation>Moalla W, Gauthier R, Maingourd Y, Ahmaidi S. Six-Minute Walking Test to Assess Exercise Tolerance and Cardiorespiratory Responses During Training Program in Children with Congenital Heart Disease. Int J Sports Med. 2005;26(9):756-62. doi: 10.1055/s-2004-830558.</Citation><ArticleIdList><ArticleId IdType="pubmed">16237621</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med. 2002;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehmeier ES, Sommer MH, Galonska A, Zeus T, Verde P, Kelm M. Diagnostic Value of the Six-Minute Walk Test (6MWT) in Grown-up Congenital Heart Disease (GUCH): Comparison with Clinical Status and Functional Exercise Capacity. Int J Cardiol. 2016;203:90-7. doi: 10.1016/j.ijcard.2015.10.074.</Citation><ArticleIdList><ArticleId IdType="pubmed">26498869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohuchi H, Watanabe K, Kishiki K, Wakisaka Y, Echigo S. Heart Rate Dynamics During and After Exercise in Postoperative Congenital Heart Disease Patients. Their Relation to Cardiac Autonomic Nervous Activity and Intrinsic Sinus Node Dysfunction. Am Heart J. 2007;154(1):165-71. doi: 10.1016/j.ahj.2007.03.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">17584572</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni LI. Consensus-Based Method for Risk Adjustment for Surgery for Congenital Heart Disease. J Thorac Cardiovasc Surg. 2002;123(1):110-8. doi: 10.1067/mtc.2002.119064.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782764</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg GA. Psychophysical Bases of Perceived Exertion. Med Sci Sports Exerc. 1982;14(5):377-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7154893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamelin FX, Baquet G, Berthoin S, Bosquet L. Validity of the Polar S810 to Measure R-R Intervals in Children. Int J Sports Med. 2008;29(2):134-8. doi: 10.1055/s-2007-964995.</Citation><ArticleIdList><ArticleId IdType="pubmed">17614016</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart Rate Variability: Standards of Measurement, Physiological Interpretation and Clinical Use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996;93(5):1043-65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8598068</ArticleId></ArticleIdList></Reference><Reference><Citation>Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, et al. Six-Minute Walk Test in Children and Adolescents. J Pediatr. 2007;150(4):395-9. doi: 10.1016/j.jpeds.2006.12.052.</Citation><ArticleIdList><ArticleId IdType="pubmed">17382117</ArticleId></ArticleIdList></Reference><Reference><Citation>Priesnitz CV, Rodrigues GH, Stumpf CS, Viapiana G, Cabral CP, Stein RT, et al. Reference Values for the 6-min Walk Test in Healthy Children Aged 6-12 years. Pediatr Pulmonol. 2009;44(12):1174-9. doi: 10.1002/ppul.21062.</Citation><ArticleIdList><ArticleId IdType="pubmed">19911357</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts MM, Cho JG, Sandoz JS, Wheatley JR. Oxygen Desaturation and Adverse Events During 6-min walk Testing in Patients with COPD. Respirology. 2015;20(3):419-25. doi: 10.1111/resp.12471.</Citation><ArticleIdList><ArticleId IdType="pubmed">25601398</ArticleId></ArticleIdList></Reference><Reference><Citation>Ora J, Calzetta L, Pezzuto G, Senis L, Paone G, Mari A, et al. A 6MWT Index to Predict O2 Flow Correcting Exercise Induced SpO2 Desaturation in ILD. Respir Med. 2013;107(12):2014-21. doi: 10.1016/j.rmed.2013.10.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">24161677</ArticleId></ArticleIdList></Reference><Reference><Citation>Briand J, Behal H, Chenivesse C, W&#xe9;meau-Stervinou L, Wallaert B. The 1-minute Sit-to-Stand Test to Detect Exercise-Induced Oxygen Desaturation in Patients with Interstitial Lung Disease. Ther Adv Respir Dis. 2018;12:1753466618793028. doi: 10.1177/1753466618793028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6088463</ArticleId><ArticleId IdType="pubmed">30091679</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaan CW, Macedo ACP, Sbruzzi G, Umpierre D, Schaan BD, Pellanda LC. Functional Capacity in Congenital Heart Disease: A Systematic Review and Meta-Analysis. Arq Bras Cardiol. 2017;109(4):357-67. doi: 10.5935/abc.20170125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5644216</ArticleId><ArticleId IdType="pubmed">28876372</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S, Bandyopadhyay B, Eriksson P, Chattopadhyay A. Functional Capacity Following Univentricular Repair-Midterm Outcome. Congenit Heart Dis. 2012;7(5):423-32. doi: 10.1111/j.1747-0803.2012.00640.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">22471644</ArticleId></ArticleIdList></Reference><Reference><Citation>Hami, K, Corcia MCG. Heart Rate Variability Modifications after Surgery for Congenital Heart Disease in Young Patients. Evid Based Med Pract, 2017;3(1):1-3. doi: 10.4172/2471-9919.1000113</Citation></Reference><Reference><Citation>Elder RW, McCabe NM, Veledar E, Kogon BE, Jokhadar M, Rodriguez FH 3rd, et al. Risk Factors for Major Adverse Events Late After Fontan Palliation. Congenit Heart Dis. 2015;10(2):159-68. doi: 10.1111/chd.12212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4512755</ArticleId><ArticleId IdType="pubmed">25130602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gewillig M, Goldberg DJ. Failure of the Fontan Circulation. Heart Fail Clin. 2014;10(1):105-16. doi: 10.1016/j.hfc.2013.09.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">24275298</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamberti A, Chessa M, Abella R, Butera G, Carlucci C, Nuri H, et al. Morbidity and Mortality Risk Factors in Adults with Congenital Heart Disease Undergoing Cardiac Reoperations. Ann Thorac Surg. 2009;88(4):1284-9. doi: 10.1016/j.athoracsur.2009.05.060.</Citation><ArticleIdList><ArticleId IdType="pubmed">19766822</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39185956</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-9159</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of surgery (London, England)</Title><ISOAbbreviation>Int J Surg</ISOAbbreviation></Journal><ArticleTitle>Pulmonary artery banding in infants and young children with end-stage left ventricular dilated cardiomyopathy: cohort study.</ArticleTitle><Pagination><StartPage>146</StartPage><EndPage>152</EndPage><MedlinePgn>146-152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JS9.0000000000002061</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Dilated cardiomyopathy (DCM) is the most common cardiomyopathy, and 40--50% of patients may die or need a heart transplant in 5 years after diagnosis. Although heart transplantation is the most effective life-saving option of end-stage DCM, scarcity of donors and series of complications prevent many patients from receiving timely treatment. Pulmonary artery banding (PAB) is recently described as an alternative strategy for end-stage DCM, with low left ventricular function (LVEF) but preserved right ventricular function, may potentially restore heart function and delay the need for heart transplantation, but current clinical evidence is still insufficient. On the other hand, the medication treatment of DCM in pediatric patients is mostly based on the experience of adults. It remains unclear whether PAB combined medication treatment could benefit infants and young children patients. The aim of this study was to assess the short-term efficacy of PAB combined with medication therapy in infants and young children with end-stage DCM, compared with medication therapy alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective analysis of 18 consecutive pediatric patients aged ranging from 1 month to 44 months old who diagnosed with end-stage DCM (LVEF &#x2264;30%) with preserved right ventricular function between 2019 and 2023 in our hospital. All patients had been treated with conventional medications for 2 months. Then they were divided in two groups: PAB surgery group (6/18), and nonsurgery group (12/18). Regardless of whether surgery was performed, both groups continued to receive medication treatment. Recovery of ventricular function was primary endpoints. Secondary endpoints included 180-day mortality and severe heart failure (LVEF &#x2264;30%).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The authors found there were no differences in age, weight, height, BMI, renal function, liver function, pulmonary hypertension, tricuspid valve regurgitation, mitral valve regurgitation, and genetic abnormalities between those with and without PAB surgery. Comparing with nonsurgery group, five patients in surgery group regain the normal cardiac ejection fraction (LVEF &#x2265;50%) (5/6, 83.3% vs. 4/12, 33.3%, P= 0.131). A total of three patients had sudden death in nonsurgery group, and there was no death in surgery group ( P= 0.180). Five patients (5/12, 41.7%) still remain the low heart failure (LVEF &#x2264;40%) after 6 months of enrollment only given medical therapy, and none of patients present with LVEF &#x2264;40% in PAB surgery group (0/6, 0% vs. 8/12, 67.7%, P= 0.034).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Pulmonary artery banding is safe and effective in infants and young children with end-stage DCM with preserved right ventricular function. Combined with conventional heart failure medication therapy, it may provide short-term benefits postoperatively, decrease the cardiogenic shock, act as a bridge to recovery, and potentially reduce the need for heart transplantation. Long-term effects remain further observation, and larger randomized controlled trials would be more persuasive in validating its efficacy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yue</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Surgery Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Surgery Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Quanlin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatric Intensive Care Unit, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Shoujun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7943-2911</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Cardiac Surgery Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg</MedlineTA><NlmUniqueID>101228232</NlmUniqueID><ISSNLinking>1743-9159</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011651" MajorTopicYN="Y">Pulmonary Artery</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>7</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>13</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39185956</ArticleId><ArticleId IdType="pmc">PMC11745709</ArticleId><ArticleId IdType="doi">10.1097/JS9.0000000000002061</ArticleId><ArticleId IdType="pii">01279778-990000000-01923</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Towbin JA, Lowe AM, Colan SD, et al. . Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867&#x2013;1876.</Citation><ArticleIdList><ArticleId IdType="pubmed">17047217</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachel EA, Matthew JF, Deborah AR, et al. . British Congenital cardiac association. Circulation 2008;117:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Melanie DE, Lynn AS, Minmin L, et al. . Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. J Am Coll Cardiol 2014;63:1405&#x2013;1413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4030008</ArticleId><ArticleId IdType="pubmed">24561146</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul FK, Jonathan RA, Anne ID, et al. . The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 2010;55:1377&#x2013;1384.</Citation><ArticleIdList><ArticleId IdType="pubmed">20338500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu DT, Shaddy R. Advantages, disadvantages and alternatives to using adult heart failure clinical trials to guide pediatric heart failure therapy. Prog Pediatr Cardiol 2006.</Citation></Reference><Reference><Citation>Sharon AH, American College of Cardiology, American Heart Association Task Force on Practice Guidelines . ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2005;46:e1&#x2013;e82.</Citation><ArticleIdList><ArticleId IdType="pubmed">16168273</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrillo JE, Cunnion RE, Epstein SE, et al. . A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med 1989;321:1061&#x2013;1068.</Citation><ArticleIdList><ArticleId IdType="pubmed">2677721</ArticleId></ArticleIdList></Reference><Reference><Citation>Karolina W, Jakob W, Wolfgang K, et al. . Add-on immunoadsorption shortly-after optimal medical treatment further significantly and persistently improves cardiac function and symptoms in recent-onset heart failure&#x2014;a single center experience. Biomolecules 2018;8:133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315717</ArticleId><ArticleId IdType="pubmed">30400209</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliessa B, William G. Pediatric heart transplant. Semin Pediatr Surg 2021;30:151039.</Citation><ArticleIdList><ArticleId IdType="pubmed">33992306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G, Agha R.for the STROCSS Group . STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. International Journal of Surgery 2021;96:106165.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774726</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth AH, Daniel B, Justin Y, et al. . Outcomes of children following a first hospitalization for dilated cardiomyopathy. Circ Heart Fail 2012;5:437&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">22570362</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietmar S, Sabine R, Ivan M, et al. . Pulmonary artery banding in dilative cardiomyopathy of young children: review and protocol based on the current knowledge. Transl Pediatr 2019;8:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6514280</ArticleId><ArticleId IdType="pubmed">31161082</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteo P, Biagio C, Massimo AP. Pulmonary artery banding for dilated cardiomyopathy in children: returning to the bench from bedside. Children (Basel) 2022;9:1392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9497481</ArticleId><ArticleId IdType="pubmed">36138701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietmar S, Hakan A, Leonard B. Pulmonary artery banding for functional regeneration of end-stage dilated cardiomyopathy in young children. Circulation 2018;137:1410&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">29581368</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteo P, Anna CF, Biagio C, et al. . Surgical strategies for the management of end-stage heart failure in infants and children: A 15-year experience with a patient-tailored approach. Artif Organs 2021;45:1543&#x2013;1553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9292686</ArticleId><ArticleId IdType="pubmed">34461675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachary AS, Anees R, John JN, et al. . Pulmonary artery banding for children with dilated cardiomyopathy: US experience. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2020;23:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">32354550</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36858907</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2623</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Transplantation proceedings</Title><ISOAbbreviation>Transplant Proc</ISOAbbreviation></Journal><ArticleTitle>Takotsubo Syndrome in Orthotopic Liver Transplant: A Systematic Review and Pooled Analysis of Published Studies and Case Reports.</ArticleTitle><Pagination><StartPage>2075</StartPage><EndPage>2083</EndPage><MedlinePgn>2075-2083</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2022.11.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0041-1345(22)00778-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Takotsubo syndrome (TTS) has been reported in solid-organ transplant recipients. However, the pooled data regarding TTS after liver transplant remain limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review was performed through February 2022 using PubMed, Embase, Scopus, and Google Scholar to review case reports/series and original studies on liver transplant-associated TTS. Descriptive analysis was performed for case reports and pooled analysis for the prevalence using random effects models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 56 case reports were included from 30 articles (51.8 % male; mean age, 53 years; India 56%, US 27%, and Europe 8.93%) and 10 original studies (US 88.65%, India 10.92%) revealing liver transplant-associated TTS. The pooled prevalence of TTS was 1.1% (95% Cl, 0.6%-1.7%) of all liver transplants with comparable rates in studies from India and the US (P&#x202f;=&#x202f;.92). Indications for liver transplant included end-stage liver disease due to alcohol-related cirrhosis (25%), hepatitis C virus infection (17.9%), hepatocellular carcinoma (10.7%), and non-alcohol-related steatohepatitis (8.9%); the average Model for End-Stage Liver Disease score was 24.75. TTS commonly presented as hypotension (30%), dyspnea (14%), and oliguria, occurring mostly post-transplant (82%), whereas 14% were intraoperative. Common electrocardiogram findings were ST changes, ventricular tachycardia, and atrial fibrillation. Common echocardiogram findings showed left ventricular apical ballooning in 46.5% of cases and reduced ejection fraction &lt; 20% in 41.9% of cases. Common complications were cardiogenic shock (32.1 %), acute kidney injury (12.5%), arrhythmia, stroke, cardiac arrest, and hepatic artery thrombosis. Mechanical circulatory support was required in 30.3%. Recurrence was reported in 15, and mortality in 30.4% of patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Takotsubo syndrome prevalence after liver transplant is significantly higher than TTS prevalence in general US hospitalizations with potentially worse outcomes. Prospective registries reporting TTS in liver transplant recipients are warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bachayev</LastName><ForeName>Milana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, International University of the Health Sciences, St. Kitts, Nevis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brereton</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Jersey General Hospital, Saint Helier, Jersey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mondal</LastName><ForeName>Avilash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Nazareth Hospital, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alli-Ramsaroop</LastName><ForeName>Bibi Amena</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Pediatric Surgery, Georgetown Public Hospital Corporation, Georgetown, Guyana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhakal</LastName><ForeName>Roshan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Nepal Medical College, Kathmandu, Nepal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leon</LastName><ForeName>Maria C Buhl</ForeName><Initials>MCB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidad de San Martin de Porres, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinones</LastName><ForeName>Camila M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidad de San Martin de Porres, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelal</LastName><ForeName>Mohamed Eyad O</ForeName><Initials>MEO</Initials><AffiliationInfo><Affiliation>Department of Medicine, International University of the Health Sciences, St. Kitts, Nevis.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Akhil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Mercy Catholic Medical Center, Darby, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhaduk</LastName><ForeName>Kartik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania. Electronic address: kartikdhaduk@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Rupak</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Independent Researcher, Atlanta, Georgia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transplant Proc</MedlineTA><NlmUniqueID>0243532</NlmUniqueID><ISSNLinking>0041-1345</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D054549" MajorTopicYN="Y">Takotsubo Cardiomyopathy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="Y">Liver Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>DISCLOSURE The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>9</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36858907</ArticleId><ArticleId IdType="doi">10.1016/j.transproceed.2022.11.005</ArticleId><ArticleId IdType="pii">S0041-1345(22)00778-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28347320</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation.</ArticleTitle><Pagination><StartPage>76</StartPage><MedlinePgn>76</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">76</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1655-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite quick implementation of reperfusion therapies, a few patients with high-risk, acute, massive, pulmonary embolism (PE) remain highly hemodynamically unstable. Others have absolute contraindication to receive reperfusion therapies. Venoarterial-extracorporeal membrane oxygenation (VA-ECMO) might lower their right ventricular overload, improve hemodynamic status, and restore tissue oxygenation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ECMO-related complications and 90-day mortality were analyzed for 17 highly unstable, ECMO-treated, massive PE patients admitted to a tertiary-care center (2006-2015). Hospital- discharge survivors were assessed for long-term health-related quality of life. A systematic review of this topic was also conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen high-risk PE patients [median age 51 (range 18-70) years, Simplified Acute Physiology Score II (SAPS II) 78 (45-95)] were placed on VA-ECMO for 4 (1-12) days. Among 15 (82%) patients with pre-ECMO cardiac arrest, seven (41%) were cannulated during cardiopulmonary resuscitation, and eight (47%) underwent pre-ECMO thrombolysis. Pre-ECMO median blood pressure, pH, and blood lactate were, respectively: 42 (0-106) mmHg, 6.99 (6.54-7.37) and 13 (4-19) mmol/L. Ninety-day survival was 47%. Fifteen (88%) patients suffered in-ICU severe hemorrhages with no impact on survival. Like other ECMO-treated patients, ours reported limitations of all physical domains but preserved mental health 19 (4-69) months post-ICU discharge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">VA-ECMO could be a lifesaving rescue therapy for patients with high-risk, acute, massive PE when thrombolytic therapy fails or the patient is too sick to benefit from surgical thrombectomy. Because heparin-induced clot dissolution and spontaneous fibrinolysis allows ECMO weaning within several days, future studies should investigate whether VA-ECMO should be the sole therapy or completed by additional mechanical clot-removal therapies in this setting.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corsi</LastName><ForeName>Fillipo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia e Rianimazione, Policlinico Universitario A. Gemelli, Universit&#xe0; Cattolica Del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreton</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Department, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xe9;chot</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hekimian</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieszkowska</LastName><ForeName>Ania</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trouillet</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyt</LastName><ForeName>Charles-Edouard</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leprince</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Department, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chastre</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, Assistance Publique-H&#xf4;pitaux de Paris, Universit&#xe9; Pierre-et-Marie-Curie, Paris 6, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France. matthieu.schmidt@aphp.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de R&#xe9;animation M&#xe9;dicale, iCAN, Institute of Cardiometabolism and Nutrition, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe8;re, 47, bd de l'H&#xf4;pital, 75651, Paris Cedex 13, France. matthieu.schmidt@aphp.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010297" MajorTopicYN="N">Paris</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Long-term quality of life</Keyword><Keyword MajorTopicYN="N">Massive pulmonary embolism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28347320</ArticleId><ArticleId IdType="pmc">PMC5369216</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1655-8</ArticleId><ArticleId IdType="pii">10.1186/s13054-017-1655-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010;363(3):266&#x2013;74. doi: 10.1056/NEJMra0907731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra0907731</ArticleId><ArticleId IdType="pubmed">20592294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper W, Konstantinides S, Geibel A, Olschewski M, Heinrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30(5):1165&#x2013;71. doi: 10.1016/S0735-1097(97)00319-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(97)00319-7</ArticleId><ArticleId IdType="pubmed">9350909</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman MV, Humbert M, Kucher N, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033&#x2013;3069. doi: 10.1093/eurheartj/ehu283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu283</ArticleId><ArticleId IdType="pubmed">25173341</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma. 2007;62(3):570&#x2013;6. doi: 10.1097/TA.0b013e318031cd0c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e318031cd0c</ArticleId><ArticleId IdType="pubmed">17414330</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekan R, Saunders PC, Yu CJ, Brown KA, Gass AL, Spielvogel D, Lansman SL. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for high-risk massive pulmonary embolism. Ann Thorac Surg. 2012;94(1):104&#x2013;8. doi: 10.1016/j.athoracsur.2012.03.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.052</ArticleId><ArticleId IdType="pubmed">22542068</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlovic G, Banfi C, Tassaux D, Peter RE, Licker MJ, Bendjelid K, Giraud R. Peri-operative massive pulmonary embolism management: is veno-arterial ECMO a therapeutic option? Acta Anaesthesiol Scand. 2014;58(10):1280&#x2013;6. doi: 10.1111/aas.12411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12411</ArticleId><ArticleId IdType="pubmed">25251898</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review. Perfusion. 2015;30(8):611&#x2013;6. doi: 10.1177/0267659115583377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659115583377</ArticleId><ArticleId IdType="pubmed">25910837</ArticleId></ArticleIdList></Reference><Reference><Citation>Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Diebold B, Chastre J, Combes A. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med. 2011;37(11):1738&#x2013;45. doi: 10.1007/s00134-011-2358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2358-2</ArticleId><ArticleId IdType="pubmed">21965097</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Leprince P, Luyt CE, Bonnet N, Trouillet JL, Leger P, Pavie A, Chastre J. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med. 2008;36(5):1404&#x2013;11. doi: 10.1097/CCM.0b013e31816f7cf7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31816f7cf7</ArticleId><ArticleId IdType="pubmed">18434909</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirabel M, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med. 2011;39(5):1029&#x2013;35. doi: 10.1097/CCM.0b013e31820ead45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31820ead45</ArticleId><ArticleId IdType="pubmed">21336134</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson GG, Arana-Sialer JA, Andersen Br Grieble HG, McCabe WR. Profiles of pyelonephritis. Arch Intern Med. 1962;110:63&#x2013;75. doi: 10.1001/archinte.1962.03620230109016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1962.03620230109016</ArticleId><ArticleId IdType="pubmed">13957202</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;83. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957&#x2013;63. doi: 10.1001/jama.1993.03510240069035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Wernovsky G, Wypij D, Jonas RA, Mayer JE, Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995;92(8):2226&#x2013;35. doi: 10.1161/01.CIR.92.8.2226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.8.2226</ArticleId><ArticleId IdType="pubmed">7554206</ArticleId></ArticleIdList></Reference><Reference><Citation>The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. The GUSTO Angiographic Investigators. N Engl J Med. 1993; 329(22):1615&#x2013;1622</Citation><ArticleIdList><ArticleId IdType="pubmed">8232430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran R, Steg PG, White HD, Rao SV. Letter by Mehran et al regarding article, &#x201c;Bleeding academic research consortium consensus report: the food and drug administration perspective&#x201d;. Circulation. 2012;125(10):e460. doi: 10.1161/CIRCULATIONAHA.111.065888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.065888</ArticleId><ArticleId IdType="pubmed">22412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013&#x2013;23. doi: 10.1016/S0895-4356(98)00093-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(98)00093-6</ArticleId><ArticleId IdType="pubmed">9817119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361&#x2013;70. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209&#x2013;18. doi: 10.1097/00006842-197905000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-197905000-00004</ArticleId><ArticleId IdType="pubmed">472086</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179&#x2013;86. doi: 10.1093/geront/9.3_Part_1.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/9.3_Part_1.179</ArticleId><ArticleId IdType="pubmed">5349366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brechot N, Luyt CE, Schmidt M, Leprince P, Trouillet JL, Leger P, Pavie A, Chastre J, Combes A. Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock. Crit Care Med. 2013;41(7):1616&#x2013;26. doi: 10.1097/CCM.0b013e31828a2370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a2370</ArticleId><ArticleId IdType="pubmed">23563585</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Zogheib E, Roze H, Repesse X, Lebreton G, Luyt CE, Trouillet JL, Brechot N, Nieszkowska A, Dupont H, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med. 2013;39(10):1704&#x2013;13. doi: 10.1007/s00134-013-3037-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-3037-2</ArticleId><ArticleId IdType="pmc">PMC7094902</ArticleId><ArticleId IdType="pubmed">23907497</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W, Management S. Prognosis of Pulmonary Embolism-3 Trial I. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002;347(15):1143&#x2013;50. doi: 10.1056/NEJMoa021274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021274</ArticleId><ArticleId IdType="pubmed">12374874</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg. 1999;15(4):508&#x2013;14. doi: 10.1016/S1010-7940(99)00061-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1010-7940(99)00061-5</ArticleId><ArticleId IdType="pubmed">10371130</ArticleId></ArticleIdList></Reference><Reference><Citation>Cengiz P, Seidel K, Rycus PT, Brogan TV, Roberts JS. Central nervous system complications during pediatric extracorporeal life support: incidence and risk factors. Crit Care Med. 2005;33(12):2817&#x2013;24. doi: 10.1097/01.CCM.0000189940.70617.C3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000189940.70617.C3</ArticleId><ArticleId IdType="pubmed">16352965</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246&#x2013;56. doi: 10.1093/eurheartj/ehv194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv194</ArticleId><ArticleId IdType="pubmed">26033984</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurtheret S, Mordant P, Paoletti X, Marijon E, Celermajer DS, Leger P, Pavie A, Combes A, Leprince P. Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program) Eur Heart J. 2013;34(2):112&#x2013;20. doi: 10.1093/eurheartj/ehs081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs081</ArticleId><ArticleId IdType="pubmed">22513777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MY, Liu YC, Tseng YH, Chang YS, Lin PJ, Wu TI. Pulmonary embolectomy in high-risk acute pulmonary embolism: the effectiveness of a comprehensive therapeutic algorithm including extracorporeal life support. Resuscitation. 2013;84(10):1365&#x2013;70. doi: 10.1016/j.resuscitation.2013.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2013.03.032</ArticleId><ArticleId IdType="pubmed">23583612</ArticleId></ArticleIdList></Reference><Reference><Citation>Munakata R, Yamamoto T, Hosokawa Y, Tokita Y, Akutsu K, Sato N, Murata S, Tajima H, Mizuno K, Tanaka K. Massive pulmonary embolism requiring extracorporeal life support treated with catheter-based interventions. Int Heart J. 2012;53(6):370&#x2013;4. doi: 10.1536/ihj.53.370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.53.370</ArticleId><ArticleId IdType="pubmed">23258138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013;41(2):462&#x2013;8. doi: 10.1183/09031936.00049312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00049312</ArticleId><ArticleId IdType="pubmed">22700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcroix M, Lang I, Pepke-Zaba J, Jansa P, D&#x2019;Armini AM, Snijder R, Bresser P, Torbicki A, Mellemkjaer S, Lewczuk J, et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2016;133(9):859&#x2013;71. doi: 10.1161/CIRCULATIONAHA.115.016522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.016522</ArticleId><ArticleId IdType="pubmed">26826181</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, Chen WJ, Huang SC, Chi NH, Wang CH, et al. Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554&#x2013;61. doi: 10.1016/S0140-6736(08)60958-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60958-7</ArticleId><ArticleId IdType="pubmed">18603291</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B, Langeron O. Extracorporeal life support following out-of-hospital refractory cardiac arrest. Crit Care. 2011;15(1):R29. doi: 10.1186/cc9976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9976</ArticleId><ArticleId IdType="pmc">PMC3222065</ArticleId><ArticleId IdType="pubmed">21244674</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahito K, Murata S, Adachi H, Ino T, Fuse K. Resuscitation and circulatory support using extracorporeal membrane oxygenation for fulminant pulmonary embolism. Artif Organs 2000;24(6):427&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">10886059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuma M, Nakamura M, Yamada N, Nakano T, Shirato K. Percutaneous cardiopulmonary support for the treatment of acute pulmonary embolism: summarized review of the literature in Japan including our own experience. Annals of vascular diseases 2009;2(1):7&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595745</ArticleId><ArticleId IdType="pubmed">23555350</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar HR, Miller J, Mangar D, Camporesi EM. Experience with extracorporeal membrane oxygenation in massive and submassive pulmonary embolism in a tertiary care center. Am J Emerg Med 2013;31(11):1616&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">24055248</ArticleId></ArticleIdList></Reference><Reference><Citation>Maj G, Melisurgo G, De Bonis M, Pappalardo F: ECLS management in pulmonary embolism with cardiac arrest: which strategy is better? Resuscitation 2014;85(10):e175&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">24709613</ArticleId></ArticleIdList></Reference><Reference><Citation>Swol J, Buchwald D, Strauch J, Schildhauer TA. Extracorporeal life support (ECLS) for cardiopulmonary resuscitation (CPR) with pulmonary embolism in surgical patients - a case series. Perfusion. 2016;31(1):54&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">25906777</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho YH, Sung K, Kim WS, Jeong DS. Management of acute massive pulmonary embolism: Is surgical embolectomy inferior to thrombolysis? International Journal of Cardiology 2016;203:579&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">26569368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38939588</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Recovery of Biventricular Function After Catheter Intervention or Surgery for Neonatal Coarctation of the Aorta.</ArticleTitle><Pagination><StartPage>100326</StartPage><MedlinePgn>100326</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100326</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2023.100326</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Critical coarctation of the aorta (CoA) is a life-threatening condition in newborns that is associated with biventricular dysfunction.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The purpose of this study was to examine clinical outcome and echocardiographic changes in isthmus diameter and biventricular function in newborns with critical CoA treated with balloon dilation/stent placement or surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This is a retrospective single-center cohort study of 26 consecutive neonates with isolated critical CoA, who underwent transcatheter intervention (balloon angioplasty/stent; n&#xa0;=&#xa0;10) or surgical CoA-repair (n&#xa0;=&#xa0;16) (2012-2021). Isthmus dimensions and biventricular function at baseline and at hospital discharge were examined by echocardiography, including strain analysis of systolic and diastolic function using 2-dimensional speckle tracking.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Cardiogenic shock at hospital admission was more frequent in the interventional vs the surgical cohort (50% vs 25% of neonates). Echocardiographic isthmus diameter increased with therapy by 0.9 &#xb1; 0.1 mm and 1.0 &#xb1; 0.1 mm, respectively. Severe systolic left ventricular (LV) dysfunction was more common in interventional patients pre-therapy (LV ejection fraction&#xa0;&lt;50% in 90% vs 38% of surgical patients), resulting in strongly reduced longitudinal strain (LV:&#xa0;-12.3% vs&#xa0;-16.3%; right ventricle:-13.8% vs&#xa0;-16.1% in the interventional and surgical patients, respectively). Prior to hospital discharge, all 26 patients had full recovery of biventricular systolic function, including normalization of longitudinal, radial, and circumferential LV strain and longitudinal right ventricular free wall strain. Improvement of LV diastolic function by strain analysis was evident in both cohorts pre-hospital discharge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Initial treatment of isolated CoA by percutaneous transcatheter intervention or surgical repair results in recovery of biventricular systolic function, making transcatheter treatment particularly suitable as rescue therapy for neonates with critical CoA.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hysko</LastName><ForeName>Klea</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohmann</LastName><ForeName>Dagmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobylev</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horke</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertram</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Happel</LastName><ForeName>Christoph M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansmann</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2D speckle tracking echocardiography</Keyword><Keyword MajorTopicYN="N">coarctation of the aorta</Keyword><Keyword MajorTopicYN="N">critical congenital heart disease</Keyword><Keyword MajorTopicYN="N">interventional cardiology</Keyword><Keyword MajorTopicYN="N">neonatal coarcation</Keyword></KeywordList><CoiStatement>This study was supported by the 10.13039/501100001659German Research Foundation DFG KFO 311 &#x201c;Pre-Terminal Heart and Lung Failure&#x2013;Unloading and Repair&#x201d; (HA4348/6-2 to G.H.). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38939588</ArticleId><ArticleId IdType="pmc">PMC11198406</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2023.100326</ArticleId><ArticleId IdType="pii">S2772-963X(23)00098-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patel H.T., Madani A., Paris Y.M., Warner K.G., Hijazi Z.M. Balloon angioplasty of native coarctation of the aorta in infants and neonates: is it&#xa0;worth the hassle? Pediatr Cardiol. 2001;22(1):53&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">11123129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xfc;h S., Knirsch W., Dodge-Khatami A., Dave H., Pr&#xea;tre R., Kretschmar O. Comparison of surgical and interventional therapy of native and recurrent aortic coarctation regarding different age groups during childhood. Eur J Cardiothorac Surg. 2011;39:898&#x2013;904. doi: 10.1016/j.ejcts.2010.09.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2010.09.048</ArticleId><ArticleId IdType="pubmed">21169030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman E.M., Groenendijk I.M., Heuvelman H.M., Roos-Hesselink J.W., Takkenberg J.J., Witsenburg M. The effectiveness of stenting of coarctation of the aorta: a systematic review. EuroIntervention. 2015;11(6):660&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">26499220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fesseha A.K., Eidem B.W., Dibardino D.J., et al. Neonates with aortic coarctation and cardiogenic shock: presentation and outcomes. Ann Thorac Surg. 2005;79(5):1650&#x2013;1655.</Citation><ArticleIdList><ArticleId IdType="pubmed">15854946</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore A.C., Fischer L.K., Schwartz T., et al. Comparison of angioplasty and surgery for neonatal aortic coarctation. Ann Thorac Surg. 2005;80(5):1659&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">16242435</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen S., Garg S., Rao S.G., Kulkarni S. Native aortic coarctation in neonates and infants: immediate and midterm outcomes with balloon angioplasty and surgery. Ann Pediatr Cardiol. 2018;11(3):261&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6146845</ArticleId><ArticleId IdType="pubmed">30271015</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamlou T., Bernasconi A., Jaeggi E., et al. Factors associated with arch reintervention and growth of the aortic arch after coarctation repair in neonates weighing less than 2.5&#xa0;kg. J&#xa0;Thorac Cardiovasc Surg. 2009;137(5):1163&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">19379984</ArticleId></ArticleIdList></Reference><Reference><Citation>Klitsie L.M., Kuipers I.M., Van der Hulst A.E., et al. Enhanced characterization of ventricular performance after coarctation repair in neonates and young children. Ann Thorac Surg. 2013;96(2):629&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">23806230</ArticleId></ArticleIdList></Reference><Reference><Citation>Jashari H.L.K., Ibrahimi P., Djekic D., Mellander M., Rydberg A., Henein M.Y. Persistent reduced myocardial deformation in neonates after CoA repair. Int J Cardiol. 2016;221:886&#x2013;891.</Citation><ArticleIdList><ArticleId IdType="pubmed">27434366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalski M., Kowalik E., Kotlinski K., et al. Regional left ventricular myocardial shortening in normotensive patients late after aortic coarctation repair - normal or impaired? Ultrasound Med Biol. 2009;35(12):1947&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828228</ArticleId></ArticleIdList></Reference><Reference><Citation>Balderr&#xe1;bano-Saucedo N.A., Vizca&#xed;no-Alarc&#xf3;n A., Reyes-de la Cruz L., Espinosa-Islas G., Ar&#xe9;valo-Salas A., Segura-Stanford B. Left ventricular function in children after successful repair of aortic coarctation. Rev Esp Cardiol. 2008;61(11):1126&#x2013;1133.</Citation><ArticleIdList><ArticleId IdType="pubmed">19000487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz J.D., Rubio A.E., Johnston T.A., Morray B.H., Jones T.K. Late outcomes of transcatheter coarctation intervention in infants with biventricular anatomy. Pediatr Cardiol. 2022;43(7):1438&#x2013;1443. doi: 10.1007/s00246-022-02865-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-022-02865-5</ArticleId><ArticleId IdType="pubmed">35274168</ArticleId></ArticleIdList></Reference><Reference><Citation>di Salvo G.P.G., Limongelli G., Verrengia M., et al. Abnormal regional myocardial deformation properties and increased aortic stiffness in normotensive patients with aortic coarctation despite successful correction:an ABPM, standard echocardiography and strain rate imaging study. Clin Sci. 2007;113(5):256&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pubmed">17477843</ArticleId></ArticleIdList></Reference><Reference><Citation>Klitsie L.M., Roest A.A., Haak M.C., Blom N.A., Ten Harkel A.D. Longitudinal follow-up of ventricular performance in healthy neonates. Early Hum Dev. 2013;89(12):993&#x2013;997.</Citation><ArticleIdList><ArticleId IdType="pubmed">24080389</ArticleId></ArticleIdList></Reference><Reference><Citation>Florianczyk T.W.B. Assessment of left ventricular diastolic function in children after successful repair of aortic coarctation. Clin Res Cardiol. 2011;100(6):493&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3100502</ArticleId><ArticleId IdType="pubmed">21193915</ArticleId></ArticleIdList></Reference><Reference><Citation>Eidem B.W., McMahon C.J., Cohen R.R., et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. J&#xa0;Am Soc Echocardiogr. 2004;17(3):212&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">14981417</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma Y., Hayabuchi Y., Terada T., Inoue M., Mori K. Early diastolic left ventricular relaxation in normal neonates is influenced by ventricular stiffness and longitudinal systolic function. Int Heart J. 2018;59(1):149&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">29332921</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy P.T., Machefsky A., Sanchez A.A., et al. Reference ranges of left ventricular strain measures by two-dimensional speckle-tracking echocardiography in children: a systematic review and meta-analysis. J&#xa0;Am Soc Echocardiogr. 2016;29(3):209&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4779733</ArticleId><ArticleId IdType="pubmed">26747685</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert U., M&#xfc;ller M., Norman M., Abdul-Khaliq H. Transition from fetal to neonatal life: changes in cardiac function assessed by speckle-tracking echocardiography. Earl Hum Dev. 2013;89(10):803&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">23948155</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiller B., Zartner P., D&#xe4;hnert I., et al. Prospective multicenter study of the breakable babystent for treatment of aortic coarctation in newborns and infants. Catheter Cardiovasc Interv. 2022;99(5):1529&#x2013;1537.</Citation><ArticleIdList><ArticleId IdType="pubmed">35170186</ArticleId></ArticleIdList></Reference><Reference><Citation>Zartner P.A., Neudorf U., Bierbach B., Hart C., Schneider M.B. First follow-up of a breakable stent for implantation in infants dedicated for a life-long stay. Catheter Cardiovasc Interv. 2018;91(6):1119&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">29469968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahn E.M., Abbott E., Tailor N., Sathanandam S., Armer D. Preliminary testing and evaluation of the renata minima stent, an infant stent capable of achieving adult dimensions. Catheter Cardiovasc Interv. 2021;98(1):117&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9543198</ArticleId><ArticleId IdType="pubmed">33942962</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40719608</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2362</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>European journal of clinical investigation</Title><ISOAbbreviation>Eur J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Parvovirus B19-associated myocarditis in children: A systematic review of clinical features, management and outcomes.</ArticleTitle><Pagination><StartPage>e70102</StartPage><MedlinePgn>e70102</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eci.70102</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Parvovirus B19 (PVB19) has emerged as a relevant etiologic agent of paediatric myocarditis, particularly during recent epidemiological surges in Europe and the United States. Despite increasing recognition, current knowledge remains fragmented, and standardised diagnostic and therapeutic strategies are lacking.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a systematic review of the literature up to May 2025, including 40 studies encompassing 53 individual case reports, 107 patients from registry-based cohorts, and 4 tissue-based investigations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Clinical presentation was frequently fulminant, with cardiogenic shock, severe left ventricular dysfunction, and need for mechanical circulatory support in up to 47% of cases. Mortality rates ranged from 10% to 30%, with heart transplantation rates varying between 5% and 42% across cohorts. Diagnosis relied primarily on blood polymerase chain reaction (PCR), while serology showed limited diagnostic utility. Histological confirmation via endomyocardial biopsy (EMB) was variably applied across studies, and myocardial viral load quantification was reported in only one study. Case series and cohort studies confirmed early age of onset (median 16-24 months), respiratory or gastrointestinal prodromes, and poor outcomes in fulminant presentations. Tissue-based studies revealed high myocardial PVB19 loads in acute myocarditis, particularly in infants, but also demonstrated viral persistence in asymptomatic individuals, complicating causal inference. Immunomodulatory therapy was administered in up to 58% of cases, although its clinical impact remains uncertain due to heterogeneity in treatment protocols. No antiviral treatments have been evaluated to date.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings highlight the need for standardised diagnostic criteria incorporating PCR, serology, imaging, and, where appropriate, EMB and viral load assessment. Given recent epidemiologic surges and high morbidity, prospective multicentre studies and surveillance efforts are urgently required to refine clinical algorithms and improve outcomes in paediatric PVB19 myocarditis.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). European Journal of Clinical Investigation published by John Wiley &amp; Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Veronese</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6257-729X</Identifier><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garascia</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adorisio</LastName><ForeName>Rachele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Heart Failure, Transplant and Mechanical Assist Device Unit, IRCCS Bambino Ges&#xf9; Children's Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonanomi</LastName><ForeName>Ezio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammirati</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Milan-Bicocca, School of Medicine and Surgery, Monza, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Clin Invest</MedlineTA><NlmUniqueID>0245331</NlmUniqueID><ISSNLinking>0014-2972</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">paediatric myocarditis</Keyword><Keyword MajorTopicYN="N">parvovirus B19</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40719608</ArticleId><ArticleId IdType="doi">10.1111/eci.70102</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA. 2023;329(13):1098&#x2010;1113.</Citation></Reference><Reference><Citation>Mahrholdt H, Wagner A, Deluigi CC, et&#xa0;al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15):1581&#x2010;1590.</Citation></Reference><Reference><Citation>Kindermann I, Barth C, Mahfoud F, et&#xa0;al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9):779&#x2010;792.</Citation></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et&#xa0;al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334&#x2010;346.</Citation></Reference><Reference><Citation>Kracalik I, Oster ME, Broder KR, et&#xa0;al. Outcomes at least 90&#x2009;days since onset of myocarditis after mRNA COVID&#x2010;19 vaccination in adolescents and young adults in the USA: a follow&#x2010;up surveillance study. Lancet Child Adolesc Health. 2022;6(11):788&#x2010;798.</Citation></Reference><Reference><Citation>Truong DT, Dionne A, Muniz JC, McHugh KE, Portman MA, Lambert LM. Clinically suspected myocarditis temporally related to COVID&#x2010;19 vaccination in adolescents and Young adults. Circulation. 2021;145:345&#x2010;356.</Citation></Reference><Reference><Citation>Freund MW, Kleinveld G, Krediet TG, van Loon AM, Verboon&#x2010;Maciolek MA. Prognosis for neonates with enterovirus myocarditis. Arch Dis Child Fetal Neonatal Ed. 2010;95(3):F206&#x2010;F212.</Citation></Reference><Reference><Citation>Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350(6):586&#x2010;597.</Citation></Reference><Reference><Citation>Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15(3):485&#x2010;505.</Citation></Reference><Reference><Citation>Simms RA, Liebling RE, Patel RR, et&#xa0;al. Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther. 2009;25(4):373&#x2010;378.</Citation></Reference><Reference><Citation>Rogo LD, Mokhtari&#x2010;Azad T, Kabir MH, Rezaei F. Human parvovirus B19: a review. Acta Virol. 2014;58(3):199&#x2010;213.</Citation></Reference><Reference><Citation>Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3):1&#x2010;13.</Citation></Reference><Reference><Citation>Bock CT, Klingel K, Kandolf R. Human parvovirus B19&#x2010;associated myocarditis. N Engl J Med. 2010;362(13):1248&#x2010;1249.</Citation></Reference><Reference><Citation>Molina KM, Garcia X, Denfield SW, et&#xa0;al. Parvovirus B19 myocarditis causes significant morbidity and mortality in children. Pediatr Cardiol. 2013;34(2):390&#x2010;397.</Citation></Reference><Reference><Citation>d'Humi&#xe8;res C, Fouillet A, Verdurme L, et&#xa0;al. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024. Euro Surveill. 2024;29(25):2400339.</Citation></Reference><Reference><Citation>Rubin R. What to know about the recent rise in parvovirus B19 infections. JAMA. 2024;332:1226&#x2010;1227.</Citation></Reference><Reference><Citation>Alfego D, Hernandez&#x2010;Romieu AC, Briggs&#x2010;Hagen M, et&#xa0;al. Detection of increased activity of human parvovirus B19 using commercial laboratory testing of clinical samples and source plasma donor pools &#x2010; United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(47):1076&#x2010;1081.</Citation></Reference><Reference><Citation>Yee MEM, Kalmus GG, Patel AP, Payne JN, Tang A, Gee BE. Notes from the field: increase in diagnoses of human parvovirus B19&#x2010;associated aplastic crises in children and adolescents with sickle cell disease&#x2014;Atlanta, Georgia, December 14, 2023&#x2010;September 30, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(47):1090&#x2010;1091.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control (ECDC). Risks posed by the reported increased circulation of human parvovirus B19 in the EU/EEA &#x2013; 17 April 2024. ECDC; 2024. https://www.ecdc.europa.eu/en/publications&#x2010;data/risks&#x2010;posed&#x2010;reported&#x2010;increased&#x2010;circulation&#x2010;human&#x2010;parvovirus&#x2010;b19&#x2010;eueea</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Increase in Pediatric Cases of Severe Acute Illness Potentially Associated with Human Parvovirus B19 Infection &#x2014; United States, May 2024. CDC Health Alert Network (HAN); 2024. HAN Archive Number: 00514. https://www.cdc.gov/han/2024/han00514.html</Citation></Reference><Reference><Citation>Tonon M, Panaite SA, Gentili D, et&#xa0;al. Retrospective and prospective surveillance and clinical presentation of parvovirus B19 in Veneto, Italy, 2024. Microorganisms. 2025;13(2):430.</Citation></Reference><Reference><Citation>Ranno S, Russo C, Colagrossi L, et&#xa0;al. Parvovirus B19 rebound. J Med Virol. 2025;97(5):e70380.</Citation></Reference><Reference><Citation>Poeta M, Moracas C, Cal&#xf2; Carducci FI, et&#xa0;al. Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024. Euro Surveill. 2024;29(48):2400746.</Citation></Reference><Reference><Citation>Russell N, Hatcher J, Best T, et&#xa0;al. Severe parvovirus B19&#x2010;associated myocarditis in children in the post&#x2010;COVID&#x2010;19 era: a multicenter observational cohort study. Open Forum Infect Dis. 2025;12(5):ofaf224.</Citation></Reference><Reference><Citation>Drazner MH, Bozkurt B, Cooper LT, et&#xa0;al. 2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and Management of Myocarditis: a report of the American College of Cardiology Solution set Oversight Committee. J Am Coll Cardiol. 2025;85(4):391&#x2010;431.</Citation></Reference><Reference><Citation>Law YM, Lal AK, Chen S, et&#xa0;al. Diagnosis and Management of Myocarditis in children: a scientific Statement from the American Heart Association. Circulation. 2021;144(6):e123&#x2010;e135.</Citation></Reference><Reference><Citation>Joanna Briggs Institute. Checklist for case reports. The Joanna Briggs Institute; 2017. https://jbi.global/critical&#x2010;appraisal&#x2010;tools</Citation></Reference><Reference><Citation>Vigneswaran TV, Brown JR, Breuer J, Burch M. Parvovirus B19 myocarditis in children: an observational study. Arch Dis Child. 2016;101(2):177&#x2010;180.</Citation></Reference><Reference><Citation>Esmel&#x2010;Vilomara R, Dolader P, Izquierdo&#x2010;Blasco J, et&#xa0;al. Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach. Eur J Pediatr. 2022;181(5):2045&#x2010;2053.</Citation></Reference><Reference><Citation>Gran F, Dolader P, Juzga&#x2010;Corrales DC, et&#xa0;al. Interferon&#x2010;beta and corticosteroid therapy for parvovirus B19 myocarditis in children. Int J Cardiol. 2025;434:133337.</Citation></Reference><Reference><Citation>Esmel&#x2010;Vilomara R, Dolader P, Melendo S, Ros&#xe9;s&#x2010;Noguer F, Gran F. High specificity electrocardiogram patterns for parvovirus B19 myocarditis in children: bridging electrocardiogram findings to aetiological diagnosis. Cardiol Young. 2025;35(5):1&#x2010;1027.</Citation></Reference><Reference><Citation>Canales Siguero D, Garc&#xed;a&#x2010;Mu&#xf1;oz C, Mart&#xed;nez de la Torre F, Ferrari Piquero JM, Granados Ru&#xed;z MA. Paediatric viral myocarditis successfully treated with interferon beta&#x2010;1b and corticoids. J Clin Pharm Ther. 2021;46(3):862&#x2010;864.</Citation></Reference><Reference><Citation>Jain P, Jain A, Khan DN, Kumar M. Human parvovirus B19 associated dilated cardiomyopathy. BMJ Case Rep. 2013;2013:bcr2013010410.</Citation></Reference><Reference><Citation>Dina J, Villedieu F, Labombarda F, et&#xa0;al. Childhood myocarditis and parvovirus B19 genotypes. J Clin Virol. 2011;50(1):61&#x2010;64.</Citation></Reference><Reference><Citation>Hu HY, Wei SY, Huang WH, Pan CH. Fatal parvovirus B19 infections: a report of two autopsy cases. Int J Legal Med. 2019;133(2):553&#x2010;560.</Citation></Reference><Reference><Citation>Koehl B, Oualha M, Lesage F, et&#xa0;al. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism. Pediatr Infect Dis J. 2012;31(4):418&#x2010;421.</Citation></Reference><Reference><Citation>Nigro G, Bastianon V, Colloridi V, et&#xa0;al. Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Infect Dis. 2000;31(1):65&#x2010;69.</Citation></Reference><Reference><Citation>Munro K, Croxson MC, Thomas S, Wilson NJ. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol. 2003;24(5):473&#x2010;475.</Citation></Reference><Reference><Citation>Enders G, D&#xf6;tsch J, Bauer J, et&#xa0;al. Life&#x2010;threatening parvovirus B19&#x2010;associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis. 1998;26(2):355&#x2010;358.</Citation></Reference><Reference><Citation>Beghetti M, Gervaix A, Haenggeli CA, Berner M, Rimensberger PC. Myocarditis associated with parvovirus B19 infection in two siblings with merosin&#x2010;deficient congenital muscular dystrophy. Eur J Pediatr. 2000;159(1&#x2013;2):135&#x2010;136.</Citation></Reference><Reference><Citation>McMahon CJ, Murchan H, Prendiville T, Burch M. Parvovirus B19 infection associated with dilated cardiomyopathy in patients with previous anthracycline exposure. Pediatr Cardiol. 2007;28(5):394&#x2010;395.</Citation></Reference><Reference><Citation>Amabile N, Fraisse A, Bouvenot J, Chetaille P, Ovaert C. Outcome of acute fulminant myocarditis in children. Heart. 2006;92(9):1269&#x2010;1273.</Citation></Reference><Reference><Citation>Simpson KE, Storch GA, Lee CK, et&#xa0;al. High frequency of detection by PCR of viral nucleic acid in the blood of infants presenting with clinical myocarditis. Pediatr Cardiol. 2016;37(2):399&#x2010;404.</Citation></Reference><Reference><Citation>Saleh M, Sajwany S. Intravenous immunoglobulins in the management of parvovirus B19&#x2010;induced fulminant myocarditis: case report. Int J Clin Cardiol. 2017;4:094. doi:10.23937/2378-2951/1410094</Citation></Reference><Reference><Citation>Wahjudi T, Nitsch A, Sperhake JP, Hoeger PH. Fulminant parvovirus B19 myocarditis in infants &#x2010;report of three post&#x2010;pandemic cases. Eur J Clin Microbiol Infect Dis. 2025;44(5):1239&#x2010;1243.</Citation></Reference><Reference><Citation>Ferro V, Pisani M, Marotta R, et&#xa0;al. Severe outcomes from suspected human parvovirus B19 infection in immunocompetent children: the need for timely recognition. J Med Virol. 2025;97(4):e70324.</Citation></Reference><Reference><Citation>Izquierdo&#x2010;Blasco J, Salcedo Allende MT, Codina Grau MG, Gran F, Mart&#xed;nez S&#xe1;ez E, Balcells J. Parvovirus B19 myocarditis: looking beyond the heart. Pediatr Dev Pathol. 2020;23(2):158&#x2010;162.</Citation></Reference><Reference><Citation>Adda J, Machado S, Eberst E, Roubille C, Macia JC, Roubille F. Parvovirus B19 infection and acute myocarditis. Intern Med. 2010;49(1):79.</Citation></Reference><Reference><Citation>Veronese G, Nonini S, Bottiroli M, et&#xa0;al. A case of parvovirus B19&#x2010;associated fulminant myocarditis in an infant successfully treated with immunosuppressive therapy. J Cardiovasc Med (Hagerstown). 2022;23(10):697&#x2010;699.</Citation></Reference><Reference><Citation>Papadogiannakis N, Tolfvenstam T, Fischler B, Norbeck O, Broliden K. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant. Clin Infect Dis. 2002;35(9):1027&#x2010;1031.</Citation></Reference><Reference><Citation>Butin M, Mekki Y, Phan A, et&#xa0;al. Successful immunotherapy in life&#x2010;threatening parvovirus B19 infection in a child. Pediatr Infect Dis J. 2013;32(7):789&#x2010;792.</Citation></Reference><Reference><Citation>Murry CE, Jerome KR, Reichenbach DD. Fatal parvovirus myocarditis in a 5&#x2010;year&#x2010;old girl. Hum Pathol. 2001;32(3):342&#x2010;345.</Citation></Reference><Reference><Citation>Dina J, Vabret A, Rambaud C, et&#xa0;al. Fulminant myocarditis associated with parvovirus B19 infection in a child. J Clin Virol. 2008;42(1):70&#x2010;71.</Citation></Reference><Reference><Citation>Krishnamurti L, Lanford L, Munoz R. Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease. Pediatr Blood Cancer. 2007;49(7):1019&#x2010;1021.</Citation></Reference><Reference><Citation>Rohayem J, Dinger J, Fischer R, Klingel K, Kandolf R, Rethwilm A. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol. 2001;39(12):4585&#x2010;4587.</Citation></Reference><Reference><Citation>Zack F, Klingel K, Kandolf R, Wegener R. Sudden cardiac death in a 5&#x2010;year&#x2010;old girl associated with parvovirus B19 infection. Forensic Sci Int. 2005;155(1):13&#x2010;17.</Citation></Reference><Reference><Citation>O'Connell MJ, Duff DF, Hayes RM. Non&#x2010;invasive investigation and management of aortic saddle embolus in a 7&#x2010;month&#x2010;old infant. Cardiovasc Intervent Radiol. 2002;25(1):74&#x2010;75.</Citation></Reference><Reference><Citation>Floyd A, Lal A, Molina K, Puchalski M, Miller D, May L. When lightning strikes twice in pediatrics: case report and review of recurrent myocarditis. Pediatrics. 2018;141(3):e20164096.</Citation></Reference><Reference><Citation>Spartalis M, Tzatzaki E, Spartalis E, Damaskos C, Mavrogeni S, Voudris V. Parvovirus B19 myocarditis of fulminant evolution. Cardiol Res. 2017;8(4):172&#x2010;175.</Citation></Reference><Reference><Citation>Ajmi H, Chemli J, Trabelsi A, et&#xa0;al. Acute myocarditis associated with parvovirus B19 infection in a child. Pediatr Infect Dis J. 2015;7:53&#x2010;55. doi:10.1016/j.pid.2015.02.001</Citation></Reference><Reference><Citation>Schowengerdt KO, Ni J, Denfield SW, et&#xa0;al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation. 1997;96(10):3549&#x2010;3554.</Citation></Reference><Reference><Citation>Pelzl L, Mantino S, Sauter M, Manuylova T, Vogel U, Klingel K. Lymphocytic myocarditis in children with parvovirus B19 infection: pathological and molecular insights. Biomedicine. 2024;12(8):1909.</Citation></Reference><Reference><Citation>Gagliardi MG, Fierabracci A, Pilati M, et&#xa0;al. The impact of specific viruses on clinical outcome in children presenting with acute heart failure. Int J Mol Sci. 2016;17(4):486.</Citation></Reference><Reference><Citation>Nielsen TS, Hansen J, Nielsen LP, Baandrup UT, Banner J. The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non&#x2010;inflamed control hearts. Forensic Sci Med Pathol. 2014;10(3):344&#x2010;350.</Citation></Reference><Reference><Citation>Keramari S, Poutoglidis A, Chatzis S, Keramaris M, Savopoulos C, Kaiafa G. Parvovirus B19&#x2010;associated myocarditis: a literature review of pediatric cases. Cureus. 2022;14(1):e21726.</Citation></Reference><Reference><Citation>Canter CE, Simpson KE. Diagnosis and treatment of myocarditis in children in the current era. Circulation. 2014;129(1):115&#x2010;128.</Citation></Reference><Reference><Citation>K&#xfc;hl U, Schultheiss HP. Myocarditis in children. Heart Fail Clin. 2010;6(4):483&#x2010;496. viii&#x2010;ix.</Citation></Reference><Reference><Citation>Werner B, Ro&#x17c;nowska&#x2010;W&#xf3;jtowicz A, Puchalski M. Diagnosis and Management of Pediatric Myocarditis. Pediatr Infect Dis J. 2025;44(3):e95&#x2010;e98.</Citation></Reference><Reference><Citation>Arola A, Pikkarainen E, Sipil&#xe4; JO, Pyk&#xe4;ri J, Rautava P, Kyt&#xf6; V. Occurrence and features of childhood myocarditis: a Nationwide study in Finland. J Am Heart Assoc. 2017;6(11):e005306.</Citation></Reference><Reference><Citation>Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. 2012;5(5):622&#x2010;627.</Citation></Reference><Reference><Citation>Butts RJ, Boyle GJ, Deshpande SR, et&#xa0;al. Characteristics of clinically diagnosed pediatric myocarditis in a contemporary multi&#x2010;center cohort. Pediatr Cardiol. 2017;38(6):1175&#x2010;1182.</Citation></Reference><Reference><Citation>Foerster SR, Canter CE, Cinar A, et&#xa0;al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the pediatric cardiomyopathy registry. Circ Heart Fail. 2010;3(6):689&#x2010;697.</Citation></Reference><Reference><Citation>Messroghli DR, Pickardt T, Fischer M, et&#xa0;al. Toward evidence&#x2010;based diagnosis of myocarditis in children and adolescents: rationale, design, and first baseline data of MYKKE, a multicenter registry and study platform. Am Heart J. 2017;187:133&#x2010;144.</Citation></Reference><Reference><Citation>Gutierrez Sanchez LH, Shiau H, Baker JM, et&#xa0;al. A case series of children with acute hepatitis and human adenovirus infection. N Engl J Med. 2022;387(7):620&#x2010;630.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32801159</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-4275</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Pediatrics</Title><ISOAbbreviation>Pediatrics</ISOAbbreviation></Journal><ArticleTitle>Trends in Mortality and Costs of Pediatric Extracorporeal Life Support.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e20193564</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1542/peds.2019-3564</ELocationID><Abstract><AbstractText Label="BACKGROUND">Extracorporeal life support (ECLS) has been used for &gt;30 years as a life-sustaining therapy in critically ill patients for a variety of indications. In the current study, we aimed to examine trends in use, mortality, length of stay (LOS), and costs for pediatric ECLS hospitalizations.</AbstractText><AbstractText Label="METHODS">We performed a retrospective cohort study of pediatric patients (between the ages of 28 days and &lt;21 years) on ECLS using the 2008-2015 National Inpatient Sample, the largest all-payer inpatient hospitalization database generated from hospital discharges. Nonparametric and Cochran-Armitage tests for trend were used to study in-hospital mortality, LOS, and hospitalization costs.</AbstractText><AbstractText Label="RESULTS">Of the estimated 5847 patients identified and included for analysis, ECLS was required for respiratory failure (36.4%), postcardiotomy syndrome (25.9%), mixed cardiopulmonary failure (21.7%), cardiogenic shock (13.1%), and transplanted graft dysfunction (2.9%). The rate of ECLS hospitalizations increased 329%, from 11 to 46 cases per 100&#x2009;000 pediatric hospitalizations, from 2008 to 2015 (<i>P</i> &lt; .001). Overall mortality decreased from 50.3% to 34.6% (<i>P</i> &lt; .001). Adjusted hospital costs increased significantly ($214&#x2009;046 &#xb1; 11&#x2009;822 to 324&#x2009;841 &#xb1; 25&#x2009;621; <i>P</i> = .002) during the study period despite a stable overall hospital LOS (46 &#xb1; 6 to 44 &#xb1; 4 days; <i>P</i> = .94).</AbstractText><AbstractText Label="CONCLUSIONS">Use of ECLS in pediatric patients has increased with substantially improved ECLS survival rates. Hospital costs have increased significantly despite a stable LOS in this group. Dissemination of this costly yet life-saving technology warrants ongoing analysis of use trends to identify areas for quality improvement.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 by the American Academy of Pediatrics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanaiha</LastName><ForeName>Yas</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoubian</LastName><ForeName>Jonathan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williamson</LastName><ForeName>Catherine G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguayo</LastName><ForeName>Esteban</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobaria</LastName><ForeName>Vishal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>Neeraj</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benharash</LastName><ForeName>Peyman</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovascular Outcomes Research Laboratory, Division of Cardiac Surgery, and pbenharash@mednet.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatrics</MedlineTA><NlmUniqueID>0376422</NlmUniqueID><ISSNLinking>0031-4005</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatrics. 2020 Sep;146(3):e2020010629. doi: 10.1542/peds.2020-010629.</RefSource><PMID Version="1">32801158</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32801159</ArticleId><ArticleId IdType="doi">10.1542/peds.2019-3564</ArticleId><ArticleId IdType="pii">peds.2019-3564</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33432794</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus.</ArticleTitle><Pagination><StartPage>714</StartPage><EndPage>732</EndPage><MedlinePgn>714-732</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0375-9393.20.14866-1</ELocationID><Abstract><AbstractText>Vasopressors and inotropic agents are widely used in critical care. However, strong evidence supporting their use in critically ill patients is lacking in many clinical scenarios. Thus, the Italian Society of Anesthesia and Intensive Care (SIAARTI) promoted a project aimed to provide indications for good clinical practice on the use of vasopressors and inotropes, and on the management of critically ill patients with shock. A panel of 16 experts in the field of intensive care medicine and hemodynamics has been established. Systematic review of the available literature was performed based on PICO questions. Basing on available evidence, the panel prepared a summary of evidence and then wrote the clinical questions. A modified semi-quantitative RAND/UCLA appropriateness method has been used to determine the appropriateness of specific clinical scenarios. The panel identified 29 clinical questions for the use of vasopressors and inotropes in patients with septic shock and cardiogenic shock. High level of agreement exists among the panel members about appropriateness of inotropes/vasopressors' use in patients with septic shock and cardiogenic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carsetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Ospedali Riuniti University Hospital, Ancona, Italy - a.carsetti@univpm.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy - a.carsetti@univpm.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bignami</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Critical Care and Pain Medicine, Department of Medicine and Surgery, University of Parma, Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortegiani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Oncological and Oral Science, Section of Anesthesia, Analgesia, Intensive Care and Emergency, Paolo Giaccone Polyclinic Hospital, University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donadello</LastName><ForeName>Katia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care B Unit, Department of Surgery, Dentistry, Pediatrics and Gynecology, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donati</LastName><ForeName>Abele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Ospedali Riuniti University Hospital, Ancona, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences and Public Health, Polytechnic University of Marche, Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, ASST Monza, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grasselli</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Critical Care and Emergency, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Anesthesiology and Intensive Care, Department of Health Science, University of Florence, Careggi University Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology Emergency and Intensive Care Medicine, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DE Blasio</LastName><ForeName>Elvio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Rummo Hospital, Benevento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forfori</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University of Pisa, Pisa Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Pisana University Hospital, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scolletta</LastName><ForeName>Sabino</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tritapepe</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, San Camillo-Forlanini Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scudeller</LastName><ForeName>Luigia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Scientific Direction, IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Units, Humanitas Clinical and Research Hospital, IRCCS, Rozzano, Milan, Italy and Department of Biomedical Science, Humanitas University, Rozzano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Modena University Hospital, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004364">Pharmaceutical Preparations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004364" MajorTopicYN="Y">Pharmaceutical Preparations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33432794</ArticleId><ArticleId IdType="doi">10.23736/S0375-9393.20.14866-1</ArticleId><ArticleId IdType="pii">S0375-9393.20.14866-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40505789</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-3117</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation</Title><ISOAbbreviation>J Heart Lung Transplant</ISOAbbreviation></Journal><ArticleTitle>Multi-institutional outcomes of Impella use in pediatric patients: A brief communication from the ACTION Network.</ArticleTitle><Pagination><StartPage>1668</StartPage><EndPage>1671</EndPage><MedlinePgn>1668-1671</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.healun.2025.06.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-2498(25)02034-0</ELocationID><Abstract><AbstractText>This retrospective cohort study includes 150 pediatric patients supported with the Impella between April 2018 and November&#xa0;2024. Median weight was 62.9&#xa0;kg (interquartile range [IQR] 51.0-79.7&#xa0;kg) and the smallest weighed 19.0&#xa0;kg. Axillary artery implants occurred in 40.1% of patients while the femoral artery was used in 29%. Most patients had dilated cardiomyopathy (57.3%); however, a significant portion had transplant graft dysfunction (14.7%) or congenital heart disease (13.3%). One quarter of the cohort (N = 38) were supported with extracorporeal membrane oxygenation (ECMO) before&#xa0;Impella; 76% (N = 29) used ECMO and Impella in tandem, while 24% (N = 9) transitioned from ECMO to Impella. Major bleeding, major infection, device malfunction, or stroke were reported in 28% of patients (N = 42). Positive clinical outcomes were achieved in 89.3% of patients; 32.7% explanted for recovery, 32% transplanted, and 23.3% changed to another device. These data demonstrate a potential role for this device in children with refractory advanced heart failure&#xa0;and a need for increased work to limit adverse events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edelson</LastName><ForeName>Jonathan B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Center, the Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: edelsonj@email.chop.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amdani</LastName><ForeName>Shahnawaz</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cleveland Clinic Children's, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>David N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Stanford University, Lucile Packard Children's Hospital, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kroslowitz</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinatti, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morray</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Seattle Children's Hospital, University of Washington, Seattle, Washington.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Morgan Stanley Children's Hospital of New York Presbyterian, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joong</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lurie Children's Hospital of Chicago, Chicago, Illinois.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkens</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Norton Children's Hospital, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>C.S. Mott Children's Hospital, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ploutz</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Utah, Salt Lake City, Utah.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Stanford University, Lucile Packard Children's Hospital, Palo Alto, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lantz</LastName><ForeName>Jodie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Children's Health Dallas/UT Southwestern, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esch</LastName><ForeName>Jesse J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Mehreen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Children's Health Dallas/UT Southwestern, Dallas, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lancaster</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>C.S. Mott Children's Hospital, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>VanderPluym</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Boston Children's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeewa</LastName><ForeName>Aamir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Hospital for Sick Children, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shugh</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Joe DiMaggio Children's Hospital, Hollywood, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Absi</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Heart Institute at Le Bonheur Children's Hospital, Memphis, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shezad</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinatti, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Cardiac Center, the Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorts</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinatti, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tume</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Texas Children's Hospital, Houston, Texas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Heart Lung Transplant</MedlineTA><NlmUniqueID>9102703</NlmUniqueID><ISSNLinking>1053-2498</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACTION</Keyword><Keyword MajorTopicYN="N">Impella</Keyword><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">pediatric heart failure</Keyword></KeywordList><CoiStatement>Disclosure statement J.E. receives grant support from the NIH under K23HL169833 and from Enduring Hearts, and consulting fees from Abbott and Abiomed. D.N.R. has received payment for expert testimony from Holgate, Slattery, Peterson, is the DSMB Chair for Berlin Heart Active Driver Trial, and is the codirector of ACTION. S.S. receives honoraria from Abiomed and participates on their advisory board. A.J. receives an unrestricted educational grant from Abbott, consulting fees from Berlin Heart, and serves on the CEC for Berlin Heart. D.P. is on the Berlin Heart EXCOR Active Trial Data Safety Monitoring Board. C.V.P. receives consulting fees from Abiomed and Astrazenaca and participates on the DSMB/Advisory board for the Merck Verciguat trial. A.L. receives grants or contracts from Abbott, Abiomed, Berlin, Bayor, Syncardia, and Medtronic, consulting fees from Abbott and participates on a DSMB or advisory board for Abiomed and International Society for Heart and Lung Transplantation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40505789</ArticleId><ArticleId IdType="doi">10.1016/j.healun.2025.06.007</ArticleId><ArticleId IdType="pii">S1053-2498(25)02034-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37576368</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2616-163X</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Ghana medical journal</Title><ISOAbbreviation>Ghana Med J</ISOAbbreviation></Journal><ArticleTitle>Short-term outcomes among patients with subclinical hypothyroidism undergoing primary percutaneous coronary intervention.</ArticleTitle><Pagination><StartPage>37</StartPage><EndPage>42</EndPage><MedlinePgn>37-42</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4314/gmj.v57i1.6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This study aimed to examine possible associations between previously undiagnosed subclinical hypothyroidism and short-term outcomes and mortality in a sample of Iraqi patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">This is a prospective observational cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">The study was conducted in a single tertiary referral centre in Baghdad, Iraq.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">Thyroid-stimulating hormone and free T4 levels were measured in 257 patients hospitalised with ST-elevation myocardial infarction who underwent primary percutaneous coronary intervention between January 2020 and March 2022.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">Adverse cardiovascular and renal events during hospitalisation and 30-day mortality were observed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Previously undiagnosed subclinical hypothyroidism was detected in 36/257 (14%) ST-elevation myocardial infarction patients and observed more commonly in females than males. Patients with subclinical hypothyroidism had significantly worse short-term outcomes, including higher rates of suboptimal TIMI Flow (&lt; III) (p =0.014), left ventricular ejection fraction &#x2264; 40% (p=0.035), Killip class &gt;I (p=0.042), cardiogenic shock (p =0.016), cardiac arrest in the hospital (p= 0.01), and acute kidney injury (p= 0.044). Additionally, 30-day mortality was significantly higher in patients with subclinical hypothyroidism (p= 0.029).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Subclinical hypothyroidism previously undiagnosed and untreated had a significant association with adverse short-term outcomes and higher short-term mortality within 30 days compared to euthyroid patients undergoing primary percutaneous coronary intervention. Routine thyroid function testing during these patients' hospitalisation may be warranted.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None declared.</AbstractText><CopyrightInformation>Copyright &#xa9; The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al-Gburi</LastName><ForeName>Abdulameer J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, al-Nahrain University, Baghdad, Iraq.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Obaidi</LastName><ForeName>Saba R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, College of Medicine, al-Nahrain University, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Wasnaa H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, al-Mustansiriyah University, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ghana</Country><MedlineTA>Ghana Med J</MedlineTA><NlmUniqueID>0073210</NlmUniqueID><ISSNLinking>0016-9560</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="Y">Hypothyroidism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Primary percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">subclinical hypothyroidism</Keyword><Keyword MajorTopicYN="N">thyroid function test</Keyword></KeywordList><CoiStatement>Conflict of interest: None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37576368</ArticleId><ArticleId IdType="pmc">PMC10416275</ArticleId><ArticleId IdType="doi">10.4314/gmj.v57i1.6</ArticleId><ArticleId IdType="pii">jGMJ.v57.i1.pg37</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cooper DS, Biondi B. Subclinical thyroid disease. The Lancet. 2012;379:1142&#x2013;1154.</Citation><ArticleIdList><ArticleId IdType="pubmed">22273398</ArticleId></ArticleIdList></Reference><Reference><Citation>Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine. 2000;160:526&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">10695693</ArticleId></ArticleIdList></Reference><Reference><Citation>Grais IM, Sowers JR. Thyroid and the heart. The American Journal of Medicine. 2014;127:691&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318631</ArticleId><ArticleId IdType="pubmed">24662620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Sara JDS, Matsuzawa Y, et al. Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention. European Heart Journal. 2016;37:2055&#x2013;2065.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940453</ArticleId><ArticleId IdType="pubmed">26757789</ArticleId></ArticleIdList></Reference><Reference><Citation>Razvi S, Weaver JU, Vanderpump MP, Pearce SHS. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. The Journal of Clinical Endocrinology &amp; Metabolism. 2010;95:1734&#x2013;1740.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150579</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon S, Kong SH, Choi HS, et al. Relation of Sub-clinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk. The American Journal of Cardiology. 2018;122:571&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">29980273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodondi N, Newman AB, Vittinghoff E, et al. Sub-clinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Archives of Internal Medicine. 2005;165:2460&#x2013;2466.</Citation><ArticleIdList><ArticleId IdType="pubmed">16314541</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyland KA, Arnold AM, Lee JS, Cappola AR. Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study. The Journal of Clinical Endocrinology &amp; Metabolism. 2013;98:533&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565111</ArticleId><ArticleId IdType="pubmed">23162099</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi B, Cappola AR, Cooper DS. Subclinical Hypothyroidism: A Review. JAMA. 2019;322:153&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">31287527</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, Ritz B, Brent GA, Ebrahimi R, Rhee CM, Leung AM. Association of Subclinical Hypothyroidism and Cardiovascular Disease With Mortality. JAMA Netw Open. 2020;3:e1920745.</Citation><ArticleIdList><ArticleId IdType="pubmed">32031647</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzmon G, Barzilai N, Surks MI, Gabriely I. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. The Journal of Clinical Endocrinology &amp; Metabolism. 2009;94:4768&#x2013;4775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795660</ArticleId><ArticleId IdType="pubmed">19837933</ArticleId></ArticleIdList></Reference><Reference><Citation>Waring AC, Harrison S, Samuels MH, et al. Thyroid function and mortality in older men: a prospective study. The Journal of Clinical Endocrinology &amp; Metabolism. 2012;97:862&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3319205</ArticleId><ArticleId IdType="pubmed">22238396</ArticleId></ArticleIdList></Reference><Reference><Citation>Gencer B, Collet T-H, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884576</ArticleId><ArticleId IdType="pubmed">22821943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, Yao L, Fang Y, et al. Relationship between Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. International Journal of Endocrinology. 2017;2017:8130796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610794</ArticleId><ArticleId IdType="pubmed">29081800</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce EN. Update in lipid alterations in subclinical hypothyroidism. The Journal of Clinical Endocrinology &amp; Metabolism. 2012;97:326&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">22205712</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh S, Kim DK. Subclinical Hypothyroidism and Cardiovascular Disease. Endocrinol Metab (Seoul) 2015;30:246&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4595347</ArticleId><ArticleId IdType="pubmed">26248862</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondi B, Fazio S, Palmieri EA, et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1999;84:2064&#x2013;2067.</Citation><ArticleIdList><ArticleId IdType="pubmed">10372711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochran WG. Sampling techniques. 3rd ed. New York, London: Wiley; 1977.</Citation></Reference><Reference><Citation>Bemben DA, Hamm RM, Morgan L, Winn P, Davis A, Barton E. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J Fam Pract. 1994;38:583&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">8195732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir NT, Najim HD, Nsaif AS. Prevalence of overt and subclinical thyroid dysfunction among Iraqi population in Baghdad city. Iraqi J Community Med. 2020;33:20&#x2013;24.</Citation></Reference><Reference><Citation>Mansour AA, Ali Alhamza AH, Abdullah Almomin AMS, et al. SUN-418 Patterns of Thyroid Disease in Basrah, Iraq. Retrospective Study. J Endocr Soc. 2020;4</Citation></Reference><Reference><Citation>O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:529&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">23247303</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicent L, Vel&#xe1;squez-Rodr&#xed;guez J, Valero-Masa MJ, et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion. Int J Cardiol. 2017;248:46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">28942880</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031&#x2013;2037.</Citation><ArticleIdList><ArticleId IdType="pubmed">11044416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodondi N, Elzen WPJ den, Bauer DC, et al. Sub-clinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3923470</ArticleId><ArticleId IdType="pubmed">20858880</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Wang Y, Ma A, Wang T. Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction. BMC Cardiovascular Disorders. 2019;19:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450005</ArticleId><ArticleId IdType="pubmed">30947691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Lim Y-H, Shin J-H, Park J, Shin J. Impact of subclinical hypothyroidism on clinical outcomes following percutaneous coronary intervention. Int J Cardiol. 2018;253:155&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306458</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-S, Wei M, Le Wang, et al. The impact of sub-clinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention. BMC Endocr Disord. 2021;21:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934482</ArticleId><ArticleId IdType="pubmed">33673843</ArticleId></ArticleIdList></Reference><Reference><Citation>Izkhakov E, Zahler D, Rozenfeld K-L, et al. Unknown Subclinical Hypothyroidism and In-Hospital Outcomes and Short- and Long-Term All-Cause Mortality among ST Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention. J Clin Med. 2020;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7760853</ArticleId><ArticleId IdType="pubmed">33256094</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SM, Koh Y-S, Park H-J, et al. Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction. Clin Cardiol. 2018;41:1367&#x2013;1373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6489767</ArticleId><ArticleId IdType="pubmed">30144126</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Shen J, Xue Y, et al. The Association between Thyroid-Stimulating Hormone and Long-Term Outcomes in Patients with ST Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention. Int J Gen Med. 2021;14:6295&#x2013;6303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494999</ArticleId><ArticleId IdType="pubmed">34629894</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Datta S, Mandal SC. Prevalence of Subclinical Hypothyroidism in Acute Coronary Syndrome in Nondiabetics: Detailed Analysis from Consecutive 1100 Patients from Eastern India. Journal of Thyroid Research. 2018;2018:9030185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142768</ArticleId><ArticleId IdType="pubmed">30254730</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias P, Bajo MA, Selgas R, D&#xed;ez JJ. Thyroid dysfunction and kidney disease: An update. Reviews in Endocrine and Metabolic Disorders. 2017;18:131&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">27864708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Sun Y, He Z, et al. Age-specific thyrotropin references decrease over-diagnosis of hypothyroidism in elderly patients in iodine-excessive areas. Clin Endocrinol (Oxf) 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34585413</ArticleId></ArticleIdList></Reference><Reference><Citation>Razvi S, Weaver JU, Butler TJ, Pearce SHS. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Archives of Internal Medicine. 2012;172:811&#x2013;817. .</Citation><ArticleIdList><ArticleId IdType="pubmed">22529180</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32156261</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2261</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC cardiovascular disorders</Title><ISOAbbreviation>BMC Cardiovasc Disord</ISOAbbreviation></Journal><ArticleTitle>Heparin-binding protein measurement improves the prediction of myocardial injury-related cardiogenic shock.</ArticleTitle><Pagination><StartPage>124</StartPage><MedlinePgn>124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12872-020-01406-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Heparin-binding protein (HBP), a potent inducer of increased vascular permeability, is a potentially useful biomarker for predicting outcomes in patients with postoperative myocardial injury-related cardiogenic shock (MIRCS). We aimed to evaluate and validate HBP as a prognostic biomarker for postoperative MIRCS.</AbstractText><AbstractText Label="METHODS">We performed a case-control study in 792 patients undergoing cardiac surgery from January 1, 2016, to August 1, 2019, including 172 patients with postoperative MIRCS and 620 age- and sex-matched controls. The association between HBP and MIRCS was determined by multivariate logistic regression analysis. Receiver operating characteristic curves (ROCs) with area under the curve (AUC) were performed to calculate the cut-off value, sensitivity and specificity. The association between HBP and cardiac troponin T (cTnT) was determined by multivariable linear regression analysis. Blood samples were drawn from the coronary sinus and arterial line of the cardiopulmonary bypass (CPB) before aortic cross-clamping (time point 1) and 5&#x2009;min after aortic declamping (time point 2).</AbstractText><AbstractText Label="RESULTS">Before aortic cross-clamping, coronary sinus HBP (HBP<sub>CS1</sub>) showed no differences between the two groups. However, after declamping, the MIRCS group had a significantly higher sinus HBP level (HBP<sub>CS2</sub>) than did the control group. HBP<sub>CS2</sub> predicted MIRCS with an AUC of 0.85 (95% CI: 0.81-0.89, cut-off: 220&#x2009;ng/ml, sensitivity: 92% and specificity: 70%). After adjusting for confounding factors, we found that HBP was an independent risk factor for MIRCS (OR: 7.65, 95% CI: 4.86-12.06, P&#x2009;&lt;&#x2009;0.01) and was positively associated with cTnT (&#x3b2;&#x2009;&gt;&#x2009;0, P&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSIONS">Elevated levels of coronary sinus HBP were useful biomarkers for predicting MIRCS after cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Tuo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Number 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Guang-Feng</ForeName><Initials>GF</Initials><AffiliationInfo><Affiliation>Department of clinical laboratory, Children's Hospital of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Number 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hai-Tao</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jun-Xia</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Number 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahaskar</LastName><ForeName>Anshu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Number 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hong-Bing</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of clinical laboratory, Children's Hospital of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. hongbing_chen_nj@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dong-Jin</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Number 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China. dongjin_wang@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZDXKA2016019</GrantID><Agency>The Project of Invigorating Health Care through Science, Technology and Education</Agency><Country>International</Country></Grant><Grant><GrantID>YKK16183</GrantID><Agency>Nanjing National Commission on Health and Family Planning</Agency><Country>International</Country></Grant><Grant><GrantID>YKK18146</GrantID><Agency>Nanjing National Commission on Health and Family Planning</Agency><Country>International</Country></Grant><Grant><GrantID>201823013</GrantID><Agency>Nanjing Science and Technology Commission</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cardiovasc Disord</MedlineTA><NlmUniqueID>100968539</NlmUniqueID><ISSNLinking>1471-2261</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C062991">AZU1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023181">Antimicrobial Cationic Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001798">Blood Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020107">Troponin T</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023181" MajorTopicYN="N">Antimicrobial Cationic Peptides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001798" MajorTopicYN="N">Blood Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="N">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020107" MajorTopicYN="N">Troponin T</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Heparin-binding protein</Keyword><Keyword MajorTopicYN="N">Myocardial injury-related cardiogenic shock</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32156261</ArticleId><ArticleId IdType="pmc">PMC7065315</ArticleId><ArticleId IdType="doi">10.1186/s12872-020-01406-3</ArticleId><ArticleId IdType="pii">10.1186/s12872-020-01406-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maganti MD, Rao V, Borger MA, Lvanov J, David TE. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation. 2005;112(9 Suppl):1448&#x2013;1452.</Citation><ArticleIdList><ArticleId IdType="pubmed">16159861</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg. 1996;112:38&#x2013;51. doi: 10.1016/S0022-5223(96)70176-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(96)70176-9</ArticleId><ArticleId IdType="pubmed">8691884</ArticleId></ArticleIdList></Reference><Reference><Citation>Maganti M, Badiwala M, Sheikh A, Scully H, Feindel C, David TE, et al. Predictors of low cardiac output syndrome after isolated aortic valve surgery. J Thorac Cardiovasc Surg. 2010;140(4):790&#x2013;796. doi: 10.1016/j.jtcvs.2009.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.11.022</ArticleId><ArticleId IdType="pubmed">20152992</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder A, Soehnlein O, Akesson P. Roles of heparin-binding protein in bacterial infections. J Innate Immun. 2010;2(5):431&#x2013;438. doi: 10.1159/000314853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000314853</ArticleId><ArticleId IdType="pubmed">20505311</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam N, Olofsson AM, Herwald H, Lversen LF, Lundgren-Akerlund E, Hdeqvist P, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med. 2010;7(10):1123&#x2013;1127. doi: 10.1038/nm1001-1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1001-1123</ArticleId><ArticleId IdType="pubmed">11590435</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder A, &#xc5;kesson P, Inghammar M, Treutiger CJ, Linner A, Sunden-Cullberg J. Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock. Crit Care. 2012;16(3):R90. doi: 10.1186/cc11353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11353</ArticleId><ArticleId IdType="pmc">PMC3580636</ArticleId><ArticleId IdType="pubmed">22613179</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder A, Christensson B, Herwald H, Bjorck L, Akesson P. Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin Infect Dis. 2009;49(7):1044&#x2013;1050. doi: 10.1086/605563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605563</ArticleId><ArticleId IdType="pubmed">19725785</ArticleId></ArticleIdList></Reference><Reference><Citation>Linder A, Akesson P, Brink M, Studahl M, Bj&#xf6;rck L, Christensson B. Heparin-binding protein: a diagnostic marker of acute bacterial meningitis. Crit Care Med. 2011;39(4):812&#x2013;817. doi: 10.1097/CCM.0b013e318206c396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318206c396</ArticleId><ArticleId IdType="pubmed">21200320</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xf6;lvmark C, Akesson P, Linder A. Elevated urine levels of heparin-binding protein in children with urinary tract infection. Pediatr Nephrol. 2012;27(8):1301&#x2013;1308. doi: 10.1007/s00467-012-2132-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-012-2132-x</ArticleId><ArticleId IdType="pubmed">22410798</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Neumar RW, Adrie C, Aibiki M, Berg RA, B&#xf6;ttiger BW, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation. 2008;79(3):350&#x2013;379. doi: 10.1016/j.resuscitation.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2008.09.017</ArticleId><ArticleId IdType="pubmed">18963350</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a &#x201c;sepsis-like&#x201d; syndrome. Circulation. 2002;106(5):562&#x2013;568. doi: 10.1161/01.CIR.0000023891.80661.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000023891.80661.AD</ArticleId><ArticleId IdType="pubmed">12147537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristagno G, Masson S, Tiainen M, Bendel S, Bemasconi R, Varpula T, et al. Elevated plasma heparin-binding protein is associated with early death after resuscitation from cardiac arrest. Crit Care. 2016;20(1):251&#x2013;259. doi: 10.1186/s13054-016-1412-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1412-4</ArticleId><ArticleId IdType="pmc">PMC4976065</ArticleId><ArticleId IdType="pubmed">27497949</ArticleId></ArticleIdList></Reference><Reference><Citation>Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002;39(9):1518&#x2013;1523. doi: 10.1016/S0735-1097(02)01789-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(02)01789-8</ArticleId><ArticleId IdType="pubmed">11985917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Pan T, Ge M, Chen T, Ye J, Lu L, et al. Evaluation of vasopressin for Vasoplegic shock in patients with preoperative left ventricular dysfunction after cardiac surgery: a propensity-score analysis. Shock. 2018;50(5):519&#x2013;524. doi: 10.1097/SHK.0000000000001114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001114</ArticleId><ArticleId IdType="pubmed">29424795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge M, Pan T, Wang JX, Chen ZJ, Wang DJ. Outcomes of early versus delayed initiation of extracorporeal life support in cardiac surgery. J Cardiothorac Surg. 2019;14(1):129&#x2013;137. doi: 10.1186/s13019-019-0950-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13019-019-0950-7</ArticleId><ArticleId IdType="pmc">PMC6610966</ArticleId><ArticleId IdType="pubmed">31272456</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Pan T, Luo X, Wang D. High central venous-to-arterial CO2 difference is associated with poor outcomes in patients after cardiac surgery:a propensity score analysis. Shock. 2019;52(6):583&#x2013;589. doi: 10.1097/SHK.0000000000001324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001324</ArticleId><ArticleId IdType="pubmed">30724815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauermann E, Bolliger D, Fassl J, Grapow M, Seeberger EE, Seeberger MD, et al. Association of troponin trends and cardiac morbidity and mortality after on-pump cardiac surgery. Ann Thorac Surg. 2017;104(4):1289&#x2013;1297. doi: 10.1016/j.athoracsur.2017.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2017.03.003</ArticleId><ArticleId IdType="pubmed">28935302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokhtar AT, Begum J, Buth KJ, Legare JF. Cardiac troponin T is an important predictor of mortality after cardiac surgery. J Crit Care. 2017;38:41&#x2013;46. doi: 10.1016/j.jcrc.2016.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.10.011</ArticleId><ArticleId IdType="pubmed">27837691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrke S, Steen H, Sievers HH, Peters H, Opitz A, Muller-Bardorff M, et al. Cardiac troponin T for prediction of short-and long-term morbidity and mortality after elective open heart surgery. Clin Chem. 2014;50(9):1560&#x2013;1567. doi: 10.1373/clinchem.2004.031468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2004.031468</ArticleId><ArticleId IdType="pubmed">15217992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurati Buse GA, Bolliger D, Seeberger E, Kasper J, Grapow M, Koller MT, et al. Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications. Circulation. 2014;130(12):948&#x2013;957. doi: 10.1161/CIRCULATIONAHA.113.007253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.007253</ArticleId><ArticleId IdType="pubmed">25098242</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesonen E, Passov A, Salminen US, Ilmakunnas M, Vento A, Aittomaki J, et al. Heparin binding protein in adult heart surgery. Ann Thorac Surg. 2019;107(4):1154&#x2013;1159. doi: 10.1016/j.athoracsur.2018.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.10.007</ArticleId><ArticleId IdType="pubmed">30447193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010;11(2):234&#x2013;238. doi: 10.1097/PCC.0b013e3181b806fc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181b806fc</ArticleId><ArticleId IdType="pubmed">19794327</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara C, Zinkernagel AS, Macheboeuf P, Cunningham MW, Nizet VV, Ghosh P. Coiled-coil irregularities and instabilities in group a Streptococcus M1 are required for virulence. Science. 2008;319(5868):1405&#x2013;1408. doi: 10.1126/science.1154470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154470</ArticleId><ArticleId IdType="pmc">PMC2288698</ArticleId><ArticleId IdType="pubmed">18323455</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapper H, Karlsson A, Morgelin M, Flodgaard H, Herwald H. Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles. Blood. 2002;99(5):1785&#x2013;1793. doi: 10.1182/blood.V99.5.1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V99.5.1785</ArticleId><ArticleId IdType="pubmed">11861296</ArticleId></ArticleIdList></Reference><Reference><Citation>Herwald H, Cramer H, M&#xf6;rgelin M, Russell W, Sollenberg U, Norrby-Teglund A, et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 2004;116(3):367&#x2013;379. doi: 10.1016/S0092-8674(04)00057-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(04)00057-1</ArticleId><ArticleId IdType="pubmed">15016372</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh TW, Carr-White GS, Desouza AC, Ferdinand FD, Hooper J, Kemp M, et al. Intraoperative cardiac troponin T release and lactate metabolism during coronary artery surgery: comparison of beating heart with conventional coronary artery surgery with cardiopulmonary bypass. Heart. 1999;81(5):495&#x2013;500. doi: 10.1136/hrt.81.5.495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.81.5.495</ArticleId><ArticleId IdType="pmc">PMC1729023</ArticleId><ArticleId IdType="pubmed">10212167</ArticleId></ArticleIdList></Reference><Reference><Citation>Engstr&#xf6;m G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindg&#xe4;rde F. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation. 2002;105(22):2632&#x2013;2637. doi: 10.1161/01.CIR.0000017327.69909.FF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000017327.69909.FF</ArticleId><ArticleId IdType="pubmed">12045169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35579899</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US.</ArticleTitle><Pagination><StartPage>e2211967</StartPage><MedlinePgn>e2211967</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2211967</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2022.11967</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Identifying the associations between severe COVID-19 and individual cardiovascular conditions in pediatric patients may inform treatment.</AbstractText><AbstractText Label="OBJECTIVE">To assess the association between previous or preexisting cardiovascular conditions and severity of COVID-19 in pediatric patients.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This retrospective cohort study used data from a large, multicenter, electronic health records database in the US. The cohort included patients aged 2 months to 17 years with a laboratory-confirmed diagnosis of COVID-19 or a diagnosis code indicating infection or exposure to SARS-CoV-2 at 85 health systems between March 1, 2020, and January 31, 2021.</AbstractText><AbstractText Label="EXPOSURES">Diagnoses for 26 cardiovascular conditions between January 1, 2015, and December 31, 2019 (before infection with SARS-CoV-2).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The main outcome was severe COVID-19, defined as need for supplemental oxygen or in-hospital death. Mixed-effects, random intercept logistic regression modeling assessed the significance and magnitude of associations between 26 cardiovascular conditions and COVID-19 severity. Multiple comparison adjustment was performed using the Benjamini-Hochberg false discovery rate procedure.</AbstractText><AbstractText Label="RESULTS">The study comprised 171&#x202f;416 pediatric patients; the median age was 8 years (IQR, 2-14 years), and 50.28% were male. Of these patients, 17 065 (9.96%) had severe COVID-19. The random intercept model showed that the following cardiovascular conditions were associated with severe COVID-19: cardiac arrest (odds ratio [OR], 9.92; 95% CI, 6.93-14.20), cardiogenic shock (OR, 3.07; 95% CI, 1.90-4.96), heart surgery (OR, 3.04; 95% CI, 2.26-4.08), cardiopulmonary disease (OR, 1.91; 95% CI, 1.56-2.34), heart failure (OR, 1.82; 95% CI, 1.46-2.26), hypotension (OR, 1.57; 95% CI, 1.38-1.79), nontraumatic cerebral hemorrhage (OR, 1.54; 95% CI, 1.24-1.91), pericarditis (OR, 1.50; 95% CI, 1.17-1.94), simple biventricular defects (OR, 1.45; 95% CI, 1.29-1.62), venous embolism and thrombosis (OR, 1.39; 95% CI, 1.11-1.73), other hypertensive disorders (OR, 1.34; 95% CI, 1.09-1.63), complex biventricular defects (OR, 1.33; 95% CI, 1.14-1.54), and essential primary hypertension (OR, 1.22; 95% CI, 1.08-1.38). Furthermore, 194 of 258 patients (75.19%) with a history of cardiac arrest were younger than 12 years.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings suggest that some previous or preexisting cardiovascular conditions are associated with increased severity of COVID-19 among pediatric patients in the US and that morbidity may be increased among individuals children younger than 12 years with previous cardiac arrest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ehwerhemuepha</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roth</LastName><ForeName>Bradley</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Anita K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Children's National Hospital System and George Washington University School of Medicine and Health Sciences, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heutlinger</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heffernan</LastName><ForeName>Carly</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrieta</LastName><ForeName>Antonio C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanger</LastName><ForeName>Terence</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Dan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahbaba</LastName><ForeName>Babak</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feaster</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taraman</LastName><ForeName>Sharief</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of California-Irvine School of Medicine, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morizono</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Children's National Hospital System and George Washington University School of Medicine and Health Sciences, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marano</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Children's Health of Orange County, Orange, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001877</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Taraman reported receiving personal fees from Pediatric Subspecialty Faculty/Children&#x2019;s Health of Orange County (CHOC) Specialists during the conduct of the study, Cognoa, Cognito Therapeutics, Chapman University, and MI10; fees as an advisor with vested stock from HandzIn and as a volunteer board member from American Academy of Pediatrics, California and Orange County Chapter; and grants from Innovative Health Solutions outside the submitted work. Dr Morizono reported receiving grants from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) during the conduct of the study. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>17</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35579899</ArticleId><ArticleId IdType="pmc">PMC9115618</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.11967</ArticleId><ArticleId IdType="pii">2792374</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Academy of Pediatrics. Children and COVID-19: state-level data report. 2021. Accessed March 23, 2022. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/</Citation></Reference><Reference><Citation>Bixler D, Miller AD, Mattison CP, et al. ; Pediatric Mortality Investigation Team . SARS-CoV-2&#x2013;associated deaths among persons aged &lt;21 years&#x2014;United States, February 12&#x2013;July 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1324-1329. doi:10.15585/mmwr.mm6937e4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6937e4</ArticleId><ArticleId IdType="pubmed">32941417</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Nardo M, van Leeuwen G, Loreti A, et al. . A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children. Pediatr Res. 2021;89(5):1101-1108. doi:10.1038/s41390-020-1065-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-020-1065-5</ArticleId><ArticleId IdType="pubmed">32679582</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabatino J, De Rosa S, Di Salvo G, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS One. 2020;15(8):e0237131. doi:10.1371/journal.pone.0237131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0237131</ArticleId><ArticleId IdType="pmc">PMC7428172</ArticleId><ArticleId IdType="pubmed">32797054</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome Coronavirus 2 infection. J Am Heart Assoc. 2020;9(7):e016219. doi:10.1161/JAHA.120.016219</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.016219</ArticleId><ArticleId IdType="pmc">PMC7428639</ArticleId><ArticleId IdType="pubmed">32233755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-558. doi:10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Castelnuovo A, Bonaccio M, Costanzo S, et al. ; COvid-19 RISk and Treatments (CORIST) Collaboration . Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST study. Nutr Metab Cardiovasc Dis. 2020;30(11):1899-1913. doi:10.1016/j.numecd.2020.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.07.031</ArticleId><ArticleId IdType="pmc">PMC7833278</ArticleId><ArticleId IdType="pubmed">32912793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehwerhemuepha L, Danioko S, Verma S, et al. . A super learner ensemble of 14 statistical learning models for predicting COVID-19 severity among patients with cardiovascular conditions. Intell Based Med. 2021;5:100030. doi:10.1016/j.ibmed.2021.100030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibmed.2021.100030</ArticleId><ArticleId IdType="pmc">PMC7963518</ArticleId><ArticleId IdType="pubmed">33748802</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano R, Cantinotti M. Congenital heart disease in the era of COVID-19 pandemic. Gen Thorac Cardiovasc Surg. 2021;69(1):172-174. doi:10.1007/s11748-020-01417-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11748-020-01417-z</ArticleId><ArticleId IdType="pmc">PMC7306555</ArticleId><ArticleId IdType="pubmed">32572816</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo RB, Botelho BG, Hollanda JVG, et al. . Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021;35(1):4-11. doi:10.1038/s41371-020-0387-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganatra S, Hammond SP, Nohria A. The Novel Coronavirus Disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncol. 2020;2(2):350-355. doi:10.1016/j.jaccao.2020.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7151392</ArticleId><ArticleId IdType="pubmed">32292919</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Shen J, Li L, Yu C. Radiographic and clinical features of children with Coronavirus disease (COVID-19) pneumonia. Indian Pediatr. 2020;57(5):423-426. doi:10.1007/s13312-020-1816-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13312-020-1816-8</ArticleId><ArticleId IdType="pmc">PMC7240239</ArticleId><ArticleId IdType="pubmed">32255437</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-260. doi:10.1038/s41569-020-0360-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik TJ, Mohiddin SA, Dimarco A, et al. . COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666-1687. doi:10.1093/cvr/cvaa106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa106</ArticleId><ArticleId IdType="pmc">PMC7197627</ArticleId><ArticleId IdType="pubmed">32352535</ArticleId></ArticleIdList></Reference><Reference><Citation>Veer M, Kumar AM, Ivanova V. COVID-19 and the cardiovascular system. Crit Care Nurs Q. 2020;43(4):381-389. doi:10.1097/CNQ.0000000000000323</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CNQ.0000000000000323</ArticleId><ArticleId IdType="pubmed">32833774</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerkin KJ, Fried JA, Raikhelkar J, et al. . COVID-19 and cardiovascular disease. Circulation. 2020;141(20):1648-1655. doi:10.1161/CIRCULATIONAHA.120.046941</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.046941</ArticleId><ArticleId IdType="pubmed">32200663</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247-250. doi:10.1016/j.dsx.2020.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.03.013</ArticleId><ArticleId IdType="pmc">PMC7102662</ArticleId><ArticleId IdType="pubmed">32247212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna G, Serrau G, Bassareo PP, Neroni P, Fanos V, Marcialis MA. Children&#x2019;s heart and COVID-19: up-to-date evidence in the form of a systematic review. Eur J Pediatr. 2020;179(7):1079-1087. doi:10.1007/s00431-020-03699-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-020-03699-0</ArticleId><ArticleId IdType="pmc">PMC7261213</ArticleId><ArticleId IdType="pubmed">32474800</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsankov BK, Allaire JM, Irvine MA, et al. . Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis. Int J Infect Dis. 2021;103:246-256. doi:10.1016/j.ijid.2020.11.163</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.163</ArticleId><ArticleId IdType="pmc">PMC7679116</ArticleId><ArticleId IdType="pubmed">33227520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastgiri S, Stone DH, Le-Ha C, Gilmour WH. Prevalence and secular trend of congenital anomalies in Glasgow, UK. Arch Dis Child. 2002;86(4):257-263. doi:10.1136/adc.86.4.257</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.86.4.257</ArticleId><ArticleId IdType="pmc">PMC1719147</ArticleId><ArticleId IdType="pubmed">11919098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tennant PWG, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet. 2010;375(9715):649-656. doi:10.1016/S0140-6736(09)61922-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61922-X</ArticleId><ArticleId IdType="pubmed">20092884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma BJ, Mulder BJM. Changing landscape of congenital heart disease. Circ Res. 2017;120(6):908-922. doi:10.1161/CIRCRESAHA.116.309302</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309302</ArticleId><ArticleId IdType="pubmed">28302739</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Chouli M, Mohr GH, Bang CN, et al. . Time trends in simple congenital heart disease over 39 years: a Danish nationwide study. J Am Heart Assoc. 2021;10(14):e020375. doi:10.1161/JAHA.120.020375</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.020375</ArticleId><ArticleId IdType="pmc">PMC8483486</ArticleId><ArticleId IdType="pubmed">34219468</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz A, Grant K, Marano R, et al. . Long-term effects of malnutrition on severity of COVID-19. Sci Rep. 2021;11(1):14974. doi:10.1038/s41598-021-94138-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94138-z</ArticleId><ArticleId IdType="pmc">PMC8298504</ArticleId><ArticleId IdType="pubmed">34294743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehwerhemuepha L, Gasperino G, Bischoff N, Taraman S, Chang A, Feaster W. HealtheDataLab - a cloud computing solution for data science and advanced analytics in healthcare with application to predicting multi-center pediatric readmissions. BMC Med Inform Decis Mak. 2020;20(1):115. doi:10.1186/s12911-020-01153-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01153-7</ArticleId><ArticleId IdType="pmc">PMC7304122</ArticleId><ArticleId IdType="pubmed">32560653</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein DS, Shamszad P, Dai D, et al. . Significant mortality, morbidity and resource utilization associated with advanced heart failure in congenital heart disease in children and young adults. Am Heart J. 2019;209:9-19. doi:10.1016/j.ahj.2018.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2018.11.010</ArticleId><ArticleId IdType="pubmed">30639612</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein DS, Rossano JW, Griffis H, et al. . Greater admissions, mortality and cost of heart failure in adults with congenital heart disease. Heart. 2021;107(10):807-813. doi:10.1136/heartjnl-2020-318246</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-318246</ArticleId><ArticleId IdType="pubmed">33361349</ArticleId></ArticleIdList></Reference><Reference><Citation>Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics. 2000;106(1 Pt 2):205-209. doi:10.1542/peds.106.S1.205</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.106.S1.205</ArticleId><ArticleId IdType="pubmed">10888693</ArticleId></ArticleIdList></Reference><Reference><Citation>Feudtner C, Feinstein JA, Zhong W, Hall M, Dai D. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14(1):199. doi:10.1186/1471-2431-14-199</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2431-14-199</ArticleId><ArticleId IdType="pmc">PMC4134331</ArticleId><ArticleId IdType="pubmed">25102958</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K, Thomson D, Seto I, et al. ; StaR Child Health Group . Standard 6: age groups for pediatric trials. Pediatrics. 2012;129(suppl 3):S153-S160. doi:10.1542/peds.2012-0055I</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-0055I</ArticleId><ArticleId IdType="pubmed">22661762</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451-2460. doi:10.1056/NEJMcp2009575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009575</ArticleId><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Preston LE, Chevinsky JR, Kompaniyets L, et al. . Characteristics and disease severity of US children and adolescents diagnosed with COVID-19. JAMA Netw Open. 2021;4(4):e215298-e215298. doi:10.1001/jamanetworkopen.2021.5298</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.5298</ArticleId><ArticleId IdType="pmc">PMC8035649</ArticleId><ArticleId IdType="pubmed">33835179</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health, COVID-19 Treatment Guidelines . Clinical spectrum of SARS-CoV-2 infection. October 19, 2021. Accessed December 15, 2021. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/</Citation></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57(1):289-300. doi:10.1111/j.2517-6161.1995.tb02031.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1995.tb02031.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Diller G-P, Enders D, Lammers AE, et al. . Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia. Heart. 2020;107(13):1069-1076. doi:10.1136/heartjnl-2020-317706</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317706</ArticleId><ArticleId IdType="pmc">PMC8223651</ArticleId><ArticleId IdType="pubmed">33109710</ArticleId></ArticleIdList></Reference><Reference><Citation>Checchia PA, Paes B, Bont L, et al. . Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among infants with congenital heart disease. Infect Dis Ther. 2017;6(1):37-56. doi:10.1007/s40121-016-0142-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-016-0142-x</ArticleId><ArticleId IdType="pmc">PMC5336417</ArticleId><ArticleId IdType="pubmed">28070870</ArticleId></ArticleIdList></Reference><Reference><Citation>Chida-Nagai A, Sato H, Sato I, et al. . Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab. Eur J Pediatr. 2022;181(2):539-547. doi:10.1007/s00431-021-04216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04216-7</ArticleId><ArticleId IdType="pubmed">34417646</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile A, Lucion MF, Juarez MDV, et al. . Burden of respiratory syncytial virus disease and mortality risk factors in Argentina: 18 years of active surveillance in a children&#x2019;s hospital. Pediatr Infect Dis J. 2019;38(6):589-594. doi:10.1097/INF.0000000000002271</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002271</ArticleId><ArticleId IdType="pubmed">30672892</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel &#xc9;B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905-919. doi:10.1007/s10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Haiduc AA, Ogunjimi M, Shammus R, et al. . COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks. Cardiol Young. 2021;31(2):233-240. doi:10.1017/S1047951120003741</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951120003741</ArticleId><ArticleId IdType="pubmed">33172515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets L, Agathis NT, Nelson JM, et al. . Underlying medical conditions associated with severe COVID-19 illness among children. JAMA Netw Open. 2021;4(6):e2111182-e2111182. doi:10.1001/jamanetworkopen.2021.11182</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11182</ArticleId><ArticleId IdType="pmc">PMC8185607</ArticleId><ArticleId IdType="pubmed">34097050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Chen C, Yan JT, Zhou N, Zhao JP, Wang DW. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Article in Chinese. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(7):567-571.</Citation><ArticleIdList><ArticleId IdType="pubmed">32141280</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34912858</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Pediatric Acute Myocarditis With Short-Term Outcomes and Factors for Extracorporeal Membrane Oxygenation: A Single-Center Retrospective Cohort Study in Vietnam.</ArticleTitle><Pagination><StartPage>741260</StartPage><MedlinePgn>741260</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">741260</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2021.741260</ELocationID><Abstract><AbstractText><b>Objective:</b> Data on the management and outcomes of acute myocarditis treated with extracorporeal membrane oxygenation (ECMO) among low- and middle-income countries are limited. This study aimed to determine the short-term outcomes and also identify factors associated with ECMO use among children with acute myocarditis at a tertiary children's hospital in Vietnam. <b>Methods:</b> A single-center, retrospective observational study was conducted between January 2016 and February 2021. Pediatric patients with acute myocarditis, aged 1 month to 16 years, were included. <b>Results:</b> In total, 54 patients (male, 46%; median age, 7 years) with acute myocarditis were included; 37 of them received ECMO support. Thirty percent (16/54) of the patients died, and 12 of them received ECMO. Laboratory variables that differed between survivors and non-survivors included median left ventricular ejection fraction (LVEF) at 48 h (42 vs. 25%; <i>p</i> = 0.001), platelet count (304 g/L [interquartile range (IQR): 243-271] vs. 219 g/L [IQR: 167-297]; <i>p</i> = 0.014), and protein (60 g/dl [IQR: 54-69] vs. 55 [IQR: 50-58]; <i>p</i> = 0.025). Among patients who received ECMO, compared with the survivors, non-survivors had a low LVEF at 48 h (odds ratio (OR), 0.8; 95% confidence interval (CI): 0.6-0.9; <i>p</i> = 0.006) and high vasoactive-inotropic score (OR, 1.0; 95% CI: 1.0-1.0; <i>p</i> = 0.038) and lactate (OR, 2.8; 95% CI, 1.2-6.1; <i>p</i> = 0.013) at 24 h post-ECMO. <b>Conclusions:</b> The case fatality rate among children with acute myocarditis was 30 and 32% among patients requiring ECMO support. Arrhythmia was an indicator for ECMO in patients with cardiogenic shock.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Tuan, Xoay, Phuc, Hung, Dung, Truong, Thuan and Dien.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tuan</LastName><ForeName>Ta Anh</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric, Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xoay</LastName><ForeName>Tran Dang</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phuc</LastName><ForeName>Phan Huu</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Dau Viet</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dung</LastName><ForeName>Nguyen Trong</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Truong</LastName><ForeName>Nguyen Ly Thinh</ForeName><Initials>NLT</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Children Heart Center, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thuan</LastName><ForeName>Nguyen Van</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Surgical Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dien</LastName><ForeName>Tran Minh</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Children's Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Surgical Intensive Care Unit, Vietnam National Children's Hospital, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute myocarditis</Keyword><Keyword MajorTopicYN="N">cardiac arrhythmia</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34912858</ArticleId><ArticleId IdType="pmc">PMC8666974</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2021.741260</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, et al. . Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail. (2010) 3:689&#x2013;97. 10.1161/CIRCHEARTFAILURE.109.902833</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.109.902833</ArticleId><ArticleId IdType="pubmed">20833772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006-2011. Circ Cardiovasc Qual Outcomes. (2012) 5:622&#x2013;27. 10.1161/CIRCOUTCOMES.112.965749</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.112.965749</ArticleId><ArticleId IdType="pubmed">22828827</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. (2001) 122:440&#x2013;8. 10.1067/mtc.2001.115243</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2001.115243</ArticleId><ArticleId IdType="pubmed">11547292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopal SK, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med. (2010) 38:382&#x2013;7. 10.1097/CCM.0b013e3181bc8293</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181bc8293</ArticleId><ArticleId IdType="pmc">PMC4273495</ArticleId><ArticleId IdType="pubmed">19789437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu HP, Lin MJ, Yang WC, Wu KH, Chen CY. Predictors of extracorporeal membrane oxygenation support for children with acute myocarditis. Biomed Res Int. (2017) 2017:2510695. 10.1155/2017/2510695</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/2510695</ArticleId><ArticleId IdType="pmc">PMC5443988</ArticleId><ArticleId IdType="pubmed">28584814</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmot I, Morales DLS, Price JF, Rossano JW, Kim JJ, Decker JA, et al. . Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail. (2011) 17:487&#x2013;94. 10.1016/j.cardfail.2011.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2011.02.008</ArticleId><ArticleId IdType="pubmed">21624737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT, Jr. Myocarditis. Lancet. (2012) 379:738&#x2013;47. 10.1016/S0140-6736(11)60648-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Extracorporeal Life Support Organization . ECLS Guidelines 2018, Guidelines for Pediatric Cardiac Failure. Available online at: https://www.elso.org/Portals/0/IGD/Archive/FileManager/ELSO_Reformatted_2018.02.23.pdf (accessed September 16, 2020).</Citation></Reference><Reference><Citation>Mcintosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med. (2017) 18:750&#x2013;7. 10.1097/PCC.0000000000001191</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001191</ArticleId><ArticleId IdType="pmc">PMC5548505</ArticleId><ArticleId IdType="pubmed">28486385</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EY, Lee HL, Kim HT, Lee HD, Park JA. Clinical features and short-term outcomes of pediatric acute fulminant myocarditis in a single center. Korean J Pediatr. (2014) 57:489&#x2013;95. 10.3345/kjp.2014.57.11.489</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2014.57.11.489</ArticleId><ArticleId IdType="pmc">PMC4279010</ArticleId><ArticleId IdType="pubmed">25550704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohki S, Hosokawa K, Tomioka S, Matsuoka M, Fushimi K, Matsuda S, et al. . Pediatric fulminant myocarditis in Japan: a retrospective nationwide database study of hospital volume, management practices, and mortality. Pediatric Crit Care Med. (2021) 22:e391&#x2013;401. 10.1097/PCC.0000000000002692</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000002692</ArticleId><ArticleId IdType="pubmed">33729728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YJ, Chao HC, Hsia SH, Yan DC. Myocarditis presenting as gastritis in children. Pediatr Emerg Care. (2006) 22:439&#x2013;40. 10.1097/01.pec.0000221346.64991.e7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.pec.0000221346.64991.e7</ArticleId><ArticleId IdType="pubmed">16801847</ArticleId></ArticleIdList></Reference><Reference><Citation>Saji T, Matsuura H, Hasegawa K, Nishikawa T, Yamamoto E, Ohki H, et al. . Comparison of the clinical presentation, treatment, and outcome of fulminant and acute myocarditis in children. Circ J. (2012) 76:1222&#x2013;8. 10.1253/circj.CJ-11-1032</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-11-1032</ArticleId><ArticleId IdType="pubmed">22307381</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury TA, Ofori-Amanfo G, Choi J, Eisenberg RE, Rycus P, Medar SS, et al. . Left heart decompression on veno-arterial extracorporeal membrane oxygenation in children with dilated cardiomyopathy and myocarditis: an extracorporeal life support organization registry review. Pediatr Crit Care Med. (2021). 10.1097/PCC.0000000000002775 (accessed Oct 18, 2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000002775</ArticleId><ArticleId IdType="pubmed">34054118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YJ, Liu HY, Kuo HC, Huang CF, Hsu MH, Cheng MC, et al. . Left ventricle decompression strategies in pediatric peripheral extracorporeal membrane oxygenation. Acta Cardiol Sin. (2019) 35:335&#x2013;41. 10.6515/ACS.201905_35(3).20181125A</Citation><ArticleIdList><ArticleId IdType="doi">10.6515/ACS.201905_35(3).20181125A</ArticleId><ArticleId IdType="pmc">PMC6533587</ArticleId><ArticleId IdType="pubmed">31249464</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F, et al. . Echocardiographic findings in myocarditis. Am J Cardiol. (1988) 62:285&#x2013;91. 10.1016/0002-9149(88)90226-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(88)90226-3</ArticleId><ArticleId IdType="pubmed">3400607</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EP, Chu SC, Huang WY, Hsia SH, Chan OW, Lin CY, et al. . Factors associated with in-hospital mortality of children with acute fulminant myocarditis on extracorporeal membrane oxygenation. Front Pediatr. (2020) 8:488. 10.3389/fped.2020.00488</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.00488</ArticleId><ArticleId IdType="pmc">PMC7481354</ArticleId><ArticleId IdType="pubmed">32984204</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini A, Calzolari V, Calabrese F, Boffa GM, Maddalena F, Chioin R, et al. . Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart. (2000) 84:245&#x2013;50. 10.1136/heart.84.3.245</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.84.3.245</ArticleId><ArticleId IdType="pmc">PMC1760950</ArticleId><ArticleId IdType="pubmed">10956283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmi SO, Sivakumar S, Karakitsos D, Alharthy A, Lazaridis C. Cerebral pathophysiology in extracorporeal membrane oxygenation: pitfalls in daily clinical management. Crit Care Res Pract. (2018) 2018:3237810. 10.1155/2018/3237810</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/3237810</ArticleId><ArticleId IdType="pmc">PMC5878897</ArticleId><ArticleId IdType="pubmed">29744226</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP. Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst Rev. (2020) 8:CD004370. 10.1002/14651858.CD004370.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004370.pub4</ArticleId><ArticleId IdType="pmc">PMC8210245</ArticleId><ArticleId IdType="pubmed">32835416</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen CY, Hung MC, Wong YC, Chang CY, Lai CC, Wu KG. Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: a systematic review and meta-analysis. Sci Rep. (2019) 9:10459. 10.1038/s41598-019-46888-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46888-0</ArticleId><ArticleId IdType="pmc">PMC6639391</ArticleId><ArticleId IdType="pubmed">31320679</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss HP, K&#xfc;hl U, Cooper LT. The management of myocarditis. Eur Heart J. (2011) 32:2616&#x2013;25. 10.1093/eurheartj/ehr165</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr165</ArticleId><ArticleId IdType="pubmed">21705357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper LT, Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, et al. . Giant cell myocarditis treatment trial investigators. usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. (2008) 102:1535&#x2013;9. 10.1016/j.amjcard.2008.07.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.07.041</ArticleId><ArticleId IdType="pmc">PMC2613862</ArticleId><ArticleId IdType="pubmed">19026310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med. (2021) 21:e505&#x2013;10. 10.7861/clinmed.2021-0121</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0121</ArticleId><ArticleId IdType="pmc">PMC8439515</ArticleId><ArticleId IdType="pubmed">34507935</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeon PY, Massot M, Beaupr&#xe9; F, Belzile D, Beaudoin J, Bernier M, et al. . Effect of acute immunosuppression on left ventricular recovery and mortality in fulminant viral myocarditis: a case series and review of literature. CJC Open. (2020) 3:292&#x2013;302. 10.1016/j.cjco.2020.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2020.10.017</ArticleId><ArticleId IdType="pmc">PMC7985012</ArticleId><ArticleId IdType="pubmed">33778446</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous immunoglobulin therapy for acute myocarditis in children and adults. Int Heart J. (2019) 60:359&#x2013;65. 10.1536/ihj.18-299</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.18-299</ArticleId><ArticleId IdType="pubmed">30745539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33249443</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Comparison of left ventricular unloading strategies on venoarterial extracorporeal life support.</ArticleTitle><Pagination><StartPage>467</StartPage><EndPage>475</EndPage><MedlinePgn>467-475</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivaa284</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Our goal was to compare the haemodynamic effects of different mechanical left ventricular (LV) unloading strategies and clinical outcomes in patients with refractory cardiogenic shock supported with venoarterial extracorporeal membrane oxygenation (VA-ECMO).</AbstractText><AbstractText Label="METHODS">A total of 448 patients supported with VA-ECMO for refractory cardiogenic shock between 1 March 2015 and 31 January 2020 were included and analysed in a single-centre, retrospective case-control study. Fifty-three patients (11.8%) on VA-ECMO required LV unloading. Percutaneous balloon atrial septostomy (PBAS), intra-aortic balloon pump (IABP) and transapical LV vent (TALVV) strategies were compared with regards to the composite rate of death, procedure-related complications and neurological complications. The secondary outcomes were reduced pulmonary capillary wedge pressure, pulmonary artery pressure, central venous pressure, left atrial diameter and resolution of pulmonary oedema on a chest X-ray within 48&#x2009;h.</AbstractText><AbstractText Label="RESULTS">No death related to the LV unloading procedure was detected. Reduction in pulmonary capillary wedge pressure was highest with the TALVV technique (17.2&#x2009;&#xb1;&#x2009;2.1&#x2009;mmHg; P&#x2009;&lt;&#x2009;0.001) and was higher in the PBAS than in the IABP group; the difference was significant (9.6&#x2009;&#xb1;&#x2009;2.5 and 3.9&#x2009;&#xb1;&#x2009;1.3, respectively; P&#x2009;=&#x2009;0.001). Reduction in central venous pressure with TALVV was highest with the other procedures (7.4&#x2009;&#xb1;&#x2009;1.1&#x2009;mmHg; P&#x2009;&lt;&#x2009;0.001). However, procedure-related complications were significantly higher with TALVV compared to the PBAS and IABP groups (50% vs 17.6% and 10%, respectively; P&#x2009;=&#x2009;0.015). We observed no significant differences in mortality or neurological complications between the groups.</AbstractText><AbstractText Label="CONCLUSIONS">Our results suggest that TALVV was the most effective method for LV unloading compared with PBAS and IABP for VA-ECMO support but was associated with complications. Efficient LV unloading may not improve survival.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hasde</LastName><ForeName>Ali &#x130;hsan</ForeName><Initials>A&#x130;</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sar&#x131;cao&#x11f;lu</LastName><ForeName>Mehmet Cahit</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikmen Yaman</LastName><ForeName>Nur</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiovascular Surgery, Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baran</LastName><ForeName>&#xc7;a&#x11f;da&#x15f;</ForeName><Initials>&#xc7;</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;z&#xe7;&#x131;nar</LastName><ForeName>Evren</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;ak&#x131;c&#x131;</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;nan</LastName><ForeName>Mustafa Bahad&#x131;r</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akar</LastName><ForeName>Ahmet Ruchan</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="N">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007423" MajorTopicYN="N">Intra-Aortic Balloon Pumping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011669" MajorTopicYN="N">Pulmonary Wedge Pressure</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Left ventricular unloading</Keyword><Keyword MajorTopicYN="N">Percutaneous balloon atrial septostomy</Keyword><Keyword MajorTopicYN="N">Transapical left ventricular vent</Keyword><Keyword MajorTopicYN="N">Venoarterial extracorporeal membrane oxygenation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>29</Day><Hour>20</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33249443</ArticleId><ArticleId IdType="pmc">PMC8906780</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivaa284</ArticleId><ArticleId IdType="pii">6010521</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guglin M, Zucker MJ, Bazan VM, Bozkurt B, El Banayosy A, Estep JD. et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 2019;73:698&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">30765037</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams D, Combes A, Brodie D.. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol 2014;63:2769&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">24814488</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA, Fortenberry JD. et al.; ELSO member centers. Extracorporeal life support organization registry international report 2016. ASAIO J 2017;63:60&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27984321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD.. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail 2018;11:e004905.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso R, Gelsomino S, Parise O, Mendiratta P, Prodhan P, Rycus P. et al. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock in elderly patients: trends in application and outcome from the Extracorporeal Life Support Organization (ELSO) Registry. Ann Thorac Surg 2017;104:62&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28131429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht L, Florchinger B, Schopka S, Schmid C, Philipp A, Lunz D. et al. Cardiac decompression on extracorporeal life support: a review and discussion of the literature. ASAIO J 2013;59:547&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">24172259</ArticleId></ArticleIdList></Reference><Reference><Citation>Werdan K, Gielen S, Ebelt H, Hochman JS.. Mechanical circulatory support in cardiogenic shock. Eur Heart J 2014;35:156&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">24014384</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie A, Forrest P, Loforte A.. Left ventricular decompression in veno-arterial extracorporeal membrane oxygenation. Ann Cardiothorac Surg 2019;8:9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6379183</ArticleId><ArticleId IdType="pubmed">30854308</ArticleId></ArticleIdList></Reference><Reference><Citation>Centofanti P, Attisani M, La Torre M, Ricci D, Boffini M, Baronetto A. et al. Left ventricular unloading during peripheral extracorporeal membrane oxygenator support: a bridge to life in profound cardiogenic shock. J Extra Corpor Technol 2017;49:201&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5621585</ArticleId><ArticleId IdType="pubmed">28979045</ArticleId></ArticleIdList></Reference><Reference><Citation>Petroni T, Harrois A, Amour J, Lebreton G, Brechot N, Tanaka S. et al. Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Crit Care Med 2014;42:2075&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">24810530</ArticleId></ArticleIdList></Reference><Reference><Citation>Aso S, Matsui H, Fushimi K, Yasunaga H.. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med 2016;44:1974&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27322361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacking DF, Best D, d'Udekem Y, Brizard CP, Konstantinov IE, Millar J. et al. Elective decompression of the left ventricle in pediatric patients may reduce the duration of venoarterial extracorporeal membrane oxygenation. Artif Organs 2015;39:319&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25327220</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli R, Bombino M, Borelli M, Rossi F, Colombo V, Osculati G. et al. Percutaneous bridge to heart transplantation by venoarterial ECMO and transaortic left ventricular venting. Int J Artif Organs 2004;27:410&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">15202819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong TH, Byun JH, Lee HM, Kim YH, Kang GH, Oh JH. et al. Initial experience of transaortic catheter venting in patients with venoarterial extracorporeal membrane oxygenation for cardiogenic shock. ASAIO J 2016;62:117&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26720735</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Oshima Y, Matsuhisa H, Higuma T, Iwaki R, Matsushima S. et al. Left atrial decompression by minithoracotomy during extracorporeal life support. Ann Thorac Surg 2019;107:e227&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">30278170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura M, Kinoshita O, Fujimoto Y, Murakami A, Shindo T, Kashiwa K. et al. Central extracorporeal membrane oxygenation requiring pulmonary arterial venting after near-drowning. Am J Emerg Med 2014;32:197.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">24176586</ArticleId></ArticleIdList></Reference><Reference><Citation>Avalli L, Maggioni E, Sangalli F, Favini G, Formica F, Fumagalli R.. Percutaneous left-heart decompression during extracorporeal membrane oxygenation: an alternative to surgical and transeptal venting in adult patients. ASAIO J 2011;57:38&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21048495</ArticleId></ArticleIdList></Reference><Reference><Citation>Hlavacek AM, Atz AM, Bradley SM, Bandisode VM.. Left atrial decompression by percutaneous cannula placement while on extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2005;130:595&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16077447</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyagari RM, Rocchini AP, Remenapp RT, Graziano JN.. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit. Crit Care Med 2006;34:2603&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16915115</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhouli M, Narins CR, Lehoux J, Knight PA, Waits B, Ling FS.. Percutaneous decompression of the left ventricle in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation. J Card Surg 2016;31:177&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">26809382</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhussein M, Osten M, Horlick E, Ross H, Fan E, Rao V. et al. Percutaneous left atrial decompression in adults with refractory cardiogenic shock supported with veno-arterial extracorporeal membrane oxygenation. J Card Surg 2017;32:396&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">28497496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YN, Chen YH, Wang HJ, Hung JS, Chang KC, Lo PH.. Atrial septostomy for left atrial decompression during extracorporeal membrane oxygenation by inoue balloon catheter. Circ J 2017;81:1419&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">28496031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruteau AE, Barnetche T, Morin L, Jalal Z, Boscamp NS, Le Bret E. et al. Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression. Eur Heart J Acute Cardiovasc Care 2018;7:70&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27742755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakici M, Gumus F, Ozcinar E, Baran C, Bermede O, Inan MB. et al. Controlled flow diversion in hybrid venoarterial-venous extracorporeal membrane oxygenation. Interact CardioVasc Thorac Surg 2018;26:112&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29155934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski M, Malvindi PG, Zielinski K, Martucci G, Slomka A, Suwalski P. et al. Left ventricle unloading with veno-arterial extracorporeal membrane oxygenation for cardiogenic shock. systematic review and meta-analysis. J Clin Med 2020;9:1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7230555</ArticleId><ArticleId IdType="pubmed">32272721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Chetan D, Rodrigues W, Sivarajan VB, Gruenwald C, Guerguerian AM. et al. Left atrial decompression during venoarterial extracorporeal membrane oxygenation for left ventricular failure in children: current strategy and clinical outcomes. Artif Organs 2013;37:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">23020884</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34391681</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0938</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Cardiovascular revascularization medicine : including molecular interventions</Title><ISOAbbreviation>Cardiovasc Revasc Med</ISOAbbreviation></Journal><ArticleTitle>Outcomes of Cardiac Arrest Complicating Acute Myocardial Infarction in Patients With Current and Historical Cancer: An 18-Year United States Cohort Study.</ArticleTitle><Pagination><StartPage>45</StartPage><EndPage>51</EndPage><MedlinePgn>45-51</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carrev.2021.08.010</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1553-8389(21)00576-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data regarding cardiac arrest (CA) complicating acute myocardial infarction (AMI) in patients with cancers are limited.</AbstractText><AbstractText Label="METHODS">Using the HCUP-NIS database (2000-2017), we identified adult admissions with AMI-CA and current or historical cancers to evaluate in-hospital mortality, utilization of coronary angiography, percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), mechanical circulatory support (MCS), palliative care consultation, do-not-resuscitate status use, among those with current, historical and without cancer.</AbstractText><AbstractText Label="RESULTS">Of 11,622,528 AMI admissions, CA was noted in 584,263 (5.0%). Current and historical cancers were identified in 14,790 (2.5%) and 26,939 (4.6%), respectively. Both current and historical cancer groups were on average older, of white race, had greater comorbidity, and received care at small/medium-sized hospitals compared to those without. The current cancer cohort had the lowest rates of coronary angiography (45.2% vs. 59.2% vs. 63.3%), PCI (32.4% vs. 42.3% vs. 47.0%), MCS (13.5% vs. 16.5% vs. 20.9%) and CABG (4.1% vs. 7.6% vs. 10.2%) compared to the historical cancer and no cancer cohorts (all p &lt; 0.001). Compared to those without, the current (61.1% vs. 44.0%; adjusted odds ratio [OR] 1.25 [95% confidence interval {CI} 1.20-1.31], p &lt; 0.001) and historical cancer cohorts (52.2% vs. 44.0%; adjusted OR 1.05 [95% CI 1.01-1.08], p = 0.003) had higher in-hospital mortality. Cancer admissions had higher rates of palliative care consultations and do-not-resuscitate status.</AbstractText><AbstractText Label="CONCLUSION">AMI-CA admissions with cancer were older, had lower utilization of cardiac procedures, and higher rates of palliative care and do-not-resuscitate status and in-hospital mortality compared to those without cancer.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patlolla</LastName><ForeName>Sri Harsha</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundaragiri</LastName><ForeName>Pranathi R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Primary Care Internal Medicine, Wake Forest Baptist Health, High Point, NC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurumurthy</LastName><ForeName>Gayathri</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheungpasitporn</LastName><ForeName>Wisit</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rab</LastName><ForeName>Syed Tanveer</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saraschandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States of America. Electronic address: svallabh@wakehealth.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiovasc Revasc Med</MedlineTA><NlmUniqueID>101238551</NlmUniqueID><ISSNLinking>1878-0938</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cardiovasc Revasc Med. 2022 May;38:52-53. doi: 10.1016/j.carrev.2022.02.009.</RefSource><PMID Version="1">35241389</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Cardio-oncology</Keyword><Keyword MajorTopicYN="N">Critical care cardiology</Keyword><Keyword MajorTopicYN="N">cancer</Keyword></KeywordList><CoiStatement>Declaration of competing interest All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>15</Day><Hour>20</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34391681</ArticleId><ArticleId IdType="doi">10.1016/j.carrev.2021.08.010</ArticleId><ArticleId IdType="pii">S1553-8389(21)00576-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37815257</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-943X</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>ASAIO journal (American Society for Artificial Internal Organs : 1992)</Title><ISOAbbreviation>ASAIO J</ISOAbbreviation></Journal><ArticleTitle>Perioperative Morbidity and Outcomes in Pediatric Patients Transitioned From Extracorporeal Membrane Oxygenation to Ventricular Assist Device Support: A Study of the Society of Thoracic Surgeons Congenital Heart Surgery Database.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>80</EndPage><MedlinePgn>75-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MAT.0000000000002052</ELocationID><Abstract><AbstractText>As a bridge to transplant strategy, children transitioned from extracorporeal membrane oxygenation (ECMO) to ventricular assist device (VAD) have higher waitlist mortality compared with those who receive de novo VAD. However, the contribution of the immediate perioperative period and differences in the two groups are not well studied. We performed a nested case-control study between children receiving de novo VAD (group 1) and those transitioned from ECMO to VAD (group 2) between 2014 and 2019 using The Society of Thoracic Surgeons (STS) database. A total of 735 children underwent VAD placement with 498 in group 1 and 237 in group 2. Patients in group 2 were significantly younger, smaller, and significantly sicker, were twice as likely to transition to biventricular VAD and need unplanned reoperations. Overall mortality was 16% for group 1 and 34% for group 2 ( p &lt; 0.01). Regression analysis showed that ECMO use (odds ratio [OR], 2.17 [1.3-3.4]), ventilator need (OR, 2.2 [1.3-3.9]), and cardiogenic shock (OR, 1.8 [1.2-2.8]) were all independent preoperative predictors of VAD mortality while dialysis need (OR, 25.5 [8.6-75.3]), stroke (OR, 6.2 [3.1-12.6]), and bleeding (OR, 1.9 [1.1-3.4]) were independent postoperative predictors of VAD mortality within 30 days (all p &lt; 0.05). The study demonstrated significant baseline differences between the two cohorts, warranting avoidance of comparison. Early elective VAD placement in this cohort of patients should be sought to avoid interim ECMO and high post-VAD mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASAIO.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Manan H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>From the Division of Pediatric Cardiac Surgery, Children's National Hospital, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivedi</LastName><ForeName>Jaimin R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Eleanor F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinha</LastName><ForeName>Pranava</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiac Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsoufi</LastName><ForeName>Bahaaldin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Thoracic and Cardiovascular Surgery, Norton Children's Hospital, University of Louisville, Louisville, Kentucky.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deshpande</LastName><ForeName>Shriprasad R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0002-8358-9783</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, Children's National Hospital, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ASAIO J</MedlineTA><NlmUniqueID>9204109</NlmUniqueID><ISSNLinking>1058-2916</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="Y">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Disclosure: The authors have no conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>8</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37815257</ArticleId><ArticleId IdType="pmc">PMC10749675</ArticleId><ArticleId IdType="doi">10.1097/MAT.0000000000002052</ArticleId><ArticleId IdType="pii">00002480-202401000-00012</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hetzer R, Potapov EV, Stiller B, et al. : Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg. 82: 917&#x2013;924; discussion 924&#x2013;945, 2006.</Citation><ArticleIdList><ArticleId IdType="pubmed">16928509</ArticleId></ArticleIdList></Reference><Reference><Citation>Dipchand AI, Rossano JW, Edwards LB, et al. ; International Society for Heart and Lung Transplantation: The registry of the International Society for Heart and Lung Transplantation: Eighteenth official pediatric heart transplantation report--2015; focus theme: Early graft failure. J Heart Lung Transplant. 34: 1233&#x2013;1243, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26454737</ArticleId></ArticleIdList></Reference><Reference><Citation>Edelson JB, Huang Y, Griffis H, et al. : The influence of mechanical circulatory support on post-transplant outcomes in pediatric patients: A multicenter study from the International Society for Heart and Lung Transplantation (ISHLT) registry. J Heart Lung Transplant. 40: 1443&#x2013;1453, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34253457</ArticleId></ArticleIdList></Reference><Reference><Citation>Dipchand AI, Mahle WT, Tresler M, et al. ; Pediatric Heart Transplant Study Investigators: Extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation: Effect on post-listing and post-transplantation outcomes. Circ Heart Fail. 8: 960&#x2013;969, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">26206854</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DLS, Rossano JW, VanderPluym C, et al. ; Pedimacs Investigators: Third annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: Preimplant characteristics and outcomes. Ann Thorac Surg. 107: 993&#x2013;1004, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">30817920</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JP, He X, Mayer JE, Jr, et al. : Mortality trends in pediatric and congenital heart surgery: An analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. Ann Thorac Surg. 102: 1345&#x2013;1352, 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27590683</ArticleId></ArticleIdList></Reference><Reference><Citation>Overman DM, Jacobs ML, O&#x2019;Brien JE, et al. : Ten years of data verification: The Society of Thoracic Surgeons Congenital Heart Surgery Database Audits. World J Pediatr Congenit Heart Surg. 10: 454&#x2013;463, 2019.</Citation><ArticleIdList><ArticleId IdType="pubmed">31307308</ArticleId></ArticleIdList></Reference><Reference><Citation>The Society of Thoracic Surgeons: STS Congenital Heart Surgery Database Data Specifications.
Available at: https://www.sts.org/sites/default/files/documents/CongenitalDataSpecsV3_22.pdf. Accessed June 24, 2023.</Citation></Reference><Reference><Citation>De Rita F, Hasan A, Haynes S, et al. : Outcome of mechanical cardiac support in children using more than one modality as a bridge to heart transplantation. Eur J Cardiothorac Surg. 48: 917&#x2013;922; discussion 922, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25605831</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura M, Dossey AM, Prodhan P, et al. : Bridge to cardiac transplant in children: Berlin Heart versus extracorporeal membrane oxygenation. Ann Thorac Surg. 87: 1894&#x2013;1901; discussion 1901, 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19463616</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeewa A, Manlhiot C, McCrindle BW, Van Arsdell G, Humpl T, Dipchand AI: Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation. Artif Organs. 34: 1087&#x2013;1091, 2010.</Citation><ArticleIdList><ArticleId IdType="pubmed">20545660</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossano JW, VanderPluym CJ, Peng DM, et al. ; Pedimacs Investigators: Fifth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report. Ann Thorac Surg. 112: 1763&#x2013;1774, 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">34648810</ArticleId></ArticleIdList></Reference><Reference><Citation>Das BB, Trivedi J, Deshpande SR, Alsoufi B, Slaughter MS: Recent era outcomes of mechanical circulatory support in children with congenital heart disease as a bridge to heart transplantation. ASAIO J. 68: 432&#x2013;439, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35213887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirklin JK, Pagani FD, Kormos RL, et al. : Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 36: 1080&#x2013;1086, 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28942782</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi I, Peng DM, Hollander SA, et al. ; Pedimacs Investigators: Sixth annual pediatric interagency registry for mechanical circulatory support (Pedimacs) report: The Society of Thoracic Surgeons Pedimacs Annual Report. Ann Thorac Surg. 115: 1098&#x2013;1108, 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">36402175</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Halloran CP, Thiagarajan RR, Yarlagadda VV, et al. : Outcomes of infants supported with extracorporeal membrane oxygenation using centrifugal versus roller pumps: An analysis from the Extracorporeal Life Support Organization registry. Pediatr Crit Care Med. 20: 1177&#x2013;1184, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175473</ArticleId><ArticleId IdType="pubmed">31567621</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimas E, Leow L, Tan YK, et al. : Centrifugal and roller pumps in neonatal and pediatric extracorporeal membrane oxygenation: A systematic review and meta-analysis of clinical outcomes. ASAIO J. 68: 311&#x2013;317, 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">34347405</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh TP, Almond CS, Semigran MJ, Piercey G, Gauvreau K: Risk prediction for early in-hospital mortality following heart transplantation in the United States. Circ Heart Fail. 5: 259&#x2013;266, 2012.</Citation><ArticleIdList><ArticleId IdType="pubmed">22308287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23838338</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1569-9285</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Interactive cardiovascular and thoracic surgery</Title><ISOAbbreviation>Interact Cardiovasc Thorac Surg</ISOAbbreviation></Journal><ArticleTitle>Might rapid implementation of cardiopulmonary bypass in patients who are failing to recover after a cardiac arrest potentially save lives?</ArticleTitle><Pagination><StartPage>725</StartPage><EndPage>730</EndPage><MedlinePgn>725-30</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/icvts/ivt296</ELocationID><Abstract><AbstractText>The question addressed was whether it might be beneficial to have a rapid-response emergency cardiopulmonary bypass service for patients who suffer an in-hospital or an out-of-hospital cardiac arrest of any aetiology. Eighty-five papers were reviewed using the reported search, of which 15 represented the best evidence to answer the clinical question. The authors, journal, date, country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The concept of using emergency cardiopulmonary bypass (ECPB) for the management of cardiogenic shock and refractory cardiac arrest was developed in the late 1990s. Since this time, a large number of centres worldwide have reported success with use of ECPB for cardiac arrest refractory to conventional resuscitation techniques and for cardiogenic shock. This is a relatively new advancement in resuscitative strategy and is expanding in clinical practice. Clinical studies and experimental data reveal that ECPB is a very effective tool in the return of spontaneous circulation following refractory cardiac arrest. Resuscitation with this technique demonstrated survival benefit when compared with patients having conventional cardiopulmonary resuscitation for &gt;10 min after witnessed in-hospital arrest, especially if the cause of arrest is of cardiac origin. The reported finding from a systematic review of 1494 patients treated with ECPB noted that the overall survival rate was 47.4%; their results indicate that the application of ECPB in cardiac arrest improves survival and the likelihood of a satisfactory neurological outcome. An additional review revealed that acceptable survival rate and neurological outcomes (30%) can be achieved with extracorporeal cardiopulmonary resuscitation in children after prolonged cardiac arrest (up to 95 min) refractory to standard resuscitation. However, no study has provided clear-cut evidence of the merits of ECPS in patients with out-of-hospital cardiac arrest, although many case reports and case series have concluded that it is an effective method. We conclude that institution of emergency cardiopulmonary bypass may save the lives of patients in whom routine attempts at resuscitation after a cardiac arrest fail, especially after &gt;10 min. The likelihood of success is much higher for patients who have in-hospital witnessed cardiac arrest.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishaq</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, University Hospital Royal Infirmary of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pessotto</LastName><ForeName>Renzo</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Interact Cardiovasc Thorac Surg</MedlineTA><NlmUniqueID>101158399</NlmUniqueID><ISSNLinking>1569-9285</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="N">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="Y">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="Y">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="N">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary resuscitation</Keyword><Keyword MajorTopicYN="N">Emergency cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">Sudden cardiac arrest</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23838338</ArticleId><ArticleId IdType="pmc">PMC3781808</ArticleId><ArticleId IdType="doi">10.1093/icvts/ivt296</ArticleId><ArticleId IdType="pii">ivt296</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg. 2003;2:405&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17670084</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Guen M, Nicolas-Robin A, Carreira S, Raux M, Leprince P, Riou B, et al. Extracorporeal life support following out-of-hospital refractory cardiac arrest. Crit Care. 2011;15:R29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3222065</ArticleId><ArticleId IdType="pubmed">21244674</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasson C, Rogers MA, Dahl J, Kellermann AL. Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2010;3:63&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20123673</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao K, Kikushima K, Watanabe K, Tachibana E, Tominaga Y, Tada K, et al. Early induction of hypothermia during cardiac arrest improves neurological outcomes in patients with out-of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention. Circ J. 2009;74:77&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">19942784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YS, Lin JW, Yu HY, Ko WJ, Jerng JS, Chang WT, et al. Cardiopulmonary resuscitation with assisted extracorporeal life support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372:554&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">18603291</ArticleId></ArticleIdList></Reference><Reference><Citation>Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G, Buklas D, et al. Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg. 2005;79:178&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">15620939</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsoufi B, Al-Radi OO, Nazer RI, Gruenwald C, Foreman C, Williams WG, et al. Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediactric patients with refractory cardiac arrest. J Thorac Cardiovasc Surg. 2007;134:952&#x2013;9.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">17903513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung K, Lee YT, Park PW, Park KH, Jun TG, Yang JH, et al. Improved survival after cardiac arrest using emergent autopriming percutaneous cardiopulmonary support. Ann Thorac Surg. 2006;82:651&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16863780</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasuleas CL, Buckberg GD, Allen BS, Beyersdorf F, Kirsh MM. Sudden cardiac death: directing the scope of resuscitation towards the heart and brain. Resuscitation. 2006;70:44&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">16759784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurusz M, Zwischenberger JB. Percutaneous cardiopulmonary bypass for cardiac emergencies. Perfusion. 2002;17:269&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">12139384</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol G, Karmy-Jones R, Salerno C, Cantore L, Becker L. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states. Resuscitation. 2006;70:381&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">16828957</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GB, Rivers EP, Paradis NA, Goetting MG, Morris DC, Nowak RM. Emergency department cardiopulmonary bypass in the treatment of human cardiac arrest. Chest. 1998;113:743&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">9515852</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisherman SA, Grenvik A, Safar P. Cardiopulmonary-cerebral resuscitation: advanced and prolonged life support with emergency cardiopulmonary bypass. Acta Anaesthesiol Scand Suppl. 1990;94:63&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">2291391</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees MR, Browne T, Sivananthan UM, Whittaker S, Hick D, Verma SP, et al. Cardiac resuscitation with percutaneous cardiopulmonary support. Lancet. 1992;340:513&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">1354278</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz B, Mair P, Margreiter J, Pomaroli A, Hoermann C, Bonatti J, et al. Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med. 2003;31:758&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">12626980</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmy-Jones R, Hamilton A, Koshal A. The management of non-traumatic cardiac arrest in the operating room with cardiopulmonary bypass. Resuscitation. 1999;40:107&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10225284</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto K, Kawahito K, Yamaguchi A, Sakuragawa H, Tsuboi J, Yuri K, et al. Percutaneous extracorporeal life support for treatment of fatal mechanical complications associated with acute myocardial infarction. Artif Organs. 2001;25:1000&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11843768</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris MC, Wernovsky G, Nadkarni VM. Survival outcomes after extracorporeal cardiopulmonary resuscitation instituted during active chest compressions following refractory in-hospital pediatric cardiac arrest. Pediatr Crit Care Med. 2004;5:440&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15329159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31918663</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2261</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC cardiovascular disorders</Title><ISOAbbreviation>BMC Cardiovasc Disord</ISOAbbreviation></Journal><ArticleTitle>The impact of Centre's heart transplant status and volume on in-hospital outcomes following extracorporeal membrane oxygenation for refractory post-cardiotomy cardiogenic shock: a meta-analysis.</ArticleTitle><Pagination><StartPage>10</StartPage><MedlinePgn>10</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12872-019-01317-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Postcardiotomy cardiogenic shock (PCS) that is refractory to inotropic support remains a major concern in cardiac surgery and is almost universally fatal unless treated with mechanical support. While reported mortality rates on ECMO vary from center to center, aim of the current report is assess if the outcomes differ between centres according to volume and heart transplantation status.</AbstractText><AbstractText Label="METHODS">A systematic search was performed according to PRISMA statement using PubMed/Medline databases between 2010 and 2018. Relevant articles were scrutinized and included in the meta-analysis only if reporting in-hospital/30-day mortality and heart transplantation status of the centre. Paediatric and congenital heart surgery-related studies along with those conducted in the setting of veno-venous ECMO for respiratory distress syndrome were excluded. Differences were assessed by means of subgroup meta-analysis and meta-regression.</AbstractText><AbstractText Label="RESULTS">Fifty-four studies enrolling N&#x2009;=&#x2009;4421 ECMO patients were included. Of those, 6 series were performed in non-HTx centres (204 pts.;4.6%). Overall 30-day survival (95% Confidence Intervals) was 35.3% (32.5-38.2%) and did not statistically differ between non-HTx: 33.3% (26.8-40.4%) and HTx centres: 35.7% (32.7-38.8%); P<sub>interaction</sub>&#x2009;=&#x2009;0.531. There was no impact of centre volume on survival as well: &#xdf;<sub>coef</sub>&#x2009;=&#x2009;0.0006; P&#x2009;=&#x2009;0.833. No statistical differences were seen between HTx and non-HTx with respect to ECMO duration, limb complications, reoperations for bleeding, kidney injury and sepsis. There were however significantly less neurological complications in the HTx as compared to non-HTx centres: 11.9% vs 19.5% respectively; P&#x2009;=&#x2009;0.009; an inverse relationship was seen for neurologic complications in centres performing more ECMOs annually &#xdf;<sub>coef</sub>&#x2009;=&#x2009;-&#x2009;0.0066; P&#x2009;=&#x2009;0.031. Weaning rates and bridging to HTx and/or VADs were higher in HTx facilities.</AbstractText><AbstractText Label="CONCLUSIONS">There was no apparent difference in survival after ECMO implantation for refractory PCS according to centre's ECMO volume and transplantation status. Potentially different risk profiles of patients in these centres must be taken account for before definite conclusions are drawn.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kowalewski</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5478-3245</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland. kowalewskimariusz@gazeta.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands. kowalewskimariusz@gazeta.pl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiothoracic Research Centre, Innovative Medical Forum, Bydgoszcz, Poland. kowalewskimariusz@gazeta.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffa</LastName><ForeName>Giuseppe Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, ISMETT-IRCCS, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zieli&#x144;ski</LastName><ForeName>Kamil</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alanazi</LastName><ForeName>Musab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbers</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuts</LastName><ForeName>Sam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natour</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bidar</LastName><ForeName>Elham</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreurs</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delnoij</LastName><ForeName>Thijs</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driessen</LastName><ForeName>Rob</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sels</LastName><ForeName>Jan-Willem</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van de Poll</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roekaerts</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meani</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology Department, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Maastricht University Medical Centre, Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maessen</LastName><ForeName>Jos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suwalski</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Central Clinical Hospital of the Ministry of Interior, Centre of Postgraduate Medical Education, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorusso</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery Department, Maastricht University Medical Centre, Cardiovascular Research Institute Maastricht (CARIM) , Maastricht, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cardiovasc Disord</MedlineTA><NlmUniqueID>100968539</NlmUniqueID><ISSNLinking>1471-2261</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061847" MajorTopicYN="Y">Hospitals, High-Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061846" MajorTopicYN="Y">Hospitals, Low-Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Extracorporeal life support</Keyword><Keyword MajorTopicYN="N">Extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31918663</ArticleId><ArticleId IdType="pmc">PMC6950870</ArticleId><ArticleId IdType="doi">10.1186/s12872-019-01317-y</ArticleId><ArticleId IdType="pii">10.1186/s12872-019-01317-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lawler PR, Silver DA, Scirica BM, Couper GS, Weinhouse GL, Camp PC., Jr Extracorporeal membrane oxygenation in adults with cardiogenic shock. Circulation. 2015;131:676&#x2013;680. doi: 10.1161/CIRCULATIONAHA.114.006647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.006647</ArticleId><ArticleId IdType="pubmed">25691703</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitman GJ. Extracorporeal membrane oxygenation for the treatment of postcardiotomy shock. J Thorac Cardiovasc Surg. 2017;153:95&#x2013;101. doi: 10.1016/j.jtcvs.2016.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2016.08.024</ArticleId><ArticleId IdType="pubmed">27666787</ArticleId></ArticleIdList></Reference><Reference><Citation>Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64:1407&#x2013;1415. doi: 10.1016/j.jacc.2014.07.958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.07.958</ArticleId><ArticleId IdType="pubmed">25277608</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, et al. Trends in U.S. extracorporeal membrane oxygenation use and outcomes: 2002-2012. Semin Thorac Cardiovasc Surg. 2015;27:81&#x2013;88. doi: 10.1053/j.semtcvs.2015.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semtcvs.2015.07.005</ArticleId><ArticleId IdType="pmc">PMC4780346</ArticleId><ArticleId IdType="pubmed">26686427</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. 2016;42:889&#x2013;896. doi: 10.1007/s00134-016-4273-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4273-z</ArticleId><ArticleId IdType="pubmed">26942446</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell BG, Powers AJ, Sheikh AY, Lee PH, Lobato RL, Wong JK. Resource use trends in extracorporeal membrane oxygenation in adults: an analysis of the nationwide inpatient sample 1998-2009. J Thorac Cardiovasc Surg. 2014;148:416&#x2013;421. doi: 10.1016/j.jtcvs.2013.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2013.09.033</ArticleId><ArticleId IdType="pubmed">24183903</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco F, Belletti A, Bove T, Landoni G, Zangrillo A. Extracorporeal membrane oxygenation: beyond cardiac surgery and intensive care unit: unconventional uses and future perspectives. J Cardiothorac Vasc Anesth. 2018;32:1955&#x2013;1970. doi: 10.1053/j.jvca.2018.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2018.03.031</ArticleId><ArticleId IdType="pubmed">29709436</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with st-segment elevation of the european society of cardiology (ESC) Eur Heart J. 2018;39:119&#x2013;177. doi: 10.1093/eurheartj/ehx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx393</ArticleId><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena P, Neal J, Joyce LD, Greason KL, Schaff HV, Guru P, et al. Extracorporeal membrane oxygenation support in postcardiotomy elderly patients: the mayo clinic experience. Ann Thorac Surg. 2015;99:2053&#x2013;2060. doi: 10.1016/j.athoracsur.2014.11.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2014.11.075</ArticleId><ArticleId IdType="pubmed">25865760</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. doi: 10.1136/bmj.b2700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2700</ArticleId><ArticleId IdType="pmc">PMC2714672</ArticleId><ArticleId IdType="pubmed">19622552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackman NJ, Koval JJ. Interval estimation for Cohen&#x2019;s kappa as a measure of agreement. Stat Med. 2000;19:723&#x2013;741. doi: 10.1002/(SICI)1097-0258(20000315)19:5&lt;723::AID-SIM379&gt;3.0.CO;2-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-0258(20000315)19:5&lt;723::AID-SIM379&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">10700742</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-meier survival curves. BMC Med Res Methodol. 2012;12:9. doi: 10.1186/1471-2288-12-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-12-9</ArticleId><ArticleId IdType="pmc">PMC3313891</ArticleId><ArticleId IdType="pubmed">22297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29:3046&#x2013;3067. doi: 10.1002/sim.4040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4040</ArticleId><ArticleId IdType="pubmed">20827667</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. doi: 10.1136/bmj.d4002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SW, Tsai FC, Lin YS, Chang CH, Chen DY, Chou AH, et al. Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock. J Thorac Cardiovasc Surg. 2017;154:469&#x2013;477. doi: 10.1016/j.jtcvs.2017.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.02.055</ArticleId><ArticleId IdType="pubmed">28413074</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarpino G, Ruggieri VG, Mariscalco G, Bounader K, Beghi C, Fischlein T, et al. Outcome in patients having salvage coronary artery bypass grafting. Am J Cardiol. 2015;116:1193&#x2013;1198. doi: 10.1016/j.amjcard.2015.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.07.034</ArticleId><ArticleId IdType="pubmed">26303635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso R, Gelsomino S, Parise O, Mendiratta P, Prodhan P, Rycus P, et al. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock in elderly patients: trends in application and outcome from the extracorporeal life support organization (ELSO) registry. Ann Thorac Surg. 2017;104:62&#x2013;69. doi: 10.1016/j.athoracsur.2016.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2016.10.023</ArticleId><ArticleId IdType="pubmed">28131429</ArticleId></ArticleIdList></Reference><Reference><Citation>Distelmaier K, Wiedemann D, Binder C, Haberl T, Zimpfer D, Heinz G, Koinig H, Felli A, Steinlechner B, Niessner A, Laufer G, Lang IM, Goliasch G. Duration of extracorporeal membrane oxygenation support and survival in cardiovascular surgery patients. J Thorac Cardiovasc Surg. 2018;155:2471&#x2013;2476. doi: 10.1016/j.jtcvs.2017.12.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2017.12.079</ArticleId><ArticleId IdType="pubmed">29395201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MY, Lin PJ, Lee MY, Tsai FC, Chu JJ, Chang YS, et al. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival. Resuscitation. 2010;81:1111&#x2013;1116. doi: 10.1016/j.resuscitation.2010.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2010.04.031</ArticleId><ArticleId IdType="pubmed">20627521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15:172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">23944202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hei F, Lou S, Li J, Yu K, Liu J, Feng Z, et al. Five-year results of 121 consecutive patients treated with extracorporeal membrane oxygenation at fu Wai hospital. Artif Organs. 2011;35:572&#x2013;578. doi: 10.1111/j.1525-1594.2010.01151.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1594.2010.01151.x</ArticleId><ArticleId IdType="pubmed">21314838</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 2010;139:302&#x2013;311. doi: 10.1016/j.jtcvs.2009.10.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2009.10.043</ArticleId><ArticleId IdType="pubmed">20106393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko WJ, Lin CY, Chen RJ, Wang SS, Lin FY, Chen YS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg. 2002;73:538&#x2013;545. doi: 10.1016/S0003-4975(01)03330-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(01)03330-6</ArticleId><ArticleId IdType="pubmed">11845871</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastan AJ, Lachmann N, Walther T, Doll N, Gradistanac T, Gommert JF, et al. Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ecmo) Int J Artif Organs. 2006;29:1121&#x2013;1131. doi: 10.1177/039139880602901205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139880602901205</ArticleId><ArticleId IdType="pubmed">17219352</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A, Ibsen LM. Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med. 2013;2:40&#x2013;47. doi: 10.5492/wjccm.v2.i4.40.</Citation><ArticleIdList><ArticleId IdType="doi">10.5492/wjccm.v2.i4.40</ArticleId><ArticleId IdType="pmc">PMC3953870</ArticleId><ArticleId IdType="pubmed">24701415</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mauro M, Lorusso R. Time is your best friend, but it soon becomes your worst enemy: the conflict of venoarterial extracorporeal membrane oxygenation in cardiac surgery. J Thorac Cardiovasc Surg. 2018;155:2477&#x2013;2478. doi: 10.1016/j.jtcvs.2018.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcvs.2018.01.033</ArticleId><ArticleId IdType="pubmed">29550069</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31094743</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation: Risk Factors for Mortality.</ArticleTitle><Pagination><StartPage>926</StartPage><EndPage>933</EndPage><MedlinePgn>926-933</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000003772</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Mortality after cardiac arrest remains high despite initiation of venoarterial extracorporeal membrane oxygenation. We aimed to identify pre-venoarterial extracorporeal membrane oxygenation risk factors of 90-day mortality in patients with witnessed cardiac arrest and with greater than or equal to 1 minute of cardiopulmonary resuscitation before venoarterial extracorporeal membrane oxygenation. The association between preimplant variables and all-cause mortality at 90 days was analyzed with multivariable logistic regression.</AbstractText><AbstractText Label="DESIGN">Retrospective observational cohort study.</AbstractText><AbstractText Label="SETTING">Tertiary medical center.</AbstractText><AbstractText Label="PATIENTS">Seventy-two consecutive patients with cardiac arrest prior to venoarterial extracorporeal membrane oxygenation cannulation.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Median age was 56 years (interquartile range, 43-56 yr), 75% (n = 54) were men. Out-of-hospital cardiac arrest occurred in 12% (n = 9) of the patients. Initial cardiac rhythm was nonshockable in 57% (n = 41) and shockable in 43% (n = 31) of patients. Median cardiopulmonary resuscitation duration was 21 minutes (interquartile range, 10-73&#x2009;min; range, 1-197 min]. No return of spontaneous circulation was present in 64% (n = 46) and postarrest cardiogenic shock in 36% (n = 26) of the patients at venoarterial extracorporeal membrane oxygenation cannulation. Median duration of venoarterial extracorporeal membrane oxygenation was 5 days (interquartile range, 2-12 d). The 90-day overall mortality and in-hospital mortality were 57% (n = 41), 53% (n = 38) died during venoarterial extracorporeal membrane oxygenation, and 43% (n = 31) were successfully weaned. All survivors had Cerebral Performance Category score 1-2 at discharge to home. Multivariable logistic regression analysis identified initial nonshockable cardiac arrest rhythm (odds ratio, 12.2; 95% CI, 2.83-52.7; p = 0.001), arterial lactate (odds ratio per unit, 1.15; 95% CI, 1.01-1.31; p = 0.041), and ischemic heart disease (7.39; 95% CI, 1.57-34.7; p = 0.011) as independent risk factors of 90-day mortality, whereas low-flow duration, return of spontaneous circulation, and age were not.</AbstractText><AbstractText Label="CONCLUSIONS">In 72 patients with cardiac arrest before venoarterial extracorporeal membrane oxygenation initiation, nonshockable rhythm, arterial lactate, and ischemic heart disease were identified as independent pre-venoarterial extracorporeal membrane oxygenation risk factors of 90-day mortality. The novelty of this study is that the metabolic state, expressed as level of lactate just before venoarterial extracorporeal membrane oxygenation initiation seems more predictive of outcome than cardiopulmonary resuscitation duration or absence of return of spontaneous circulation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fux</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Perioperative Medicine and Intensive Care, Section Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Manne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Perioperative Medicine and Intensive Care, Section Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbascio</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Heart and Vascular Division, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Linden</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Perioperative Medicine and Intensive Care, Section Cardiothoracic Surgery and Anesthesiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2020 Feb;48(2):e155. doi: 10.1097/CCM.0000000000004028.</RefSource><PMID Version="1">31939818</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2020 Feb;48(2):e155-e156. doi: 10.1097/CCM.0000000000004089.</RefSource><PMID Version="1">31939819</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31094743</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003772</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28553783</PMID><DateCompleted><Year>2018</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-111X</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>5</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Perfusion</Title><ISOAbbreviation>Perfusion</ISOAbbreviation></Journal><ArticleTitle>A retrospective cohort analysis of percutaneous versus side-graft perfusion techniques for veno-arterial extracorporeal membrane oxygenation in patients with refractory cardiogenic shock.</ArticleTitle><Pagination><StartPage>363</StartPage><EndPage>371</EndPage><MedlinePgn>363-371</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0267659116683792</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study was designed to compare vascular complications and the outcomes of ultrasound (US)-guided percutaneous cannulation with distal perfusion catheter (PC-DP) and arterial side-graft perfusion (SGP) techniques in patients who require veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support for refractory cardiogenic shock (RCS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective, observational cohort study of consequtive patients with RCS treated with VA-ECMO at a single transplant center from March 2010 until August 2015. Overall, 148 patients underwent VA-ECMO for RCS (99 men, aged 56.6 &#xb1; 12.0 years; BSA, 1.85 &#xb1; 0.19). Patients were categorized based on VA-ECMO perfusion technique into PC-DP via femoral artery and SGP via axillary/femoral artery groups.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median duration of VA-ECMO support was 5 days (range, 8 hours-80 days). Hospital mortality (PC-DP group, 54.7%; SGP group, 64.4%; p=0.23) and overall ECMO survival (PC-DP group, 36.9%; SGP group, 32.2%; p=0.47) was similar between the groups. There were no significant between-group differences in the rate of acute limb ischemia (PC-DP group, 4/75, 5.3%; SGP group, 2/73, 2.7%; p=0.68). However, the rate of surgical/cannulation site bleeding (PC-DP, 9/75 (12%) vs SGP, 18/73 (24.7%), p=0.05) and hyperperfusion syndrome (PC-DP, 2/75 (2.7%) vs SGP, 22/73 (30.1%),p=0.001) were higher in the SGP group than in the PC-DP group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We observed no significant difference in major vascular complications or survival between patients who underwent the PC-DP technique and those who underwent arterial SGP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cakici</LastName><ForeName>Mehmet</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ozcinar</LastName><ForeName>Evren</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baran</LastName><ForeName>Cagdas</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bermede</LastName><ForeName>Ahmet Onat</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>2 Department of Anesthesiology and Reanimation, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sar&#x131;caoglu</LastName><ForeName>Mehmet Cahit</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inan</LastName><ForeName>Mustafa Bahad&#x131;r</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durdu</LastName><ForeName>Mustafa Serkan</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aral</LastName><ForeName>Atilla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sirlak</LastName><ForeName>Mustafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akar</LastName><ForeName>Ahmet Ruchan</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>1 Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Perfusion</MedlineTA><NlmUniqueID>8700166</NlmUniqueID><ISSNLinking>0267-6591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002404" MajorTopicYN="Y">Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014652" MajorTopicYN="Y">Vascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">assisted circulation</Keyword><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">vascular complications</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28553783</ArticleId><ArticleId IdType="doi">10.1177/0267659116683792</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36124416</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8191</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiac surgery</Title><ISOAbbreviation>J Card Surg</ISOAbbreviation></Journal><ArticleTitle>The impact of race on utilization of durable left ventricular assist device therapy in patients with advanced heart failure.</ArticleTitle><Pagination><StartPage>3586</StartPage><EndPage>3594</EndPage><MedlinePgn>3586-3594</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/jocs.16926</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heart failure affects &gt;6 million people in the United States alone&#xa0;and is most prevalent in Black patients who suffer the highest mortality risk. Yet prior studies have suggested that Black patients are less likely to receive advanced heart failure therapy. We hypothesized that Black patients would have decreased rates of durable left ventricular assist device (LVAD) implantation within our expansive heart failure program.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective single-center cohort study was conducted at a single high-volume academic medical center. Patients between 18 and 85 years admitted with a diagnosis of cardiogenic shock or congestive heart failure between 1, 2013 and 12, 2017 with a left ventricular ejection fraction&#x2009;&lt;&#x2009;30% and inotropic dependence or need for mechanical circulatory support were included. Patients with contraindications to durable LVAD were excluded. An adjusted logistic regression model for durable LVAD implantation within 90 days of the index admission was used to determine the effect of race on durable LVAD implantation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 702 study patients (60.9% White, 34.1% Black), durable LVAD implantation was performed within 90 days of the index admission in 183 (26%) of the cohort. After multivariate analysis, Black patients were not found to have a statistically significant difference in durable LVAD implantation rates compared to White patients in our study (OR: 0.68 [95%&#xa0;confidence interval: 0.45-1.04; p: .074]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Black patients in our study did not have a statistically significant difference in the rate of durable LVAD implantation compared with White patients after adjustments were made for age, sex, socioeconomic, and clinical covariates. Larger prospective studies are needed to validate these findings.</AbstractText><CopyrightInformation>&#xa9; 2022 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Mandisa-Maia</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0001-5574-4355</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology,&#xa0;Division of Cardiothoracic&#xa0;and Critical Care Medicine, Weill Cornell Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McElroy</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Division of Abdominal Transplant Surgery, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirreh</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Division of Pediatric Anesthesiology, University of Michigan Hospital, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Division of Cardiothoracic and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeder</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Duke University School of Medicine, VAMC, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghadimi</LastName><ForeName>Kamrouz</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Division of Cardiothoracic and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeVore</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Chetan B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black-Maier</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 MD012530</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Card Surg</MedlineTA><NlmUniqueID>8908809</NlmUniqueID><ISSNLinking>0886-0440</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gender</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">left ventricular assist device</Keyword><Keyword MajorTopicYN="N">race</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>2</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36124416</ArticleId><ArticleId IdType="mid">NIHMS2000640</ArticleId><ArticleId IdType="pmc">PMC11193413</ArticleId><ArticleId IdType="doi">10.1111/jocs.16926</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wang X, Luke AA, Vader JM, Maddox TM, Joynt Maddox KE. Disparities and impact of medicaid expansion on left ventricular assist device implantation and outcomes. Circ Cardiovasc Qual Outcomes. 2020;13(6):e006284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8627192</ArticleId><ArticleId IdType="pubmed">32394720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Colvin-Adams M, Yancy CW. Heart failure in African Americans: disparities can be overcome. Cleve Clin J Med. 2014; 81(5):301&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">24789589</ArticleId></ArticleIdList></Reference><Reference><Citation>Breathett K, Liu WG, Allen LA, et al. African Americans are less likely to receive care by a cardiologist during an intensive care unit admission for heart failure. JACC Heart Fail. 2018;6(5):413&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5940011</ArticleId><ArticleId IdType="pubmed">29724363</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson E, Yancy CW. Eliminating racial and ethnic disparities in cardiac care. N Engl J Med. 2009;360(12):1172&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">19297569</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinney SP. Disparities in heart failure care: now is the time to focus on health care delivery. J Am Coll Cardiol. 2014;64(8):808&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">25145525</ArticleId></ArticleIdList></Reference><Reference><Citation>Kressin NR, Petersen LA. Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research. Ann Intern Med. 2001;135(5):352&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">11529699</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794191</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamdar F, John R, Eckman P, Colvin-Adams M, Shumway SJ, Liao K. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2013;145(2):575&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">23321132</ArticleId></ArticleIdList></Reference><Reference><Citation>Estep JD, Starling RC, Horstmanshof DA, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66(16):1747&#x2013;1761.</Citation><ArticleIdList><ArticleId IdType="pubmed">26483097</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce DL, Conte JV, Russell SD, Joyce LD, Chang DC. Disparities in access to left ventricular assist device therapy. J Surg Res. 2009; 152(1):111&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">18466923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutcheson SS, Phillips V, Patzer R, Smith A, Vega JD, Morris AA. Impact of insurance type on eligibility for advanced heart failure therapies and survival. Clin Transplant. 2018;32(8):e13328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113069</ArticleId><ArticleId IdType="pubmed">29905971</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis EM, Truby LK, Garan AR, et al. Sex-related differences in use and outcomes of left ventricular assist devices as bridge to transplantation. JACC Heart Fail. 2019;7(3):250&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">30819381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsich EM. Sex differences in advanced heart failure therapies. Circulation. 2019;139(8):1080&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6383806</ArticleId><ArticleId IdType="pubmed">30779645</ArticleId></ArticleIdList></Reference><Reference><Citation>Breathett K, Yee E, Pool N, et al. Association of gender and race with allocation of advanced heart failure therapies. JAMA Netw Open. 2020;3(7):e2011044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412827</ArticleId><ArticleId IdType="pubmed">32692370</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J, Moskowitz GB, Zestcott CA, Wolsiefer KJ. Testing active learning workshops for reducing implicit stereotyping of Hispanics by majority and minority group medical students. Stigma Health. 2019;5(1):94&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7597671</ArticleId><ArticleId IdType="pubmed">33134507</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnes M, Devine PG, Baier Manwell L, et al. The effect of an intervention to break the gender bias habit for faculty at one institution: a cluster randomized, controlled trial. Acad Med. 2015; 90(2):221&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310758</ArticleId><ArticleId IdType="pubmed">25374039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24678718</PMID><DateCompleted><Year>2014</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1749-8090</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of cardiothoracic surgery</Title><ISOAbbreviation>J Cardiothorac Surg</ISOAbbreviation></Journal><ArticleTitle>Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure.</ArticleTitle><Pagination><StartPage>60</StartPage><MedlinePgn>60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1749-8090-9-60</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this prospective study was to evaluate the effects and functional outcome of central extracorporeal life support (ECLS) with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between August 2010 and August 2013, 12 consecutive patients (2 female) with a mean age of 31.6 &#xb1; 15.1&#xa0;years received central ECLS with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure. Underlying disease was acute cardiac decompensation due to dilated cardiomyopathy (n = 3, 25%), coronary artery disease with acute myocardial infarction (AMI) (n = 3, 25%), and acute myocarditis (n = 6, 50%). We routinely implemented ECLS by cannulating the ascending aorta, right atrium and inserting a left ventricular decompression cannula vent via the right superior pulmonary vein.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All patients were successfully bridged to either recovery (n = 3, 25%), long-term biventricular support (n = 6, 50%) or cardiac transplantation (n = 3, 25%). Seven patients (58.3%) were discharged after a mean hospital stay of 42 &#xb1; 11.9&#xa0;days. The overall survival from ECLS implantation to the end of the study was 58.3%. The cumulative ICU stay was 23.1 &#xb1; 9.6&#xa0;days. The length of support was 8.0 &#xb1; 4.3&#xa0;days (range 3-17&#xa0;days).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We strongly recommend left ventricular decompression in refractory cardiogenic shock and lung failure to avoid pulmonary edema, left heart distension and facilitate myocardial recovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weymann</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Transplantation &amp; Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Hill End Road, Harefield, Middlesex, UB9 6JH London, UK. weymann.alexander@googlemail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmack</LastName><ForeName>Bastian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Sabashnikov</LastName><ForeName>Anton</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bowles</LastName><ForeName>Christopher T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Raake</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Arif</LastName><ForeName>Rawa</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Verch</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tochtermann</LastName><ForeName>Ursula</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Roggenbach</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Popov</LastName><ForeName>Aron Frederik</ForeName><Initials>AF</Initials></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Andre Ruediger</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Karck</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ruhparwar</LastName><ForeName>Arjang</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Cardiothorac Surg</MedlineTA><NlmUniqueID>101265113</NlmUniqueID><ISSNLinking>1749-8090</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>RFM9X3LJ49</RegistryNumber><NameOfSubstance UI="D001663">Bilirubin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001663" MajorTopicYN="N">Bilirubin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24678718</ArticleId><ArticleId IdType="pmc">PMC3974212</ArticleId><ArticleId IdType="doi">10.1186/1749-8090-9-60</ArticleId><ArticleId IdType="pii">1749-8090-9-60</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H. Shock Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation. 1995;9:873&#x2013;881. doi: 10.1161/01.CIR.91.3.873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.91.3.873</ArticleId><ArticleId IdType="pubmed">7828316</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayara W, Starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 2006;9:504&#x2013;509. doi: 10.1016/j.healun.2005.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2005.10.011</ArticleId><ArticleId IdType="pubmed">16678027</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YS, Chao A, Yu HY, Ko WJ, Wu IH, Chen RJ, Huang SC, Lin FY, Wang SS. Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation. J Am Coll Cardiol. 2003;9:197&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">12535808</ArticleId></ArticleIdList></Reference><Reference><Citation>Dembitsky WP, Moreno-Cabral RJ, Adamson RM, Daily PO. Emergency resuscitation using portable extracorporeal membrane oxygenation. Ann Thorac Surg. 1993;9:304&#x2013;309. doi: 10.1016/0003-4975(93)90542-P.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-4975(93)90542-P</ArticleId><ArticleId IdType="pubmed">8417705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. The fourth INTERMACS annual report: 4,000 implants and counting. J Heart Lung Transplant. 2012;9:117&#x2013;126. doi: 10.1016/j.healun.2011.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2011.12.001</ArticleId><ArticleId IdType="pubmed">22305376</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyagari RM, Rocchini AP, Remenapp RT, Graziano JN. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit. Crit Care Med. 2006;9:2603&#x2013;2606. doi: 10.1097/01.CCM.0000239113.02836.F1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000239113.02836.F1</ArticleId><ArticleId IdType="pubmed">16915115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato J, Seo T, Ando H, Takagi H, Ito T. Coronary arterial perfusion during venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg. 1996;9:630&#x2013;636. doi: 10.1016/S0022-5223(96)70315-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(96)70315-X</ArticleId><ArticleId IdType="pubmed">8601978</ArticleId></ArticleIdList></Reference><Reference><Citation>Secker-Walker JS, Edmonds JF, Spratt EH, Conn AW. The source of coronary perfusion during partial bypass for extracorporeal membrane oxygenation (ECMO) Ann Thorac Surg. 1976;9:138&#x2013;143. doi: 10.1016/S0003-4975(10)64277-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(10)64277-4</ArticleId><ArticleId IdType="pubmed">1267911</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg AA, Kinsella JP. Effect of extracorporeal membrane oxygenation on cerebral hemodynamics in newborn lambs. Crit Care Med. 1992;9:1575&#x2013;1581.</Citation><ArticleIdList><ArticleId IdType="pubmed">1424702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SR1, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;9:91&#x2013;96. doi: 10.1016/j.jcin.2008.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2008.11.005</ArticleId><ArticleId IdType="pubmed">19463408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, Myers TJ, Gregoric ID, Delgado RM 3rd. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006;9:111&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1524679</ArticleId><ArticleId IdType="pubmed">16878609</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the american college of cardiology foundation/american heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. 2011;9(124):e574&#x2013;e651.</Citation><ArticleIdList><ArticleId IdType="pubmed">22064601</ArticleId></ArticleIdList></Reference><Reference><Citation>Buz S, Jurmann MJ, Gutsch E, Jurmann B, Koster AA, Hetzer R. Portable mechanical circulatory support: human experience with the LIFEBRIDGE system. Ann Thorac Surg. 2011;9:1591&#x2013;1595. doi: 10.1016/j.athoracsur.2010.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2010.12.018</ArticleId><ArticleId IdType="pubmed">21524467</ArticleId></ArticleIdList></Reference><Reference><Citation>Leontiadis E, Koertke H, Bairaktaris A, Koerfer R. Thrombosis of the ascending aorta during mechanical circulatory support in a patient with cardiogenic shock. Interact Cardiovasc Thorac Surg. 2010;9:510&#x2013;511. doi: 10.1510/icvts.2010.240689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2010.240689</ArticleId><ArticleId IdType="pubmed">20656800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gander JW, Fisher JC, Reichstein AR, Gross ER, Aspelund G, Middlesworth W, Stolar CJ. Limb ischemia after common femoral artery cannulation for venoarterial extracorporeal membrane oxygenation: an unresolved problem. J Pediatr Surg. 2010;9:2136&#x2013;2140. doi: 10.1016/j.jpedsurg.2010.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpedsurg.2010.07.005</ArticleId><ArticleId IdType="pmc">PMC4297677</ArticleId><ArticleId IdType="pubmed">21034934</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisdas T, Beutel G, Warnecke G, Hoeper MM, Kuehn C, Haverich A, Teebken OE. Vascular complications in patients undergoing femoral cannulation for extracorporeal membrane oxygenation support. Ann Thorac Surg. 2011;9:626&#x2013;631. doi: 10.1016/j.athoracsur.2011.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2011.02.018</ArticleId><ArticleId IdType="pubmed">21550582</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley PJ, Morris RJ, Woo EY, Acker MA, Wang GJ, Fairman RM, Jackson BM. Limb ischemia during femoral cannulation for cardiopulmonary support. J Vasc Surg. 2010;9:850&#x2013;853. doi: 10.1016/j.jvs.2010.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2010.05.012</ArticleId><ArticleId IdType="pubmed">20615644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, Ulisney K, Young JB. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant. 2008;9:1065&#x2013;1072. doi: 10.1016/j.healun.2008.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2008.07.021</ArticleId><ArticleId IdType="pubmed">18926395</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed W, Esmailian F, Hernandez Conte A. Con: the total artificial heart-is It an appropriate replacement to existing biventricular assist devices? J Cardiothorac Vasc Anesth. 2013. doi:10.1053/j.jvca.2013.07.005. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">24200493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritschi AJ, Laumen M, Spiliopoulos S, Finocchiaro T, Egger C, Schmitz-Rode T, Tenderich G, Koerfer R, Steinseifer U. Image based evaluation of mediastinal constraints for the development of a pulsatile total artificial heart. Biomed Eng Online. 2013;9:81. doi: 10.1186/1475-925X-12-81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-925X-12-81</ArticleId><ArticleId IdType="pmc">PMC3751639</ArticleId><ArticleId IdType="pubmed">23941400</ArticleId></ArticleIdList></Reference><Reference><Citation>Emin A, Rogers CA, Parameshwar J, Macgowan G, Taylor R, Yonan N, Simon A, Tsui S, Schueler S, Banner NR, Forum UV. Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail. 2013;9:1185&#x2013;1193. doi: 10.1093/eurjhf/hft127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hft127</ArticleId><ArticleId IdType="pubmed">23901056</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia Saez D, Zych B, Mohite PN, Simon AR. Transplantation of lungs after ex vivo reconditioning in a patient on semi-elective long-term veno-arterial extracorporeal life support. Eur J Cardiothorac Surg. 2014;9:389&#x2013;90. doi: 10.1093/ejcts/ezt294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt294</ArticleId><ArticleId IdType="pubmed">23729751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabashnikov A, Mohite PN, Simon AR, Popov AF. HeartWare miniaturized intrapericardial ventricular assist device: advantages and adverse events in comparison to contemporary devices. Expert Rev Med Devices. 2013;9:441&#x2013;452. doi: 10.1586/17434440.2013.811851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17434440.2013.811851</ArticleId><ArticleId IdType="pubmed">23895071</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohite PN, Popov AF, Sabashnikov A, Simon AR. HeartWare ventricular assist device experience in the real world. Eur J Cardiothorac Surg. 2014;9:765. doi: 10.1093/ejcts/ezt365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezt365</ArticleId><ArticleId IdType="pubmed">23925130</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohite PN, Zych B, Banner NR, Simon AR. Refractory heart failure dependent on short-term mechanical circulatory support: what next? heart transplant or long-term ventricular assist device. Artif Organs. 2013. doi:10.1111/aor.12157. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pubmed">23981114</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmonik C, Partovi S, Schmack B, Weymann A, Loebe M, Noon GP, Piontek P, Karck M, Lumsden AB, Ruhparwar A. Comparison of hemodynamics in the ascending aorta between pulsatile and continuous flow left ventricular assist devices using computational fluid dynamics based on computed tomography images. Artif Organs. 2014;9:142&#x2013;8. doi: 10.1111/aor.12132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.12132</ArticleId><ArticleId IdType="pubmed">23889366</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmonik C, Partovi S, Loebe M, Schmack B, Ghodsizad A, Robbin MR, Noon GP, Kallenbach K, Karck M, Davies MG, Lumsden AB, Ruhparwar A. Influence of LVAD cannula outflow tract location on hemodynamics in the ascending aorta: a patient-specific computational fluid dynamics approach. ASAIO J. 2012;9:562&#x2013;567. doi: 10.1097/MAT.0b013e31826d6232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0b013e31826d6232</ArticleId><ArticleId IdType="pubmed">23013842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghodsizad A, Kar BJ, Layolka P, Okur A, Gonzales J, Bara C, Ungerer MN, Karck M, Gregoric ID, Ruhparwar A. Less invasive off-pump implantation of axial flow pumps in chronic ischemic heart failure: survival effects. J Heart Lung Transplant. 2011;9:834&#x2013;837. doi: 10.1016/j.healun.2011.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2011.03.012</ArticleId><ArticleId IdType="pubmed">21530315</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabashnikov A, Patil NP, Mohite PN, Garc&#xed;a S&#xe1;ez D, Zych B, Popov AF, Weymann A, Wahlers T, De Robertis F, Bahrami T, Amrani M, Simon AR. Influence of donor smoking on midterm outcomes after lung transplantation. Ann Thorac Surg. 2014;9:1015&#x2013;21. doi: 10.1016/j.athoracsur.2013.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.11.020</ArticleId><ArticleId IdType="pubmed">24462412</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36681561</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Temporary ventricular assist device support with a catheter-based axial pump: Changing the paradigm at a pediatric heart center.</ArticleTitle><Pagination><StartPage>1756</StartPage><EndPage>1763.e2</EndPage><MedlinePgn>1756-1763.e2</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2022.11.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(22)01353-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We report the largest pediatric single-center experience with an Impella (Abiomed Inc) catheter-based axial pump support.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective cohort study of all patients with acute decompensated heart failure or cardiogenic shock requiring catheter-based axial pump support between October 2014 and February 2022. The primary outcome per individual encounter (hospital admission) was defined as bridge-to-recovery, bridge-to-durable ventricular assist device support, bridge-to-cardiac transplantation, or death at 6&#xa0;months after catheter-based axial pump explantation. Adverse events were defined according to the Pediatric Interagency Registry for Mechanical Circulatory Support criteria.</AbstractText><AbstractText Label="RESULTS">Our final study cohort included 37 encounters with 43 catheter-based axial pump implantations. A single catheter-based axial pump device was used for support in 33 encounters (89%), with 2 catheter-based axial pump devices used in 3 (8%) separate encounters and 3 catheter-based axial pump devices used in 1 (3%) encounter. The median [range] age, weight, and body surface area at implantation were 16.8 [6.9-42.8] years, 61.1 [23.1-123.8] kg, and 1.7 [0.8-2.5] m<sup>2</sup>, respectively. The predominant causes of circulatory failure were graft failure/rejection in 16 patients (43%), followed by cardiomyopathy in 7 patients (19%), arrhythmia refractory to medical therapies in 6 patients (16%), myocarditis/endocarditis in 4 patients (11%), and heart failure due to congenital heart disease in 4 patients (11%). Competing outcomes analysis showed a positive outcome with bridge-to-recovery in 58%, bridge-to-durable VAD support in 14%, and bridge-to-cardiac transplantation in 14% at 6&#xa0;months. Fourteen percent of encounters resulted in death at 6&#xa0;months.</AbstractText><AbstractText Label="CONCLUSIONS">We demonstrate that catheter-based axial pump support in children results in excellent 1- and 6-month survival with an acceptable adverse event profile.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tume</LastName><ForeName>Sebastian C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex. Electronic address: sctume@texaschildrens.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuentes-Baldemar</LastName><ForeName>Andres A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Division of Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anders</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinner</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tunuguntla</LastName><ForeName>Hari</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imamura</LastName><ForeName>Michiaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razavi</LastName><ForeName>Asma</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickey</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stapleton</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Athar M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex; The Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adachi</LastName><ForeName>Iki</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Congenital Heart Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Tex.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thorac Cardiovasc Surg. 2023 Dec;166(6):1764-1765. doi: 10.1016/j.jtcvs.2022.12.015.</RefSource><PMID Version="1">36610883</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016027" MajorTopicYN="Y">Heart Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057785" MajorTopicYN="N">Catheters</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute decompensated heart failure</Keyword><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">catheter-based axial pump</Keyword><Keyword MajorTopicYN="N">mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">outcomes</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>22</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36681561</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2022.11.039</ArticleId><ArticleId IdType="pii">S0022-5223(22)01353-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40276546</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Percutaneous atrial septostomy for left ventricular unloading in patients on peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>100542</StartPage><MedlinePgn>100542</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100542</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2025.100542</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">This study systematically reviewed the safety and efficacy of atrial septostomy as a left ventricular (LV) unloading intervention in paediatric and adult patients undergoing peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The PubMed, Cochrane, and Google Scholar online databases were searched, and studies describing patients who received VA-ECMO for refractory cardiogenic shock and underwent atrial septostomy for LV unloading were included. Laboratory experiments, animal studies, and patients who received ECMO with a method other than atrial septostomy for LV unloading were excluded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">From the 12 studies analysed, data were collected on 197 patients, including 97 (49&#xa0;%) males and 75 (38&#xa0;%) females (data unavailable for 25 patients) with ages ranging from 3.65&#xa0;days to 70&#xa0;years. VA-ECMO duration was 1.71 to 40&#xa0;days (<i>P</i>&#xa0;&lt;&#xa0;0.001). Weaning from VA-ECMO with LV discharge was achieved successfully in 126 (64&#xa0;%) patients, with 60 (30.5&#xa0;%) in recovery (<i>P</i>&#xa0;=&#xa0;0.006) and 66 (33.5&#xa0;%) converted to a ventricular assistant device or transplantation. Additionally, 54 (27.4&#xa0;%) patients experienced unsuccessful weaning. During atrial septostomy for LV unloading, 14 (7.1&#xa0;%) patients experienced complications, whereas 180 (91.4&#xa0;%) did not (<i>P</i>&#xa0;=&#xa0;0.250). After LV unloading in patients receiving VA-ECMO, 60 (30.5&#xa0;%) experienced early mortality (<i>P</i>&#xa0;=&#xa0;0.286).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">VA-ECMO-assisted percutaneous atrial septostomy is a viable, safe, and successful alternative for LV unloading in both children and adults with refractory cardiogenic shock. However, further studies with larger sample sizes are required to comprehensively assess the morbidity and mortality associated with this approach.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AlGhamdi</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Division, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Surgery Division, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Sorbonne University, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Surgery, H&#xf4;pitaux Universitaires de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saiydoun</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Division, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Sorbonne University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreton</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiac Surgery Division, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Sorbonne University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzucotelli</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, H&#xf4;pitaux Universitaires de Strasbourg, Nouvel H&#xf4;pital Civil, Strasbourg, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial septostomy</Keyword><Keyword MajorTopicYN="N">Cardiac assist device implantation</Keyword><Keyword MajorTopicYN="N">Left ventricular decompression</Keyword><Keyword MajorTopicYN="N">Left ventricular unloading</Keyword><Keyword MajorTopicYN="N">Peripheral venoarterial extracorporeal membrane oxygenation</Keyword><Keyword MajorTopicYN="N">Refractory cardiogenic shock</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40276546</ArticleId><ArticleId IdType="pmc">PMC12019464</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2025.100542</ArticleId><ArticleId IdType="pii">S2666-6022(25)00045-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amancherla K., Menachem J.N., Shah A.S., et al. Limited balloon atrial septostomy for left ventricular unloading in peripheral extracorporeal membrane oxygenation. J. Card. Fail. 2021;27:501&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">33358956</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker W.F., Chung K., Anderson A.S., et al. Practice changes at U.S. transplant centers after the new adult heart allocation policy. J. Am. Coll. Cardiol. 2020;75:2906&#x2013;2916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304520</ArticleId><ArticleId IdType="pubmed">32527399</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanff T.C., Harhay M.O., Kimmel S.E., et al. Trends in mechanical support use as a bridge to adult heart transplant under new allocation rules. JAMA Cardiol. 2020;5:728&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7160744</ArticleId><ArticleId IdType="pubmed">32293645</ArticleId></ArticleIdList></Reference><Reference><Citation>Bednarczyk J.M., White C.W., Ducas R.A., et al. Resuscitative extracorporeal membrane oxygenation for in hospital cardiac arrest: a Canadian observational experience. Resuscitation. 2014;85:1713&#x2013;1719.</Citation><ArticleIdList><ArticleId IdType="pubmed">25449345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rupprecht L., Fl&#xf6;rchinger B., Schopka S., et al. Cardiac decompression on extracorporeal life support: a review and discussion of the literature. ASAIO J. 2013;59:547&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">24172259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A., Landoni G., Biondi-Zoccai G., et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit. Care Resusc. 2013;15:172&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">23944202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostadal P., Mlcek M., Kruger A., et al. Increasing venoarterial extracorporeal membrane oxygenation flow negatively affects left ventricular performance in a porcine model of cardiogenic shock. J. Transl. Med. 2015;13:266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537539</ArticleId><ArticleId IdType="pubmed">26275717</ArticleId></ArticleIdList></Reference><Reference><Citation>Banfi C., Pozzi M., Brunner M.E., et al. Veno-arterial extracorporeal membrane oxygenation: an overview of different cannulation techniques. J. Thorac. Dis. 2016;8(9):E875&#x2013;E885. doi: 10.21037/jtd.2016.09.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.09.25</ArticleId><ArticleId IdType="pmc">PMC5059274</ArticleId><ArticleId IdType="pubmed">27747024</ArticleId></ArticleIdList></Reference><Reference><Citation>Meani P., Gelsomino S., Natour E., et al. Modalities and effects of left ventricle unloading on extracorporeal life support: a review of the current literature. Eur. J. Heart Fail. 2017;19(Supplement 2):84&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28470925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cevasco M., Takayama H., Ando M., Garan A.R., Naka Y., Takeda K., et al. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. J. Thorac. Dis. 2019;11:1676&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6531683</ArticleId><ArticleId IdType="pubmed">31179113</ArticleId></ArticleIdList></Reference><Reference><Citation>Aissaoui N., Guerot E., Combes A., et al. Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support. J. Am. Soc. Echocardiogr. 2012;25:632&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">22421027</ArticleId></ArticleIdList></Reference><Reference><Citation>Soleimani B., Pae W.E. Management of left ventricular distension during peripheral extracorporeal membrane oxygenation for cardiogenic shock. Perfusion. 2012;27:326&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">22473862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima D., Gojo S., Nishimura T., et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation. ASAIO J. 2011;57:169&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">21317769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.N., Chen Y.H., Wang H.J., et al. Atrial septostomy for left atrial decompression during extracorporeal membrane oxygenation by Inoue balloon catheter. Circ. J. 2017;81:1419&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pubmed">28496031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y., Chetan D., Rodrigues W., et al. Left atrial decompression during venoarterial extracorporeal membrane oxygenation for left ventricular failure in children: current strategy and clinical outcomes. Artif. Organs. 2013;37:29&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">23020884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng R., Hachamovitch R., Makkar R., et al. Lack of survival benefit found with use of intraaortic balloon pump in extracorporeal membrane oxygenation: a pooled experience of 1517 patients. J. Invasive Cardiol. 2015;27:453&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">26208379</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A., Swartz M.F., Massey H.T. Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation. ASAIO J. 2013;59:533&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pubmed">23995997</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayer G.T., Baker J.N., Parks K.A. Heart rescue: the role of mechanical circulatory support in the management of severe refractory cardiogenic shock. Curr. Opin. Crit. Care. 2012;18:409&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">22895213</ArticleId></ArticleIdList></Reference><Reference><Citation>Weymann A., Schmack B., Sabashnikov A., et al. Central extracorporeal life support with left ventricular decompression for the treatment of refractory cardiogenic shock and lung failure. J. Cardiothorac. Surg. 2014;9:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974212</ArticleId><ArticleId IdType="pubmed">24678718</ArticleId></ArticleIdList></Reference><Reference><Citation>Avalli L., Maggioni E., Sangalli F., et al. Percutaneous left-heart decompression during extracorporeal membrane oxygenation: an alternative to surgical and transeptal venting in adult patients. ASAIO J. 2011;57:38&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21048495</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig P.R., Ralston M.A., Kimball T.R., et al. Balloon atrial septostomy for left ventricular decompression in patients receiving extracorporeal membrane oxygenation for myocardial failure. J. Pediatr. 1993;122:S95&#x2013;S99.</Citation><ArticleIdList><ArticleId IdType="pubmed">8501556</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M., Oshima Y., Matsuhisa H., et al. Left atrial decompression by minithoracotomy during extracorporeal life support. Ann. Thorac. Surg. 2019;107:e227&#x2013;e228.</Citation><ArticleIdList><ArticleId IdType="pubmed">30278170</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston T.A., Jaggers J., McGovern J.J., et al. Bedside transseptal balloon dilation atrial septostomy for decompression of the left heart during extracorporeal membrane oxygenation. Catheter. Cardiovasc. Interv. 1999;46:197&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">10348543</ArticleId></ArticleIdList></Reference><Reference><Citation>Seib P.M., Faulkner S.C., Erickson C.C., et al. Blade and balloon atrial septostomy for left heart decompression in patients with severe ventricular dysfunction on extracorporeal membrane oxygenation. Catheter. Cardiovasc. Interv. 1999;46:179&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">10348539</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastaugh L.J., Thiagarajan R.R., Darst J.R., et al. Percutaneous left atrial decompression in patients supported with extracorporeal membrane oxygenation for cardiac disease. Pediatr. Crit. Care Med. 2015;16:59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">25319629</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Byrne M.L., Glatz A.C., Rossano J.W., et al. Middle-term results of trans-catheter creation of atrial communication in patients receiving mechanical circulatory support. Catheter. Cardiovasc. Interv. 2015;85:1189&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441844</ArticleId><ArticleId IdType="pubmed">25573820</ArticleId></ArticleIdList></Reference><Reference><Citation>Baruteau A.E., Barnetche T., Morin L., et al. Percutaneous balloon atrial septostomy on top of venoarterial extracorporeal membrane oxygenation results in safe and effective left heart decompression. Eur. Heart J. Acute Cardiovasc. Care. 2018;7:70&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">27742755</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhussein M., Osten M., Horlick E., et al. Percutaneous left atrial decompression in adults with refractory cardiogenic shock supported with veno-arterial extracorporeal membrane oxygenation. J. Card. Surg. 2017;32:396&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">28497496</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Ghodsizad A., Brehm C., et al. Refractory pulmonary edema and upper body hypoxemia during veno-arterial extracorporeal membrane oxygenation-a case for atrial septostomy. Artif. Organs. 2018;42:664&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">29344963</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasde A.&#x130;., Sar&#x131;cao&#x11f;lu M.C., Dikmen Yaman N., et al. Comparison of left ventricular unloading strategies on venoarterial extracorporeal life support. Interact. Cardiovasc. Thorac. Surg. 2021;32:467&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906780</ArticleId><ArticleId IdType="pubmed">33249443</ArticleId></ArticleIdList></Reference><Reference><Citation>Meuwese C.L., de Haan M., Zwetsloot P.P., et al. The hemodynamic effect of different left ventricular unloading techniques during veno-arterial extracorporeal life support: a systematic review and meta-analysis. Perfusion. 2020;35:664&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pubmed">31948360</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X., Wang W., Liu J., et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 2014;14:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso R., Barili F., Mauro M.D., et al. In-hospital neurologic complications in adult patients undergoing venoarterial extracorporeal membrane oxygenation: results from the extracorporeal life support organization registry. Crit. Care Med. 2016;44:e964&#x2013;e972.</Citation><ArticleIdList><ArticleId IdType="pubmed">27340754</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo J.J., Aleksova N., Pitcher I., et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J. Am. Coll. Cardiol. 2019;73:654&#x2013;662.</Citation><ArticleIdList><ArticleId IdType="pubmed">30765031</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A.P., Spertus J.A., Curtis J.P., et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">31735078</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhruva S.S., Ross J.S., Mortazavi B.J., et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2020;323:734&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042879</ArticleId><ArticleId IdType="pubmed">32040163</ArticleId></ArticleIdList></Reference><Reference><Citation>Badiye A.P., Hernandez G.A., Novoa I., et al. Incidence of hemolysis in patients with cardiogenic shock treated with Impella percutaneous left ventricular assist device. ASAIO J. 2016;62:11&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">26418208</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappalardo F., Schulte C., Pieri M., et al. Concomitant implantation of Impella&#xae; on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur. J. Heart Fail. 2017;19:404&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">27709750</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrage B., Ibrahim K., Loehn T., et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139:1249&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">30586755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A.R., Park H., Lee S.E., et al. Outcomes of left ventricular unloading with a transseptal cannula during extracorporeal membrane oxygenation in adults. Artif. Organs. 2021;45:390&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">33001468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32984204</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation.</ArticleTitle><Pagination><StartPage>488</StartPage><MedlinePgn>488</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">488</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.00488</ELocationID><Abstract><AbstractText><b>Aim:</b> To analyze the factors associated with in-hospital mortality of children with acute fulminant myocarditis on venoarterial extracorporeal membrane oxygenation (VA-ECMO). <b>Methods:</b> This was a retrospective cohort study using chart reviews of patients diagnosed with acute fulminant myocarditis at the pediatric intensive care unit of two tertiary medical centers between January 1, 2005 and December 31, 2017. The inclusion criteria for this study were: (1) age from 1 month to 18 years; (2) diagnosed with acute myocarditis; (3) cardiogenic shock and need vasoactive-inotropic score &#x2265;20 within 48 h after the use of vasoactive-inotropic agents; and (4) the need for ECMO placement. <b>Results:</b> Thirty-three children with acute fulminant myocarditis who needed ECMO were included. Clinical parameters were retrospectively reviewed. The overall survival rate was 69.6%. Higher levels of pre-ECMO troponin-I and pre-ECMO lactate, and lower post-ECMO left ventricular ejection fraction (LVEF) were significantly associated with in-hospital mortality in univariate analysis. Only higher pre-ECMO lactate and lower post-ECMO LVEF remained as predictors for in-hospital mortality in multivariate analysis. The areas under the curve of pre-ECMO lactate and post-ECMO LVEF in predicting survival were 0.848 (95% CI, 0.697-0.999, <i>p</i> = 0.002) and 0.824 (95% CI, 0.704-0.996, <i>p</i> = 0.01), respectively. A pre-ECMO lactate level of 79.8 mg/dL and post-ECMO LVEF of 39% were appropriate cutoff points to predict mortality. <b>Conclusion:</b> Pre-ECMO lactate level was associated with mortality in children with acute fulminant myocarditis, with an optimal cutoff value of 79.8 mg/dL. After VA-ECMO implantation, post-ECMO LVEF was associated with mortality, with an optimal cutoff value of 39%. The use of LVADs or urgent heart transplantation should be considered if the post-ECMO LVEF does not improve.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Lee, Chu, Huang, Hsia, Chan, Lin, Su, Chang, Chung, Wu and Lin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>En-Pei</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, and Pediatric Sepsis Study Group, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Sheng-Chih</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Cardiovascular Internal Medicine, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Defense Medical Center, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Wun-Yan</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Pediatric Emergency Medicine, China Medical University Children Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Children's Hospital, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsia</LastName><ForeName>Shao-Hsuan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, and Pediatric Sepsis Study Group, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Oi-Wa</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, and Pediatric Sepsis Study Group, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chia-Ying</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, and Pediatric Sepsis Study Group, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Ya-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yu-Sheng</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiovascular Surgery, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Hung-Tao</ForeName><Initials>HT</Initials><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Cardiovascular Internal Medicine, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Han-Ping</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Pediatric Emergency Medicine, China Medical University Children Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, Children's Hospital, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jainn-Jim</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, and Pediatric Sepsis Study Group, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VA-ECMO</Keyword><Keyword MajorTopicYN="N">acute fulminant myocarditis</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">predictors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>28</Day><Hour>5</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32984204</ArticleId><ArticleId IdType="pmc">PMC7481354</ArticleId><ArticleId IdType="doi">10.3389/fped.2020.00488</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. . Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. (1996) 93:841&#x2013;2. 10.1161/01.CIR.93.5.841</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.93.5.841</ArticleId><ArticleId IdType="pubmed">8598070</ArticleId></ArticleIdList></Reference><Reference><Citation>Arola A, Pikkarainen E, Sipil&#xe4; JO, Pyk&#xe4;ri J, Rautava P, Kyt&#xf6; V. Occurrence and features of childhood myocarditis: a nationwide study in Finland. J Am Heart Assoc. (2017) 6:11. 10.1161/JAHA.116.005306</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.005306</ArticleId><ArticleId IdType="pmc">PMC5721735</ArticleId><ArticleId IdType="pubmed">29151030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MH, Wu ET, Wang CC, Lu F, Chen HC, Kao FY, et al. . Contemporary postnatal incidence of acquiring acute myocarditis by age 15 years and the outcomes from a nationwide birth cohort. Pediatr Crit Care Med. (2017) 18:1153. 10.1097/PCC.0000000000001363</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001363</ArticleId><ArticleId IdType="pubmed">29068909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghelani SJ, Spaeder MC, Pastor W, Spurney CF, Klugman D. Demographics, trends, and outcomes in pediatric acute myocarditis in the United States, 2006 to 2011. Circ Cardiovasc Qual Outcomes. (2012) 5:622. 10.1161/CIRCOUTCOMES.112.965749</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.112.965749</ArticleId><ArticleId IdType="pubmed">22828827</ArticleId></ArticleIdList></Reference><Reference><Citation>Butts RJ, Boyle GJ, Deshpande SR, Gambetta K, Knecht KR, Prada-Ruiz CA, et al. . Characteristics of clinically diagnosed pediatric myocarditis in a contemporary multi-center cohort. Pediatr Cardiol. (2017) 38:1175. 10.1007/s00246-017-1638-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-017-1638-1</ArticleId><ArticleId IdType="pubmed">28536746</ArticleId></ArticleIdList></Reference><Reference><Citation>Durani Y, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med. (2009) 27:942&#x2013;7. 10.1016/j.ajem.2008.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2008.07.032</ArticleId><ArticleId IdType="pubmed">19857412</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber MA, Ashworth MT, Risdon RA, Malone M, Burch M, Sebire NJ. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child. (2008) 93:594. 10.1136/adc.2007.128686</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2007.128686</ArticleId><ArticleId IdType="pubmed">18263694</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. (2004) 180:110. 10.5694/j.1326-5377.2004.tb05830.x</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/j.1326-5377.2004.tb05830.x</ArticleId><ArticleId IdType="pubmed">14748671</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasten-Almqvist P, Eksborg S, Rajs J. Myocarditis and sudden infant death syndrome. APMIS. (2002) 110:469. 10.1034/j.1600-0463.2002.100605.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2002.100605.x</ArticleId><ArticleId IdType="pubmed">12193208</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu C, Rambaud C, Cheron G, Rouzioux C, Lozinski GM, Rao A, et al. . Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. Pediatr Infect Dis J. (1995) 14:584. 10.1097/00006454-199507000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-199507000-00006</ArticleId><ArticleId IdType="pubmed">7567286</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettmeyer R, Baasner A, Schlamann M, Haag C, Madea B. Coxsackie B3 myocarditis in 4 cases of suspected sudden infant death syndrome: diagnosis by immunohistochemical and molecular-pathologic investigations. Pathol Res Pract. (2002) 198:689. 10.1078/0344-0338-00322</Citation><ArticleIdList><ArticleId IdType="doi">10.1078/0344-0338-00322</ArticleId><ArticleId IdType="pubmed">12498225</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg. (2001) 122:440&#x2013;8. 10.1067/mtc.2001.115243</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mtc.2001.115243</ArticleId><ArticleId IdType="pubmed">11547292</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmot I, Morales DL, Price JF, Rossano JW, Kim JJ, Decker JA, et al. . Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail. (2011) 17:487&#x2013;94. 10.1016/j.cardfail.2011.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2011.02.008</ArticleId><ArticleId IdType="pubmed">21624737</ArticleId></ArticleIdList></Reference><Reference><Citation>Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, Jr, et al. . Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. (1987) 1:3&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">3455232</ArticleId></ArticleIdList></Reference><Reference><Citation>Canter CE, Simpson KE. Diagnosis and treatment of myocarditis in children in the current era. Circulation. (2014) 129:115&#x2013;28. 10.1161/CIRCULATIONAHA.113.001372</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.001372</ArticleId><ArticleId IdType="pubmed">24396015</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez F, K&#xfc;hl U, Pieske B, Garcia-Pavia P, Tsch&#xf6;pe C. Update on myocarditis and inflammatory cardiomyopathy: reemergence of endomyocardial biopsy. Rev Esp Cardiol. (2016) 69:178&#x2013;87. 10.1016/j.rec.2015.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2015.10.015</ArticleId><ArticleId IdType="pubmed">26795929</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, et al. . Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med. (2014) 15:529&#x2013;37. 10.1097/PCC.0000000000000153</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000153</ArticleId><ArticleId IdType="pmc">PMC4159673</ArticleId><ArticleId IdType="pubmed">24777300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong SZ, Fang CY, Fang HY, Chen HC, Chen CJ, Yang CH, et al. Associations with the in-hospital survival following extracorporeal membrane oxygenation in adult acute fulminant myocarditis. J Clin Med. (2018) 20:7 10.3390/jcm7110452</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7110452</ArticleId><ArticleId IdType="pmc">PMC6262600</ArticleId><ArticleId IdType="pubmed">30463365</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopal S.K, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med. (2010) 38:382.e7. 10.1097/CCM.0b013e3181bc8293</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181bc8293</ArticleId><ArticleId IdType="pmc">PMC4273495</ArticleId><ArticleId IdType="pubmed">19789437</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiss N, El-Banayosy A, Arusoglu L, Blanz U, Bairaktaris A, Koerfer R. Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist. ASAIOJ. (2006) 52:211e4. 10.1097/01.mat.0000178049.13589.31</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mat.0000178049.13589.31</ArticleId><ArticleId IdType="pubmed">16557111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and long term mortality of the clinical subtypes of myocarditis. Jpn Circ J. (2001) 65:961&#x2013;64. 10.1253/jcj.65.961</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/jcj.65.961</ArticleId><ArticleId IdType="pubmed">11716247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning B, Zhang C, Lin R, Tan L1, Chen Z1, Yu J1, et al. . Local experience with extracorporeal membrane oxygenation in children with acute fulminant myocarditis. PLoS One. (2013) 8:e82258. 10.1371/journal.pone.0082258</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082258</ArticleId><ArticleId IdType="pmc">PMC3857228</ArticleId><ArticleId IdType="pubmed">24349238</ArticleId></ArticleIdList></Reference><Reference><Citation>Catena E, Paino R, Milazzo F, Colombo T, Marianeschi S, Lanfranconi M, et al. . Mechanical circulatory support for patients with fulminant myocarditis: the role of echocardiography to address diagnosis, choice of device, management, and recovery. J Cardiothorac Vasc Anesth. (2009) 23:87&#x2013;94. 10.1053/j.jvca.2008.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2008.03.008</ArticleId><ArticleId IdType="pubmed">18834846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT, Jr. Myocarditis. Lancet. (2012) 379:738&#x2013;47. 10.1016/S0140-6736(11)60648-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Brighenti M, Donti A, Giulia Gagliardi M, Maschietto N, Marini D, Lombardi M, et al. . Endomyocardial biopsy safety and clinical yield in pediatric myocarditis: an Italian perspective. Catheter Cardiovasc Interv. (2016) 87:762&#x2013;67. 10.1002/ccd.26319</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26319</ArticleId><ArticleId IdType="pubmed">26510399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pophal SG, Sigfusson G, Booth KL. Complications of endomyocardial biopsy in children. J Am Coll Cardiol. (1999) 34:2105. 10.1016/S0735-1097(99)00452-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(99)00452-0</ArticleId><ArticleId IdType="pubmed">10588231</ArticleId></ArticleIdList></Reference><Reference><Citation>Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, et al. . National Australian childhood cardiomyopathy study. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. (2006) 114:2671&#x2013;8. 10.1161/CIRCULATIONAHA.106.635128</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.106.635128</ArticleId><ArticleId IdType="pubmed">17116768</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson K, Storch GA, Lee CK, Cunningham M, Ward K, Tong A, et al. Blood viral PCR frequently identifies cardiotropic viruses in pediatric patients with clinical myocarditis or recent onset dilated cardiomyopathy at time of presentation [abstract]. J Am Coll Cardiol. (2013) 61:A312 10.1016/S0735-1097(13)61264-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(13)61264-4</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32946639</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-0528</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>BJOG : an international journal of obstetrics and gynaecology</Title><ISOAbbreviation>BJOG</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular severe maternal morbidity in pregnant and postpartum women: development and internal validation of risk prediction models.</ArticleTitle><Pagination><StartPage>922</StartPage><EndPage>932</EndPage><MedlinePgn>922-932</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/1471-0528.16512</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To develop and internally validate risk prediction models identifying women at risk for cardiovascular severe maternal morbidity (CSMM).</AbstractText><AbstractText Label="DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="SETTING">An obstetric teaching hospital between 2007 and 2017.</AbstractText><AbstractText Label="POPULATION">A total of 89&#xa0;681 delivery hospitalisations.</AbstractText><AbstractText Label="METHODS">We created and evaluated two models, one predicting CSMM at delivery (delivery model) and the other predicting CSMM postpartum following discharge from delivery hospitalisation (postpartum CSMM). We assessed model discrimination and calibration and used bootstrapping for internal validation.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Cardiovascular severe maternal morbidity comprised the following confirmed conditions: pulmonary oedema/acute heart failure, myocardial infarction, aneurysm, cardiac arrest/ventricular fibrillation, heart failure/arrest during surgery or procedure, cerebrovascular disorders, cardiogenic shock, conversion of cardiac rhythm and difficult-to-control severe hypertension.</AbstractText><AbstractText Label="RESULTS">The delivery model contained 11 variables and 3 interaction terms. The strongest predictors were gestational hypertension, chronic hypertension, multiple gestation, cardiac lesions or valvular heart disease, maternal age &#x2265;40&#xa0;years and history of poor pregnancy outcome. The postpartum model comprised eight variables. The strongest predictors were severe pre-eclampsia, non-Hispanic Black race/ethnicity, chronic hypertension, gestational hypertension, non-severe pre-eclampsia and maternal age &#x2265;40&#xa0;years at delivery. The delivery and postpartum models had an area under the receiver operating characteristic curve of 0.87 (95% CI 0.85-0.89) and 0.85 (95% CI 0.80-0.90), respectively. Both models were adequately calibrated and performed well on internal validation.</AbstractText><AbstractText Label="CONCLUSIONS">These tools may help providers to identify women at highest risk of CSMM and enable future prevention measures.</AbstractText><AbstractText Label="TWEETABLE ABSTRACT">Risk assessment tools for cardiovascular severe maternal morbidity were developed and internally validated.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malham&#xe9;</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Women and Infants Hospital, Warren Alpert School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danilack</LastName><ForeName>V A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women &amp; Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raker</LastName><ForeName>C A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women &amp; Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>E J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Women and Infants Hospital, Warren Alpert School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women &amp; Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spalding</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Women and Infants Hospital, Warren Alpert School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouvier</LastName><ForeName>B A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Women and Infants Hospital, Warren Alpert School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hurlburt</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Brigham and Women's Cardiovascular Associates of Care New England, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrees</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women &amp; Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savitz</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Women &amp; Infants Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Women and Infants Hospital, Warren Alpert School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Rhode Island Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Women &amp;amp; Infants Hospital of Rhode Island Constance A. Howes Innovation Research Fund Award</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BJOG</MedlineTA><NlmUniqueID>100935741</NlmUniqueID><ISSNLinking>1470-0328</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BJOG. 2021 Apr;128(5):933-934. doi: 10.1111/1471-0528.16580.</RefSource><PMID Version="1">33089919</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081415" MajorTopicYN="Y">Clinical Decision Rules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011249" MajorTopicYN="N">Pregnancy Complications, Cardiovascular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular</Keyword><Keyword MajorTopicYN="N">maternal mortality</Keyword><Keyword MajorTopicYN="N">maternal near miss</Keyword><Keyword MajorTopicYN="N">pre-eclampsia</Keyword><Keyword MajorTopicYN="N">severe maternal morbidity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32946639</ArticleId><ArticleId IdType="doi">10.1111/1471-0528.16512</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>CDC. Pregnancy Mortality Surveillance System [cited 2020 September 8]. Available from: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm</Citation></Reference><Reference><Citation>Marian Knight KB, Tuffnell D, Shakespeare J, Rohit Kotnis SK, Kurinczuk JJ (Eds.). Saving Lives, Improving Mothers' Care 2019 [cited 2020 September 8]. Available from: https://www.npeu.ox.ac.uk/downloads/files/mbrrace-uk/reports/MBRRACE-UK%20Maternal%20Report%202019%20-%20WEB%20VERSION.pdf</Citation></Reference><Reference><Citation>Lisonkova S, Liu S, Bartholomew S, Liston RM, Joseph KS. Temporal trends in maternal mortality in Canada II: estimates based on hospitalization data. J Obstet Gynaecol Can 2011;33:1020-30.</Citation></Reference><Reference><Citation>Schutte JM, Steegers EA, Schuitemaker NW, Santema JG, de Boer K, Pel M, et al. Rise in maternal mortality in the Netherlands. BJOG 2010;117:399-406.</Citation></Reference><Reference><Citation>Chou D, Tun&#xe7;alp &#xd6;, Firoz T, Barreix M, Filippi V, von Dadelszen P, et al. Constructing maternal morbidity - towards a standard tool to measure and monitor maternal health beyond mortality. BMC Pregnancy Childbirth 2016;16:45.</Citation></Reference><Reference><Citation>Kilpatrick SK, Ecker JL. Severe maternal morbidity: screening and review. Am J Obstet Gynecol 2016;215:B17-22.</Citation></Reference><Reference><Citation>Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012;120:1029-36.</Citation></Reference><Reference><Citation>Moussa HN, Rajapreyar I. ACOG practice bulletin no. 212: pregnancy and heart disease. Obstet Gynecol 2019;134:881-2.</Citation></Reference><Reference><Citation>Briller J, Koch AR, Geller SE. Maternal Cardiovascular Mortality in Illinois, 2002-2011. Obstet Gynecol 2017;129:819-26.</Citation></Reference><Reference><Citation>Bourjeily G, Danilack VA, Bublitz MH, Lipkind H, Muri J, Caldwell D, et al. Obstructive sleep apnea in pregnancy is associated with adverse maternal outcomes: a national cohort. Sleep Med 2017;38:50-7.</Citation></Reference><Reference><Citation>CDC. Severe Maternal Morbidity in the United States [cited 2020 September 8]. Available from: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/severematernalmorbidity.html#anchor_trends</Citation></Reference><Reference><Citation>Magee LA, von Dadelszen P, Singer J, Lee T, Rey E, Ross S, et al. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure? Hypertension 1979;68:1153-9.</Citation></Reference><Reference><Citation>von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011;377:219-27.</Citation></Reference><Reference><Citation>Judy AE, McCain CL, Lawton ES, Morton CH, Main EK, Druzin ML. Systolic Hypertension, Preeclampsia-Related Mortality, and Stroke in California. Obstet Gynecol 2019;133:1151-9.</Citation></Reference><Reference><Citation>Kilpatrick SJ, Abreo A, Greene N, Melsop K, Peterson N, Shields LE, et al. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension. Am J Obstet Gynecol 2016;215:91.e1-e7.</Citation></Reference><Reference><Citation>Malham&#xe9; I, Mehta N, Raker CA, Hardy EJ, Spalding H, Bouvier BA, et al. Identifying cardiovascular severe maternal morbidity in epidemiologic studies. Paediatr Perinat Epidemiol 2020;34:452-9.</Citation></Reference><Reference><Citation>Jones CP. Invited commentary: "race," racism, and the practice of epidemiology. Am J Epidemiol 2001;154:299-304. discussion 5-6.</Citation></Reference><Reference><Citation>Boyd RW, Lindo EG, Weeks LD, McLemore MR. On Racism: A New Standard For Publishing On Racial Health Inequities 2020 [cited 2020 July 7]. Available from: https://www.healthaffairs.org/do/10.1377/hblog20200630.939347/full/?utm_medium=social&amp;utm_source=twitter&amp;utm_campaign=blog&amp;utm_content=Boyd&amp;</Citation></Reference><Reference><Citation>Lazariu V, Nguyen T, McNutt LA, Jeffrey J, Kacica M. Severe maternal morbidity: A population-based study of an expanded measure and associated factors. PLoS One 2017;12:e0182343.</Citation></Reference><Reference><Citation>Pigott TD. A review of methods for missing data. Educ Res Eval 2001;7:353-83.</Citation></Reference><Reference><Citation>Payne B, Hodgson S, Hutcheon JA, Joseph KS, Li J, Lee T, et al. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission. BJOG 2013;120:113-8.</Citation></Reference><Reference><Citation>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.</Citation></Reference><Reference><Citation>Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, et al. A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study. PLoS Medicine 2014;11:e1001589.</Citation></Reference><Reference><Citation>Firth D. Bias reduction of maximum likelihood estimates. Biometrika 1993;80:27-38.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.</Citation></Reference><Reference><Citation>Harris, PA, Taylor, R, Minor, BL, Elliott, V, Fernandez, M, O'Neal, L, McLeod, L, Delacqua, F, Kirby, J, Duda, SN, &amp; REDCap Consortium. The REDCap consortium: Building an international community of software partners. J Biomed Inform 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.</Citation></Reference><Reference><Citation>Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015;162:W1-73.</Citation></Reference><Reference><Citation>Drenthen W, Boersma E, Balci A, Moons P, Roos-Hesselink JW, Mulder BJM, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010;31:2124-32.</Citation></Reference><Reference><Citation>Silversides CK, Grewal J, Mason J, Sermer M, Kiess M, Rychel V, et al. Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study. J Am Coll Cardiol 2018;71:2419-30.</Citation></Reference><Reference><Citation>Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165-241.</Citation></Reference><Reference><Citation>Salemi JL, Hansen MA, Modak S, Matas JL, Germanos GJ, Raza SA, et al. Estimating the obstetric co-morbidity burden using administrative data: The impact of the pregnancy-related assessment window. Paediatr Perinat Epidemiol 2020;34:440-51.</Citation></Reference><Reference><Citation>Johnson JD, Louis JM. Does race or ethnicity play a role in the origin, pathophysiology, and outcomes of preeclampsia? An expert review of the literature. Am J Obstet Gynecol. 2020. https://doi.org/10.1016/j.ajog.2020.07.038.</Citation></Reference><Reference><Citation>Rossi RM, Hall E, Dufendach K, DeFranco EA. Predictive model of factors associated with maternal intensive care unit admission. Obstet Gynecol 2019;134:216-24.</Citation></Reference><Reference><Citation>Easter SR, Bateman BT, Sweeney VH, Manganaro K, Lassey SC, Gagne JJ, et al. A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery. Am J Obstet Gynecol 2019;221:271.e1-.e10.</Citation></Reference><Reference><Citation>Grobman WA, Bailit JL, Rice MM, Wapner RJ, Reddy UM, Varner MW, et al. Frequency of and factors associated with severe maternal morbidity. Obstet Gynecol 2014;123:804-10.</Citation></Reference><Reference><Citation>Kilpatrick SJ, Menard MK, Zahn CM, Callaghan WM. obstetric care consensus #9: levels of maternal care: (Replaces Obstetric Care Consensus Number 2, February 2015). Am J Obstet Gynecol 2019;221:B19-b30.</Citation></Reference><Reference><Citation>Hankins GD, Clark SL, Pacheco LD, O'Keeffe D, D'Alton M, Saade GR. Maternal mortality, near misses, and severe morbidity: lowering rates through designated levels of maternity care. Obstet Gynecol 2012;120:929-34.</Citation></Reference><Reference><Citation>Ackerman CM, Platner MH, Spatz ES, Illuzzi JL, Xu X, Campbell KH, et al. Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization. Am J Obstet Gynecol 2019;220:582.e1-e11.</Citation></Reference><Reference><Citation>Brousseau EC, Danilack V, Cai F, Matteson K. Emergency department visits for postpartum hypertension. Hypertens Pregnancy 2017;36:212-6.</Citation></Reference><Reference><Citation>Clapp MA, Little SE, Zheng J, Robinson JN. A multi-state analysis of postpartum readmissions in the United States. Am J Obstet Gynecol 2016;215:113.e1-.e10.</Citation></Reference><Reference><Citation>Hirshberg A, Levine LD, Srinivas SK. Clinical factors associated with readmission for postpartum hypertension in women with pregnancy-related hypertension: a nested case control study. J Perinatol 2016;36:405-9.</Citation></Reference><Reference><Citation>Jarvie JL, Metz TD, Davis MB, Ehrig JC, Kao DP. Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy. Heart 2018;104:1187-94.</Citation></Reference><Reference><Citation>Mogos MF, Piano MR, McFarlin BL, Salemi JL, Liese KL, Briller JE. Heart Failure in Pregnant Women: A Concern Across the Pregnancy Continuum. Circ Heart Fail 2018;11:e004005.</Citation></Reference><Reference><Citation>Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015;36:1090-7.</Citation></Reference><Reference><Citation>Too G, Wen T, Boehme AK, Miller EC, Leffert LR, Attenello FJ, et al. Timing and Risk Factors of Postpartum Stroke. Obstet Gynecol 2018;131:70-8.</Citation></Reference><Reference><Citation>Miller EC, Gatollari HJ, Too G, Boehme AK, Leffert L, Elkind MS, et al. Risk of pregnancy-associated stroke across age groups in New York State. JAMA Neurology 2016;73:1461-7.</Citation></Reference><Reference><Citation>Miller EC, Zambrano Espinoza MD, Huang Y, Friedman AM, Boehme AK, Bello NA, et al. Maternal Race/Ethnicity, Hypertension, and Risk for Stroke During Delivery Admission. J Am Heart Assoc 2020;9:e014775.</Citation></Reference><Reference><Citation>Bryant AS, Worjoloh A, Caughey AB, Washington AE. Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants. Am J Obstet Gynecol 2010;202:335-43.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">31885693</PMID><DateRevised><Year>2020</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1792-0981</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>Effects of cardiopulmonary bypass on the development of lymphopenia and sepsis after cardiac surgery in children with congenital cardiopathy.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>442</EndPage><MedlinePgn>435-442</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2019.8241</ELocationID><Abstract><AbstractText>The objective of the present study was to investigate whether lymphopenia occurring after heart surgery with cardiopulmonary bypass (CPB) is related to apoptosis and or sepsis in children. The design was a prospective cohort study in a third level care hospital in Mexico City. In total, 68 children (31 girls and 37 boys) with congenital cardiopathy who needed corrective cardiac surgery with or without CPB were included. The samples were obtained from central blood before, immediately after and 24 h after surgery. Complete blood counts and lymphocyte apoptosis were analyzed. Systemic inflammatory response syndrome (SIRS), sepsis and the type of microorganism were recorded. A total of 53 patients received CPB and 15 did not. Lymphocyte count decreased after surgery in both groups (P&lt;0.001). However, neutrophil count increased markedly in both groups. Apoptosis of B (CD19<sup>+</sup>) lymphocytes was higher in the non-CPB group (14, 2 and 21% before, immediately after and 24 h after surgery, respectively) than the CPB group (0, 2 and 3%, respectively), but apoptosis of cytotoxic T lymphocytes (CD8<sup>+</sup>) was higher in the CPB group (5, 4 and 3% before, immediately after and 24 h after surgery, respectively) than in the non-CPB group (2, 3 and 2%, respectively). However, the extent of apoptosis of T and B lymphocytes after surgery did not differ between groups. The CPB group had more complications than the non-CPB group [38 (71.7%) vs. 9 (60.0%)]. In conclusion, the decrease in lymphocyte count may be related to apoptosis of cytotoxic T lymphocytes in children receiving cardiac surgery with CPB and to apoptosis of B lymphocytes in those not receiving CPB. The decreased lymphocyte counts in both groups suggested that CPB is not the main cause of this decrease. Children who received CPB during surgery had more complications, such as sepsis and cardiogenic shock than did those who did not receive CPB.</AbstractText><CopyrightInformation>Copyright: &#xa9; Jim&#xe9;nez-Aguilar et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jim&#xe9;nez-Aguilar</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Terapia Intensiva, Unidad M&#xe9;dica de Alta Especialidad, Hospital General Gaudencio Gonz&#xe1;lez de la Garza, Centro M&#xe9;dico Nacional 'La Raza', IMSS, Mexico City C.P. 02990, M&#xe9;xico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Morfolog&#xed;a, Laboratorio de Bacteriolog&#xed;a, Escuela Nacional de Ciencias Biol&#xf3;gicas, Instituto Polit&#xe9;cnico Nacional, Mexico City C.P. 11350, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Zauco</LastName><ForeName>Norma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Auxiliares de Diagn&#xf3;stico y Tratamiento UMAE, Hospital de Especialidades, Centro M&#xe9;dico Nacional-Siglo XXI, IMSS, Mexico City C.P. 06725, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiburcio-Felix</LastName><ForeName>Reynaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Departamento de Gen&#xe9;tica y Biolog&#xed;a Molecular, Centro de Investigaci&#xf3;n y de Estudios Avanzados del Instituto Polit&#xe9;cnico Nacional, Mexico City C.P. 07240, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Jorge Zavala</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Departamento de Circulaci&#xf3;n Extracorporea, Hospital de Pediatr&#xed;a del Centro M&#xe9;dico Nacional SXXI, Mexico City C.P. 06725, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solano-Guti&#xe9;rrez</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a Cardiovascular, Hospital de Cardiolog&#xed;a del Centro M&#xe9;dico Nacional Siglo XXI, IMSS, Unidad M&#xe9;dica de Alta Especialidad, Mexico City C.P. 06725, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riera</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Circulaci&#xf3;n Extracorporea, Hospital de Pediatr&#xed;a del Centro M&#xe9;dico Nacional SXXI, Mexico City C.P. 06725, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Maldonado</LastName><ForeName>Elba</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departamento de Morfolog&#xed;a, Laboratorio de Bacteriolog&#xed;a, Escuela Nacional de Ciencias Biol&#xf3;gicas, Instituto Polit&#xe9;cnico Nacional, Mexico City C.P. 11350, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado-Bernal</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n en Inmunolog&#xed;a y Prote&#xf3;mica, Hospital Infantil de M&#xe9;xico Federico G&#xf3;mez, Mexico City C.P. 06171, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apoptosis</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">cardiopulmonary derivation</Keyword><Keyword MajorTopicYN="N">child cardiac surgery</Keyword><Keyword MajorTopicYN="N">lymphopenia</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>31</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31885693</ArticleId><ArticleId IdType="pmc">PMC6913339</ArticleId><ArticleId IdType="doi">10.3892/etm.2019.8241</ArticleId><ArticleId IdType="pii">ETM-0-0-8241</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Instituto Nacional de Estad&#xed;stica y Geograf&#xed;a (INEGI). Webpage. http://www.inegi.org.mx/  [Jul 12;2018 ];</Citation></Reference><Reference><Citation>Shi SS, Shi CC, Zhao ZY, Shen HQ, Fang XM, Tan LH, Zhang XH, Shi Z, Lin R, Shu Q. Effect of open heart surgery with cardiopulmonary bypass on peripheral blood lymphocyte apoptosis in children. Pediatr Cardiol. 2009;30:153&#x2013;159. doi: 10.1007/s00246-008-9302-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-008-9302-4</ArticleId><ArticleId IdType="pubmed">18726644</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology. 2002;97:215&#x2013;252. doi: 10.1097/00000542-200207000-00030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200207000-00030</ArticleId><ArticleId IdType="pubmed">12131125</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark J, Gallivan S, Lovegrove J, Hamilton JR, Monro JL, Pollock JC, Watterson KG. Mortality rates after surgery for congenital heart defects in children and surgeons' performance. Lancet. 2000;355:1004&#x2013;1007. doi: 10.1016/S0140-6736(00)90001-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)90001-1</ArticleId><ArticleId IdType="pubmed">10768449</ArticleId></ArticleIdList></Reference><Reference><Citation>Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation. J Thorac Cardiovasc Surg. 1993;105:15&#x2013;24. doi: 10.1016/S0022-5223(19)33842-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)33842-5</ArticleId><ArticleId IdType="pubmed">8419695</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisatomi K, Isomura T, Kawara T, Yamashita M, Hirano A, Yoshida H, Eriguchi N, Kosuga K, Ohishi K. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg. 1989;98:580&#x2013;591. doi: 10.1016/S0022-5223(19)34361-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-5223(19)34361-2</ArticleId><ArticleId IdType="pubmed">2796364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chello M, Mastroroberto P, Quirino A, Cuda G, Perticone F, Cirillo F, Covino E. Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg. 2002;73:123&#x2013;130. doi: 10.1016/S0003-4975(01)03055-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(01)03055-7</ArticleId><ArticleId IdType="pubmed">11833998</ArticleId></ArticleIdList></Reference><Reference><Citation>Habermehl P, Knuf M, Kampmann C, Mannhardt W, Schranz D, Kuroczynski W, Wippermann CF, Zepp F. Changes in lymphocyte subsets after cardiac surgery in children. Eur J Pediatr. 2003;162:15&#x2013;21. doi: 10.1007/s00431-001-0892-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-001-0892-6</ArticleId><ArticleId IdType="pubmed">12486502</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol. 2005;78:325&#x2013;337. doi: 10.1189/jlb.0105017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0105017</ArticleId><ArticleId IdType="pubmed">15817707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ, Karl IE. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol. 1999;162:4148&#x2013;4156.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201940</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T, Cohen J, International Sepsis Forum Definition of Infection in the ICU Consensus Conference The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33:1538&#x2013;1548. doi: 10.1097/01.CCM.0000168253.91200.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000168253.91200.83</ArticleId><ArticleId IdType="pubmed">16003060</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2&#x2013;8. doi: 10.1097/01.PCC.0000149131.72248.E6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000149131.72248.E6</ArticleId><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo G, Romics L, Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002;6:1045&#x2013;1066. doi: 10.1016/S1089-3261(02)00058-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1089-3261(02)00058-2</ArticleId><ArticleId IdType="pubmed">12516206</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1&#x2013;14. doi: 10.1093/intimm/dxh186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxh186</ArticleId><ArticleId IdType="pubmed">15585605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi ME. DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol. 2007;81:1&#x2013;5. doi: 10.1189/jlb.0306164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0306164</ArticleId><ArticleId IdType="pubmed">17032697</ArticleId></ArticleIdList></Reference><Reference><Citation>Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85&#x2013;94. doi: 10.1016/S0898-6568(00)00149-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0898-6568(00)00149-2</ArticleId><ArticleId IdType="pubmed">11257452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M, Rikihisa Y. Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factors PU.1 and inhibits lipopolysaccharide activation of NF-kappaB, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol. 2004;6:175&#x2013;186. doi: 10.1046/j.1462-5822.2003.00355.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1462-5822.2003.00355.x</ArticleId><ArticleId IdType="pubmed">14706103</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal SM. The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol. 2007;297:365&#x2013;377. doi: 10.1016/j.ijmm.2007.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmm.2007.03.006</ArticleId><ArticleId IdType="pubmed">17452016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien E, Ingalls RR. Toll-like receptors. Crit Care Med. 2002;30(Suppl 1):S1&#x2013;S11. doi: 10.1097/00003246-200201001-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200201001-00001</ArticleId><ArticleId IdType="pubmed">11839939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JE, J&#xf8;rgensen PF, Alml&#xf6;f M, Thiemermann C, Foster SJ, Aasen AO, Solberg R. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000;68:3965&#x2013;3970. doi: 10.1128/IAI.68.7.3965-3970.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.68.7.3965-3970.2000</ArticleId><ArticleId IdType="pmc">PMC101674</ArticleId><ArticleId IdType="pubmed">10858210</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe5;lsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology. 2004;113:153&#x2013;162. doi: 10.1111/j.1365-2567.2004.01976.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2004.01976.x</ArticleId><ArticleId IdType="pmc">PMC1782563</ArticleId><ArticleId IdType="pubmed">15379975</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimaoka M, Park EJ. Advances in understanding sepsis. Eur J Anaesthesiol Suppl. 2008;42:146&#x2013;153. doi: 10.1017/S0265021507003389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0265021507003389</ArticleId><ArticleId IdType="pmc">PMC2490719</ArticleId><ArticleId IdType="pubmed">18289433</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigand MA, H&#xf6;rner C, Bardenheuer HJ, Bouchon A. The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol. 2004;18:455&#x2013;475. doi: 10.1016/j.bpa.2003.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2003.12.005</ArticleId><ArticleId IdType="pubmed">15212339</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Price R, Phiroz D, Swan K, Crane TA. Systemic inflammatory response during cardiopulmonary bypass and strategies. J Extra Corpor Technol. 2005;37:180&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">16117456</ArticleId></ArticleIdList></Reference><Reference><Citation>Day JR, Taylor KM. The systemic inflammatory response syndrome and cardiopulmonary bypass. Int J Surg. 2005;3:129&#x2013;140. doi: 10.1016/j.ijsu.2005.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2005.04.002</ArticleId><ArticleId IdType="pubmed">17462274</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009;69:479&#x2013;491. doi: 10.1111/j.1365-3083.2009.02255.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2009.02255.x</ArticleId><ArticleId IdType="pubmed">19439008</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldemir M, Baki ED, Adali F, &#xc7;ar&#x15f;anba G, Tecer E, Ta&#x15f; HU. Comparison of neutrophil:lymphocyte ratios following coronary artery bypass surgery with or without cardiopulmonary bypass. Cardiovasc J Afr. 2015;26:159&#x2013;164. doi: 10.5830/CVJA-2015-015.</Citation><ArticleIdList><ArticleId IdType="doi">10.5830/CVJA-2015-015</ArticleId><ArticleId IdType="pmc">PMC4683287</ArticleId><ArticleId IdType="pubmed">25903477</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh H, Ichiba S, Ujike Y, Douguchi T, Kasahara S, Arai S, Sano S. A prospective randomized trial comparing the clinical effectiveness and biocompatibility of heparin-coated circuits and PMEA-coated circuits in pediatric cardiopulmonary bypass. Perfusion. 2016;31:247&#x2013;254. doi: 10.1177/0267659115598217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659115598217</ArticleId><ArticleId IdType="pubmed">26228276</ArticleId></ArticleIdList></Reference><Reference><Citation>Khabar KS, elBarbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: Differential correlation with duration of bypass and systemic inflammatory response/multiple organ dysfunction syndromes. Clin Immunol Immunopathol. 1997;85:97&#x2013;103. doi: 10.1006/clin.1997.4413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1997.4413</ArticleId><ArticleId IdType="pubmed">9325075</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller BE, Levy JH. The inflammatory response to cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:355&#x2013;366. doi: 10.1016/S1053-0770(97)90106-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1053-0770(97)90106-3</ArticleId><ArticleId IdType="pubmed">9161905</ArticleId></ArticleIdList></Reference><Reference><Citation>Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577&#x2013;R595.</Citation><ArticleIdList><ArticleId IdType="pubmed">9530222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill GE. Cardiopulmonary bypass-induced inflammation: Is it important? J Cardiothorac Vasc Anesth. 1998;12(2 Suppl 1):S21&#x2013;S25.</Citation><ArticleIdList><ArticleId IdType="pubmed">9583572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23339839</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-7632</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Circulation. Cardiovascular interventions</Title><ISOAbbreviation>Circ Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Transcatheter closure of post-myocardial infarction ventricular septal rupture.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>67</EndPage><MedlinePgn>59-67</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCINTERVENTIONS.112.972711</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Ventricular septal rupture (VSR) after acute myocardial infarction (AMI) is a potentially lethal mechanical complication of acute coronary syndromes. Given high surgical mortality, transcatheter closure has emerged as a potential strategy in selected cases. We report our single-center experience with double-umbrella device percutaneous closure of post-AMI VSR.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">In this single-center, retrospective, cohort study, patients who underwent transcatheter closure of post-AMI VSR between 1988 and 2008 at Boston Children's Hospital were included. Data were analysed according to whether the patients underwent direct percutaneous VSR closure or closure of a residual VSR after a previous surgical approach. Primary outcome was mortality rate at 30 days. Clinical predictors of primary outcome were investigated using univariate logistic regression. Thirty patients were included in the study (mean age, 67&#xb1;8 years). A total of 40 closure devices were implanted. Major periprocedural complications occurred in 4 (13%) patients. Cardiogenic shock, increasing pulmonary/systemic flow ratio, and the use of the new generation (6-arm) STARFlex device all were associated with higher risk of mortality. The Model for End-Stage Liver Disease Excluding international normalized ratio (MELD-XI) score at the time of VSR closure seemed to be most strongly associated with death (odds ratio, 1.6; confidence interval, 1.1-2.2; P&lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Transcatheter closure of post-AMI VSR using CardioSEAL or STARFlex devices is feasible and effective. The MELD-XI score, a marker of multiorgan dysfunction, is a promising risk stratifier in this population of patients. Early closure of post-AMI VSR is advisable before establishment of multiorgan failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Assenza</LastName><ForeName>Gabriele Egidy</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115. USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McElhinney</LastName><ForeName>Doff B</ForeName><Initials>DB</Initials></Author><Author ValidYN="Y"><LastName>Valente</LastName><ForeName>Anne Marie</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Pearson</LastName><ForeName>Disty D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Volpe</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Martucci</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Landzberg</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Lock</LastName><ForeName>James E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Cardiovasc Interv</MedlineTA><NlmUniqueID>101499602</NlmUniqueID><ISSNLinking>1941-7640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018658" MajorTopicYN="N">Ventricular Septal Rupture</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23339839</ArticleId><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.112.972711</ArticleId><ArticleId IdType="pii">CIRCINTERVENTIONS.112.972711</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24014392</PMID><DateCompleted><Year>2014</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial.</ArticleTitle><Pagination><StartPage>176</StartPage><EndPage>183</EndPage><MedlinePgn>176-83</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/eht346</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aim of this study was to evaluate whether remote ischaemic preconditioning (RIPC) combined with remote ischaemic postconditioning (RIPostC) improves the clinical outcomes of patients undergoing cardiac surgery.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">From June 2009 to November 2010, 1280 patients who underwent elective cardiac surgery were randomized into the RIPC with RIPostC group or the control group in the morning of the surgery. In the RIPC with RIPostC group, four cycles of 5-min ischaemia and 5-min reperfusion were administered twice to the upper limb-before cardiopulmonary bypass (CPB) or coronary anastomoses for RIPC and after CPB or coronary anastomoses for RIPostC. The primary endpoint was the composite of major adverse outcomes, including death, myocardial infarction, arrhythmia, stroke, coma, renal failure or dysfunction, respiratory failure, cardiogenic shock, gastrointestinal complication, and multiorgan failure. Remote ischaemic preconditioning with RIPostC did not reduce the composite outcome compared with the control group (38.0 vs. 38.1%, respectively; P = 0.998) and there was no difference in each major adverse outcome. The intensive care unit and hospital stays were not different between the two groups. However, in the off-pump coronary artery bypass surgery subgroup, multivariate logistic regression analysis revealed that RIPC with RIPostC was related to increased composite outcome (odds ratio: 1.54; 95% confidence interval: 1.02-2.30; P = 0.038).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Remote ischaemic preconditioning with RIPostC by transient upper limb ischaemia did not improve clinical outcome in patients who underwent cardiac surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Deok Man</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Daehakro 101 Seoul 110-744, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eun-Ho</ForeName><Initials>EH</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyun Joo</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>Min</LastName><ForeName>Jeong Jin</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Chin</LastName><ForeName>Ji-Hyun</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Dae-Kee</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Bahk</LastName><ForeName>Jae-Hyon</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Ji-Yeon</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>In-Cheol</ForeName><Initials>IC</Initials></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Yunseok</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00997217</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Heart J. 2014 Jan;35(3):141-3. doi: 10.1093/eurheartj/eht517.</RefSource><PMID Version="1">24394382</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="N">Intraoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057775" MajorTopicYN="N">Ischemic Postconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019157" MajorTopicYN="N">Ischemic Preconditioning, Myocardial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Postconditioning</Keyword><Keyword MajorTopicYN="N">Preconditioning</Keyword><Keyword MajorTopicYN="N">Remote ischaemic preconditioning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24014392</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/eht346</ArticleId><ArticleId IdType="pii">eht346</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">27013747</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0019-5049</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2016</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Indian journal of anaesthesia</Title><ISOAbbreviation>Indian J Anaesth</ISOAbbreviation></Journal><ArticleTitle>A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery.</ArticleTitle><Pagination><StartPage>94</StartPage><EndPage>101</EndPage><MedlinePgn>94-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0019-5049.176279</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Tranexamic acid (TA) is used for prophylactic antifibrinolysis in coronary artery bypass surgeries to reduce bleeding. We evaluated the efficacy of two different doses of TA for prophylactic antifibrinolysis in patients undergoing primary coronary artery bypass grafting (CABG) surgery in this retrospective cohort study at a tertiary care referral centre.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">One-hundred eighty-four patients who underwent primary CABG with cardiopulmonary bypass (CPB) via sternotomy between January 2009 and June 2011 were evaluated. Pre-operative patient characteristics, intraoperative data, post-operative bleeding, transfusions, organ dysfunction and 30-day mortality were compared between high-dose TA (30 mg/kg loading dose followed by infusion of 15 mg/kg/h until the end of surgery along with 2 mg/kg priming dose in the bypass circuit) and low-dose TA (15 mg/kg loading dose followed by infusion of 6 mg/kg/h until the end of surgery along with 1 mg/kg priming dose in the bypass circuit) groups. Univariate comparative analysis of all categorical and continuous variables was performed between the two groups by appropriate statistical tests. Linear and logistic regression analyses were performed to control for the effect of confounding on the outcome variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Chest tube output, perioperative transfusion of blood products and incidence of re-exploration for bleeding did not differ significantly (P&gt; 0.05) between groups. Post-operative complications and 30-day mortality were comparable between the groups. The presence of cardiogenic shock and increased pre-operative creatinine were found to be associated with increased chest tube output on the post-operative day 2 by multivariable linear regression model.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Low-dose TA protocol is as effective as high-dose protocol for antifibrinolysis in patients undergoing primary CABG with CPB.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McHugh</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolarczyk</LastName><ForeName>Lavinia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of North Carolina at Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Children Hospital of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Lawrence M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jose</LastName><ForeName>Marquez</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramaniam</LastName><ForeName>Kathirvel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000005</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Anaesth</MedlineTA><NlmUniqueID>0013243</NlmUniqueID><ISSNLinking>0019-5049</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antifibrinolytic</Keyword><Keyword MajorTopicYN="N">bleeding</Keyword><Keyword MajorTopicYN="N">coronary artery bypass</Keyword><Keyword MajorTopicYN="N">tranexamic acid</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27013747</ArticleId><ArticleId IdType="pmc">PMC4787140</ArticleId><ArticleId IdType="doi">10.4103/0019-5049.176279</ArticleId><ArticleId IdType="pii">IJA-60-94</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">16607235</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81:1650&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16631651</ArticleId></ArticleIdList></Reference><Reference><Citation>Divatia J. Blood transfusion in anaesthesia and critical care: Less is more! Indian J Anaesth. 2014;58:511&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260294</ArticleId><ArticleId IdType="pubmed">25535410</ArticleId></ArticleIdList></Reference><Reference><Citation>Fergusson DA, H&#xe9;bert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">18480196</ArticleId></ArticleIdList></Reference><Reference><Citation>Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology. 1995;82:383&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">7856897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012;93:148&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">22054656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure &#x2013; Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology. 1998;88:327&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">9477051</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgenor SD, DeFoe GR, Fillinger MP, Likosky DS, Groom RC, Clark C, et al. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation. 2006;114(1 Suppl):I43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16820613</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: A double-blind, randomized, placebo-controlled trial. Anesth Analg. 1997;85:963&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">9356085</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos AT, Kalil RA, Bauemann C, Pereira JB, Nesralla IA. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Braz J Med Biol Res. 2006;39:63&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16400465</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Wang G, Lv H, Yuan S, Wang Y, Ji H, et al. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: Randomized trial and 1-year follow-up. Ann Thorac Surg. 2013;95:795&#x2013;802.</Citation><ArticleIdList><ArticleId IdType="pubmed">22959576</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, Fergusson DA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;1:CD001886.</Citation><ArticleIdList><ArticleId IdType="pubmed">17943760</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldow T, Szlapka M, Haferkorn M, B&#xfc;rger L, Pl&#xf6;tze K, Matschke K. Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures. Clin Hemorheol Microcirc. 2013;55:457&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">24113504</ArticleId></ArticleIdList></Reference><Reference><Citation>Karski JM, Dowd NP, Joiner R, Carroll J, Peniston C, Bailey K, et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 degrees C) J Cardiothorac Vasc Anesth. 1998;12:642&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9854660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) 1980;14:41&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347104</ArticleId><ArticleId IdType="pubmed">7000846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigaut S, Tremey B, Ouattara A, Couturier R, Taberlet C, Grassin-Delyle S, et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology. 2014;120:590&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">23903022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowd NP, Karski JM, Cheng DC, Carroll JA, Lin Y, James RL, et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology. 2002;97:390&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12151929</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiechtner BK, Nuttall GA, Johnson ME, Dong Y, Sujirattanawimol N, Oliver WC, Jr, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg. 2001;92:1131&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11323334</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuttall GA, Gutierrez MC, Dewey JD, Johnson ME, Oyen LJ, Hanson AC, et al. A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:230&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18375325</ArticleId></ArticleIdList></Reference><Reference><Citation>Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg. 2010;110:350&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19996135</ArticleId></ArticleIdList></Reference><Reference><Citation>Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, et al. Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors. Can J Anaesth. 2012;59:6&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">22065333</ArticleId></ArticleIdList></Reference><Reference><Citation>Keyl C, Uhl R, Beyersdorf F, Stampf S, Lehane C, Wiesenack C, et al. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. Eur J Cardiothorac Surg. 2011;39:e114&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">21295991</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes FR, Pardo DF, Carre&#xf1;o M, Arciniegas C, Dennis RJ, Uma&#xf1;a JP. Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: A case-control study. Ann Card Anaesth. 2012;15:6&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">22234015</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstone AB, Bronster DJ, Anyanwu AC, Goldstein MA, Filsoufi F, Adams DH, et al. Predictors and outcomes of seizures after cardiac surgery: A multivariable analysis of 2,578 patients. Ann Thorac Surg. 2011;91:514&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21256303</ArticleId></ArticleIdList></Reference><Reference><Citation>Furtm&#xfc;ller R, Schlag MG, Berger M, Hopf R, Huck S, Sieghart W, et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther. 2002;301:168&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11907171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni K, Jafari A, Nobahar MR, Arami A. Polymyoclonus seizure resulting from accidental injection of tranexamic acid in spinal anesthesia. Anesth Analg. 2009;108:1984&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19448237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh HM, Lau HP, Lin PL, Sun WZ, Mok MS. Convulsions and refractory ventricular fibrillation after intrathecal injection of a massive dose of tranexamic acid. Anesthesiology. 2003;98:270&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">12503009</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg J, Pinnamaneni S, Aronow WS, Ahmad H. ST elevation myocardial infarction after tranexamic acid:First reported case in the United States. Am J Ther. 2014;21:e221&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">23782758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal AK, Missouris CG. Tranexamic acid and acute myocardial infarction. Br J Cardiol. 2005;12:306&#x2013;7.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16822925</PMID><DateCompleted><Year>2006</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1469-0756</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>969</Issue><PubDate><Year>2006</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Postgraduate medical journal</Title><ISOAbbreviation>Postgrad Med J</ISOAbbreviation></Journal><ArticleTitle>Delayed recognition of congenital heart disease.</ArticleTitle><Pagination><StartPage>468</StartPage><EndPage>470</EndPage><MedlinePgn>468-70</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this prospective study was to evaluate the proportion of children with delayed recognition of congenital heart disease (CHD).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Of the 744 children with CHD primarily diagnosed during a 10 year period in one hospital, the patients were identified where the diagnosis of CHD was established with a significant delay.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty six patients (8.9%) had delayed diagnosis of CHD. Among patients with cyanotic CHD, 10.4% (7 of 67 cases) were referred after they had initially been discharged home from the birth clinic. Among patients with acyanotic CHD, 8.7% (59 of 677) of all children and 35.1% (59 of 168) of the children who required surgery or interventional catheterisation were referred at an age where elective repair should have already been performed or needed immediate treatment because of their haemodynamic status. Of the 66 patients with delayed diagnosis, one infant with cor triatriatum died at admission because of delayed referral and 10 children had severe complications: preoperative cardiogenic shock in seven cases of aortic coarctation and one case of endocardial fibroelastosis, pulmonary hypertensive crisis in one child after delayed repair of a ventricular septal defect, and infectious endocarditis after dental care in a teenager with undiagnosed moderate aortic stenosis, who required Ross operation a few months later.</AbstractText><AbstractText Label="DISCUSSION AND CONCLUSION" NlmCategory="CONCLUSIONS">A substantial proportion of CHD was detected with relevant delay. In all cases of late diagnosis, clinical cardiac findings were present that should have alerted the physician on the possible presence of underlying CHD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Massin</LastName><ForeName>M M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Paediatric Cardiology, Queen Fabiola Children's University Hospital, Free University of Brussels, Belgium. martial.massin@chrcitadelle.be</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dessy</LastName><ForeName>H</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Postgrad Med J</MedlineTA><NlmUniqueID>0234135</NlmUniqueID><ISSNLinking>0032-5473</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006330" MajorTopicYN="N">Heart Defects, Congenital</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012017" MajorTopicYN="N">Referral and Consultation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest: none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>12</Month><Day>14</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>7</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16822925</ArticleId><ArticleId IdType="pmc">PMC2563766</ArticleId><ArticleId IdType="doi">10.1136/pgmj.2005.044495</ArticleId><ArticleId IdType="pii">82/969/468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hoffman J I E, Christianson R. Congenital heart disease in a cohort of 19502 births with long&#x2010;term follow&#x2010;up. Am J Cardiol 197842641&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">696646</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorn P, S&#xfc;tsch G, Jenni R. Echokardiographisch neu entdeckte kongenitale Vitien und Anomalien bei Adoleszenten und Erwachsenen. Schweiz Med Wochenschr 199012031&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">2251488</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu&#x2010;Harb M, Hey E, Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child 1994713&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1029901</ArticleId><ArticleId IdType="pubmed">8067789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfammatter J P, Stocker F P. Delayed recognition of haemodynamically relevant congenital heart disease. Eur J Pediatr 2001160231&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">11317645</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Z, Roguin N, Barak M. Clinical and echocardiographic evaluation of neonates with heart murmurs. Acta Paediatr 199786752&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">9240885</ArticleId></ArticleIdList></Reference><Reference><Citation>Meberg A, Otterstad J E, Froland G.et al Early clinical screening of neonates for congenital heart defects: the cases we miss. Cardiol Young 19999169&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">10323515</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J G, Bersh B S, McGoon M D. Long&#x2010;term outcome after surgical repair of isolated atrial septal defect. N Engl J Med 19903231645&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pubmed">2233961</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer R M, Erasmus M E, Ebels T.et al Influence of age on survival, late hypertension and recoarctation in elective aortic coarctation repair. J Thorac Cardiovasc Surg 1994108525&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">8078345</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeyns K, Massin M, Radermecker M.et al Early diagnosis of coarctation of the aorta in children: a challenge. Rev Med Liege 200055770&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">11051773</ArticleId></ArticleIdList></Reference><Reference><Citation>Silove , ed. Assessment and management of congenital heart in the newborn by the district paediatrician. Arch Dis Child 199470F71&#x2013;F74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1060995</ArticleId><ArticleId IdType="pubmed">8117134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehl K S, Loffrado C A, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics 1999103743&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">10103296</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15489105</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0735-1097</ISSN><JournalIssue CitedMedium="Print"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2004</Year><Month>Oct</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American College of Cardiology</Title><ISOAbbreviation>J Am Coll Cardiol</ISOAbbreviation></Journal><ArticleTitle>Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.</ArticleTitle><Pagination><StartPage>1690</StartPage><EndPage>1699</EndPage><MedlinePgn>1690-9</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The Transplantation of Progenitor Cells And Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI) trial investigates both safety, feasibility, and potential effects on parameters of myocardial function of intracoronary infusion of either circulating progenitor cells (CPC) or bone marrow-derived progenitor cells (BMC) in patients with acute myocardial infarction (AMI).</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In animal experiments, therapy with adult progenitor cells was shown to improve vascularization, left ventricular (LV) remodeling, and contractility after AMI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 59 patients with AMI were randomly assigned to receive either CPC (n = 30) or BMC (n = 29) into the infarct artery at 4.9 +/- 1.5 days after AMI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Intracoronary progenitor cell application did not incur any measurable ischemic myocardial damage, but one patient experienced distal embolization before cell therapy. During hospital follow-up, one patient in each cell group developed myocardial infarction; one of these patients died of cardiogenic shock. No further cardiovascular events, including ventricular arrhythmias or syncope, occurred during one-year follow-up. By quantitative LV angiography at four months, LV ejection fraction (EF) significantly increased (50 +/- 10% to 58 +/- 10%; p &lt; 0.001), and end-systolic volumes significantly decreased (54 +/- 19 ml to 44 +/- 20 ml; p &lt; 0.001), without differences between the two cell groups. Contrast-enhanced magnetic resonance imaging after one year revealed an increased EF (p &lt; 0.001), reduced infarct size (p &lt; 0.001), and absence of reactive hypertrophy, suggesting functional regeneration of the infarcted ventricles.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Intracoronary infusion of progenitor cells (either BMC or CPC) is safe and feasible in patients after AMI successfully revascularized by stent implantation. Both the excellent safety profile and the observed favorable effects on LV remodeling, provide the rationale for larger randomized double-blind trials.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sch&#xe4;chinger</LastName><ForeName>Volker</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Johann Wolfgang Goethe-University Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assmus</LastName><ForeName>Birgit</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Britten</LastName><ForeName>Martina B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Honold</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lehmann</LastName><ForeName>Ralf</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Teupe</LastName><ForeName>Claudius</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Abolmaali</LastName><ForeName>Nasreddin D</ForeName><Initials>ND</Initials></Author><Author ValidYN="Y"><LastName>Vogl</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Wolf-Karsten</ForeName><Initials>WK</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Hans</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Dimmeler</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zeiher</LastName><ForeName>Andreas M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Cardiol</MedlineTA><NlmUniqueID>8301365</NlmUniqueID><ISSNLinking>0735-1097</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016026" MajorTopicYN="Y">Bone Marrow Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003326" MajorTopicYN="N">Coronary Circulation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="N">Heart Ventricles</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018380" MajorTopicYN="Y">Hematopoietic Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009200" MajorTopicYN="N">Myocardial Contraction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012038" MajorTopicYN="N">Regeneration</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020257" MajorTopicYN="N">Ventricular Remodeling</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2004</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2004</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>10</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>12</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>10</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15489105</ArticleId><ArticleId IdType="doi">10.1016/j.jacc.2004.08.014</ArticleId><ArticleId IdType="pii">S0735-1097(04)01629-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">23074453</PMID><DateCompleted><Year>2012</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1915-7398</ISSN><JournalIssue CitedMedium="Print"><Volume>4</Volume><Issue>3</Issue><PubDate><Year>2004</Year></PubDate></JournalIssue><Title>Ontario health technology assessment series</Title><ISOAbbreviation>Ont Health Technol Assess Ser</ISOAbbreviation></Journal><ArticleTitle>Left ventricular assist devices: an evidence-based analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>69</EndPage><MedlinePgn>1-69</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of this health technology policy assessment was to determine the effectiveness and cost-effectiveness of using implantable ventricular assist devices in the treatment of end-stage heart failure.</AbstractText><AbstractText Label="HEART FAILURE" NlmCategory="UNASSIGNED">Heart failure is a complex syndrome that impairs the ability of the heart to maintain adequate blood circulation, resulting in multiorgan abnormalities and, eventually, death. In the period of 1994 to 1997, 38,702 individuals in Ontario had a first hospital admission for heart failure. Despite reported improvement in survival, the five-year mortality rate for heart failure is about 50%. For patients with end-stage heart failure that does not respond to medical therapy, surgical treatment or traditional circulatory assist devices, heart transplantation (in appropriate patients) is the only treatment that provides significant patient benefit. HEART TRANSPLANT IN ONTARIO: With a shortage in the supply of donor hearts, patients are waiting longer for a heart transplant and may die before a donor heart is available. From 1999 to 2003, 55 to 74 people received a heart transplant in Ontario each year. Another 12 to 21 people died while waiting for a suitable donor heart. Of these, 1 to 5 deaths occurred in people under 18 years old. The rate-limiting factor in heart transplant is the supply of donor hearts. Without an increase in available donor hearts, attempts at prolonging the life of some patients on the transplant wait list could have a harmful effect on other patients that are being pushed down the waiting list (knock on effect). LVAD TECHNOLOGY: Ventricular assist devices [VADs] have been developed to provide circulatory assistance to patients with end-stage heart failure. These are small pumps that usually assist the damaged left ventricle [LVADs] and may be situated within the body (intracorporeal] or outside the body [extracorporeal). Some of these devices were designed for use in the right ventricle [RVAD] or both ventricles (bi-ventricular). LVADs have been mainly used as a "bridge-to-transplant" for patients on a transplant waiting list. As well, they have been used as a "bridge-to-recovery" in acute heart failure, but this experience is limited. There has been an increasing interest in using LVAD as a permanent (destination) therapy. REVIEW OF LVAD BY THE MEDICAL ADVISORY SECRETARIAT: The Medical Advisory Secretariat's review included a descriptive synthesis of findings from five systematic reviews and 60 reports published between January 2000 and December 2003. Additional information was obtained through consultation and by searching the websites of Health Canada, the United Network of Organ Sharing, Organ Donation Ontario, and LVAD manufacturers.</AbstractText><AbstractText Label="SUMMARY OF FINDINGS" NlmCategory="RESULTS">SAFETY AND EFFECTIVENESS: Previous HTAs and current Level 3 evidence from prospective non-randomized controlled studies showed that when compared to optimal medical therapy, LVAD support significantly improved the pre-transplant survival rates of heart transplant candidates waiting for a suitable donor heart (71% for LVAD and 36% for medical therapy). Pre-transplant survival rates reported ranged from 58% to 90% (median 74%). Improved transplant rates were also reported for people who received pre-transplant LVAD support (e.g. 67% for LVAD vs 33% for medical therapy). Reported transplant rates for LVAD patients ranged from 39% to 90% (median 71%). Patient's age greater than 60 years and pre-existing conditions of respiratory failure associated with septicemia, ventilation, and right heart failure were independent risk factors for mortality after the LVAD implantation. LVAD support was shown to improve the New York Heart Association [NYHA)] functional classification and quality of life of patients waiting for heart transplant. LVAD also enabled approximately 41% - 49% of patients to be discharged from hospitals and wait for a heart transplant at home. However, over 50% of the discharged patients required re-hospitalization due to adverse events. Post-transplant survival rates for LVAD-bridged patients were similar to or better than the survival rates of patients bridged by medical therapy. LVAD support has been associated with serious adverse events, including infection (median 53%, range 6%-72%), bleeding (8.6%-48%, median 35%), thromboembolism (5%-37%), neurologic disorders (7%-28%), right ventricular failure (11%-26%), organ dysfunction (5%-50%) and hemolysis (6%-20%). Bleeding tends to occur in the first few post-implant days and is rare thereafter. It is fatal in 2%-7% of patients. Infection and thromboembolism occurred throughout the duration of the implant, though their frequency tended to diminish with time. Device malfunction has been identified as one of the major complications. Fatalities directly attributable to the devices were about 1% in short-term LVAD use. However, mechanical failure was the second most frequent cause of death in patients on prolonged LVAD support. Malfunctions were mainly associated with the external components, and often could be replaced by backed up components. LVAD has been used as a bridge-to-recovery in patients suffering from acute cardiogenic shock due to cardiomyopathy, myocarditis or cardiotomy. The survival rates were reported to be lower than in bridge-to-transplant (median 26%). Some of the bridge-to-recovery patients (14%-75%) required a heart transplant or remained on prolonged LVAD support. According to an expert in the field, experience with LVAD as a bridge-to-recovery technology has been more favourable in Germany than in North America, where it is not regarded as a major indication since evidence for its effectiveness in this setting is limited. LVAD has also been explored as a destination therapy. A small, randomized, controlled trial (level 2 evidence) showed that LVAD significantly increased the 1-year survival rate of patients with end-stage heart failure but were not eligible for a heart transplant (51% LVAD vs 25% for medical therapy). However, improved survival was associated with adverse events 2.35 times higher than medically treated patients and a higher hospital re-admission rate. The 2-year survival rate on LVAD decreased to 23%, although it was still significantly better compared to patients on medical therapy (8%). The leading causes of deaths were sepsis (41%) and device failure (17%). The FDA has given conditional approval for the permanent use of HeartMate SNAP VE LVAS in patients with end-stage heart failure who are not eligible for heart transplantation, although the long-term effect of this application is not known. In Canada, four LVAD systems have been licensed for bridge-to-transplant only. The use of LVAD support raises ethical issues because of the implications of potential explantation that could be perceived as a withdrawal of life support. POTENTIAL IMPACT ON THE TRANSPLANT WAITING LIST: With the shortage of donor hearts for adults, LVAD support probably would not increase the number of patients who receive a heart transplant. If LVAD supported candidates are prioritized for urgent heart transplant, there will be a knock on effect as other transplant candidates without LVAD support would be pushed down, resulting in longer wait, deterioration in health status and die before a suitable donor heart becomes available. Under the current policy for allocating donor hearts in Ontario, patients on LVAD support would be downgraded to Status 3 with a lower priority to receive a transplant. This would likely result in an expansion of the transplant waiting list with an increasing number of patients on prolonged LVAD support, which is not consistent with the indication of LVAD use approved by Health Canada. There is indication in the United Kingdom that LVAD support in conjunction with an urgent transplant listing in the pediatric population may decrease the number of deaths on the waiting list without a harmful knock-on effect on other transplant candidates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">LVAD support as a bridge-to-transplant has been shown to improve the survival rate, functional status and quality of life of patients on the heart transplant waiting list. However, due to the shortage of donor hearts and the current heart transplant algorithm, LVAD support for transplant candidates of all age groups would likely result in an expansion of the waiting list and prolonged use of LVAD with significant budget implications but without increasing the number of heart transplants. Limited level 4 evidence showed that LVAD support in children yielded survival rates comparable to those in the adult population. The introduction of LVAD in the pediatric population would be more cost-effective and might not have a negative effect on the transplant waiting list.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>Medical Advisory Secretariat</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2004</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Ont Health Technol Assess Ser</MedlineTA><NlmUniqueID>101521610</NlmUniqueID><ISSNLinking>1915-7398</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2004</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23074453</ArticleId><ArticleId IdType="pmc">PMC3387736</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cowie MR, Zaphiriou A. Management of chronic heart failure. BMJ. 2002;325:422&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1123941</ArticleId><ArticleId IdType="pubmed">12193359</ArticleId></ArticleIdList></Reference><Reference><Citation>Topol EJ. Textbook of Cardiovascular Medicine. Lippincott, Williams &amp; Wilkins, PA. Textbook of Cardiovascular Medicine, Williams &amp; Wilkins, PA. 2nd. 2002. 2002. 2004. Chapters 88-92.</Citation></Reference><Reference><Citation>Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 2002;347:1397&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">12409541</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessup M. Mechanical cardiac-support devices--dreams and devilish details. N. Engl. J. Med. 2001;345:1490&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794200</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor CD sP. Cardiovascular Health &amp; Services in Ontario-An ICES Atlas. Institute for Clinical Evaluative Sciences. 1999. 2004. p. 112. Chapter 6.</Citation></Reference><Reference><Citation>Keon WJ, Olsen DB. Mechanical circulatory support as a bridge to transplantation: past, present and future. Can. J. Cardiol. 1996;12:1017&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9191495</ArticleId></ArticleIdList></Reference><Reference><Citation>Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch. Intern. Med. 2002;162:1689&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">12153371</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyns B, Sergeant P, Herijgers P, Flameng W, Vanhaecke J, Van Cleemput J, et al. Bridging procedures to heart transplantation. World J. Surg. 2002;26:212&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11865351</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti JB. Biventricular pacing therapy for congestive heart failure: a review of the literature. Cardiol. Rev. 2001;9:217&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">11405902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese FA, Frota Filho JD, Blacher C, Pereira W, Lucio E, Beck L, et al. Partial left ventriculectomy: overall and late results in 44 class IV patients with 4-year follow-up. J. Card Surg. 2000;15:179&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">11414603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirshbom PM, Bridges ND, Myung RJ, Gaynor JW, Clark BJ, Spray TL. Use of extracorporeal membrane oxygenation in pediatric thoracic organ transplantation. J. Thorac. Cardiovasc. Surg. 2002;123:130&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999. J. Heart Lung Transplant. 1999;18:611&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">10452337</ArticleId></ArticleIdList></Reference><Reference><Citation>Implantable Ventricular Assist Devices: Should They be Used in Quebec? Agence d&#x2019;Evaluation des Technologies et des Modes d&#x2019;Intervention en Sant&#xe9; (AETMIS), corpauthor 2000. 2002.</Citation></Reference><Reference><Citation>Stahl MA, Richards NM. Ventricular assist devices: developing and maintaining a training and competency program. J. Cardiovasc. Nurs. 2002;16:34&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">11958442</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical technology assessment and health resources plan for ventricular assist devices, corpauthor. Oregon Health Resources Commission. 1998.</Citation></Reference><Reference><Citation>Jouveshomme S, Baffert S, Fay AF. Artificial heart (systematic review, expert panel) Comite d&#x2019;Evaluation et de Diffusion des Innovations Technologiques (CEDIT) (92.10):46. 1998.</Citation></Reference><Reference><Citation>Christopher F, Clegg A. Development and Evaluation Committee Report No. 103. Southampton: Wessex Institute for Health Research and Development; 1999. Sep, 1999. Left Ventricular assist devices (LVADs) for end stage heart failure.</Citation></Reference><Reference><Citation>Evaluation de l&#x2019;assistance ventriculaire en attente ou en alternative a la transplantation cardiaque, corpauthor. Aence Nationale d&#x2019;Accreditation et d&#x2019;Evaluation en Sant&#xe9; (ANAES) Apr, 2001.</Citation></Reference><Reference><Citation>Frazier OH, Rose EA, McCarthy P, Burton NA, Tector A, Levin H, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann. Surg. 1995;222:327&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1234813</ArticleId><ArticleId IdType="pubmed">7677462</ArticleId></ArticleIdList></Reference><Reference><Citation>Frazier OH, Rose EA, Oz MC, Dembitsky W, McCarthy P, Radovancevic B, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. Journal of Thoracic &amp; Cardiovascular Surgery. 2001;122:1186&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">11726895</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter Healthcare Corporation, corpauthor. Summary of Safety and Effective Data-Novacor Left Ventricular Assist System 1998. FDA Website. 1998.</Citation></Reference><Reference><Citation>Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Left ventricular assist device therapy improves utilization of donor hearts. J. Am. Coll. Cardiol. 2002;39:1247&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">11955839</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffatt s, Chan M, Demers P, Oyer P, Reitz B, Robins R. Bridge to Heart Transplantation: A Comparison of Ventricular Assist Device and Inotropic Support. Abstract155. Journal of Cardiac Failure. 2003;9(5 Supplement)</Citation></Reference><Reference><Citation>Morgan JA, Park Y, Kherani AR, Vigilance DW, Cheema FH, Oz MC, et al. Does bridging to transplantation with a left ventricular assist device adversely affect posttransplantation survival? A comparative analysis of mechanical versus inotropic support. J. Thorac. Cardiovasc. Surg. 2003;126:1188&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">14566269</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaski BE, Kim JC, Naftel DC, Jarcho J, Costanzo MR, Eisen HJ, et al. Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. Journal of Heart &amp; Lung Transplantation. 2001;20:449&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">11295583</ArticleId></ArticleIdList></Reference><Reference><Citation>Bank AJ, Mir SH, Nguyen DQ, Bolman RM, III, Shumway SJ, Miller LW, et al. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Annals of Thoracic Surgery. 2000;69:1369&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">10881807</ArticleId></ArticleIdList></Reference><Reference><Citation>Massad MG, McCarthy PM, Smedira NG, Cook DJ, Ratliff NB, Goormastic M, et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? J. Thorac. Cardiovasc. Surg. 1996;112:1275&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">8911324</ArticleId></ArticleIdList></Reference><Reference><Citation>Navia JL, McCarthy PM, Hoercher KJ, Feng J, Jeevantham R, Smedira NG, et al. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann. Thorac. Surg. 2002;74:2051&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12643395</ArticleId></ArticleIdList></Reference><Reference><Citation>Torre-Amione G FOSRMLAKMSMKMSMS. Cellular Regression of Fibrosis and Hypertrophy Following Chronic LVAD Support Does Not Translate into sustained Improvement in Contratile Function: Results from the LVAD Working Group (Abstract) Journal of Cardiac Failure. 2003;1555;9(5) Supplement.</Citation></Reference><Reference><Citation>Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J. Heart Lung Transplant. 2002;21:516&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983540</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Fey O, Sarnowski P, Arusoglu L, Boethig D, Milting H, et al. Midterm follow-up of patients discharged from hospital under left ventricular assistance. Journal of Heart &amp; Lung Transplantation. 2001;20:53&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11166612</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabia FA, Smith RG, Jaffe C, Wild JC, Rose DS, Nelson RJ, et al. Cost analysis of the Novacor Left Ventricular Assist System as an outpatient bridge to heart transplantation. ASAIO J. 1996;42:M546&#x2013;M549.</Citation><ArticleIdList><ArticleId IdType="pubmed">8944939</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelijns AC, Richards AF, Williams DL, Oz MC, Oliveira J, Moskowitz AJ. Evolving costs of long-term left ventricular assist device implantation. Ann. Thorac. Surg. 1997;64:1312&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9386696</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman WL, Davies JE, Rayburn BK, McGiffin DC, Foley BA, Benza RL, et al. Treatment of end-stage heart disease with outpatient ventricular assist devices. Ann. Thorac. Surg. 2002;73:1489&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">12022538</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DL, Catanese KA, Helman DN, Williams MR, Weinberg A, Goldstein DJ, et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. Journal of Thoracic &amp; Cardiovascular Surgery. 2000;119:251&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10649200</ArticleId></ArticleIdList></Reference><Reference><Citation>Dew MA, Kormos RL, Winowich S, Harris RC, Stanford EA, Carozza L, et al. Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices. J. Heart Lung Transplant. 2001;20:1199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pubmed">11704480</ArticleId></ArticleIdList></Reference><Reference><Citation>Dew MA, Kormos RL, Winowich S, Stanford EA, Carozza L, Borovetz HS, et al. Human factors issues in ventricular assist device recipients and their family caregivers. ASAIO J. 2000;46:367&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">10826754</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor M. Implantable ventricular assist devices: is it time to introduce them in Canada? Canadian Journal of Cardiology. 2000;16:629&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10833542</ArticleId></ArticleIdList></Reference><Reference><Citation>Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin. Infect. Dis. 2002;34:1295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">11981723</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjan TD, Asfour B, Hammel D, Schmidt C, Scheld HH, Schmid C. Wound complications after left ventricular assist device implantation. Ann. Thorac. Surg. 2000;70:538&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10969676</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Annals of Thoracic Surgery. 2001;72:725&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11565648</ArticleId></ArticleIdList></Reference><Reference><Citation>Oz MC, Argenziano M, Catanese KA, Gardocki MT, Goldstein DJ, Ashton RC, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation. 1997;95:1844&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9107172</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentz B, Hupcey JE, Polomano RC, Boehmer JP. A retrospective study of left ventricular assist device-related infections. J. Cardiovasc. Manag. 2004;15:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">14976692</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitali E, Lanfranconi M, Bruschi G, Russo C, Colombo T, Ribera E. Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience. J. Card Surg. 2003;18:107&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">12757336</ArticleId></ArticleIdList></Reference><Reference><Citation>Granfeldt H, Koul B, Wiklund L, Peterzen B, Lonn U, Babic A, et al. Risk factor analysis of Swedish Left Ventricular Assist Device (LVAD) patients. Ann. Thorac. Surg. 2003;76:1993&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14667628</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi P, Dalla GD, Pagani F, Marone P, Vigano M, Minoli L. Infectious complications in patients with the Novacor left ventricular assist system. Transplant. Proc. 2001;33:1969&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">11267591</ArticleId></ArticleIdList></Reference><Reference><Citation>Helman DN, Addonizio LJ, Morales DL, Catanese KA, Flannery MA, Quagebeur JM, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J. Heart Lung Transplant. 2000;19:121&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10703686</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, et al. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology. J. Thorac. Cardiovasc. Surg. 1998;115:904&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576228</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Korfer R, Arusoglu L, Kizner L, Morshuis M, Milting H, et al. Device and patient management in a bridge-to-transplant setting. Ann. Thorac. Surg. 2001;71:S98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">11265874</ArticleId></ArticleIdList></Reference><Reference><Citation>Loisance DY, Jansen PG, Wheeldon DR, Portner PM. Long-term mechanical circulatory support with the wearable Novacor left ventricular assist system. Eur J. Cardiothorac. Surg. 2000;18:220&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10925233</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurozler F, Argenziano M, Oz MC, Naka Y. Fungal left ventricular assist device endocarditis. Annals of Thoracic Surgery. 2001;71:614&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11235716</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdat PA, Gygax E, Nydegger U, Carrel T. Short- and long-term mechanical cardiac assistance. Int. J. Artif. Organs. 2001;24:263&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11420875</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Arusoglu L, Kizner L, Tenderich G, Minami K, InoueK, et al. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J. Thorac. Cardiovasc. Surg. 2000;119:581&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10694620</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Arusoglu L, Kizner L, Fey O, Minami K, Korfer R. Complications of circulatory assist. Perfusion. 2000;15:327&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10926415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochiai Y, McCarthy PM, Smedira NG, Banbury MK, Navia JL, Feng J, et al. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106 Suppl-202.</Citation><ArticleIdList><ArticleId IdType="pubmed">12354733</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Arusoglu L, Kizner L, Tenderich G, Boethig D, Minami K, et al. Predictors of survival in patients bridged to transplantation with the thoratec VAD device: a single-center retrospective study on more than 100 patients. J. Heart Lung Transplant. 2000;19:964&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11044691</ArticleId></ArticleIdList></Reference><Reference><Citation>Heverly DN, Prayson RA. Neuropathology associated with ventricular assist devices: an autopsy series of 33 patients. Annals of Diagnostic Pathology. 2001;5:67&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11294990</ArticleId></ArticleIdList></Reference><Reference><Citation>Couper GS, Dekkers RJ, Adams DH. The logistics and cost-effectiveness of circulatory support: advantages of the ABIOMED BVS 5000. Ann. Thorac. Surg. 1999;68:646&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10475464</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride LR, Naunheim KS, Fiore AC, Moroney DA, Swartz MT. Clinical experience with 111 thoratec ventricular assist devices. Ann. Thorac. Surg. 1999;67:1233&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10355389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry PJ, Masters RG, Mussivand TV, Smith S, Davies RA, Finlay S, et al. Circulatory support for cardiogenic shock due to acute myocardial infarction: a Canadian experience. Can. J. Cardiol. 1999;15:1090&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10523475</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekontso-Dessap A, Kirsch M, Vermes E, Brun-Buisson C, Loisance D, Houel R. Nosocomial infections occurring during receipt of circulatory support with the paracorporeal ventricular assist system. Clin. Infect. Dis. 2002;35:1308&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12439792</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetzer R, Jurmann MJ, Potapov EV, Hennig E, Stiller B, Muller JH, et al. Herz. 2002;27:407&#x2013;17. [Heart assist systems--current status]</Citation><ArticleIdList><ArticleId IdType="pubmed">12365281</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoratec Laboratories Corporation, corpauthor. Premarket Approval (PMA) Application supplement P870072/S5. Summary of Safety and Effectiveness, 1998. 1998. (FDA Website)</Citation></Reference><Reference><Citation>Samuels LE, Holmes EC, Thomas MP, Entwistle JC, III, Morris RJ, Narula J, et al. Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann. Thorac. Surg. 2001;71:S67&#x2013;S72.</Citation><ArticleIdList><ArticleId IdType="pubmed">11265869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigus IE, Amsel BJ, Conraads V, De Hert S, Moulijn AC. Emergency ventricular assist device: better survival rates in non-post cardiotomy-related cardiogenic shock. Acta Chir Belg. 2001;101:226&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">11758106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumpati GS, McCarthy PM, Hoercher KJ. Left ventricular assist device as a bridge to recovery: present status. Journal of Cardiac Surgery. 2001;16:294&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">11833702</ArticleId></ArticleIdList></Reference><Reference><Citation>El Banayosy A, Korfer R, Arusoglu L, Minami K, Kizner L, Fey O, et al. Bridging to cardiac transplantation with the Thoratec Ventricular Assist Device. Thorac. Cardiovasc. Surg. 1999;47(Suppl 2):307&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10218606</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. New England Journal of Medicine. 2001;345:1435&#x2013;43. Long-term mechanical left ventricular assistance for end-stage heart failure.[see comment][summary for patients in J Card Fail. 2002 Apr;8(2):59-60; PMID: 12016626]</Citation><ArticleIdList><ArticleId IdType="pubmed">11794191</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendry PJ, Masters RG, Davies RA, Mesana T, Struthers C, Mussivand T, et al. Mechanical circulatory support for adolescent patients: the Ottawa Heart Institute experience. Can. J. Cardiol. 2003;19:409&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">12704488</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhartz O, Keith FM, El Banayosy A, McBride LR, Robbins RC, Copeland JG, et al. Multicenter experience with the thoratec ventricular assist device in children and adolescents. Journal of Heart &amp; Lung Transplantation. 2001;20:439&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">11295582</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi D, Marelli D, Plunkett M, Alejos J, Bresson J, Tran J, et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J. Heart Lung Transplant. 2002;21:760&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">12100902</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman AP, Cassidy J, de Leval M, Haynes S, Brown K, Whitmore P, et al. The waiting game: bridging to paediatric heart transplantation. Lancet. 2003;362:1967&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">14683656</ArticleId></ArticleIdList></Reference><Reference><Citation>Price JF FCMERBea, corpauthor. Ventricular Device as Bridge to Transplant or Recovery to Childre: A Single Center Experience. Journal of Cardaic Failure. 2003;9 Supplement 155.</Citation></Reference><Reference><Citation>Deng MC, Loebe M, El Banayosy A, Gronda E, Jansen PG, Vigano M, et al. Mechanical Circulatory Support for Advanced Heart Failure : Effect of Patient Selection on Outcome. Circulation. 2001;103:231&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11208682</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng MC, Weyand M, Hammel D, Schmid C, Kerber S, Schmidt C, et al. Selection and management of ventricular assist device patients: the Muenster experience. Journal of Heart &amp; Lung Transplantation. 2000;19 Suppl-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11016493</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecere R, Ergina P, deVarennes B, Lachapelle K, Giannetti N. Single Center Canadian Experience with Pulsatile Mechanical Bridging to Heart Transplantation (Abstract) 2001.  http://www.ccs.ca/society/congress2001/abstracts/abs/a273.htm .</Citation></Reference><Reference><Citation>Moskowitz AJ, Rose EA, Gelijns AC. The cost of long-term LVAD implantation. Annals of Thoracic Surgery. 2001;71 Suppl-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11265862</ArticleId></ArticleIdList></Reference><Reference><Citation>Oz MC, Gelijns AC, Miller L, Wang C, Nickens P, Arons R, et al. Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann. Surg. 2003;238:577&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360116</ArticleId><ArticleId IdType="pubmed">14530729</ArticleId></ArticleIdList></Reference><Reference><Citation>Dew MA, Kormos RL, Winowich S, Stanford EA, Carozza L, Borovetz HS, et al. Human factors issues in ventricular assist device recipients and their family caregivers. ASAIO Journal. 2000;46:367&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">10826754</ArticleId></ArticleIdList></Reference><Reference><Citation>Di B, I, Pagani F, Banfi C, Ardemagni E, Capo A, Klersy C, et al. Results with the Novacor assist system and evaluation of long-term assistance. Eur. J. Cardiothorac. Surg. 2000;18:112&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun BC, Catanese KA, Spanier TB, Flannery MR, Gardocki MT, Marcus LS, et al. 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience. Ann. Thorac. Surg. 1999;68:688&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">10475472</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>